primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Nasal congestion,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Headache,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Drug resistance,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Sinusitis,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Anxiety,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Movement disorder,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Illness,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Blood cholesterol abnormal,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Sciatic nerve injury,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Facial pain,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Cortisol decreased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,COVID-19,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Subcutaneous abscess,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Blood pressure increased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Back pain,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Muscle spasms,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Oropharyngeal pain,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Laryngitis bacterial,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Stress,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Blood growth hormone increased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Body temperature decreased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Ligament sprain,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Drug ineffective,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Cough,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Heart rate increased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Groin abscess,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Abdominal pain,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Blood pressure systolic increased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Back injury,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Insulin-like growth factor increased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Infectious mononucleosis,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Heart rate decreased,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1436788039,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Intervertebral disc protrusion,,2023,Q1,39,F,20151225.0,20230221.0,20180109,20230227,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Abdominal distension,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Renal pain,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Sinusitis,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Illness,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Nausea,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Urinary tract infection,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Hepatic pain,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Headache,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Blood glucose abnormal,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Coma,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Discoloured vomit,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Decreased appetite,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Nephrolithiasis,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Abdominal pain upper,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Head injury,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Breast mass,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Injection site pain,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Hypercholesterolaemia,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Fall,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Hepatic enzyme increased,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,White blood cell count increased,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Gait disturbance,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Palpitations,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1524593421,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,21,F,20180105.0,20230209.0,20180806,20230217,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20230217,,MD,CA,CA,2023,Q1,Adult
1545908810,15459088,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 ml, QW",,,U,,,,,3.0,ML,,/WK,2023,Q1,Diabetic ketoacidosis,,2023,Q1,10,F,20180704.0,20230101.0,20181003,20230104,EXP,,PHHY2018GB113319,NOVARTIS,,57.0,YR,,F,Y,,,20230104,,MD,GB,GB,2023,Q1,Adult
1545908810,15459088,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 ml, QW",,,U,,,,,3.0,ML,,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,10,F,20180704.0,20230101.0,20181003,20230104,EXP,,PHHY2018GB113319,NOVARTIS,,57.0,YR,,F,Y,,,20230104,,MD,GB,GB,2023,Q1,Adult
1545908810,15459088,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 ml, QW",,,U,,,,,3.0,ML,,/WK,2023,Q1,Pneumonia,,2023,Q1,10,F,20180704.0,20230101.0,20181003,20230104,EXP,,PHHY2018GB113319,NOVARTIS,,57.0,YR,,F,Y,,,20230104,,MD,GB,GB,2023,Q1,Adult
1545908810,15459088,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 ml, QW",,,U,,,,,3.0,ML,,/WK,2023,Q1,Sepsis,,2023,Q1,10,F,20180704.0,20230101.0,20181003,20230104,EXP,,PHHY2018GB113319,NOVARTIS,,57.0,YR,,F,Y,,,20230104,,MD,GB,GB,2023,Q1,Adult
1545908810,15459088,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 ml, QW",,,U,,,,,3.0,ML,,/WK,2023,Q1,Pneumonia,,2023,Q1,10,F,20180704.0,20230101.0,20181003,20230104,EXP,,PHHY2018GB113319,NOVARTIS,,57.0,YR,,F,Y,,,20230104,,MD,GB,GB,2023,Q1,Adult
166163478,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2023,Q1,Sepsis,,2023,Q1,8,F,20180704.0,20230201.0,20190723,20230207,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20230207,,MD,GB,GB,2023,Q1,Adult
166163478,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2023,Q1,Pneumonia,,2023,Q1,8,F,20180704.0,20230201.0,20190723,20230207,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20230207,,MD,GB,GB,2023,Q1,Adult
166163478,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,8,F,20180704.0,20230201.0,20190723,20230207,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20230207,,MD,GB,GB,2023,Q1,Adult
166163478,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2023,Q1,Diabetic ketoacidosis,,2023,Q1,8,F,20180704.0,20230201.0,20190723,20230207,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20230207,,MD,GB,GB,2023,Q1,Adult
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Sleep disorder,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Depression,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Off label use,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Urinary tract infection,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Chronic kidney disease,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Blood magnesium decreased,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Malaise,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Hypertension,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Product use issue,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Constipation,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Hypotension,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
181831482,18183148,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,2,F,,20230217.0,20200821,20230223,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-042276",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,131.0,KG,20230223,,HP,CA,CA,2023,Q1,Elderly
183998542,18399854,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,Unknown,,,,,,,2023,Q1,Tardive dyskinesia,,2023,Q1,2,F,20201206.0,20221012.0,20201019,20230323,PER,,US-ALLERGAN-2029237US,ALLERGAN,,39.0,YR,,F,Y,112.03,KG,20230323,,MD,US,US,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Condition aggravated,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Pain,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Sinusitis,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Feeling abnormal,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Pain in extremity,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Rash,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Headache,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Somnolence,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,COVID-19,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Fracture,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Nausea,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Oropharyngeal pain,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Off label use,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Vomiting,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Cystitis haemorrhagic,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Cough,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,0.25,MG,,,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Condition aggravated,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Pain,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Sinusitis,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Feeling abnormal,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Pain in extremity,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Rash,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Headache,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Somnolence,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,COVID-19,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Fracture,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Nausea,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Oropharyngeal pain,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Off label use,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Vomiting,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Cystitis haemorrhagic,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Cough,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
187022393,18702239,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,,,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230206.0,20210105,20230214,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-38411,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,82.0,KG,20230214,,HP,CA,CA,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Liver function test abnormal,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Urinary retention,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Wrong technique in product usage process,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Temperature intolerance,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Intervertebral disc degeneration,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Lumbar radiculopathy,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Fall,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Musculoskeletal stiffness,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Neurogenic bladder,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Neuralgia,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,White blood cell count decreased,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Urinary tract infection,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Loss of bladder sensation,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Fatigue,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Anal incontinence,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
1910650310,19106503,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q1,Progressive multiple sclerosis,,2023,Q1,10,F,20210405.0,20230104.0,20210407,20230109,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230109,,CN,US,US,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,269,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,270,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,271,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,272,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,273,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,274,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Chest discomfort,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Flank pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Asthma,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Influenza,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Malaise,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Fall,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Productive cough,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Angina pectoris,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Prolonged expiration,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Pyrexia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Heart sounds,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Wheezing,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Appetite disorder,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Nasal congestion,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Chest pain,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Depressed mood,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Insomnia,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Rales,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Depressive symptom,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Stress,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Injury,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Respiration abnormal,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
191958367,19195836,275,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,7,F,,20230208.0,20210429,20230216,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20230216,,HP,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Productive cough,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Hypertension,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Lower respiratory tract infection,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Urinary incontinence,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Sleep apnoea syndrome,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Asthma,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Oropharyngeal pain,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Hyperlipidaemia,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Chronic kidney disease,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Pharyngitis,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Nasal congestion,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
194844248,19484424,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days, solution subcutaneous",,,U,,,,,0.25,MG,Injection,QD,2023,Q1,Nasopharyngitis,,2023,Q1,8,F,,20230104.0,20210701,20230112,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20230112,,MD,CA,CA,2023,Q1,Adult
195925146,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q1,Bile duct stone,,2023,Q1,6,F,20210220.0,20230215.0,20210722,20230302,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20230227,,MD,GB,GB,2023,Q1,Elderly
195925146,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q1,Cholecystitis acute,,2023,Q1,6,F,20210220.0,20230215.0,20210722,20230302,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20230227,,MD,GB,GB,2023,Q1,Elderly
195925146,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q1,Gallbladder rupture,,2023,Q1,6,F,20210220.0,20230215.0,20210722,20230302,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20230227,,MD,GB,GB,2023,Q1,Elderly
195925146,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q1,Hepatobiliary procedural complication,,2023,Q1,6,F,20210220.0,20230215.0,20210722,20230302,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20230227,,MD,GB,GB,2023,Q1,Elderly
195925146,19592514,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",13.0,MG,D,,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q1,Gastrointestinal wall thickening,,2023,Q1,6,F,20210220.0,20230215.0,20210722,20230302,EXP,,GB-NOVOPROD-790144,NOVO NORDISK,,70.0,YR,,M,Y,95.0,KG,20230227,,MD,GB,GB,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Tenderness,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Injection site infection,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Infusion site pain,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Treatment noncompliance,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Malaise,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Tinnitus,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Dysphonia,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Malaise,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,No adverse event,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Swelling,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood glucose increased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood glucose increased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Infusion site extravasation,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Erythema,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Abdominal discomfort,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood immunoglobulin M decreased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Injection site pruritus,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood pressure increased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood pressure systolic increased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Injection site erythema,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Infusion site scar,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Infusion site extravasation,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Infusion site swelling,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood immunoglobulin A decreased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
1967798211,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q1,Blood glucose decreased,,2023,Q1,11,F,20210804.0,20230208.0,20210810,20230220,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230220,,MD,US,US,2023,Q1,Elderly
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Flank pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Appetite disorder,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Heart sounds,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Stress,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Prolonged expiration,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Insomnia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Influenza,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rales,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Malaise,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Angina pectoris,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Fall,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Injury,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Respiration abnormal,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressed mood,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Productive cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressive symptom,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Wheezing,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,69,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Asthma,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Flank pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Appetite disorder,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Heart sounds,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Stress,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Prolonged expiration,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Insomnia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Influenza,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rales,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Malaise,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Angina pectoris,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Fall,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Injury,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Respiration abnormal,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressed mood,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Productive cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressive symptom,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Wheezing,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,70,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Asthma,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Flank pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Appetite disorder,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Heart sounds,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Stress,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Prolonged expiration,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Insomnia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Influenza,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rales,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Malaise,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Angina pectoris,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Fall,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Injury,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Respiration abnormal,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressed mood,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Productive cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Depressive symptom,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Wheezing,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,71,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q1,Asthma,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Flank pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Appetite disorder,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Heart sounds,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Stress,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Chest pain,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Prolonged expiration,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Insomnia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Influenza,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Rales,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Malaise,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Angina pectoris,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Fall,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Injury,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Respiration abnormal,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Depressed mood,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Productive cough,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Depressive symptom,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Wheezing,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
198816073,19881607,72,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q1,Asthma,,2023,Q1,3,F,,20230126.0,20210925,20230202,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Nasopharyngitis,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Appetite disorder,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Upper respiratory tract infection,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Depressed mood,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Angina pectoris,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Stress,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Rales,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Chest pain,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Dyspnoea exertional,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Cough,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Fall,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Malaise,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Productive cough,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Respiration abnormal,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Nasal congestion,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Rhinorrhoea,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Wheezing,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Asthma,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Flank pain,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Prolonged expiration,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Heart sounds,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Influenza,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Pyrexia,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Depressive symptom,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Insomnia,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
199676583,19967658,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q1,Injury,,2023,Q1,3,F,,20230126.0,20211019,20230203,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230203,,HP,CA,CA,2023,Q1,Adult
200125467,20012546,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Bile duct stone,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Obstructive pancreatitis,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",23.28,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q1,Bile duct stone,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",23.28,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q1,Obstructive pancreatitis,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Bile duct stone,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Obstructive pancreatitis,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Bile duct stone,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200125467,20012546,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,D,,,,215256.0,,,Solution for injection,,2023,Q1,Obstructive pancreatitis,,2023,Q1,7,F,20210818.0,20230105.0,20211029,20230112,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20230112,,MD,DE,DE,2023,Q1,Elderly
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Lower respiratory tract infection,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Asthma,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Urinary incontinence,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Pharyngitis,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Productive cough,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Hyperlipidaemia,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Sleep apnoea syndrome,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Hypertension,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Oropharyngeal pain,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Chronic kidney disease,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Nasopharyngitis,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Nasal congestion,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
200869054,20086905,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,4,F,,20230123.0,20211118,20230127,EXP,,CA-ORGANON-O2111CAN002134,ORGANON,,51.0,YR,,F,Y,,,20230127,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Asthma,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Wheezing,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Depression,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202392555,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,5,F,,20230123.0,20211228,20230130,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230130,,MD,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Asthma,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Diabetes mellitus,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Depression,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Dyspnoea,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Wheezing,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202440624,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q1,Hypoacusis,,2023,Q1,4,F,,20230125.0,20211228,20230201,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230201,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
202669074,20266907,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,4,F,,20230119.0,20211231,20230125,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230125,,CN,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
209251032,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230310.0,20220607,20230320,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230320,,HP,CA,CA,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Blood pressure systolic abnormal,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Discomfort,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Product preparation issue,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Anxiety,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210238622,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,2,F,,20221224.0,20220629,20230103,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20230103,,CN,CA,,2023,Q1,Adult
210392332,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2023,Q1,Constipation,,2023,Q1,2,F,20220320.0,20230302.0,20220704,20230314,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20230314,,PH,FR,FR,2023,Q1,Elderly
210392332,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2023,Q1,Confusional state,,2023,Q1,2,F,20220320.0,20230302.0,20220704,20230314,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20230314,,PH,FR,FR,2023,Q1,Elderly
210392332,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2023,Q1,Acute kidney injury,,2023,Q1,2,F,20220320.0,20230302.0,20220704,20230314,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20230314,,PH,FR,FR,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Drug interaction,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Aortic arteriosclerosis,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Weight increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution for subcutaneous,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Drug interaction,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Aortic arteriosclerosis,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Weight increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211882333,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,3,F,,20230216.0,20220809,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,85.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Blood pressure systolic increased,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Nausea,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Product preparation issue,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Blood pressure systolic abnormal,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Blood pressure fluctuation,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Asthenia,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Anxiety,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Heart rate increased,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Off label use,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211964902,21196490,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2023,Q1,Discomfort,,2023,Q1,2,F,,20230109.0,20220810,20230111,EXP,,CA-PFIZER INC-2021530748,PFIZER,,39.0,YR,,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood pressure increased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood pressure systolic increased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Aortic arteriosclerosis,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Weight increased,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
211972482,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood pressure fluctuation,,2023,Q1,2,F,,20230302.0,20220810,20230309,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230309,,HP,CA,CA,2023,Q1,Elderly
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212243713,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,3,F,,20230222.0,20220817,20230302,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230302,,HP,CA,CA,2023,Q1,Adult
212410842,21241084,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 Milligram Daily; Therapy duration :260.0 Days,,,U,,,,,3.0,MG,,QD,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 Milligram Daily; Therapy duration :260.0 Days,,,U,,,,,3.0,MG,,QD,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,,,,7.0,MG,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,,,,7.0,MG,,,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,,,,14.0,MG,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,,,,14.0,MG,,,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Therapy duration : 261.0 Days,,,U,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Therapy duration : 261.0 Days,,,U,,,,,,,,,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Therapy duration :260.0 Days,,,,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212410842,21241084,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Therapy duration :260.0 Days,,,,,,,,,,,,2023,Q1,Fall,,2023,Q1,2,F,,20230223.0,20220823,20230304,EXP,,CA-TEVA-2022-CA-2066127,TEVA,,68.0,YR,E,M,Y,87.0,KG,20230304,,HP,CA,CA,2023,Q1,Elderly
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Musculoskeletal pain,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Musculoskeletal stiffness,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Arthralgia,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Exposure to SARS-CoV-2,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Back pain,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Psoriasis,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Tenderness,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Needle issue,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Cholelithiasis,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Psoriatic arthropathy,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Joint swelling,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Injection site haemorrhage,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Insomnia,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Atrial fibrillation,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212483732,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q1,Accidental exposure to product,,2023,Q1,2,F,20211111.0,20230321.0,20220824,20230327,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230327,,MD,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Intentional product use issue,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Fatigue,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Product dose omission issue,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Surgery,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Blood pressure increased,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
212712732,21271273,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Off label use,,2023,Q1,2,F,,20221228.0,20220830,20230103,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Poor quality sleep,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Transient ischaemic attack,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Blood cholesterol increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Stress,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Poor quality sleep,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Transient ischaemic attack,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Blood cholesterol increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Stress,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Poor quality sleep,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Transient ischaemic attack,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Blood cholesterol increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Stress,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Poor quality sleep,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Transient ischaemic attack,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Blood cholesterol increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Stress,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Hypertension,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213030493,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230202.0,20220907,20230207,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230207,,HP,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
213286662,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230315.0,20220913,20230323,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20230323,,MD,CA,,2023,Q1,Adult
214073835,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Drug interaction,,2023,Q1,5,F,,20230119.0,20221004,20230123,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20230123,,MD,US,US,2023,Q1,Elderly
214073835,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Blood creatinine increased,,2023,Q1,5,F,,20230119.0,20221004,20230123,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20230123,,MD,US,US,2023,Q1,Elderly
214073835,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,5,F,,20230119.0,20221004,20230123,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20230123,,MD,US,US,2023,Q1,Elderly
214073835,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Immunosuppressant drug level increased,,2023,Q1,5,F,,20230119.0,20221004,20230123,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20230123,,MD,US,US,2023,Q1,Elderly
214073835,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Labelled drug-drug interaction medication error,,2023,Q1,5,F,,20230119.0,20221004,20230123,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20230123,,MD,US,US,2023,Q1,Elderly
215259132,21525913,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Cholecystitis chronic,,2023,Q1,2,F,20221014.0,20230109.0,20221031,20230118,EXP,,RU-NOVOPROD-972282,NOVO NORDISK,,61.0,YR,,F,Y,93.0,KG,20230118,,MD,RU,RU,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Muscular weakness,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Muscular weakness,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Breast cancer,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Hypoaesthesia,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215339632,21533963,6,C,semaglutide (OZEMPIC ),,2,Subcutaneous,1 mg?Frequency Text: 1 mg under the skin once a week Fridays,,,,,,,,,,,,2023,Q1,Hypoaesthesia,,2023,Q1,2,F,20220927.0,20230214.0,20221101,20230220,EXP,,US-ABBVIE-4182446,ABBVIE,,58.0,YR,,F,Y,73.028,KG,20230220,,CN,US,US,2023,Q1,Adult
215346023,21534602,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9.0,MG,Y,Y,,,209637.0,,,Solution for injection,,2023,Q1,Gastrointestinal disorder,,2023,Q1,3,F,20220923.0,20230103.0,20221101,20230106,EXP,,PL-NOVOPROD-972666,NOVO NORDISK,,62.0,YR,,F,Y,81.0,KG,20230106,,MD,PL,PL,2023,Q1,Adult
215346023,21534602,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9.0,MG,Y,Y,,,209637.0,,,Solution for injection,,2023,Q1,Gastrointestinal disorder,Gastrointestinal disorder,2023,Q1,3,F,20220923.0,20230103.0,20221101,20230106,EXP,,PL-NOVOPROD-972666,NOVO NORDISK,,62.0,YR,,F,Y,81.0,KG,20230106,,MD,PL,PL,2023,Q1,Adult
215346023,21534602,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",9.0,MG,Y,Y,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q1,Gastrointestinal disorder,,2023,Q1,3,F,20220923.0,20230103.0,20221101,20230106,EXP,,PL-NOVOPROD-972666,NOVO NORDISK,,62.0,YR,,F,Y,81.0,KG,20230106,,MD,PL,PL,2023,Q1,Adult
215346023,21534602,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",9.0,MG,Y,Y,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q1,Gastrointestinal disorder,Gastrointestinal disorder,2023,Q1,3,F,20220923.0,20230103.0,20221101,20230106,EXP,,PL-NOVOPROD-972666,NOVO NORDISK,,62.0,YR,,F,Y,81.0,KG,20230106,,MD,PL,PL,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Cardiac dysfunction,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Myalgia,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Weight increased,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Fatigue,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Cough,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
215985675,21598567,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW(pen)",,,U,,,,,2.0,MG,Solution for injection,/WK,2023,Q1,Ejection fraction decreased,,2023,Q1,5,F,20221110.0,20230309.0,20221115,20230316,PER,,NVSC2022US255444,NOVARTIS,,59.0,YR,,F,Y,106.6,KG,20230316,,CN,US,US,2023,Q1,Adult
217590992,21759099,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Vascular device infection,,2023,Q1,2,F,,20221226.0,20221221,20230106,EXP,,CA-AUROBINDO-AUR-APL-2022-053139,AUROBINDO,,56.0,YR,,F,Y,,,20230106,,HP,CA,CA,2023,Q1,Adult
217590992,21759099,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Off label use,,2023,Q1,2,F,,20221226.0,20221221,20230106,EXP,,CA-AUROBINDO-AUR-APL-2022-053139,AUROBINDO,,56.0,YR,,F,Y,,,20230106,,HP,CA,CA,2023,Q1,Adult
217590992,21759099,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Nasopharyngitis,,2023,Q1,2,F,,20221226.0,20221221,20230106,EXP,,CA-AUROBINDO-AUR-APL-2022-053139,AUROBINDO,,56.0,YR,,F,Y,,,20230106,,HP,CA,CA,2023,Q1,Adult
217590992,21759099,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Malaise,,2023,Q1,2,F,,20221226.0,20221221,20230106,EXP,,CA-AUROBINDO-AUR-APL-2022-053139,AUROBINDO,,56.0,YR,,F,Y,,,20230106,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Skin ulcer,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Papilloma,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Hypoaesthesia,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Lichenification,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Mouth ulceration,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Peripheral swelling,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Haemoglobin decreased,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Inflammation,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Hyperkeratosis,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Haematocrit decreased,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Keloid scar,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Rheumatoid arthritis,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Mean cell haemoglobin decreased,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Tension,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Polyuria,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Oedema,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
217960032,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Ulcer,,2023,Q1,2,F,20220816.0,20230109.0,20221229,20230113,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20230113,,HP,CA,CA,2023,Q1,Adult
218103901,21810390,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Drug intolerance,,2023,Q1,1,I,,20221223.0,20230103,20230103,EXP,,CA-APOTEX-2022AP017632,APOTEX,,43.0,YR,,F,Y,,,20230103,,HP,CA,CA,2023,Q1,Adult
218103901,21810390,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Polyneuropathy,,2023,Q1,1,I,,20221223.0,20230103,20230103,EXP,,CA-APOTEX-2022AP017632,APOTEX,,43.0,YR,,F,Y,,,20230103,,HP,CA,CA,2023,Q1,Adult
218103901,21810390,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20221223.0,20230103,20230103,EXP,,CA-APOTEX-2022AP017632,APOTEX,,43.0,YR,,F,Y,,,20230103,,HP,CA,CA,2023,Q1,Adult
218138462,21813846,54,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, Every Week",,,U,,,,,3.0,ML,,/WK,2023,Q1,Diabetic ketoacidosis,,2023,Q1,2,F,20180704.0,20230101.0,20230104,20230113,EXP,,GB-AUROBINDO-AUR-APL-2022-056667,AUROBINDO,,57.0,YR,,F,Y,,,20230113,,MD,GB,GB,2023,Q1,Adult
218138462,21813846,54,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, Every Week",,,U,,,,,3.0,ML,,/WK,2023,Q1,Lower respiratory tract infection,,2023,Q1,2,F,20180704.0,20230101.0,20230104,20230113,EXP,,GB-AUROBINDO-AUR-APL-2022-056667,AUROBINDO,,57.0,YR,,F,Y,,,20230113,,MD,GB,GB,2023,Q1,Adult
218138462,21813846,54,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, Every Week",,,U,,,,,3.0,ML,,/WK,2023,Q1,Pneumonia,,2023,Q1,2,F,20180704.0,20230101.0,20230104,20230113,EXP,,GB-AUROBINDO-AUR-APL-2022-056667,AUROBINDO,,57.0,YR,,F,Y,,,20230113,,MD,GB,GB,2023,Q1,Adult
218138462,21813846,54,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, Every Week",,,U,,,,,3.0,ML,,/WK,2023,Q1,Sepsis,,2023,Q1,2,F,20180704.0,20230101.0,20230104,20230113,EXP,,GB-AUROBINDO-AUR-APL-2022-056667,AUROBINDO,,57.0,YR,,F,Y,,,20230113,,MD,GB,GB,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Chills,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Bronchitis,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Greater trochanteric pain syndrome,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Immunodeficiency,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Anxiety,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Panic attack,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Pneumonia,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Osteoarthritis,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Proteus infection,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Pulmonary mass,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Dry eye,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Pain in extremity,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Carpal tunnel syndrome,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Nail bed infection,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Paraesthesia,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218139031,21813903,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q1,Fungal infection,,2023,Q1,1,I,,20221223.0,20230104,20230104,EXP,,CA-APOTEX-2022AP017607,APOTEX,,57.0,YR,,F,Y,80.0,KG,20230104,,HP,CA,CA,2023,Q1,Adult
218164151,21816415,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw",,,Y,U,,,,1.0,MG,Injection,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20221227.0,20230104,20230104,EXP,,US-MYLANLABS-2022M1142783,MYLAN,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. [Review]. Diabetes-Metab-Syndr 2021;15(1):361-363.",71.0,YR,,M,Y,,,20230104,,HP,US,US,2023,Q1,Elderly
218164151,21816415,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw",,,Y,U,,,,1.0,MG,Injection,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20221227.0,20230104,20230104,EXP,,US-MYLANLABS-2022M1142783,MYLAN,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. [Review]. Diabetes-Metab-Syndr 2021;15(1):361-363.",71.0,YR,,M,Y,,,20230104,,HP,US,US,2023,Q1,Elderly
218171471,21817147,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230102.0,20230104,20230104,EXP,,NVSC2023US000881,NOVARTIS,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. DIABETES AND METABOLIC SYNDROME: CLINICAL RESEARCH AND REVIEWS. 2021;15(1):361-3",71.0,YR,,M,Y,,,20230104,,HP,US,US,2023,Q1,Elderly
218174681,21817468,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg weekly,,,Y,U,Unknown,,,,,,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20221227.0,20230104,20230104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-14927,LUPIN,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes + Metabolic Syndrome: Clinical Research + Reviews. 2021;15:361-363",71.0,YR,,M,Y,,,20230104,,HP,US,US,2023,Q1,Elderly
218174681,21817468,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg weekly,,,Y,U,Unknown,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20221227.0,20230104,20230104,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-14927,LUPIN,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes + Metabolic Syndrome: Clinical Research + Reviews. 2021;15:361-363",71.0,YR,,M,Y,,,20230104,,HP,US,US,2023,Q1,Elderly
218228471,21822847,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg once weekly,,,U,,,,,0.5,MG,,/WK,2023,Q1,Hypertriglyceridaemia,,2023,Q1,1,I,,20221226.0,20230105,20230105,EXP,,US-TEVA-2022-US-2841369,TEVA,,72.0,YR,E,F,Y,,,20230105,,PH,US,US,2023,Q1,Elderly
218355181,21835518,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,D,,,,,1.0,MG,,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20221227.0,20230109,20230109,EXP,,US-APOTEX-2022AP017672,APOTEX,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes + Metabolic Syndrome: Clinical Research + Reviews. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230109,,HP,US,US,2023,Q1,Elderly
218364681,21836468,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qd",,,,,Unknown,,,,,,QD,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20221206.0,20230109,20230109,EXP,GB-MHRA-ADR 27505803,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-14072,ALKEM,,65.0,YR,,F,Y,55.0,KG,20230109,,MD,GB,GB,2023,Q1,Elderly
218390881,21839088,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ?,,,Y,,KP50857,20221031.0,,0.25,MG,Injection,QW,2023,Q1,Abdominal pain,,2023,Q1,1,I,20200713.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2122,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,HP,US,,2023,Q1,Elderly
218390881,21839088,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ?,,,Y,,KP50857,20221031.0,,0.25,MG,Injection,QW,2023,Q1,Nausea,,2023,Q1,1,I,20200713.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2122,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,HP,US,,2023,Q1,Elderly
218390881,21839088,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ?,,,Y,,KP50857,20221031.0,,0.25,MG,Injection,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20200713.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2122,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Metabolic acidosis,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Hypokalaemia,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Sepsis,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Pancreatitis,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Acute kidney injury,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390891,21839089,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,D,,,,1.0,MG,,QW,2023,Q1,Therapy cessation,,2023,Q1,1,I,20221106.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2086,,FDA-CTU,,75.0,YR,,M,N,81.19,KG,20221230,N,HP,US,,2023,Q1,Elderly
218390921,21839092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D, ,,,0.5,MG,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20210820.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2113,,FDA-CTU,,52.0,YR,,M,N,146.0,KG,20211222,N,PH,US,,2023,Q1,Adult
218390921,21839092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D, ,,,0.5,MG,,QW,2023,Q1,Blood urea increased,,2023,Q1,1,I,20210820.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2113,,FDA-CTU,,52.0,YR,,M,N,146.0,KG,20211222,N,PH,US,,2023,Q1,Adult
218390921,21839092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D, ,,,0.5,MG,,QW,2023,Q1,Diarrhoea,,2023,Q1,1,I,20210820.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2113,,FDA-CTU,,52.0,YR,,M,N,146.0,KG,20211222,N,PH,US,,2023,Q1,Adult
218390921,21839092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D, ,,,0.5,MG,,QW,2023,Q1,Acute kidney injury,,2023,Q1,1,I,20210820.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2113,,FDA-CTU,,52.0,YR,,M,N,146.0,KG,20211222,N,PH,US,,2023,Q1,Adult
218390921,21839092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D, ,,,0.5,MG,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20210820.0,,20230108,20230108,DIR,FDA-CDER-CTU-2023-2113,,FDA-CTU,,52.0,YR,,M,N,146.0,KG,20211222,N,PH,US,,2023,Q1,Adult
218392591,21839259,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20200211.0,,20230107,20230107,DIR,FDA-CDER-CTU-2023-2053,,FDA-CTU,,71.0,YR,,M,N,,,20200818,N,HP,US,,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Decreased appetite,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Nausea,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Vomiting,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Hyponatraemia,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218448211,21844821,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Not Specified,,,U,,,,,,,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230109.0,20230110,20230110,EXP,,CA-BAUSCH-BL-2023-000426,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230110,,CN,CA,CA,2023,Q1,Elderly
218454051,21845405,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Weekly",,,,,,,,1.0,MG,,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20221227.0,20230111,20230111,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-372236,RANBAXY,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes Metab Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230111,,HP,US,US,2023,Q1,Elderly
218457781,21845778,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Stevens-Johnson syndrome,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-TEVA-2023-CA-2843999,TEVA,,51.0,YR,A,M,Y,103.0,KG,20230111,,HP,CA,CA,2023,Q1,Adult
218457781,21845778,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pulmonary alveolar haemorrhage,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-TEVA-2023-CA-2843999,TEVA,,51.0,YR,A,M,Y,103.0,KG,20230111,,HP,CA,CA,2023,Q1,Adult
218468551,21846855,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D,KP50857,20221031.0,,0.25,MG,,QW,2023,Q1,Abdominal pain,,2023,Q1,1,I,20200713.0,,20230110,20230110,DIR,FDA-CDER-CTU-2023-2452,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,PH,US,,2023,Q1,Elderly
218468551,21846855,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D,KP50857,20221031.0,,0.25,MG,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20200713.0,,20230110,20230110,DIR,FDA-CDER-CTU-2023-2452,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,PH,US,,2023,Q1,Elderly
218468551,21846855,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D,KP50857,20221031.0,,0.25,MG,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20200713.0,,20230110,20230110,DIR,FDA-CDER-CTU-2023-2452,,FDA-CTU,,71.0,YR,,M,N,,,20200714,N,PH,US,,2023,Q1,Elderly
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Erythema nodosum,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Therapeutic response shortened,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Infusion site pain,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Heart rate decreased,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Vital functions abnormal,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Incorrect route of product administration,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Poor venous access,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218495851,21849585,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,1,I,,20230103.0,20230111,20230111,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230111,,HP,CA,CA,2023,Q1,Youth
218504081,21850408,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : weekley;?,,,Y,D,,,,,,,999,2023,Q1,Nausea,,2023,Q1,1,I,20230109.0,,20230111,20230111,DIR,644201,,FDA-CTU,,63.0,YR,,F,N,72.0,KG,20230111,N,CN,US,,2023,Q1,Adult
218504081,21850408,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : weekley;?,,,Y,D,,,,,,,999,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,20230109.0,,20230111,20230111,DIR,644201,,FDA-CTU,,63.0,YR,,F,N,72.0,KG,20230111,N,CN,US,,2023,Q1,Adult
218504081,21850408,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : weekley;?,,,Y,D,,,,,,,999,2023,Q1,Headache,,2023,Q1,1,I,20230109.0,,20230111,20230111,DIR,644201,,FDA-CTU,,63.0,YR,,F,N,72.0,KG,20230111,N,CN,US,,2023,Q1,Adult
218504081,21850408,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : weekley;?,,,Y,D,,,,,,,999,2023,Q1,Vomiting,,2023,Q1,1,I,20230109.0,,20230111,20230111,DIR,644201,,FDA-CTU,,63.0,YR,,F,N,72.0,KG,20230111,N,CN,US,,2023,Q1,Adult
218505581,21850558,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,C-reactive protein increased,,2023,Q1,1,I,,20230109.0,20230111,20230111,EXP,,CA-BAUSCH-BL-2023-000418,BAUSCH AND LOMB,,19.0,YR,,F,Y,,,20230111,,CN,CA,CA,2023,Q1,Youth
218505581,21850558,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Ankylosing spondylitis,,2023,Q1,1,I,,20230109.0,20230111,20230111,EXP,,CA-BAUSCH-BL-2023-000418,BAUSCH AND LOMB,,19.0,YR,,F,Y,,,20230111,,CN,CA,CA,2023,Q1,Youth
218505581,21850558,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230109.0,20230111,20230111,EXP,,CA-BAUSCH-BL-2023-000418,BAUSCH AND LOMB,,19.0,YR,,F,Y,,,20230111,,CN,CA,CA,2023,Q1,Youth
218517131,21851713,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q1,Staphylococcal infection,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q1,Back disorder,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q1,Muscle tightness,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218535812,21853581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg weekly,,,U,,,,,1.0,MG,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,2,F,,20230116.0,20230112,20230123,EXP,,US-TEVA-2023-US-2843170,TEVA,,71.0,YR,E,M,Y,,,20230123,,HP,US,US,2023,Q1,Elderly
218535812,21853581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg weekly,,,U,,,,,1.0,MG,,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,2,F,,20230116.0,20230112,20230123,EXP,,US-TEVA-2023-US-2843170,TEVA,,71.0,YR,E,M,Y,,,20230123,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Nausea,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Vomiting,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Abdominal pain,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Metabolic acidosis,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Leukocytosis,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218585682,21858568,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,2,F,,20230111.0,20230113,20230124,EXP,,US-AUROBINDO-AUR-APL-2023-001232,AUROBINDO,"Paul N, Jonklaas J. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Diabetes-Metab-Syndr. 2021;15(1):361-363",71.0,YR,,M,Y,,,20230124,,HP,US,US,2023,Q1,Elderly
218635812,21863581,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,U,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Bile duct stone,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,U,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Cholangitis,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,U,,,213051.0,,,Tablet,,2023,Q1,Bile duct stone,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,U,,,213051.0,,,Tablet,,2023,Q1,Cholangitis,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,U,,,213051.0,,,Tablet,,2023,Q1,Bile duct stone,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,U,,,213051.0,,,Tablet,,2023,Q1,Cholangitis,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,U,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Bile duct stone,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218635812,21863581,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,U,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Cholangitis,,2023,Q1,2,F,20221220.0,20230112.0,20230116,20230123,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230123,,MD,GB,GB,2023,Q1,Elderly
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Poor venous access,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Discomfort,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Back pain,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Intentional product use issue,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218707121,21870712,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,1.0,MG,,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230106.0,20230117,20230117,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00637,SAMSUNG BIOEPIS,,46.0,YR,A,M,Y,75.0,KG,20230117,,HP,CA,CA,2023,Q1,Adult
218757461,21875746,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd (on empty stomach),,,,,,,,,,,,2023,Q1,Flatulence,,2023,Q1,1,I,20230105.0,20230108.0,20230118,20230118,EXP,GB-MHRA-TPP21454856C7748691YC1672914021921,GB-NOVOPROD-1011244,NOVO NORDISK,,46.0,YR,,M,Y,171.0,KG,20230118,,PH,GB,GB,2023,Q1,Adult
218757461,21875746,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd (on empty stomach),,,,,,,,,,,,2023,Q1,Eructation,,2023,Q1,1,I,20230105.0,20230108.0,20230118,20230118,EXP,GB-MHRA-TPP21454856C7748691YC1672914021921,GB-NOVOPROD-1011244,NOVO NORDISK,,46.0,YR,,M,Y,171.0,KG,20230118,,PH,GB,GB,2023,Q1,Adult
218757461,21875746,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd (on empty stomach),,,,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,1,I,20230105.0,20230108.0,20230118,20230118,EXP,GB-MHRA-TPP21454856C7748691YC1672914021921,GB-NOVOPROD-1011244,NOVO NORDISK,,46.0,YR,,M,Y,171.0,KG,20230118,,PH,GB,GB,2023,Q1,Adult
218757461,21875746,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd (on empty stomach),,,,,,,,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,20230105.0,20230108.0,20230118,20230118,EXP,GB-MHRA-TPP21454856C7748691YC1672914021921,GB-NOVOPROD-1011244,NOVO NORDISK,,46.0,YR,,M,Y,171.0,KG,20230118,,PH,GB,GB,2023,Q1,Adult
218757461,21875746,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 tab qd (on empty stomach),,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20230105.0,20230108.0,20230118,20230118,EXP,GB-MHRA-TPP21454856C7748691YC1672914021921,GB-NOVOPROD-1011244,NOVO NORDISK,,46.0,YR,,M,Y,171.0,KG,20230118,,PH,GB,GB,2023,Q1,Adult
218786801,21878680,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D,,,,0.5,MG,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20221221.0,,20230117,20230117,DIR,FDA-CDER-CTU-2023-4377,,FDA-CTU,,40.0,YR,,M,N,,,20230103,N,PH,US,,2023,Q1,Adult
218786801,21878680,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,D,D,,,,0.5,MG,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20221221.0,,20230117,20230117,DIR,FDA-CDER-CTU-2023-4377,,FDA-CTU,,40.0,YR,,M,N,,,20230103,N,PH,US,,2023,Q1,Adult
218875461,21887546,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,,,2023,Q1,Pancreatic failure,,2023,Q1,1,I,,20230109.0,20230120,20230120,EXP,,CH-NOVOPROD-1012160,NOVO NORDISK,"Prof. Dr. Bernd Schultes, Stoffwechselzentrum St. Gallen. Diabetes patients: Recognizing and managing exocrine pancreatic insufficiency. Medical Tribune",54.0,YR,,F,Y,,,20230120,,MD,CH,CH,2023,Q1,Adult
218875482,21887548,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,Tablet,,2023,Q1,Diverticulum intestinal,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218875482,21887548,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,Tablet,,2023,Q1,Cholecystitis chronic,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218875482,21887548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,Tablet,,2023,Q1,Diverticulum intestinal,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218875482,21887548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,213051.0,,,Tablet,,2023,Q1,Cholecystitis chronic,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218875482,21887548,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Diverticulum intestinal,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218875482,21887548,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q1,Cholecystitis chronic,,2023,Q1,2,F,20221212.0,20230119.0,20230120,20230130,EXP,,US-NOVOPROD-1011390,NOVO NORDISK,,78.0,YR,,M,Y,98.0,KG,20230130,,MD,US,US,2023,Q1,Elderly
218880332,21888033,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unk,,,,,,,2023,Q1,Pulmonary embolism,,2023,Q1,2,F,20230105.0,20230118.0,20230120,20230222,EXP,GB-MHRA-WEBRADR-202301120937303680-WWTFF,NVSC2023GB012098,NOVARTIS,,61.0,YR,,F,Y,127.0,KG,20230222,,HP,GB,GB,2023,Q1,Adult
218913641,21891364,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,,20230119,20230119,DIR,FDA-CDER-CTU-2023-5113,,FDA-CTU,,67.0,YR,,F,N,71.85,KG,20230119,N,,US,,2023,Q1,Elderly
218920182,21892018,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 milligram, qd",,,,,,,,3.0,MG,Tablet,QD,2023,Q1,Blood creatinine increased,,2023,Q1,2,F,20220615.0,20230227.0,20230120,20230310,EXP,,US-INTERCEPT-CT2023000057,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,95.0,KG,20230310,,MD,US,US,2023,Q1,Adult
218920182,21892018,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 milligram, qd",,,,,,,,3.0,MG,Tablet,QD,2023,Q1,Blood creatinine increased,,2023,Q1,2,F,20220615.0,20230227.0,20230120,20230310,EXP,,US-INTERCEPT-CT2023000057,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,95.0,KG,20230310,,MD,US,US,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Albumin urine present,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Gamma-glutamyltransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q1,Alanine aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Macroangiopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Diabetic neuropathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, qod",,,,,,,,1.0,MG,,QOD,2023,Q1,Fatigue,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219012741,21901274,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230119.0,20230123,20230123,EXP,,CA-BAUSCH-BL-2023-001028,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230123,,HP,CA,CA,2023,Q1,Adult
219023721,21902372,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg,,,U,,,,,0.5,MG,Solution for injection/infusion,,2023,Q1,Product use issue,,2023,Q1,1,I,,20230118.0,20230124,20230124,EXP,,NVSC2023CA012219,NOVARTIS,,32.0,YR,,F,Y,,,20230124,,CN,CA,CA,2023,Q1,Young Adult
219023721,21902372,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg,,,U,,,,,0.5,MG,Solution for injection/infusion,,2023,Q1,Bronchiolitis,,2023,Q1,1,I,,20230118.0,20230124,20230124,EXP,,NVSC2023CA012219,NOVARTIS,,32.0,YR,,F,Y,,,20230124,,CN,CA,CA,2023,Q1,Young Adult
219047461,21904746,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Nephrolithiasis,,2023,Q1,1,I,,20230116.0,20230124,20230124,EXP,,CA-AstraZeneca-2023A015104,ASTRAZENECA,,52.0,YR,,F,Y,,,20230124,,MD,CA,,2023,Q1,Adult
219047461,21904746,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Escherichia bacteraemia,,2023,Q1,1,I,,20230116.0,20230124,20230124,EXP,,CA-AstraZeneca-2023A015104,ASTRAZENECA,,52.0,YR,,F,Y,,,20230124,,MD,CA,,2023,Q1,Adult
219047461,21904746,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Pyelonephritis acute,,2023,Q1,1,I,,20230116.0,20230124,20230124,EXP,,CA-AstraZeneca-2023A015104,ASTRAZENECA,,52.0,YR,,F,Y,,,20230124,,MD,CA,,2023,Q1,Adult
219067171,21906717,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",124.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q1,Appendicitis,,2023,Q1,1,I,20230109.0,20230120.0,20230125,20230125,EXP,,DE-NOVOPROD-1015739,NOVO NORDISK,,82.0,YR,,F,Y,92.0,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
219067171,21906717,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",124.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q1,Cholelithiasis,,2023,Q1,1,I,20230109.0,20230120.0,20230125,20230125,EXP,,DE-NOVOPROD-1015739,NOVO NORDISK,,82.0,YR,,F,Y,92.0,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
219076924,21907692,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,4,F,20230102.0,20230303.0,20230125,20230315,EXP,,ES-Accord-296554,ACCORD,,67.0,YR,E,M,Y,87.3,KG,20230315,,HP,ES,ES,2023,Q1,Elderly
219076924,21907692,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Febrile neutropenia,,2023,Q1,4,F,20230102.0,20230303.0,20230125,20230315,EXP,,ES-Accord-296554,ACCORD,,67.0,YR,E,M,Y,87.3,KG,20230315,,HP,ES,ES,2023,Q1,Elderly
219086072,21908607,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Limb injury,,2023,Q1,2,F,20230101.0,20230309.0,20230125,20230309,EXP,,CA-PFIZER INC-202300012707,PFIZER,,58.0,YR,,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
219086072,21908607,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Intentional dose omission,,2023,Q1,2,F,20230101.0,20230309.0,20230125,20230309,EXP,,CA-PFIZER INC-202300012707,PFIZER,,58.0,YR,,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Weight increased,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Pain in extremity,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Arthritis,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Blood pressure fluctuation,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Arthralgia,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Back pain,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Rash,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Blood pressure increased,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Off label use,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219138712,21913871,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Musculoskeletal stiffness,,2023,Q1,2,F,,20230118.0,20230125,20230131,EXP,,CA-JNJFOC-20230140526,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,64.0,KG,20230131,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Off label use,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Weight increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Rash,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Off label use,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Weight increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Rash,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,/WK,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Rash,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219142691,21914269,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230118.0,20230126,20230126,EXP,,CA-JNJFOC-20230140540,JOHNSON AND JOHNSON,,47.0,YR,A,F,Y,64.0,KG,20230126,,HP,CA,CA,2023,Q1,Adult
219147121,21914712,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230119.0,20230126,20230126,EXP,,US-ROCHE-3269983,ROCHE,"Stawiarski K, Avery R, Strout S and Umapathi P Risks of paxlovid in a heart transplant recipient. Doi: 10.1016/j.healun.2022.08.029. Journal of Heart and Lung Transplantation 2023 Jan;42 (1):30-2.",76.0,YR,,M,Y,,,20230126,,MD,US,,2023,Q1,Elderly
219147121,21914712,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230119.0,20230126,20230126,EXP,,US-ROCHE-3269983,ROCHE,"Stawiarski K, Avery R, Strout S and Umapathi P Risks of paxlovid in a heart transplant recipient. Doi: 10.1016/j.healun.2022.08.029. Journal of Heart and Lung Transplantation 2023 Jan;42 (1):30-2.",76.0,YR,,M,Y,,,20230126,,MD,US,,2023,Q1,Elderly
219169331,21916933,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,As Directed,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20221116.0,20230126.0,20230126,20230126,EXP,GB-MHRA-TPP59375269C8843027YC1674481817380,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-214911",BOEHRINGER INGELHEIM,,48.0,YR,A,M,Y,97.0,KG,20230126,,MD,GB,GB,2023,Q1,Adult
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Withdrawal syndrome,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Retching,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Eating disorder symptom,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood glucose decreased,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Feeling abnormal,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219192061,21919206,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Drug interaction,,2023,Q1,1,I,20221201.0,20230115.0,20230127,20230127,EXP,,US-Accord-297371,ACCORD,,67.0,YR,E,M,Y,97.98,KG,20230127,,CN,US,US,2023,Q1,Elderly
219202791,21920279,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly SQ;?,,,,,,20230131.0,99.0,,,,999,2023,Q1,Impaired gastric emptying,,2023,Q1,1,I,20230125.0,,20230127,20230127,DIR,646234,,FDA-CTU,,49.0,YR,,M,N,119.25,KG,20230127,N,CN,US,,2023,Q1,Adult
219227093,21922709,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,3,F,20230102.0,20230316.0,20230128,20230329,PER,ES-Accord-296554,ES-Shilpa Medicare Limited-SML-ES-2023-00079,SHILPA MEDICARE,,67.0,YR,E,M,Y,87.3,KG,20230329,,HP,ES,ES,2023,Q1,Elderly
219227093,21922709,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Febrile neutropenia,,2023,Q1,3,F,20230102.0,20230316.0,20230128,20230329,PER,ES-Accord-296554,ES-Shilpa Medicare Limited-SML-ES-2023-00079,SHILPA MEDICARE,,67.0,YR,E,M,Y,87.3,KG,20230329,,HP,ES,ES,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Vomiting,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Angina unstable,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Asthenia,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Acute myocardial infarction,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Dizziness,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219231101,21923110,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg,,,U,,,,,2.4,MG,,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230123.0,20230129,20230129,EXP,,NVSC2023CA015451,NOVARTIS,,67.0,YR,,M,Y,122.0,KG,20230129,,HP,CA,CA,2023,Q1,Elderly
219249031,21924903,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2023,Q1,Hypotension,,2023,Q1,1,I,,20230123.0,20230130,20230130,EXP,,NVSC2023CA015962,NOVARTIS,,68.0,YR,,M,Y,87.0,KG,20230130,,CN,CA,CA,2023,Q1,Elderly
219249031,21924903,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2023,Q1,Fall,,2023,Q1,1,I,,20230123.0,20230130,20230130,EXP,,NVSC2023CA015962,NOVARTIS,,68.0,YR,,M,Y,87.0,KG,20230130,,CN,CA,CA,2023,Q1,Elderly
219249031,21924903,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230123.0,20230130,20230130,EXP,,NVSC2023CA015962,NOVARTIS,,68.0,YR,,M,Y,87.0,KG,20230130,,CN,CA,CA,2023,Q1,Elderly
219249031,21924903,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Fall,,2023,Q1,1,I,,20230123.0,20230130,20230130,EXP,,NVSC2023CA015962,NOVARTIS,,68.0,YR,,M,Y,87.0,KG,20230130,,CN,CA,CA,2023,Q1,Elderly
219262951,21926295,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,Unknown,,,1.0,MG,UNK,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230118.0,20230130,20230130,EXP,,US-GRANULES-US-2023GRALIT00029,GRANULES INDIA,Namrata Paul.Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.Diabetes and Metabolic Syndrome: Clinical Research and Reviews.2021;15:361-363,71.0,YR,E,M,Y,,,20230130,,MD,US,US,2023,Q1,Elderly
219319211,21931921,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,use as directed,,,,,,,,,,,,2023,Q1,Myalgia,,2023,Q1,1,I,,20230124.0,20230131,20230131,EXP,GB-MHRA-ADR 27630221,GB-Accord-298359,ACCORD,,71.0,YR,E,F,Y,67.0,KG,20230131,,PH,GB,GB,2023,Q1,Elderly
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219322052,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230123.0,20230131,20230221,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230221,,MD,CA,,2023,Q1,Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Urine ketone body present,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Cognitive disorder,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Extrapyramidal disorder,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Drug screen positive,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Red blood cells urine positive,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Dysphemia,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Abdominal discomfort,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Speech disorder,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Hypoaesthesia,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Paraesthesia,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Protein urine present,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Smear cervix abnormal,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Pain in extremity,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219325712,21932571,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, 1x/week",,,,,,,,0.5,MG,,/WK,2023,Q1,Headache,,2023,Q1,2,F,20230101.0,20230215.0,20230131,20230227,EXP,,"US-INTRA-CELLULAR THERAPIES, INC.-2023ICT00086",INTRA-CELLULAR THERAPIES,,34.0,YR,,F,Y,110.84,KG,20230227,,HP,US,US,2023,Q1,Young Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Muscle spasms,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Rhabdomyolysis,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Blood creatine phosphokinase increased,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Flank pain,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Blood creatine increased,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219350571,21935057,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form: solution subcutaneous,,,,,,,,,,,,2023,Q1,Decreased appetite,,2023,Q1,1,I,,20230127.0,20230201,20230201,EXP,,CA-ORGANON-O2301CAN002563,ORGANON,,61.0,YR,,F,Y,79.0,KG,20230201,,HP,CA,CA,2023,Q1,Adult
219374021,21937402,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230119.0,20230201,20230201,EXP,,US-SCIEGENP-2023SCLIT00028,SCIEGEN,"Paul N, et al..Low carbohydrate diet while taking dapagliflozin: A case report and review of literature..Diabetes and Metabolic Syndrome: Clinical Research and Reviews.Jan-2021;15 (1):361-363",71.0,YR,E,M,Y,,,20230201,,HP,US,US,2023,Q1,Elderly
219401974,21940197,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 milligram, qd",,,Y,,,,,7.0,MG,Tablet,QD,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,4,F,20220615.0,20230317.0,20230201,20230324,EXP,,JP-JNJFOC-20230200949,JOHNSON AND JOHNSON,"Okamoto Y, Todo H, Kanamoto M, and Yamauchi K. 2-A A case of the patient with type 2 diabetes mellitus who was revealed to be pregnant at 33 weeks after taking 5 oral hypoglycemic drugs -12. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 79",37.0,YR,A,F,Y,,,20230324,,MD,JP,JP,2023,Q1,Adult
219401974,21940197,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 milligram, qd",,,Y,,,,,7.0,MG,Tablet,QD,2023,Q1,Hypertensive nephropathy,,2023,Q1,4,F,20220615.0,20230317.0,20230201,20230324,EXP,,JP-JNJFOC-20230200949,JOHNSON AND JOHNSON,"Okamoto Y, Todo H, Kanamoto M, and Yamauchi K. 2-A A case of the patient with type 2 diabetes mellitus who was revealed to be pregnant at 33 weeks after taking 5 oral hypoglycemic drugs -12. The 60th General Meeting of the Chugoku-Shikoku Regional Meeting of the Japan Diabetes Society. 2022.11. 11, 12; 79",37.0,YR,A,F,Y,,,20230324,,MD,JP,JP,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Dysphonia,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Blood iron increased,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Fungal infection,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Stomatitis,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Erythema,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Pulmonary mass,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Dry mouth,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219413111,21941311,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Hypothyroidism,,2023,Q1,1,I,20220301.0,20220805.0,20230202,20230202,PER,,US-EXELIXIS-CABO-22053851,EXELIXIS,,64.0,YR,,M,Y,,,20230201,,MD,US,US,2023,Q1,Adult
219441711,21944171,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Polyneuropathy,,2023,Q1,1,I,,20230123.0,20230202,20230202,EXP,,CA-TEVA-2023-CA-2850423,TEVA,,43.0,YR,A,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
219441711,21944171,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230123.0,20230202,20230202,EXP,,CA-TEVA-2023-CA-2850423,TEVA,,43.0,YR,A,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
219441711,21944171,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q1,Drug intolerance,,2023,Q1,1,I,,20230123.0,20230202,20230202,EXP,,CA-TEVA-2023-CA-2850423,TEVA,,43.0,YR,A,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Adult
219469821,21946982,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,Disease recurrence,,2023,Q1,1,I,20230124.0,20230131.0,20230202,20230202,EXP,,US-PFIZER INC-202300047615,PFIZER,,53.0,YR,,M,Y,,,20230202,,CN,US,US,2023,Q1,Adult
219469821,21946982,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,20230124.0,20230131.0,20230202,20230202,EXP,,US-PFIZER INC-202300047615,PFIZER,,53.0,YR,,M,Y,,,20230202,,CN,US,US,2023,Q1,Adult
219509371,21950937,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pulmonary embolism,,2023,Q1,1,I,20230105.0,20230125.0,20230203,20230203,EXP,GB-MHRA-WEBRADR-202301120937303680-WWTFF,GB-TEVA-2023-XI-2851027,TEVA,,61.0,YR,A,F,Y,127.0,KG,20230203,,HP,GB,GB,2023,Q1,Adult
219527911,21952791,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,Unknown,,,1.0,MG,,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230123.0,20230204,20230204,EXP,,US-EPICPHARMA-US-2023EPCLIT00150,EPIC PHARM,N Paul.Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.Diabetes and Metabolic Syndrome: Clinical Research and Reviews.FEB-2021;15:361-363,71.0,YR,E,M,Y,,,20230204,,HP,US,US,2023,Q1,Elderly
219532182,21953218,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Febrile neutropenia,,2023,Q1,2,F,20230102.0,20230304.0,20230204,20230314,EXP,,ES-AUROBINDO-AUR-APL-2023-003728,AUROBINDO,,67.0,YR,,F,Y,87.3,KG,20230314,,HP,ES,ES,2023,Q1,Elderly
219532182,21953218,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,2,F,20230102.0,20230304.0,20230204,20230314,EXP,,ES-AUROBINDO-AUR-APL-2023-003728,AUROBINDO,,67.0,YR,,F,Y,87.3,KG,20230314,,HP,ES,ES,2023,Q1,Elderly
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Arthritis infective,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Knee arthroplasty,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Joint debridement,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Staphylococcal bacteraemia,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Joint stiffness,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219591091,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Joint irrigation,,2023,Q1,1,I,20230125.0,20230125.0,20230206,20230206,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230206,,PH,CA,CA,2023,Q1,Adult
219606181,21960618,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,42.48,MG,N,,,,215256.0,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,1,I,20221125.0,20230127.0,20230207,20230207,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230207,,MD,FR,FR,2023,Q1,Elderly
219606181,21960618,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",42.48,MG,N,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q1,Weight decreased,,2023,Q1,1,I,20221125.0,20230127.0,20230207,20230207,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230207,,MD,FR,FR,2023,Q1,Elderly
219606181,21960618,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,42.48,MG,N,,,,215256.0,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,1,I,20221125.0,20230127.0,20230207,20230207,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230207,,MD,FR,FR,2023,Q1,Elderly
219612961,21961296,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,D,,,,,,,,,2023,Q1,Ankylosing spondylitis,,2023,Q1,1,I,,20230131.0,20230207,20230207,EXP,,CA-APOTEX-2023AP002650,APOTEX,,19.0,YR,,F,Y,,,20230207,,HP,CA,CA,2023,Q1,Youth
219612961,21961296,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,D,,,,,,,,,2023,Q1,C-reactive protein increased,,2023,Q1,1,I,,20230131.0,20230207,20230207,EXP,,CA-APOTEX-2023AP002650,APOTEX,,19.0,YR,,F,Y,,,20230207,,HP,CA,CA,2023,Q1,Youth
219612961,21961296,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,D,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230131.0,20230207,20230207,EXP,,CA-APOTEX-2023AP002650,APOTEX,,19.0,YR,,F,Y,,,20230207,,HP,CA,CA,2023,Q1,Youth
219618011,21961801,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Insomnia,,2023,Q1,1,I,20230129.0,,20230204,20230204,DIR,647231,,FDA-CTU,,59.0,YR,,F,N,68.85,KG,20230204,N,CN,US,,2023,Q1,Adult
219634461,21963446,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20200420.0,,20230207,20230207,DIR,FDA-CDER-CTU-2023-10592,,FDA-CTU,,74.0,YR,,M,N,,,20211107,N,HP,US,,2023,Q1,Elderly
219634701,21963470,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Emergency care,,2023,Q1,1,I,20200505.0,,20230207,20230207,DIR,FDA-CDER-CTU-2023-10593,,FDA-CTU,,64.0,YR,,M,N,,,20211107,N,HP,US,,2023,Q1,Adult
219634871,21963487,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Emergency care,,2023,Q1,1,I,20200505.0,,20230207,20230207,DIR,FDA-CDER-CTU-2023-10598,,FDA-CTU,,74.0,YR,,M,N,,,20211107,N,HP,US,,2023,Q1,Elderly
219676041,21967604,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.5 ml weekly subcutaneous?,,,Y,D,155180,20230702.0,99.0,0.5,ML,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20230201.0,,20230206,20230206,DIR,647399,,FDA-CTU,,26.0,YR,,F,N,,,20230206,N,HP,US,,2023,Q1,Young Adult
219676041,21967604,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.5 ml weekly subcutaneous?,,,Y,D,155180,20230702.0,99.0,0.5,ML,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20230201.0,,20230206,20230206,DIR,647399,,FDA-CTU,,26.0,YR,,F,N,,,20230206,N,HP,US,,2023,Q1,Young Adult
219759671,21975967,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,3140.143,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221211.0,20230131.0,20230210,20230210,EXP,,IT-NOVOPROD-1019518,NOVO NORDISK,,52.0,YR,,M,Y,126.0,KG,20230210,,MD,IT,IT,2023,Q1,Adult
219759671,21975967,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,3140.143,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221211.0,20230131.0,20230210,20230210,EXP,,IT-NOVOPROD-1019518,NOVO NORDISK,,52.0,YR,,M,Y,126.0,KG,20230210,,MD,IT,IT,2023,Q1,Adult
219759671,21975967,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"17 mg, qw",3140.143,MG,Y,,,,215256.0,17.0,MG,Solution for injection,/WK,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221211.0,20230131.0,20230210,20230210,EXP,,IT-NOVOPROD-1019518,NOVO NORDISK,,52.0,YR,,M,Y,126.0,KG,20230210,,MD,IT,IT,2023,Q1,Adult
219759671,21975967,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,3140.143,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221211.0,20230131.0,20230210,20230210,EXP,,IT-NOVOPROD-1019518,NOVO NORDISK,,52.0,YR,,M,Y,126.0,KG,20230210,,MD,IT,IT,2023,Q1,Adult
219759671,21975967,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,3140.143,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221211.0,20230131.0,20230210,20230210,EXP,,IT-NOVOPROD-1019518,NOVO NORDISK,,52.0,YR,,M,Y,126.0,KG,20230210,,MD,IT,IT,2023,Q1,Adult
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Hyponatraemia,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Decreased appetite,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Nausea,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219776361,21977636,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 1.0 Months,,,U,,,,,,,,/WK,2023,Q1,Vomiting,,2023,Q1,1,I,,20230131.0,20230210,20230210,EXP,,CA-TEVA-2023-CA-2852312,TEVA,,89.0,YR,E,F,Y,,,20230210,,CN,CA,CA,2023,Q1,Elderly
219778851,21977885,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, QW",,,U,,,,,2.4,MG,,/WK,2023,Q1,Sinus bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, QW",,,U,,,,,2.4,MG,,/WK,2023,Q1,Chest pain,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, QW",,,U,,,,,2.4,MG,,/WK,2023,Q1,Bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Sinus bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Chest pain,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Sinus bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219778851,21977885,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Bradycardia,,2023,Q1,1,I,,20230206.0,20230210,20230210,EXP,,NVSC2023CA027146,NOVARTIS,,78.0,YR,,F,Y,65.0,KG,20230210,,HP,CA,CA,2023,Q1,Elderly
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219832372,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230308.0,20230213,20230315,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230315,,CN,CA,CA,2023,Q1,Adult
219902461,21990246,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2023,Q1,Acute myocardial infarction,,2023,Q1,1,I,20230121.0,20230205.0,20230214,20230214,EXP,,"CA-Amarin Pharma, Inc.-2023AMR000049",AMARIN,,63.0,YR,A,M,Y,99.0,KG,20230214,,CN,CA,CA,2023,Q1,Adult
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Blood magnesium decreased,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Hypertension,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Product use issue,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Sleep disorder,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Depression,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Constipation,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Hypotension,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
219906321,21990632,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (1 every 1 Weeks)",,,U,,,,,0.25,MG,Solution,/WK,2023,Q1,Urinary tract infection,,2023,Q1,1,I,,20230206.0,20230214,20230214,EXP,,NVSC2023CA027562,NOVARTIS,,73.0,YR,,M,Y,131.0,KG,20230214,,HP,CA,CA,2023,Q1,Elderly
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,,,2023,Q1,Stress,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Stress,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,,,2023,Q1,Stress,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220035391,22003539,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Injection,,2023,Q1,Stress,,2023,Q1,1,I,,20230214.0,20230217,20230217,EXP,,CA-EMD Serono-9383904,EMD SERONO INC,,47.0,YR,A,F,Y,,,20230217,,HP,CA,,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood pressure decreased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Influenza,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Spinal pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Breast pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Blood creatine increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Swelling,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220058331,22005833,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,CA-APOTEX-2023AP003499,APOTEX,,68.0,YR,,M,Y,87.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
220058331,22005833,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK, qd",,,U,,,,,,,,,2023,Q1,Fall,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,CA-APOTEX-2023AP003499,APOTEX,,68.0,YR,,M,Y,87.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
220058331,22005833,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,CA-APOTEX-2023AP003499,APOTEX,,68.0,YR,,M,Y,87.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
220058331,22005833,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2023,Q1,Fall,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,CA-APOTEX-2023AP003499,APOTEX,,68.0,YR,,M,Y,87.0,KG,20230217,,HP,CA,CA,2023,Q1,Elderly
220062401,22006240,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Upper gastrointestinal haemorrhage,,2023,Q1,1,I,,20230207.0,20230217,20230217,EXP,,CA-TEVA-2023-CA-2855369,TEVA,,76.0,YR,E,M,Y,,,20230217,,PH,CA,CA,2023,Q1,Elderly
220062401,22006240,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Angiodysplasia,,2023,Q1,1,I,,20230207.0,20230217,20230217,EXP,,CA-TEVA-2023-CA-2855369,TEVA,,76.0,YR,E,M,Y,,,20230217,,PH,CA,CA,2023,Q1,Elderly
220071001,22007100,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,foa- SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,,,,,2023,Q1,Psychotic disorder,,2023,Q1,1,I,,20230216.0,20230217,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219616",BOEHRINGER INGELHEIM,,35.0,YR,A,M,Y,103.0,KG,20230217,,MD,CA,CA,2023,Q1,Adult
220071001,22007100,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,foa- SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,,,,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230216.0,20230217,20230217,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-219616",BOEHRINGER INGELHEIM,,35.0,YR,A,M,Y,103.0,KG,20230217,,MD,CA,CA,2023,Q1,Adult
220101381,22010138,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.5,MG,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,20220501.0,20230210.0,20230220,20230220,EXP,,JP-EMD Serono-9384768,EMD SERONO INC,,74.0,YR,E,M,Y,83.0,KG,20230220,,MD,JP,,2023,Q1,Elderly
220101381,22010138,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.5,MG,,/WK,2023,Q1,Pyrexia,,2023,Q1,1,I,20220501.0,20230210.0,20230220,20230220,EXP,,JP-EMD Serono-9384768,EMD SERONO INC,,74.0,YR,E,M,Y,83.0,KG,20230220,,MD,JP,,2023,Q1,Elderly
220129031,22012903,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Unknown,,2023,Q1,Adverse event,,2023,Q1,1,I,,20230217.0,20230220,20230220,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-024359,BRISTOL MYERS SQUIBB,,69.0,YR,E,F,Y,,,20230220,,CN,US,US,2023,Q1,Elderly
220152941,22015294,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,1,I,20220102.0,20230215.0,20230221,20230221,EXP,SE-MPA-2022-007062,SE-UCBSA-2023008279,UCB,,51.0,YR,,M,Y,106.0,KG,20230221,,CN,SE,SE,2023,Q1,Adult
220152941,22015294,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2023,Q1,Seizure,,2023,Q1,1,I,20220102.0,20230215.0,20230221,20230221,EXP,SE-MPA-2022-007062,SE-UCBSA-2023008279,UCB,,51.0,YR,,M,Y,106.0,KG,20230221,,CN,SE,SE,2023,Q1,Adult
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Vomiting,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Nausea,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Decreased appetite,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Hyponatraemia,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220200481,22020048,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230214.0,20230222,20230222,EXP,,CA-APOTEX-2023AP003636,APOTEX,,89.0,YR,,F,Y,,,20230222,,CN,CA,CA,2023,Q1,Elderly
220277751,22027775,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,D,154479,20230519.0,99.0,0.25,ML,,QW,2023,Q1,Drug hypersensitivity,,2023,Q1,1,I,20230217.0,,20230220,20230220,DIR,649212,,FDA-CTU,,49.0,YR,,F,N,,,20230220,N,PH,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Chest pain,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,C-reactive protein increased,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Arthralgia,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Joint stiffness,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Fibrin D dimer increased,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Red blood cell sedimentation rate increased,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Blood fibrinogen increased,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Rash,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Brain natriuretic peptide increased,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220294771,22029477,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,12142022@2,20230314.0,99.0,,,,999,2023,Q1,Dyspnoea exertional,,2023,Q1,1,I,20230120.0,,20230221,20230221,DIR,649372,,FDA-CTU,,50.0,YR,,F,N,81.0,KG,20230221,N,CN,US,,2023,Q1,Adult
220359511,22035951,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q1,Atrioventricular block first degree,,2023,Q1,1,I,20220304.0,20230204.0,20230224,20230224,EXP,AU-TG-0000737459,AU-NOVOPROD-1023040,NOVO NORDISK,,46.0,YR,,M,Y,121.5,KG,20230215,,HP,AU,AU,2023,Q1,Adult
220359511,22035951,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q1,Cardiomyopathy,,2023,Q1,1,I,20220304.0,20230204.0,20230224,20230224,EXP,AU-TG-0000737459,AU-NOVOPROD-1023040,NOVO NORDISK,,46.0,YR,,M,Y,121.5,KG,20230215,,HP,AU,AU,2023,Q1,Adult
220359511,22035951,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q1,Trifascicular block,,2023,Q1,1,I,20220304.0,20230204.0,20230224,20230224,EXP,AU-TG-0000737459,AU-NOVOPROD-1023040,NOVO NORDISK,,46.0,YR,,M,Y,121.5,KG,20230215,,HP,AU,AU,2023,Q1,Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Ventricular internal diameter abnormal,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Blood triglycerides increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,QRS axis abnormal,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Electrocardiogram T wave inversion,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Blood lactic acid increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Left atrial dilatation,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Hyperhidrosis,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Electrocardiogram ST segment elevation,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,"Hallucination, auditory",,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Myocardial infarction,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Blood sodium decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Blood pressure systolic decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Left ventricular dysfunction,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Sinus tachycardia,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Mean cell volume decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Anion gap increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Mean cell haemoglobin decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Electrocardiogram QRS complex prolonged,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Cardiomyopathy,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Ejection fraction decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Left ventricular hypertrophy,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Electrocardiogram ST-T segment abnormal,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Haematocrit decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Electrocardiogram QT prolonged,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Body temperature increased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Haemoglobin decreased,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220414401,22041440,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Drug hypersensitivity,,2023,Q1,1,I,,20230217.0,20230227,20230227,EXP,,AU-MYLANLABS-2023M1020540,MYLAN,,27.0,YR,,M,Y,,,20230227,,HP,AU,AU,2023,Q1,Young Adult
220419521,22041952,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q1,Vomiting,,2023,Q1,1,I,,20230222.0,20230227,20230227,EXP,,CA-BAUSCH-BL-2023-003285,BAUSCH AND LOMB,,33.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
220419521,22041952,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q1,Nausea,,2023,Q1,1,I,,20230222.0,20230227,20230227,EXP,,CA-BAUSCH-BL-2023-003285,BAUSCH AND LOMB,,33.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
220419521,22041952,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20230222.0,20230227,20230227,EXP,,CA-BAUSCH-BL-2023-003285,BAUSCH AND LOMB,,33.0,YR,,F,Y,,,20230227,,CN,CA,CA,2023,Q1,Young Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Illness,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Tachycardia,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Clostridium difficile colitis,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Asthenia,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Pruritus,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Irregular sleep phase,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Muscle spasms,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220424551,22042455,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,UNKNOWN,,,,,,,2023,Q1,Disturbance in attention,,2023,Q1,1,I,,20230215.0,20230228,20230228,EXP,,CA-drreddys-SPO/CAN/23/0161782,DR REDDYS,,61.0,YR,A,F,Y,,,20230228,,HP,CA,CA,2023,Q1,Adult
220465982,22046598,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,qd",7028.0,MG,D,,,,213051.0,7.0,MG,Tablet,QD,2023,Q1,Cholecystitis acute,,2023,Q1,2,F,20221224.0,20230310.0,20230228,20230315,EXP,,CZ-NOVOPROD-1025875,NOVO NORDISK,,66.0,YR,,M,Y,99.0,KG,20230315,,MD,CZ,CZ,2023,Q1,Elderly
220465982,22046598,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,qd",7028.0,MG,D,,,,213051.0,7.0,MG,Tablet,QD,2023,Q1,Cholelithiasis,,2023,Q1,2,F,20221224.0,20230310.0,20230228,20230315,EXP,,CZ-NOVOPROD-1025875,NOVO NORDISK,,66.0,YR,,M,Y,99.0,KG,20230315,,MD,CZ,CZ,2023,Q1,Elderly
220470702,22047070,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,,,,U,,,,,7.0,MG,,QD,2023,Q1,Ureterolithiasis,,2023,Q1,2,F,,20230330.0,20230301,20230331,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221904",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,,,20230331,,MD,JP,JP,2023,Q1,Elderly
220470702,22047070,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,,,,U,,,,,7.0,MG,,QD,2023,Q1,Urinary tract infection,,2023,Q1,2,F,,20230330.0,20230301,20230331,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221904",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,,,20230331,,MD,JP,JP,2023,Q1,Elderly
220495581,22049558,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, weekly",,,U,,,,,,,,/WK,2023,Q1,Hyperkalaemia,,2023,Q1,1,I,,20230224.0,20230301,20230301,EXP,,CA-PFIZER INC-202300082988,PFIZER,,78.0,YR,,F,Y,96.0,KG,20230301,,HP,CA,CA,2023,Q1,Elderly
220495581,22049558,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, weekly",,,U,,,,,,,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230224.0,20230301,20230301,EXP,,CA-PFIZER INC-202300082988,PFIZER,,78.0,YR,,F,Y,96.0,KG,20230301,,HP,CA,CA,2023,Q1,Elderly
220525273,22052527,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2023,Q1,Somatic symptom disorder,,2023,Q1,3,F,20230218.0,20230302.0,20230302,20230306,EXP,,FR-ABBVIE-4323306,ABBVIE,,65.0,YR,,F,Y,71.0,KG,20230306,,MD,FR,FR,2023,Q1,Elderly
220525273,22052527,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2023,Q1,Neurological symptom,,2023,Q1,3,F,20230218.0,20230302.0,20230302,20230306,EXP,,FR-ABBVIE-4323306,ABBVIE,,65.0,YR,,F,Y,71.0,KG,20230306,,MD,FR,FR,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Vomiting,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Nausea,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Hyponatraemia,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220554541,22055454,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q1,Decreased appetite,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230302,,CN,CA,CA,2023,Q1,Elderly
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Malaise,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Drug interaction,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220566401,22056640,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q1,Feeling of body temperature change,,2023,Q1,1,I,,20230214.0,20230302,20230302,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-NOVOPROD-1027366,NOVO NORDISK,,51.0,YR,,F,Y,,,20230228,,CN,CA,CA,2023,Q1,Adult
220569731,22056973,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 mg,,,U,,,,209637.0,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,,20230220.0,20230303,20230303,EXP,,GB-NOVOPROD-1028149,NOVO NORDISK,,58.0,YR,,F,Y,,,20230303,,HP,GB,ZA,2023,Q1,Adult
220569731,22056973,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 mg,,,U,,,,209637.0,,,,,2023,Q1,Overdose,,2023,Q1,1,I,,20230220.0,20230303,20230303,EXP,,GB-NOVOPROD-1028149,NOVO NORDISK,,58.0,YR,,F,Y,,,20230303,,HP,GB,ZA,2023,Q1,Adult
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Vomiting,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Anxiety,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Sciatica,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Product use in unapproved indication,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Dyspepsia,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Abnormal dreams,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Appetite disorder,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Diplopia,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Product dose omission issue,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Pain in extremity,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Nausea,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Retinal detachment,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Mobility decreased,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Sleep disorder,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Headache,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Drug titration error,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Chest pain,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Migraine,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Joint stiffness,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Cataract,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Muscle spasms,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Product prescribing error,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Contraindicated product administered,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Hepatic mass,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Myalgia,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Fatigue,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Feeling abnormal,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Blood pressure decreased,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Arterial disorder,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Post procedural complication,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Dizziness,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220575801,22057580,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,U,,,,,0.5,MG,Solution,QD,2023,Q1,Abdominal distension,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044110,NOVARTIS,,69.0,YR,,M,Y,144.0,KG,20230303,,CN,CA,CA,2023,Q1,Elderly
220583401,22058340,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,,,,,,,,,500.0,MG,Unknown,/WK,2023,Q1,Bone cancer,,2023,Q1,1,I,20200830.0,20201102.0,20230303,20230303,EXP,,IE-JNJFOC-20201103844,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,,,20230303,,HP,IE,IE,2023,Q1,Elderly
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Dizziness,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Hypertension,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Gait disturbance,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Stress,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220585291,22058529,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,,,,/WK,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230224.0,20230303,20230303,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-05566,SAMSUNG BIOEPIS,,58.0,YR,A,M,Y,74.0,KG,20230303,,HP,CA,CA,2023,Q1,Adult
220601571,22060157,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once weekly;?,,,N,D,26-Jan-2023-001,20230526.0,99.0,,,,999,2023,Q1,Therapy change,,2023,Q1,1,I,20230223.0,,20230302,20230302,DIR,650799,,FDA-CTU,,42.0,YR,,F,N,70.2,KG,20230302,N,CN,US,,2023,Q1,Adult
220632581,22063258,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Haematuria,,2023,Q1,1,I,20210520.0,20230224.0,20230306,20230306,EXP,,FR-AUROBINDO-AUR-APL-2023-009493,AUROBINDO,,84.0,YR,,M,Y,97.0,KG,20230306,,HP,FR,FR,2023,Q1,Elderly
220632581,22063258,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Nephrolithiasis,,2023,Q1,1,I,20210520.0,20230224.0,20230306,20230306,EXP,,FR-AUROBINDO-AUR-APL-2023-009493,AUROBINDO,,84.0,YR,,M,Y,97.0,KG,20230306,,HP,FR,FR,2023,Q1,Elderly
220647111,22064711,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230302.0,,20230304,20230304,DIR,651000,,FDA-CTU,,30.0,YR,,F,N,,,20230304,N,CN,US,,2023,Q1,Young Adult
220647111,22064711,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,1,I,20230302.0,,20230304,20230304,DIR,651000,,FDA-CTU,,30.0,YR,,F,N,,,20230304,N,CN,US,,2023,Q1,Young Adult
220702652,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QOW",,,D,,,,,0.5,MG,,QOW,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QOW",,,D,,,,,0.5,MG,,QOW,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QOW",,,D,,,,,0.5,MG,,QOW,2023,Q1,Nausea,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QOW",,,D,,,,,0.5,MG,,QOW,2023,Q1,Vomiting,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,D,,,,,0.5,MG,,QD,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,D,,,,,0.5,MG,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,D,,,,,0.5,MG,,QD,2023,Q1,Nausea,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220702652,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",,,D,,,,,0.5,MG,,QD,2023,Q1,Vomiting,,2023,Q1,2,F,,20230303.0,20230307,20230309,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230310,,HP,CA,CA,2023,Q1,Adult
220723431,22072343,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230302.0,20230303.0,20230308,20230308,EXP,,AU-NOVOPROD-1034217,NOVO NORDISK,,71.0,YR,,F,Y,86.0,KG,20230308,,MD,AU,AU,2023,Q1,Elderly
220757051,22075705,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 (unit unspecified),,,U,,,,,,,,,2023,Q1,Type 1 diabetes mellitus,,2023,Q1,1,I,,20230226.0,20230308,20230308,EXP,,GR-BAUSCH-BL-2023-003484,BAUSCH AND LOMB,,62.0,YR,,F,Y,62.0,KG,20230308,,HP,GR,GR,2023,Q1,Adult
220757051,22075705,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 (unit unspecified),,,U,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230226.0,20230308,20230308,EXP,,GR-BAUSCH-BL-2023-003484,BAUSCH AND LOMB,,62.0,YR,,F,Y,62.0,KG,20230308,,HP,GR,GR,2023,Q1,Adult
220757051,22075705,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 (unit unspecified),,,U,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230226.0,20230308,20230308,EXP,,GR-BAUSCH-BL-2023-003484,BAUSCH AND LOMB,,62.0,YR,,F,Y,62.0,KG,20230308,,HP,GR,GR,2023,Q1,Adult
220757051,22075705,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 (unit unspecified),,,U,,,,,,,,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,,20230226.0,20230308,20230308,EXP,,GR-BAUSCH-BL-2023-003484,BAUSCH AND LOMB,,62.0,YR,,F,Y,62.0,KG,20230308,,HP,GR,GR,2023,Q1,Adult
220772751,22077275,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,0.25,MG,,QD,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,0.25,MG,,QD,2023,Q1,Insulin C-peptide increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,0.25,MG,,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,0.25,MG,,QD,2023,Q1,Faeces soft,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,at the time of change,,,U,,,,,0.5,MG,,QD,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,at the time of change,,,U,,,,,0.5,MG,,QD,2023,Q1,Insulin C-peptide increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,at the time of change,,,U,,,,,0.5,MG,,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,at the time of change,,,U,,,,,0.5,MG,,QD,2023,Q1,Faeces soft,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 month after change,,,U,,,,,0.25,MG,,QD,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 month after change,,,U,,,,,0.25,MG,,QD,2023,Q1,Insulin C-peptide increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 month after change,,,U,,,,,0.25,MG,,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220772751,22077275,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 month after change,,,U,,,,,0.25,MG,,QD,2023,Q1,Faeces soft,,2023,Q1,1,I,,20230228.0,20230309,20230309,EXP,,JP-EMD Serono-9382541,EMD SERONO INC,,37.0,YR,A,M,Y,94.0,KG,20230309,,MD,JP,,2023,Q1,Adult
220816281,22081628,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2 milligram per week,,,D,,,,,2.0,MG,,,2023,Q1,Drug ineffective for unapproved indication,,2023,Q1,1,I,,20220719.0,20230310,20230310,PER,,US-STRIDES ARCOLAB LIMITED-2022SP009502,STRIDES,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al.. A woman presenting with an unusual cause of fulminant liver failure and sepsis.. Clin-Res-Hepatol-Gastroenterol. 2022;46No. 3.",61.0,YR,,F,Y,,,20230310,,HP,US,US,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Feeling of body temperature change,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Vomiting,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Rheumatoid arthritis,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Malaise,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220883952,22088395,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,,,,,,2023,Q1,Drug interaction,,2023,Q1,2,F,,20230227.0,20230313,20230314,EXP,CA- HEALTHCANVIG- E2B_05987381,CA-UCBSA-2023012476,UCB,,51.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Product use issue,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Malaise,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Hypotension,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Depression,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Constipation,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Off label use,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Sleep disorder,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Urinary tract infection,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Hypertension,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220890811,22089081,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q1,Blood magnesium decreased,,2023,Q1,1,I,,20230306.0,20230313,20230313,EXP,,NVSC2023CA052373,NOVARTIS,,72.0,YR,,M,Y,131.0,KG,20230313,,HP,CA,CA,2023,Q1,Elderly
220935771,22093577,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.5 ml weekly subcutaneous,,,Y,D,156456,20230709.0,99.0,0.5,ML,,999,2023,Q1,Abdominal distension,,2023,Q1,1,I,20230228.0,,20230313,20230313,DIR,652138,,FDA-CTU,,35.0,YR,,UNK,N,99.0,KG,20230313,N,HP,US,,2023,Q1,Adult
220935771,22093577,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.5 ml weekly subcutaneous,,,Y,D,156456,20230709.0,99.0,0.5,ML,,999,2023,Q1,Vomiting,,2023,Q1,1,I,20230228.0,,20230313,20230313,DIR,652138,,FDA-CTU,,35.0,YR,,UNK,N,99.0,KG,20230313,N,HP,US,,2023,Q1,Adult
220935771,22093577,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.5 ml weekly subcutaneous,,,Y,D,156456,20230709.0,99.0,0.5,ML,,999,2023,Q1,Nausea,,2023,Q1,1,I,20230228.0,,20230313,20230313,DIR,652138,,FDA-CTU,,35.0,YR,,UNK,N,99.0,KG,20230313,N,HP,US,,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Feeling abnormal,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Hypertension,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Middle insomnia,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Headache,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Headache,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Thirst,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Feeling abnormal,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Poisoning,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Infusion related reaction,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Anxiety,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Peroneal nerve palsy,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Hangover,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Fatigue,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Throat tightness,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Dizziness,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,COVID-19,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
220944641,22094464,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,1.0,MG,Solution,/WK,2023,Q1,Flushing,,2023,Q1,1,I,,20230308.0,20230314,20230314,EXP,,CA-BAUSCH-BL-2023-004037,BAUSCH AND LOMB,,53.0,YR,,F,Y,,,20230314,,CN,CA,CA,2023,Q1,Adult
221004201,22100420,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Semaglutide injectable 0.5 mg/week,,,,,,,,0.5,MG,Injection,,2023,Q1,Epilepsy,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,RO-ALS-000924,ALIGNSCIENCE PHARMA,"Jurca C.M., Kozma K., Petchesi C.D., Zaha D.C., Magyar I., Munteanu M. et.al., Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review. Genes (Basel) 2023; 14(2):433. Doi: 10.3390/genes14020433",33.0,YR,A,F,Y,,,20230316,,HP,RO,RO,2023,Q1,Young Adult
221004201,22100420,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Semaglutide injectable 0.5 mg/week,,,,,,,,0.5,MG,Injection,,2023,Q1,Blood triglycerides increased,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,RO-ALS-000924,ALIGNSCIENCE PHARMA,"Jurca C.M., Kozma K., Petchesi C.D., Zaha D.C., Magyar I., Munteanu M. et.al., Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review. Genes (Basel) 2023; 14(2):433. Doi: 10.3390/genes14020433",33.0,YR,A,F,Y,,,20230316,,HP,RO,RO,2023,Q1,Young Adult
221004201,22100420,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Semaglutide injectable 0.5 mg/week,,,,,,,,0.5,MG,Injection,,2023,Q1,Therapeutic response unexpected,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,RO-ALS-000924,ALIGNSCIENCE PHARMA,"Jurca C.M., Kozma K., Petchesi C.D., Zaha D.C., Magyar I., Munteanu M. et.al., Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review. Genes (Basel) 2023; 14(2):433. Doi: 10.3390/genes14020433",33.0,YR,A,F,Y,,,20230316,,HP,RO,RO,2023,Q1,Young Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Dizziness,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Dyspnoea,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Overdose,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Hyperhidrosis,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Sinus tachycardia,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Cardiomyopathy,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Hypotension,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Body temperature increased,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q1,"Hallucination, auditory",,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Dizziness,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Overdose,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Hyperhidrosis,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Sinus tachycardia,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Cardiomyopathy,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Hypotension,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Body temperature increased,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221005701,22100570,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,,2023,Q1,"Hallucination, auditory",,2023,Q1,1,I,20220625.0,20230306.0,20230316,20230316,EXP,,AU-AstraZeneca-2023A061977,ASTRAZENECA,,48.0,YR,,M,Y,,,20230315,,MD,AU,,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Heart rate decreased,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Hot flush,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221007851,22100785,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,1.0,MG,,,2023,Q1,Illness,,2023,Q1,1,I,,20230309.0,20230316,20230316,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-06802,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,82.0,KG,20230316,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221026872,22102687,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,2,F,,20230308.0,20230316,20230321,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230321,,HP,CA,CA,2023,Q1,Adult
221077401,22107740,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 mg (blinded),,,Y,,,,,3.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 mg (blinded),,,Y,,,,,3.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 mg (blinded),,,Y,,,,,3.0,MG,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 mg (blinded),,,Y,,,,,3.0,MG,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 mg (blinded),,,Y,,,,,3.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg (blinded),,,Y,,,,,7.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg (blinded),,,Y,,,,,7.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg (blinded),,,Y,,,,,7.0,MG,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg (blinded),,,Y,,,,,7.0,MG,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg (blinded),,,Y,,,,,7.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 mg (blinded),,,Y,,,,,14.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 mg (blinded),,,Y,,,,,14.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 mg (blinded),,,Y,,,,,14.0,MG,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 mg (blinded),,,Y,,,,,14.0,MG,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 mg (blinded),,,Y,,,,,14.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,25 mg (C)  (blinded),,,Y,,,,,25.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,25 mg (C)  (blinded),,,Y,,,,,25.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,25 mg (C)  (blinded),,,Y,,,,,25.0,MG,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,25 mg (C)  (blinded),,,Y,,,,,25.0,MG,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,25 mg (C)  (blinded),,,Y,,,,,25.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,50 mg (C) blinded),,,Y,,,,,50.0,MG,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,50 mg (C) blinded),,,Y,,,,,50.0,MG,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,50 mg (C) blinded),,,Y,,,,,50.0,MG,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,50 mg (C) blinded),,,Y,,,,,50.0,MG,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,50 mg (C) blinded),,,Y,,,,,50.0,MG,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q1,Erythema,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q1,Pruritus,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221077401,22107740,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q1,Peripheral swelling,,2023,Q1,1,I,20220306.0,20230309.0,20230317,20230317,EXP,,NVSC2023DK061214,NOVARTIS,,52.0,YR,,M,Y,118.0,KG,20230317,,HP,DK,DK,2023,Q1,Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Product administration interrupted,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Chest discomfort,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Lower respiratory tract infection,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Cough,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Feeling cold,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Intentional product use issue,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Gallbladder disorder,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221099781,22109978,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q1,Exposure to SARS-CoV-2,,2023,Q1,1,I,,20230313.0,20230317,20230317,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-06931,SAMSUNG BIOEPIS,,30.0,YR,A,F,Y,88.0,KG,20230317,,HP,CA,CA,2023,Q1,Young Adult
221137691,22113769,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q1,Nightmare,,2023,Q1,1,I,20230226.0,20230307.0,20230320,20230320,EXP,,"GB-Valinor Pharma, LLC-VLR202303-000039",Unknown Manufacturer,,27.0,YR,A,F,Y,98.0,KG,20230320,,HP,GB,,2023,Q1,Young Adult
221137691,22113769,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q1,Abnormal dreams,,2023,Q1,1,I,20230226.0,20230307.0,20230320,20230320,EXP,,"GB-Valinor Pharma, LLC-VLR202303-000039",Unknown Manufacturer,,27.0,YR,A,F,Y,98.0,KG,20230320,,HP,GB,,2023,Q1,Young Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Asthma,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Lower respiratory tract infection,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Oropharyngeal pain,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Hyperlipidaemia,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Urinary incontinence,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Pharyngitis,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Sleep apnoea syndrome,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Productive cough,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Hypertension,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Asthma,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Lower respiratory tract infection,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Oropharyngeal pain,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Hyperlipidaemia,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Urinary incontinence,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Pharyngitis,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Sleep apnoea syndrome,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Productive cough,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Hypertension,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221166831,22116683,22,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,.25 Milligram Daily;,,,U,,,,,0.25,MG,,QD,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,CA-TEVA-2020-CA-1792419,TEVA,,51.0,YR,A,F,Y,,,20230320,,MD,CA,CA,2023,Q1,Adult
221183342,22118334,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis,,2023,Q1,2,F,20221226.0,20230317.0,20230321,20230322,EXP,,CZ-NOVOPROD-1039541,NOVO NORDISK,,75.0,YR,,M,Y,92.0,KG,20230322,,MD,CZ,CZ,2023,Q1,Elderly
221183342,22118334,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q1,Cholecystitis,,2023,Q1,2,F,20221226.0,20230317.0,20230321,20230322,EXP,,CZ-NOVOPROD-1039541,NOVO NORDISK,,75.0,YR,,M,Y,92.0,KG,20230322,,MD,CZ,CZ,2023,Q1,Elderly
221183342,22118334,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,215256.0,,,Solution for injection,,2023,Q1,Cholecystitis,,2023,Q1,2,F,20221226.0,20230317.0,20230321,20230322,EXP,,CZ-NOVOPROD-1039541,NOVO NORDISK,,75.0,YR,,M,Y,92.0,KG,20230322,,MD,CZ,CZ,2023,Q1,Elderly
221183451,22118345,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221183451,22118345,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q1,Retinal haemorrhage,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221183451,22118345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221183451,22118345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q1,Retinal haemorrhage,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221183451,22118345,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221183451,22118345,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q1,Retinal haemorrhage,,2023,Q1,1,I,20221021.0,20230310.0,20230321,20230321,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230321,,MD,BG,BG,2023,Q1,Adult
221232772,22123277,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Fluid retention,,2023,Q1,2,F,20221004.0,20230321.0,20230322,20230328,EXP,,US-ROCHE-3214150,ROCHE,,54.0,YR,,M,Y,92.0,KG,20230328,,MD,US,,2023,Q1,Adult
221232772,22123277,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Cardiac failure congestive,,2023,Q1,2,F,20221004.0,20230321.0,20230322,20230328,EXP,,US-ROCHE-3214150,ROCHE,,54.0,YR,,M,Y,92.0,KG,20230328,,MD,US,,2023,Q1,Adult
221232772,22123277,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Oedema,,2023,Q1,2,F,20221004.0,20230321.0,20230322,20230328,EXP,,US-ROCHE-3214150,ROCHE,,54.0,YR,,M,Y,92.0,KG,20230328,,MD,US,,2023,Q1,Adult
221232772,22123277,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Ejection fraction decreased,,2023,Q1,2,F,20221004.0,20230321.0,20230322,20230328,EXP,,US-ROCHE-3214150,ROCHE,,54.0,YR,,M,Y,92.0,KG,20230328,,MD,US,,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Stress,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Solution,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Stress,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 mg,,,U,,,,,1.0,MG,Solution,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Stress,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Solution,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Stress,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Poor quality sleep,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Blood cholesterol increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221277961,22127796,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q1,Transient ischaemic attack,,2023,Q1,1,I,,20230314.0,20230323,20230323,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Off label use,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Intentional product use issue,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Appendix disorder,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q1,Hernia,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Off label use,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Intentional product use issue,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Appendix disorder,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221288481,22128848,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q1,Hernia,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,CA-JNJFOC-20230347550,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,81.0,KG,20230323,,HP,CA,CA,2023,Q1,Adult
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood pressure fluctuation,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Aortic arteriosclerosis,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Type 2 diabetes mellitus,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood pressure diastolic decreased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221317141,22131714,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (dosage form: solution subcutaneous),,,U,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230315.0,20230323,20230323,EXP,,NVSC2023CA062732,NOVARTIS,,66.0,YR,,F,Y,85.0,KG,20230323,,HP,CA,CA,2023,Q1,Elderly
221334101,22133410,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,qw",444.688,MG,Y,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q1,Oedematous pancreatitis,,2023,Q1,1,I,20230108.0,20230313.0,20230324,20230324,EXP,,DE-NOVOPROD-1012931,NOVO NORDISK,,78.0,YR,,M,Y,112.0,KG,20230324,,MD,DE,DE,2023,Q1,Elderly
221334321,22133432,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg Once per week",79.2,MG,D,,,,209637.0,2.4,MG,Solution for injection,/WK,2023,Q1,Cholecystitis chronic,,2023,Q1,1,I,20221005.0,20230315.0,20230324,20230324,EXP,,BG-NOVOPROD-1039545,NOVO NORDISK,,52.0,YR,,F,Y,89.0,KG,20230324,,MD,BG,BG,2023,Q1,Adult
221369701,22136970,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, unknown",,,N,,,,,3.0,MG,Tablet,,2023,Q1,Confusional state,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, unknown",,,N,,,,,3.0,MG,Tablet,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, unknown",,,N,,,,,3.0,MG,Tablet,,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, unknown",,,N,,,,,7.0,MG,Tablet,,2023,Q1,Confusional state,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, unknown",,,N,,,,,7.0,MG,Tablet,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, unknown",,,N,,,,,7.0,MG,Tablet,,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, unknown",,,N,,,,,14.0,MG,Tablet,,2023,Q1,Confusional state,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, unknown",,,N,,,,,14.0,MG,Tablet,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369701,22136970,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, unknown",,,N,,,,,14.0,MG,Tablet,,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230302.0,20230313.0,20230324,20230324,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202303007123,ELI LILLY AND CO,,77.0,YR,,M,Y,104.0,KG,20230324,,CN,GB,GB,2023,Q1,Elderly
221369771,22136977,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q1,Coronary arterial stent insertion,,2023,Q1,1,I,,20230313.0,20230324,20230324,EXP,,HR-JNJFOC-20230350442,JOHNSON AND JOHNSON,,76.0,YR,E,F,Y,84.0,KG,20230321,,HP,HR,HR,2023,Q1,Elderly
221398111,22139811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",121.429,MG,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q1,Bile duct stone,,2023,Q1,1,I,20230303.0,20230315.0,20230327,20230327,EXP,,CN-NOVOPROD-1039551,NOVO NORDISK,,68.0,YR,,M,Y,77.0,KG,20230327,,MD,CN,CN,2023,Q1,Elderly
221398111,22139811,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",121.429,MG,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q1,Cholangitis,,2023,Q1,1,I,20230303.0,20230315.0,20230327,20230327,EXP,,CN-NOVOPROD-1039551,NOVO NORDISK,,68.0,YR,,M,Y,77.0,KG,20230327,,MD,CN,CN,2023,Q1,Elderly
221458521,22145852,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5030592,20230507.0,99.0,0.05,ML,,QW,2023,Q1,Dyspepsia,,2023,Q1,1,I,20230215.0,,20230327,20230327,DIR,654037,,FDA-CTU,,53.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458571,22145857,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5029395,20230305.0,99.0,0.25,ML,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20230128.0,,20230327,20230327,DIR,654038,,FDA-CTU,,36.0,YR,,M,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458571,22145857,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5029395,20230305.0,99.0,0.25,ML,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20230128.0,,20230327,20230327,DIR,654038,,FDA-CTU,,36.0,YR,,M,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458581,22145858,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5019716,20221016.0,99.0,0.2,ML,,QW,2023,Q1,Product prescribing error,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654043,,FDA-CTU,,75.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Elderly
221458581,22145858,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5019716,20221016.0,99.0,0.2,ML,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654043,,FDA-CTU,,75.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Elderly
221458581,22145858,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5019716,20221016.0,99.0,0.2,ML,,QW,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654043,,FDA-CTU,,75.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Elderly
221458581,22145858,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5019716,20221016.0,99.0,0.2,ML,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654043,,FDA-CTU,,75.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Elderly
221458641,22145864,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5022457,20221126.0,99.0,0.125,ML,,QW,2023,Q1,Diarrhoea,,2023,Q1,1,I,20221026.0,,20230327,20230327,DIR,654040,,FDA-CTU,,25.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Young Adult
221458641,22145864,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5022457,20221126.0,99.0,0.125,ML,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20221026.0,,20230327,20230327,DIR,654040,,FDA-CTU,,25.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Young Adult
221458651,22145865,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5022237,20221124.0,99.0,0.25,ML,,QW,2023,Q1,Vomiting,,2023,Q1,1,I,20221020.0,,20230327,20230327,DIR,654041,,FDA-CTU,,64.0,YR,,M,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458651,22145865,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,LG5022237,20221124.0,99.0,0.25,ML,,QW,2023,Q1,Nausea,,2023,Q1,1,I,20221020.0,,20230327,20230327,DIR,654041,,FDA-CTU,,64.0,YR,,M,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458701,22145870,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5028616,20230225.0,99.0,0.25,ML,,999,2023,Q1,Nausea,,2023,Q1,1,I,20230119.0,,20230327,20230327,DIR,654039,,FDA-CTU,,63.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458701,22145870,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5028616,20230225.0,99.0,0.25,ML,,999,2023,Q1,Vomiting,,2023,Q1,1,I,20230119.0,,20230327,20230327,DIR,654039,,FDA-CTU,,63.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458861,22145886,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Product prescribing error,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654045,,FDA-CTU,,49.0,YR,,UNK,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458861,22145886,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654045,,FDA-CTU,,49.0,YR,,UNK,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458861,22145886,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Vomiting,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654045,,FDA-CTU,,49.0,YR,,UNK,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458861,22145886,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Nausea,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654045,,FDA-CTU,,49.0,YR,,UNK,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458881,22145888,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Product prescribing error,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654044,,FDA-CTU,,47.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458881,22145888,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Nausea,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654044,,FDA-CTU,,47.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458881,22145888,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Vomiting,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654044,,FDA-CTU,,47.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221458881,22145888,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5019071,20221006.0,99.0,0.2,ML,,999,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20220910.0,,20230327,20230327,DIR,654044,,FDA-CTU,,47.0,YR,,F,N,,,20230327,Y,PH,US,,2023,Q1,Adult
221493721,22149372,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 mg,,,U,,,,,4.0,MG,,,2023,Q1,Drug interaction,,2023,Q1,1,I,,20230322.0,20230329,20230329,EXP,,NVSC2023CA067562,NOVARTIS,,56.0,YR,,M,Y,63.0,KG,20230329,,MD,CA,CA,2023,Q1,Adult
221493721,22149372,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 mg,,,U,,,,,4.0,MG,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230322.0,20230329,20230329,EXP,,NVSC2023CA067562,NOVARTIS,,56.0,YR,,M,Y,63.0,KG,20230329,,MD,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Arthropathy,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Femur fracture,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Gait disturbance,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Tooth abscess,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Musculoskeletal stiffness,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Joint stiffness,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Joint swelling,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Treatment failure,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Tooth disorder,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Neutrophil count increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Pyrexia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Synovitis,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,White blood cell count increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Red blood cell sedimentation rate increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Hepatic enzyme increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Lymphocyte count increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Infection,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Gastric disorder,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Pain,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Anaemia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Insomnia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Nausea,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Osteopenia,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Drug intolerance,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Red cell distribution width increased,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221520151,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q1,Infusion related reaction,,2023,Q1,1,I,,20230321.0,20230329,20230329,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230329,,HP,CA,CA,2023,Q1,Adult
221564861,22156486,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,,,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221564861,22156486,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,,,2023,Q1,Thrombocytopenia,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221564861,22156486,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,,,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221564861,22156486,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,,,2023,Q1,Thrombocytopenia,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221564861,22156486,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,NOT SPECIFIED,,2023,Q1,Chronic kidney disease,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221564861,22156486,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,unknown,,,,,NOT SPECIFIED,,2023,Q1,Thrombocytopenia,,2023,Q1,1,I,,20230322.0,20230330,20230330,EXP,,CA-FreseniusKabi-FK202303926,FRESENIUS KABI,,85.0,YR,,M,Y,117.0,KG,20230330,,HP,CA,CA,2023,Q1,Elderly
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Hypoacusis,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Wheezing,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Loss of personal independence in daily activities,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Sleep disorder due to a general medical condition,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221575971,22157597,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230320.0,20230330,20230330,EXP,,CA-TEVA-2023-CA-2869720,TEVA,,51.0,YR,A,F,Y,,,20230330,,HP,CA,CA,2023,Q1,Adult
221587111,22158711,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 milligram, Once a Day(qd)",,,U,,,,,14.0,MG,,QD,2023,Q1,Vascular device infection,,2023,Q1,1,I,20220203.0,20230319.0,20230331,20230331,EXP,,GB-AUROBINDO-AUR-APL-2023-013813,AUROBINDO,,62.0,YR,,M,Y,113.0,KG,20230331,,MD,GB,GB,2023,Q1,Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Heart rate increased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Intervertebral disc protrusion,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Illness,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Laryngitis bacterial,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Nasal congestion,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Oropharyngeal pain,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,COVID-19,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Stress,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Insulin-like growth factor increased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Blood pressure increased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Ligament sprain,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Cortisol decreased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Drug resistance,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Infectious mononucleosis,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Abscess,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Blood growth hormone increased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Heart rate decreased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Blood pressure systolic increased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Abdominal pain,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Drug ineffective,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Movement disorder,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Groin abscess,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Anxiety,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Subcutaneous abscess,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Back pain,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Sciatic nerve injury,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Sinusitis,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Back injury,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Facial pain,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Blood cholesterol abnormal,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Body temperature decreased,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Muscle spasms,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Cough,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1436788040,14367880,50,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Headache,,2023,Q2,40,F,20151225.0,20230612.0,20180109,20230623,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Young Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site bruising,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Cough,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Vaccination site pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Anxiety,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Bell's palsy,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Oropharyngeal pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site swelling,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Asthenia,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Malaise,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Anaphylactic reaction,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Paralysis,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Mobility decreased,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Eye haemorrhage,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Urinary incontinence,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Throat clearing,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Lipoma,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Foreign body sensation in eyes,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site swelling,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Limb discomfort,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Hypoaesthesia,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Oxygen saturation decreased,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Lacrimation increased,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Sputum discoloured,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injury,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Symptom recurrence,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Symptom recurrence,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Dizziness,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site bruising,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Back pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Decreased appetite,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Productive cough,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Feeling abnormal,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Lethargy,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Discomfort,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Loss of consciousness,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Weight increased,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Sinus congestion,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Asthenia,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Sputum discoloured,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Headache,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Tinnitus,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Paranasal sinus discomfort,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Upper-airway cough syndrome,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Tinnitus,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Aphthous ulcer,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Chills,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Hypertensive crisis,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Throat clearing,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Dizziness,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Fall,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Eyelid ptosis,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Contusion,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Procedural pain,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Illness,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,COVID-19,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1475009818,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,18,F,20171205.0,20230516.0,20180412,20230529,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Insomnia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Platelet count increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Stress,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasal congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oedema peripheral,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod bite,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Claustrophobia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fibromyalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,C-reactive protein increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diplopia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Autoimmune disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Ulcer,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Sinusitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Abdominal pain upper,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lacrimation increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oropharyngeal pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Back pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Alopecia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nausea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Throat irritation,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Drug ineffective,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemorrhage,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Productive cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Eye pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Optic neuritis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Mean cell haemoglobin decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Electrocardiogram T wave abnormal,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Expired product administered,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Food allergy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Loss of consciousness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash vesicular,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Bronchitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lung disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Swelling,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dermatitis allergic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anaphylactic shock,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Headache,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Influenza,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Myalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lethargy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Body temperature decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Blood pressure increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Urticaria,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Migraine,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Heart rate increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemoptysis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lymphadenopathy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Acne cystic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Choking,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Tachycardia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Malaise,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injury,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Gastrointestinal motility disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oxygen saturation decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chills,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Illness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Wheezing,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Allergy to chemicals,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anxiety,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Hypersensitivity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vomiting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Psoriasis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Red cell distribution width increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Muscle spasms,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Balance disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vision blurred,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Laryngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dizziness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Paranasal sinus discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pruritus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain in extremity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod sting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Insomnia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Platelet count increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Stress,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasal congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oedema peripheral,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod bite,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Claustrophobia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fibromyalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,C-reactive protein increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diplopia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Autoimmune disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Ulcer,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Sinusitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Abdominal pain upper,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lacrimation increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oropharyngeal pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Back pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Alopecia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nausea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Throat irritation,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Drug ineffective,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemorrhage,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Productive cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Eye pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Optic neuritis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Mean cell haemoglobin decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Electrocardiogram T wave abnormal,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Expired product administered,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Food allergy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Loss of consciousness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash vesicular,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Bronchitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lung disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Swelling,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dermatitis allergic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anaphylactic shock,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Headache,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Influenza,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Myalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lethargy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Body temperature decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Blood pressure increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Urticaria,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Migraine,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Heart rate increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemoptysis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lymphadenopathy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Acne cystic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Choking,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Tachycardia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Malaise,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injury,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Gastrointestinal motility disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oxygen saturation decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chills,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Illness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Wheezing,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Allergy to chemicals,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anxiety,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Hypersensitivity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vomiting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Psoriasis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Red cell distribution width increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Muscle spasms,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Balance disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vision blurred,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Laryngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dizziness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Paranasal sinus discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pruritus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain in extremity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod sting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Insomnia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Platelet count increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Stress,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasal congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oedema peripheral,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod bite,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Claustrophobia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fibromyalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,C-reactive protein increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diplopia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Autoimmune disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Ulcer,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Sinusitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Abdominal pain upper,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lacrimation increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oropharyngeal pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Back pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Alopecia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nausea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Throat irritation,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Drug ineffective,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemorrhage,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Productive cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Eye pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Optic neuritis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Mean cell haemoglobin decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Electrocardiogram T wave abnormal,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Expired product administered,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Food allergy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Cough,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Loss of consciousness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash vesicular,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Bronchitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Respiratory tract congestion,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lung disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Swelling,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dermatitis allergic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anaphylactic shock,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Headache,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Influenza,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Myalgia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lethargy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Body temperature decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Blood pressure increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Diarrhoea,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Urticaria,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Migraine,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Heart rate increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Haemoptysis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Lymphadenopathy,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Acne cystic,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Choking,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Tachycardia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Malaise,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injury,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Gastrointestinal motility disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Oxygen saturation decreased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chest discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Chills,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Illness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Wheezing,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Allergy to chemicals,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Anxiety,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Injection site pain,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Hypersensitivity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vomiting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Psoriasis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Rash,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Red cell distribution width increased,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Muscle spasms,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Balance disorder,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Vision blurred,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Laryngitis,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Dizziness,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Paranasal sinus discomfort,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pruritus,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Pain in extremity,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1670401337,16704013,67,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2023,Q2,Arthropod sting,,2023,Q2,37,F,20170215.0,20230327.0,20190814,20230405,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20230405,,CN,CA,CA,2023,Q2,Young Adult
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Muscular weakness,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Conjunctivitis,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Vascular cognitive impairment,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Mood swings,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Eye inflammation,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Arthralgia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Ocular discomfort,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Glaucoma,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Dementia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Paranoia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Bronchitis,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Gene mutation,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Asthenia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Blood pressure systolic increased,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Autoinflammatory disease,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Joint swelling,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Treatment failure,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Ocular hyperaemia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Amnesia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Skin disorder,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Myalgia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Deafness neurosensory,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Arthralgia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Chills,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Decreased appetite,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Eye pain,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Cryopyrin associated periodic syndrome,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Drug intolerance,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Illness,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Serum amyloid A protein increased,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Drug effect less than expected,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Lethargy,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Delirium,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Urticaria,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Agitation,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Pneumonia,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Rash,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
1672248916,16722489,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2023,Q2,Hypertension,,2023,Q2,16,F,20190301.0,20230524.0,20190820,20230601,EXP,,PHHY2019CA193318,NOVARTIS,,86.0,YR,,M,Y,,,20230601,,MD,CA,CA,2023,Q2,Elderly
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181601217,18160121,53,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230412.0,20200818,20230421,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20230421,,HP,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Stress,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Prolonged expiration,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Appetite disorder,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Nasal congestion,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Depressed mood,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Insomnia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Flank pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Chest discomfort,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Productive cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Rhinorrhoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Lower respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Rales,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Wheezing,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Malaise,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Fall,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Heart sounds,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Pyrexia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Nasopharyngitis,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Asthma,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Influenza,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Respiration abnormal,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Chest pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Injury,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Depressive symptom,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Dyspnoea exertional,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Upper respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q2,Angina pectoris,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
181801444,18180144,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,4,F,,20230515.0,20200821,20230523,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20230523,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Chest discomfort,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Depressed mood,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Dyspnoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Pyrexia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Wheezing,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Flank pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Chest pain,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Rales,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Respiration abnormal,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Fall,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Asthma,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Stress,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Nasal congestion,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Prolonged expiration,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Depressive symptom,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Appetite disorder,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Weight decreased,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Influenza,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Malaise,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Insomnia,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Angina pectoris,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Injury,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Heart sounds,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182657237,18265723,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q2,Productive cough,,2023,Q2,7,F,,20230504.0,20200915,20230509,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230509,,CN,CA,CA,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Neutrophil count increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Bronchitis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood urea increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Syncope,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Depression,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood alkaline phosphatase increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Demyelination,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Infusion related reaction,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Electric shock,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dry mouth,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Rheumatoid factor increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood pressure systolic decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Drug hypersensitivity,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood creatinine increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Vitamin D deficiency,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Monocyte count increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Pain,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Glycosylated haemoglobin increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood immunoglobulin A increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Adrenal insufficiency,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Neuropathy peripheral,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood glucose decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,White blood cell count increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Glomerular filtration rate increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Anaphylactic reaction,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Back pain,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Depressed mood,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Granulocyte count increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Miosis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood uric acid increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Cognitive disorder,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood test abnormal,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dysphagia,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Oxygen saturation decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Spinal disorder,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Urine leukocyte esterase positive,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Temperature intolerance,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Red blood cell sedimentation rate increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Balance disorder,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Vitamin B12 deficiency,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Hyperhidrosis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,C-reactive protein increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Intervertebral discitis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dry eye,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Red blood cell count decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Urticaria,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Therapeutic response decreased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Aspartate aminotransferase increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Vitamin B12 increased,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Progressive multifocal leukoencephalopathy,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Muscular weakness,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Ulcer,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Cholecystitis acute,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Throat irritation,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Multiple sclerosis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Coordination abnormal,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Hypotension,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Rheumatoid arthritis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dactylitis,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Post cholecystectomy syndrome,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint noise,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Post-traumatic stress disorder,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
182734398,18273439,82,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Throat clearing,,2023,Q2,8,F,,20230612.0,20200916,20230620,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20230620,,MD,CA,,2023,Q2,Adult
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Blood magnesium decreased,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Hypertension,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Product use issue,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Off label use,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Chronic kidney disease,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Acute kidney injury,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Hypotension,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Depression,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Malaise,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Urinary tract infection,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Constipation,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Diarrhoea,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
191540623,19154062,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2023,Q2,Sleep disorder,,2023,Q2,3,F,,20230418.0,20210419,20230501,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-09374,SAMSUNG BIOEPIS,,72.0,YR,E,M,Y,131.0,KG,20230501,,HP,CA,CA,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood glucose increased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Tenderness,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood immunoglobulin M decreased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood glucose decreased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Swelling,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Injection site infection,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Treatment noncompliance,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Infusion site extravasation,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Tinnitus,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Injection site erythema,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Malaise,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Infusion site swelling,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Feeling abnormal,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Dysphonia,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Infusion site pain,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood glucose increased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,No adverse event,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood pressure systolic increased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Infusion site scar,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Abdominal discomfort,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Infusion site extravasation,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood pressure increased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Erythema,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Blood immunoglobulin A decreased,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Malaise,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
1967798212,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2023,Q2,Injection site pruritus,,2023,Q2,12,F,20210804.0,20230517.0,20210810,20230525,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20230525,,MD,US,US,2023,Q2,Elderly
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,129,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,130,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,131,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,132,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,133,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
199676585,19967658,134,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230515.0,20211019,20230529,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230529,,HP,CA,CA,2023,Q2,Adult
202356048,20235604,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,,,,,215256.0,1.7,MG,Solution for injection,/WK,2023,Q2,Bile duct stone,,2023,Q2,8,F,20211218.0,20230329.0,20211228,20230406,EXP,,GR-NOVOPROD-877957,NOVO NORDISK,,69.0,YR,,M,Y,99.0,KG,20230406,,MD,GR,GR,2023,Q2,Elderly
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Wheezing,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Asthma,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Depression,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
202392556,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,6,F,,20230516.0,20211228,20230521,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230520,,MD,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Dyspepsia,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,COVID-19,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Hyperthyroidism,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Pain,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Impaired gastric emptying,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Insomnia,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Synovitis,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Expired product administered,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Herpes virus infection,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Intentional product use issue,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Diabetic neuropathy,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Prescribed underdose,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
203360275,20336027,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230531.0,20220114,20230610,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-00502,SAMSUNG BIOEPIS,,39.0,YR,A,F,Y,92.0,KG,20230609,,HP,CA,CA,2023,Q2,Adult
205103166,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Diabetic retinopathy,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Diabetic retinopathy,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Diabetic retinopathy,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Macular oedema,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
205103166,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Diabetic retinopathy,,2023,Q2,6,F,20210712.0,20230608.0,20220224,20230619,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20230619,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Back pain,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Sepsis,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Vascular device infection,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Ecchymosis,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Haematoma,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Hypotension,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Vomiting,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Pyrexia,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Infusion related reaction,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206157334,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,UNKNOWN,,,14.0,MG,Unknown,QD,2023,Q2,Diarrhoea,,2023,Q2,4,F,20220101.0,20230320.0,20220321,20230403,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20230331,,MD,GB,GB,2023,Q2,Adult
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Hypotension,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Angina unstable,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Dizziness,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Acute myocardial infarction,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Vomiting,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
206250403,20625040,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2023,Q2,Asthenia,,2023,Q2,3,F,20210727.0,20230412.0,20220323,20230420,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20230420,,HP,CA,CA,2023,Q2,Elderly
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Headache,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Ocular hyperaemia,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Cough,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Asthma,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Exposure to SARS-CoV-2,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Tooth infection,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Infection,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Malaise,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Intentional product use issue,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,COVID-19,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Off label use,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Incorrect dose administered,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Infusion site swelling,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208137084,20813708,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2023,Q2,Nasal congestion,,2023,Q2,4,F,,20230518.0,20220511,20230526,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20230526,,HP,CA,CA,2023,Q2,Adult
208406013,20840601,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Malaise,,2023,Q2,3,F,,20230516.0,20220517,20230523,PER,,US-PFIZER INC-202200586136,PFIZER,,71.0,YR,,F,Y,,,20230523,,CN,US,US,2023,Q2,Elderly
208406013,20840601,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,3,F,,20230516.0,20220517,20230523,PER,,US-PFIZER INC-202200586136,PFIZER,,71.0,YR,,F,Y,,,20230523,,CN,US,US,2023,Q2,Elderly
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Blood pressure systolic abnormal,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Blood pressure systolic increased,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Heart rate increased,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Discomfort,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Anxiety,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
210238623,21023862,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Indication WEIGHT DECREASED,,,,,,,,,,,,2023,Q2,Product preparation issue,,2023,Q2,3,F,,20230615.0,20220629,20230619,EXP,,CA-ROCHE-3124891,ROCHE,,39.0,YR,,F,Y,,,20230619,,CN,CA,,2023,Q2,Adult
211124152,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,2,F,,20230614.0,20220721,20230622,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20230622,,HP,CA,CA,2023,Q2,Adult
211124152,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2023,Q2,Crohn's disease,,2023,Q2,2,F,,20230614.0,20220721,20230622,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20230622,,HP,CA,CA,2023,Q2,Adult
211124152,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2023,Q2,Infection,,2023,Q2,2,F,,20230614.0,20220721,20230622,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20230622,,HP,CA,CA,2023,Q2,Adult
211124152,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2023,Q2,Heart rate increased,,2023,Q2,2,F,,20230614.0,20220721,20230622,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20230622,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211604104,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,4,F,,20230530.0,20220802,20230607,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20230608,,HP,CA,CA,2023,Q2,Adult
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Oxygen saturation decreased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Aortic arteriosclerosis,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood pressure increased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Weight decreased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Weight increased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood pressure fluctuation,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood pressure diastolic abnormal,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood pressure systolic increased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
211972483,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,3,F,,20230503.0,20220810,20230509,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20230509,,HP,CA,CA,2023,Q2,Elderly
212259183,21225918,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q2,Intentional product use issue,,2023,Q2,3,F,,20230328.0,20220818,20230405,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230405,,HP,CA,CA,2023,Q2,Adult
212259183,21225918,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,3,F,,20230328.0,20220818,20230405,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230405,,HP,CA,CA,2023,Q2,Adult
212259183,21225918,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,3,F,,20230328.0,20220818,20230405,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230405,,HP,CA,CA,2023,Q2,Adult
212259183,21225918,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,3,F,,20230328.0,20220818,20230405,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230405,,HP,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212346083,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230621.0,20220820,20230630,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20230630,,CN,CA,CA,2023,Q2,Adult
212640503,21264050,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Cholelithiasis,,2023,Q2,3,F,20220724.0,20230511.0,20220829,20230519,EXP,,NO-NOVOPROD-949768,NOVO NORDISK,,61.0,YR,,M,Y,114.0,KG,20230519,,MD,NO,NO,2023,Q2,Adult
212640503,21264050,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Cholangitis,,2023,Q2,3,F,20220724.0,20230511.0,20220829,20230519,EXP,,NO-NOVOPROD-949768,NOVO NORDISK,,61.0,YR,,M,Y,114.0,KG,20230519,,MD,NO,NO,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Abdominal hernia,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Intentional product use issue,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Off label use,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Blood pressure increased,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Internal haemorrhage,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Condition aggravated,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
212712733,21271273,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,/WK,2023,Q2,Fatigue,,2023,Q2,3,F,,20230531.0,20220830,20230612,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-21439,SAMSUNG BIOEPIS,,41.0,YR,A,F,Y,92.0,KG,20230612,,HP,CA,CA,2023,Q2,Adult
213320442,21332044,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,2,F,20180801.0,20230428.0,20220914,20230504,EXP,,CA-AMGEN-CAN-20180905325,AMGEN,,49.0,YR,A,F,Y,,,20230504,,CN,CA,CA,2023,Q2,Adult
213320442,21332044,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Osteochondroma,,2023,Q2,2,F,20180801.0,20230428.0,20220914,20230504,EXP,,CA-AMGEN-CAN-20180905325,AMGEN,,49.0,YR,A,F,Y,,,20230504,,CN,CA,CA,2023,Q2,Adult
213320442,21332044,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,2,F,20180801.0,20230428.0,20220914,20230504,EXP,,CA-AMGEN-CAN-20180905325,AMGEN,,49.0,YR,A,F,Y,,,20230504,,CN,CA,CA,2023,Q2,Adult
213320442,21332044,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,2,F,20180801.0,20230428.0,20220914,20230504,EXP,,CA-AMGEN-CAN-20180905325,AMGEN,,49.0,YR,A,F,Y,,,20230504,,CN,CA,CA,2023,Q2,Adult
213320442,21332044,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Musculoskeletal pain,,2023,Q2,2,F,20180801.0,20230428.0,20220914,20230504,EXP,,CA-AMGEN-CAN-20180905325,AMGEN,,49.0,YR,A,F,Y,,,20230504,,CN,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Visual impairment,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Abdominal pain,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Hordeolum,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Ocular hyperaemia,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Eye infection,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Purulent discharge,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Eye disorder,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213329862,21332986,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,2,F,,20230512.0,20220914,20230519,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,70.0,KG,20230519,,HP,CA,CA,2023,Q2,Adult
213858562,21385856,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Acute myocardial infarction,,2023,Q2,2,F,20210110.0,20230526.0,20220928,20230530,EXP,,FR-ABBVIE-4132080,ABBVIE,,63.0,YR,,F,Y,,,20230530,,MD,FR,FR,2023,Q2,Adult
213858562,21385856,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,2,F,20210110.0,20230526.0,20220928,20230530,EXP,,FR-ABBVIE-4132080,ABBVIE,,63.0,YR,,F,Y,,,20230530,,MD,FR,FR,2023,Q2,Adult
213858562,21385856,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Troponin increased,,2023,Q2,2,F,20210110.0,20230526.0,20220928,20230530,EXP,,FR-ABBVIE-4132080,ABBVIE,,63.0,YR,,F,Y,,,20230530,,MD,FR,FR,2023,Q2,Adult
213858562,21385856,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Acute coronary syndrome,,2023,Q2,2,F,20210110.0,20230526.0,20220928,20230530,EXP,,FR-ABBVIE-4132080,ABBVIE,,63.0,YR,,F,Y,,,20230530,,MD,FR,FR,2023,Q2,Adult
215306952,21530695,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Wound,,2023,Q2,2,F,,20230607.0,20221031,20230608,EXP,,CA-BAUSCH-BL-2022-024421,BAUSCH AND LOMB,,56.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
215306952,21530695,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Cardiac failure congestive,,2023,Q2,2,F,,20230607.0,20221031,20230608,EXP,,CA-BAUSCH-BL-2022-024421,BAUSCH AND LOMB,,56.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Productive cough,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Rales,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Stress,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fall,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Injury,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Insomnia,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Cough,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Flank pain,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Malaise,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Influenza,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,169,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Asthma,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Productive cough,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Appetite disorder,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Depressed mood,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Heart sounds,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Chest pain,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Rales,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Angina pectoris,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Stress,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Dyspnoea,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Depressive symptom,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Fall,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Chest discomfort,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Respiration abnormal,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Wheezing,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Injury,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Nasal congestion,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Insomnia,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Pyrexia,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Cough,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Flank pain,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Malaise,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Influenza,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
216754195,21675419,170,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week",,,U,,,,,1.25,MG,,/WK,2023,Q2,Prolonged expiration,,2023,Q2,5,F,,20230516.0,20221202,20230519,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230519,,HP,CA,CA,2023,Q2,Adult
2168303613,21683036,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Hypoxia,,2023,Q2,13,F,20221120.0,20230418.0,20221205,20230425,PER,,HR-Eisai Medical Research-EC-2022-129202,EISAI,,61.0,YR,A,F,Y,94.0,KG,20230425,,MD,HR,,2023,Q2,Adult
2168303613,21683036,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Anaemia,,2023,Q2,13,F,20221120.0,20230418.0,20221205,20230425,PER,,HR-Eisai Medical Research-EC-2022-129202,EISAI,,61.0,YR,A,F,Y,94.0,KG,20230425,,MD,HR,,2023,Q2,Adult
2168303613,21683036,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,13,F,20221120.0,20230418.0,20221205,20230425,PER,,HR-Eisai Medical Research-EC-2022-129202,EISAI,,61.0,YR,A,F,Y,94.0,KG,20230425,,MD,HR,,2023,Q2,Adult
217299062,21729906,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q2,Acute kidney injury,,2023,Q2,2,F,,20230607.0,20221214,20230608,EXP,,CA-BAUSCH-BL-2022-027297,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
217299062,21729906,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q2,Vomiting,,2023,Q2,2,F,,20230607.0,20221214,20230608,EXP,,CA-BAUSCH-BL-2022-027297,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
217299062,21729906,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q2,Nausea,,2023,Q2,2,F,,20230607.0,20221214,20230608,EXP,,CA-BAUSCH-BL-2022-027297,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
217299062,21729906,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q2,Decreased appetite,,2023,Q2,2,F,,20230607.0,20221214,20230608,EXP,,CA-BAUSCH-BL-2022-027297,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
217299062,21729906,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q2,Malaise,,2023,Q2,2,F,,20230607.0,20221214,20230608,EXP,,CA-BAUSCH-BL-2022-027297,BAUSCH AND LOMB,,89.0,YR,,F,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
217704487,21770448,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,Injection,/WK,2023,Q2,Pneumonia viral,,2023,Q2,7,F,20221107.0,20230518.0,20221223,20230523,EXP,,ES-JNJFOC-20221121575,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,,,20230523,,MD,ES,ES,2023,Q2,Adult
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Hyponatraemia,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Malaise,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218147963,21814796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, 1 week",,,U,,,,,,,,,2023,Q2,Nausea,,2023,Q2,3,F,,20230414.0,20230104,20230427,EXP,,CA-AUROBINDO-AUR-APL-2022-057230,AUROBINDO,,89.0,YR,,F,Y,,,20230427,,HP,CA,CA,2023,Q2,Elderly
218449122,21844912,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218449122,21844912,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230508.0,20230110,20230511,EXP,,CA-BAUSCH-BL-2023-000419,BAUSCH AND LOMB,,70.0,YR,,F,Y,69.0,KG,20230511,,CN,CA,CA,2023,Q2,Elderly
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Infusion site pain,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,COVID-19,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Poor venous access,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Vital functions abnormal,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Blood pressure diastolic decreased,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Erythema nodosum,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Abdominal pain,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Heart rate decreased,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Therapeutic response shortened,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Incorrect route of product administration,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
218495852,21849585,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2023,Q2,Nasal congestion,,2023,Q2,2,F,,20230609.0,20230111,20230620,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-00229,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,91.0,KG,20230620,,HP,CA,CA,2023,Q2,Youth
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint debridement,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Staphylococcal bacteraemia,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint stiffness,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Knee arthroplasty,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthritis infective,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint irrigation,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219591093,21959109,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint swelling,,2023,Q2,3,F,20230125.0,20230530.0,20230206,20230616,EXP,,CA-BAUSCH-BL-2023-001999,BAUSCH AND LOMB,,63.0,YR,,M,Y,129.0,KG,20230616,,PH,CA,CA,2023,Q2,Adult
219606182,21960618,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,42.48,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q2,Weight decreased,,2023,Q2,2,F,20221125.0,20230515.0,20230207,20230525,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230525,,MD,FR,FR,2023,Q2,Elderly
219606182,21960618,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",42.48,MG,Y,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,2,F,20221125.0,20230515.0,20230207,20230525,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230525,,MD,FR,FR,2023,Q2,Elderly
219606182,21960618,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,42.48,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q2,Weight decreased,,2023,Q2,2,F,20221125.0,20230515.0,20230207,20230525,EXP,,FR-NOVOPROD-1009647,NOVO NORDISK,,70.0,YR,,F,Y,90.0,KG,20230525,,MD,FR,FR,2023,Q2,Elderly
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
219832373,21983237,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230524.0,20230213,20230530,EXP,,NVSC2023CA026799,NOVARTIS,,51.0,YR,,F,Y,,,20230530,,CN,CA,CA,2023,Q2,Adult
220470703,22047070,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,,,,U,,,,,7.0,MG,,QD,2023,Q2,Urinary tract infection,,2023,Q2,3,F,20220802.0,20230420.0,20230301,20230421,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221904",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,,,20230421,,MD,JP,JP,2023,Q2,Elderly
220470703,22047070,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,,,,U,,,,,7.0,MG,,QD,2023,Q2,Ureterolithiasis,,2023,Q2,3,F,20220802.0,20230420.0,20230301,20230421,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-221904",BOEHRINGER INGELHEIM,,65.0,YR,E,M,Y,,,20230421,,MD,JP,JP,2023,Q2,Elderly
220497432,22049743,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Cardiac failure congestive,,2023,Q2,2,F,,20230524.0,20230301,20230531,EXP,,NVSC2023CA044266,NOVARTIS,,56.0,YR,,M,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
220497432,22049743,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Wound,,2023,Q2,2,F,,20230524.0,20230301,20230531,EXP,,NVSC2023CA044266,NOVARTIS,,56.0,YR,,M,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Malaise,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Acute kidney injury,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Hyponatraemia,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Decreased appetite,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Vomiting,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220554542,22055454,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Nausea,,2023,Q2,2,F,,20230524.0,20230302,20230531,EXP,,NVSC2023CA044188,NOVARTIS,,89.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrointestinal disorder,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220557692,22055769,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,,20230426.0,20230302,20230503,EXP,,NVSC2023CA044178,NOVARTIS,,70.0,YR,,F,Y,69.0,KG,20230503,,CN,CA,CA,2023,Q2,Elderly
220921522,22092152,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.65 milligram, qwk",,,,,,,,0.65,MG,,/WK,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230201.0,20230326.0,20230314,20230403,EXP,,FI-AMGEN-FINSP2023043772,AMGEN,,53.0,YR,A,F,Y,,,20230403,,MD,FI,FI,2023,Q2,Adult
220921522,22092152,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.65 milligram, qwk",,,,,,,,0.65,MG,,/WK,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230201.0,20230326.0,20230314,20230403,EXP,,FI-AMGEN-FINSP2023043772,AMGEN,,53.0,YR,A,F,Y,,,20230403,,MD,FI,FI,2023,Q2,Adult
220921522,22092152,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.65 milligram, qwk",,,,,,,,0.65,MG,,/WK,2023,Q2,Constipation,,2023,Q2,2,F,20230201.0,20230326.0,20230314,20230403,EXP,,FI-AMGEN-FINSP2023043772,AMGEN,,53.0,YR,A,F,Y,,,20230403,,MD,FI,FI,2023,Q2,Adult
220921522,22092152,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.65 milligram, qwk",,,,,,,,0.65,MG,,/WK,2023,Q2,Alanine aminotransferase increased,,2023,Q2,2,F,20230201.0,20230326.0,20230314,20230403,EXP,,FI-AMGEN-FINSP2023043772,AMGEN,,53.0,YR,A,F,Y,,,20230403,,MD,FI,FI,2023,Q2,Adult
220921522,22092152,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.65 milligram, qwk",,,,,,,,0.65,MG,,/WK,2023,Q2,Cholelithiasis,,2023,Q2,2,F,20230201.0,20230326.0,20230314,20230403,EXP,,FI-AMGEN-FINSP2023043772,AMGEN,,53.0,YR,A,F,Y,,,20230403,,MD,FI,FI,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221026873,22102687,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,3,F,,20230613.0,20230316,20230623,EXP,,NVSC2023CA055630,NOVARTIS,,51.0,YR,,F,Y,,,20230620,,HP,CA,CA,2023,Q2,Adult
221034064,22103406,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q2,Osteonecrosis,,2023,Q2,4,F,20220101.0,20230519.0,20230316,20230524,EXP,,JP-ROCHE-3311221,ROCHE,,50.0,YR,,M,Y,,,20230524,,MD,JP,JP,2023,Q2,Adult
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Nephrosclerosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Kidney fibrosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Respiratory failure,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Thrombocytopenia,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Renal tubular dysfunction,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Infection,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Renal disorder,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Blood potassium abnormal,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Hepatic steatosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,start date : 21-Oct-2020,,,,,,,,,,,,2023,Q2,Glomerular filtration rate decreased,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Nephrosclerosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Kidney fibrosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Respiratory failure,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Thrombocytopenia,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Renal tubular dysfunction,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Infection,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Renal disorder,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood potassium abnormal,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Hepatic steatosis,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221040702,22104070,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Glomerular filtration rate decreased,,2023,Q2,2,F,20220101.0,20230330.0,20230316,20230406,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224128",BOEHRINGER INGELHEIM,,68.0,YR,E,M,Y,90.0,KG,20230406,,HP,DE,DE,2023,Q2,Elderly
221098403,22109840,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Take 14 mg by mouth once daily- Oral,714.0,MG,,,,,,14.0,MG,Tablet,QD,2023,Q2,No adverse event,,2023,Q2,3,F,20230309.0,20230419.0,20230317,20230426,EXP,,US-ORGANON-O2303USA001172,ORGANON,,43.0,YR,,F,Y,102.49,KG,20230426,,HP,US,US,2023,Q2,Adult
221098403,22109840,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Take 14 mg by mouth once daily- Oral,714.0,MG,,,,,,14.0,MG,Tablet,QD,2023,Q2,Device expulsion,,2023,Q2,3,F,20230309.0,20230419.0,20230317,20230426,EXP,,US-ORGANON-O2303USA001172,ORGANON,,43.0,YR,,F,Y,102.49,KG,20230426,,HP,US,US,2023,Q2,Adult
221183452,22118345,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Diabetic retinopathy,,2023,Q2,2,F,20221021.0,20230504.0,20230321,20230515,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230515,,MD,BG,BG,2023,Q2,Adult
221183452,22118345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q2,Diabetic retinopathy,,2023,Q2,2,F,20221021.0,20230504.0,20230321,20230515,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230515,,MD,BG,BG,2023,Q2,Adult
221183452,22118345,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2023,Q2,Diabetic retinopathy,,2023,Q2,2,F,20221021.0,20230504.0,20230321,20230515,EXP,,BG-NOVOPROD-974385,NOVO NORDISK,,49.0,YR,,F,Y,107.0,KG,20230515,,MD,BG,BG,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Stress,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Blood cholesterol increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Transient ischaemic attack,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Poor quality sleep,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,0.5,MG,Injection,,2023,Q2,Hypertension,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Stress,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Blood cholesterol increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Transient ischaemic attack,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Poor quality sleep,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg,,,U,,,,,1.0,MG,Injection,,2023,Q2,Hypertension,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Stress,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Blood cholesterol increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Transient ischaemic attack,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Poor quality sleep,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221277962,22127796,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,Injection,,2023,Q2,Hypertension,,2023,Q2,2,F,,20230619.0,20230323,20230623,EXP,,NVSC2023CA059697,NOVARTIS,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
221353392,22135339,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"Dose text: 3 mg, 7 mg, 14 mg",,,U,N,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,2,F,20210301.0,20230413.0,20230324,20230414,EXP,,CA-ANIPHARMA-2023-CA-000637,ANI,,78.0,YR,,M,Y,106.0,KG,20230414,,HP,CA,CA,2023,Q2,Elderly
221353392,22135339,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"Dose text: 3 mg, 7 mg, 14 mg",,,U,N,,,,,,,,2023,Q2,Head injury,,2023,Q2,2,F,20210301.0,20230413.0,20230324,20230414,EXP,,CA-ANIPHARMA-2023-CA-000637,ANI,,78.0,YR,,M,Y,106.0,KG,20230414,,HP,CA,CA,2023,Q2,Elderly
221353392,22135339,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"Dose text: 3 mg, 7 mg, 14 mg",,,U,N,,,,,,,,2023,Q2,Disorientation,,2023,Q2,2,F,20210301.0,20230413.0,20230324,20230414,EXP,,CA-ANIPHARMA-2023-CA-000637,ANI,,78.0,YR,,M,Y,106.0,KG,20230414,,HP,CA,CA,2023,Q2,Elderly
221353392,22135339,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"Dose text: 3 mg, 7 mg, 14 mg",,,U,N,,,,,,,,2023,Q2,Fall,,2023,Q2,2,F,20210301.0,20230413.0,20230324,20230414,EXP,,CA-ANIPHARMA-2023-CA-000637,ANI,,78.0,YR,,M,Y,106.0,KG,20230414,,HP,CA,CA,2023,Q2,Elderly
221353392,22135339,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"Dose text: 3 mg, 7 mg, 14 mg",,,U,N,,,,,,,,2023,Q2,Confusional state,,2023,Q2,2,F,20210301.0,20230413.0,20230324,20230414,EXP,,CA-ANIPHARMA-2023-CA-000637,ANI,,78.0,YR,,M,Y,106.0,KG,20230414,,HP,CA,CA,2023,Q2,Elderly
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Nasopharyngitis,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,COVID-19,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Arthralgia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Rheumatoid arthritis,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Joint swelling,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Blood pressure increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Red cell distribution width increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Tooth disorder,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Gastric disorder,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Weight decreased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Gait disturbance,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Infusion related reaction,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Lymphocyte count increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Glycosylated haemoglobin increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug ineffective,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Rheumatoid arthritis,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Tooth abscess,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Red blood cell sedimentation rate increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Anaemia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Joint stiffness,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Treatment failure,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug intolerance,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Insomnia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Neutrophil count increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Fatigue,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Blood pressure increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Arthralgia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Weight increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,White blood cell count increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Osteopenia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Arthropathy,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Nasal congestion,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Pyrexia,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Infection,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Pain,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Femur fracture,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Heart rate increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Synovitis,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Fatigue,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Nausea,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221520152,22152015,27,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution,,2023,Q2,Hepatic enzyme increased,,2023,Q2,2,F,,20230424.0,20230329,20230501,EXP,,NVSC2023CA066763,NOVARTIS,,54.0,YR,,F,Y,110.0,KG,20230501,,HP,CA,CA,2023,Q2,Adult
221666891,22166689,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"1 dosage form, QW (au long cours)",,,,,,,,,,Solution for injection in pre-filled pen,/WK,2023,Q2,Lipase increased,,2023,Q2,1,I,20230309.0,20230327.0,20230403,20230403,EXP,FR-AFSSAPS-TO2023000536,NVSC2023FR070706,NOVARTIS,,76.0,YR,,F,Y,67.0,KG,20230403,,MD,FR,FR,2023,Q2,Elderly
221666891,22166689,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"1 dosage form, QW (au long cours)",,,,,,,,,,Solution for injection in pre-filled pen,/WK,2023,Q2,Hypokalaemia,,2023,Q2,1,I,20230309.0,20230327.0,20230403,20230403,EXP,FR-AFSSAPS-TO2023000536,NVSC2023FR070706,NOVARTIS,,76.0,YR,,F,Y,67.0,KG,20230403,,MD,FR,FR,2023,Q2,Elderly
221666891,22166689,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"1 dosage form, QW (au long cours)",,,,,,,,,,Solution for injection in pre-filled pen,/WK,2023,Q2,Hyponatraemia,,2023,Q2,1,I,20230309.0,20230327.0,20230403,20230403,EXP,FR-AFSSAPS-TO2023000536,NVSC2023FR070706,NOVARTIS,,76.0,YR,,F,Y,67.0,KG,20230403,,MD,FR,FR,2023,Q2,Elderly
221696102,22169610,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",,,,,,,215256.0,0.5,MG,Solution for injection,/WK,2023,Q2,Gastroenteritis,,2023,Q2,2,F,20230305.0,20230412.0,20230404,20230421,EXP,,US-NOVOPROD-1043796,NOVO NORDISK,,56.0,YR,,F,Y,103.0,KG,20230421,,MD,US,US,2023,Q2,Adult
221701871,22170187,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Swelling,,2023,Q2,1,I,,20230327.0,20230404,20230404,EXP,,CA-AstraZeneca-2023A072225,ASTRAZENECA,,55.0,YR,,F,Y,,,20230404,,MD,CA,,2023,Q2,Adult
221701871,22170187,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Swelling face,,2023,Q2,1,I,,20230327.0,20230404,20230404,EXP,,CA-AstraZeneca-2023A072225,ASTRAZENECA,,55.0,YR,,F,Y,,,20230404,,MD,CA,,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Joint swelling,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Oral herpes,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Influenza,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Hemiparesis,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Psoriatic arthropathy,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221735431,22173543,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Pain,,2023,Q2,1,I,20191007.0,20230327.0,20230404,20230404,EXP,,NVSC2019CA014571,NOVARTIS,,52.0,YR,,F,Y,,,20230404,,CN,CA,CA,2023,Q2,Adult
221756281,22175628,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.05 ML WEEKLY SUBCUTANEOUS?,,,D,D,156456,20220709.0,99.0,0.05,ML,,QW,2023,Q2,Nausea,,2023,Q2,1,I,20230401.0,,20230404,20230404,DIR,655097,,FDA-CTU,,46.0,YR,,M,N,,,20230404,N,HP,US,,2023,Q2,Adult
221756281,22175628,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.05 ML WEEKLY SUBCUTANEOUS?,,,D,D,156456,20220709.0,99.0,0.05,ML,,QW,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,,20230404,20230404,DIR,655097,,FDA-CTU,,46.0,YR,,M,N,,,20230404,N,HP,US,,2023,Q2,Adult
221756281,22175628,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.05 ML WEEKLY SUBCUTANEOUS?,,,D,D,156456,20220709.0,99.0,0.05,ML,,QW,2023,Q2,Headache,,2023,Q2,1,I,20230401.0,,20230404,20230404,DIR,655097,,FDA-CTU,,46.0,YR,,M,N,,,20230404,N,HP,US,,2023,Q2,Adult
221756281,22175628,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,0.05 ML WEEKLY SUBCUTANEOUS?,,,D,D,156456,20220709.0,99.0,0.05,ML,,QW,2023,Q2,Vomiting,,2023,Q2,1,I,20230401.0,,20230404,20230404,DIR,655097,,FDA-CTU,,46.0,YR,,M,N,,,20230404,N,HP,US,,2023,Q2,Adult
221786391,22178639,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,,20230330.0,20230405,20230405,EXP,,US-009507513-2304USA000569,MERCK,"Forman JL, Mercurio MG.. Vulvar Pruritus in Postmenopausal Diabetic Women With Candidiasis Secondary to Sodium-Glucose Cotransporter Receptor-2 Inhibitors.. Journal of Lower Genital Tract Disease.. 2023;27 (1):68-70",66.0,YR,,F,Y,,,20230405,,HP,US,US,2023,Q2,Elderly
221786391,22178639,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q2,Vulvovaginal candidiasis,,2023,Q2,1,I,,20230330.0,20230405,20230405,EXP,,US-009507513-2304USA000569,MERCK,"Forman JL, Mercurio MG.. Vulvar Pruritus in Postmenopausal Diabetic Women With Candidiasis Secondary to Sodium-Glucose Cotransporter Receptor-2 Inhibitors.. Journal of Lower Genital Tract Disease.. 2023;27 (1):68-70",66.0,YR,,F,Y,,,20230405,,HP,US,US,2023,Q2,Elderly
221790481,22179048,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.1mg,,,N,U,,,209637.0,,,Solution for injection,,2023,Q2,Illness,,2023,Q2,1,I,20230325.0,20230327.0,20230406,20230406,EXP,,GB-NOVOPROD-1045335,NOVO NORDISK,,42.0,YR,,F,Y,150.0,KG,20230406,,CN,GB,GB,2023,Q2,Adult
221790651,22179065,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",8.64,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",8.64,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q2,Cholangitis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",8.64,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q2,Cholecystitis acute,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholangitis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholecystitis acute,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholangitis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholecystitis acute,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholangitis,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221790651,22179065,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.64,MG,D,,,,215256.0,,,Solution for injection,,2023,Q2,Cholecystitis acute,,2023,Q2,1,I,20210428.0,20210618.0,20230406,20230406,EXP,,PL-NOVOPROD-820629,NOVO NORDISK,,71.0,YR,,M,Y,93.0,KG,20230406,,MD,PL,PL,2023,Q2,Elderly
221845085,22184508,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",379.2,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Hepatic enzyme abnormal,,2023,Q2,5,F,20230328.0,20230614.0,20230407,20230626,EXP,,US-NOVOPROD-1045755,NOVO NORDISK,,57.0,YR,,F,Y,73.0,KG,20230626,,MD,US,US,2023,Q2,Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Speech disorder,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Hypertension,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Muscle spasms,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Loss of libido,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Condition aggravated,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Bradykinesia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Weight increased,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Gait disturbance,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Injury,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Disturbance in attention,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Muscular weakness,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Diabetes mellitus,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Headache,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Myocardial infarction,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Mood swings,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Anger,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Insomnia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Laziness,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Mental impairment,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Azoospermia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Disorientation,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Blood testosterone decreased,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Hyperactive pharyngeal reflex,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Self esteem decreased,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Tardive dyskinesia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Brain fog,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Erectile dysfunction,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Depression,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Confusional state,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Delusion,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Paranoia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Mental impairment,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Sperm concentration decreased,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Emotional distress,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Product taste abnormal,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Post-traumatic stress disorder,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Gynaecomastia,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Coordination abnormal,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Memory impairment,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221864053,22186405,12,C,semaglutide 0.25 mg or 0.5 mg(2 mg/1.5 mL) Pnij,,2,Intradermal,Inject 0.25 mg under the skin every seven (7) days.,,,U,,,,,0.25,MG,Injection,,2023,Q2,Vomiting,,2023,Q2,3,F,20210101.0,20230526.0,20230407,20230606,EXP,,US-TORRENT-00012590,TORRENT,,30.0,YR,A,M,Y,113.0,KG,20230606,,CN,US,US,2023,Q2,Young Adult
221872941,22187294,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,4.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230405.0,20230407,20230407,EXP,,CA-BAUSCH-BL-2023-005683,BAUSCH AND LOMB,,56.0,YR,,M,Y,63.0,KG,20230407,,MD,CA,CA,2023,Q2,Adult
221872941,22187294,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,4.0,MG,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230405.0,20230407,20230407,EXP,,CA-BAUSCH-BL-2023-005683,BAUSCH AND LOMB,,56.0,YR,,M,Y,63.0,KG,20230407,,MD,CA,CA,2023,Q2,Adult
221919421,22191942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,1,I,,20230331.0,20230410,20230410,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-09002,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,99.0,KG,20230410,,HP,CA,CA,2023,Q2,Adult
221919421,22191942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q2,Intentional product use issue,,2023,Q2,1,I,,20230331.0,20230410,20230410,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-09002,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,99.0,KG,20230410,,HP,CA,CA,2023,Q2,Adult
221919421,22191942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230331.0,20230410,20230410,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-09002,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,99.0,KG,20230410,,HP,CA,CA,2023,Q2,Adult
221919421,22191942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230331.0,20230410,20230410,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-09002,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,99.0,KG,20230410,,HP,CA,CA,2023,Q2,Adult
222003191,22200319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Urinary tract infection,,2023,Q2,1,I,20211014.0,20220302.0,20230412,20230412,EXP,,CA-JNJFOC-20220327562,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,87.0,KG,20230412,,HP,CA,CA,2023,Q2,Elderly
222003191,22200319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Haematuria,,2023,Q2,1,I,20211014.0,20220302.0,20230412,20230412,EXP,,CA-JNJFOC-20220327562,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,87.0,KG,20230412,,HP,CA,CA,2023,Q2,Elderly
222003191,22200319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Bladder irrigation,,2023,Q2,1,I,20211014.0,20220302.0,20230412,20230412,EXP,,CA-JNJFOC-20220327562,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,87.0,KG,20230412,,HP,CA,CA,2023,Q2,Elderly
222003191,22200319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Transurethral prostatectomy,,2023,Q2,1,I,20211014.0,20220302.0,20230412,20230412,EXP,,CA-JNJFOC-20220327562,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,87.0,KG,20230412,,HP,CA,CA,2023,Q2,Elderly
222028161,22202816,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,20230328.0,,20230412,20230412,DIR,656060,,FDA-CTU,,79.0,YR,,M,N,100.0,KG,20230412,N,PH,US,,2023,Q2,Elderly
222028161,22202816,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Laboratory test abnormal,,2023,Q2,1,I,20230328.0,,20230412,20230412,DIR,656060,,FDA-CTU,,79.0,YR,,M,N,100.0,KG,20230412,N,PH,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Temporomandibular joint syndrome,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Infusion related reaction,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Impaired driving ability,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Bone pain,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Myalgia,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood alkaline phosphatase increased,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Red blood cell sedimentation rate increased,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Autoimmune arthritis,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,C-reactive protein increased,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Vasculitis,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Pain in jaw,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222033791,22203379,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Spinal pain,,2023,Q2,1,I,20230324.0,,20230412,20230412,DIR,FDA-CDER-CTU-2023-27298,,FDA-CTU,,69.0,YR,,F,N,63.5,KG,20230412,N,CN,US,,2023,Q2,Elderly
222049772,22204977,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypophagia,,2023,Q2,2,F,,20230426.0,20230413,20230502,EXP,,JP-SA-2023SA111496,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20230502,,MD,JP,JP,2023,Q2,Elderly
222049772,22204977,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Nephropathy,,2023,Q2,2,F,,20230426.0,20230413,20230502,EXP,,JP-SA-2023SA111496,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20230502,,MD,JP,JP,2023,Q2,Elderly
222049772,22204977,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Ketoacidosis,,2023,Q2,2,F,,20230426.0,20230413,20230502,EXP,,JP-SA-2023SA111496,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20230502,,MD,JP,JP,2023,Q2,Elderly
222049772,22204977,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,,20230426.0,20230413,20230502,EXP,,JP-SA-2023SA111496,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20230502,,MD,JP,JP,2023,Q2,Elderly
222049772,22204977,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Malaise,,2023,Q2,2,F,,20230426.0,20230413,20230502,EXP,,JP-SA-2023SA111496,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20230502,,MD,JP,JP,2023,Q2,Elderly
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Fluid intake reduced,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Nausea,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Vomiting,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Lethargy,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Product storage error,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Vision blurred,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Product distribution issue,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222064371,22206437,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,159612,20230807.0,99.0,0.25,ML,,999,2023,Q2,Fatigue,,2023,Q2,1,I,20230330.0,,20230412,20230412,DIR,656175,,FDA-CTU,,54.0,YR,,F,N,,,20230412,N,PH,US,,2023,Q2,Adult
222070181,22207018,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,20230410.0,20230410.0,20230413,20230413,PER,,US-PFIZER INC-202300150063,PFIZER,,57.0,YR,,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222114752,22211475,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (Semaglutide B 3.0mg/ml PDS290 semaglutide 2.4 mg Blinded Semaglutide),,,U,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,2,F,20221025.0,20230410.0,20230414,20230428,EXP,,NVSC2023FR082295,NOVARTIS,,71.0,YR,,F,Y,68.0,KG,20230428,,HP,FR,FR,2023,Q2,Elderly
222116402,22211640,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,3.0,MG,,,2023,Q2,Pulmonary embolism,,2023,Q2,2,F,20230404.0,20230504.0,20230414,20230505,EXP,,GB-Eisai Medical Research-EC-2023-137924,EISAI,,76.0,YR,E,M,Y,80.4,KG,20230505,,MD,GB,,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222129261,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,UNKNOWN,,,,,Solution,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20221107.0,20230414,20230414,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20230414,,MD,CA,CA,2023,Q2,Elderly
222157462,22215746,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14 mg,,,,,,,,14.0,MG,,,2023,Q2,Hypotension,,2023,Q2,2,F,,20230515.0,20230416,20230517,EXP,,NVSJ2023JP006405,NOVARTIS,,35.0,YR,,M,Y,,,20230517,,MD,JP,JP,2023,Q2,Adult
222157462,22215746,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14 mg,,,,,,,,14.0,MG,,,2023,Q2,Blood pressure increased,,2023,Q2,2,F,,20230515.0,20230416,20230517,EXP,,NVSJ2023JP006405,NOVARTIS,,35.0,YR,,M,Y,,,20230517,,MD,JP,JP,2023,Q2,Adult
222168762,22216876,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Semaglutide B 3.0mg/ml PDS290 semaglutide 2.4 mg Blinded Semaglutide",,,U,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,2,F,20221025.0,20230502.0,20230417,20230510,EXP,,FR-AUROBINDO-AUR-APL-2023-030460,AUROBINDO,,71.0,YR,,F,Y,68.0,KG,20230510,,HP,FR,FR,2023,Q2,Elderly
222172403,22217240,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1mg/ dose (2mg/1,5ml) pen injector, as directed",,,,,,,,,,,,2023,Q2,Death,,2023,Q2,3,F,20230118.0,20230410.0,20230417,20230420,EXP,,US-ABBVIE-4730581,ABBVIE,,82.0,YR,,F,Y,,,20230420,,MD,US,US,2023,Q2,Elderly
222172403,22217240,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1mg/ dose (2mg/1,5ml) pen injector, as directed",,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,3,F,20230118.0,20230410.0,20230417,20230420,EXP,,US-ABBVIE-4730581,ABBVIE,,82.0,YR,,F,Y,,,20230420,,MD,US,US,2023,Q2,Elderly
222238441,22223844,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Faeces hard,,2023,Q2,1,I,20230112.0,20230113.0,20230418,20230418,PER,,US-UROVANT SCIENCES GMBH-202301-URV-000047,UROVANT SCIENCES,,83.0,YR,,F,Y,75.737,KG,20230418,,CN,US,US,2023,Q2,Elderly
222238441,22223844,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Urinary retention,,2023,Q2,1,I,20230112.0,20230113.0,20230418,20230418,PER,,US-UROVANT SCIENCES GMBH-202301-URV-000047,UROVANT SCIENCES,,83.0,YR,,F,Y,75.737,KG,20230418,,CN,US,US,2023,Q2,Elderly
222249921,22224992,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20200420.0,,20230414,20230414,DIR,FDA-CDER-CTU-2023-28284,,FDA-CTU,,75.0,YR,,M,N,,,20211107,N,,US,,2023,Q2,Elderly
222249931,22224993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Emergency care,,2023,Q2,1,I,20200505.0,,20230414,20230414,DIR,FDA-CDER-CTU-2023-28288,,FDA-CTU,,65.0,YR,,M,N,,,20211107,N,,US,,2023,Q2,Elderly
222249941,22224994,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Emergency care,,2023,Q2,1,I,20200505.0,,20230414,20230414,DIR,FDA-CDER-CTU-2023-28294,,FDA-CTU,,75.0,YR,,M,N,,,20211107,N,,US,,2023,Q2,Elderly
222269801,22226980,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 milligram,,,D,,,,,4.0,MG,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230412.0,20230419,20230419,EXP,,CA-APOTEX-2023AP007053,APOTEX,,56.0,YR,,M,Y,63.0,KG,20230419,,MD,CA,CA,2023,Q2,Adult
222269801,22226980,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 milligram,,,D,,,,,4.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230412.0,20230419,20230419,EXP,,CA-APOTEX-2023AP007053,APOTEX,,56.0,YR,,M,Y,63.0,KG,20230419,,MD,CA,CA,2023,Q2,Adult
222285091,22228509,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Semaglutide B 3.0mg/ml PDS290, 2.4 mg.",,,,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,1,I,20221025.0,20230413.0,20230419,20230419,EXP,,FR-MYLANLABS-2023M1040514,MYLAN,,71.0,YR,,F,Y,68.0,KG,20230419,,HP,FR,FR,2023,Q2,Elderly
222306251,22230625,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20230411.0,20230420,20230420,EXP,,IE-AMGEN-IRLSP2023063674,AMGEN,Kearney N.; Hughes R.; Kirby B. et al.. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,A,F,Y,132.3,KG,20230419,,HP,IE,IE,2023,Q2,Young Adult
222306251,22230625,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q2,Hidradenitis,,2023,Q2,1,I,,20230411.0,20230420,20230420,EXP,,IE-AMGEN-IRLSP2023063674,AMGEN,Kearney N.; Hughes R.; Kirby B. et al.. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,A,F,Y,132.3,KG,20230419,,HP,IE,IE,2023,Q2,Young Adult
222306251,22230625,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,1,I,,20230411.0,20230420,20230420,EXP,,IE-AMGEN-IRLSP2023063674,AMGEN,Kearney N.; Hughes R.; Kirby B. et al.. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,A,F,Y,132.3,KG,20230419,,HP,IE,IE,2023,Q2,Young Adult
222337431,22233743,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Sunburn,,2023,Q2,1,I,20230417.0,20230418.0,20230420,20230420,PER,,US-SA-2023SA122238,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20230420,,MD,US,US,2023,Q2,Elderly
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222423442,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,2,F,,20230414.0,20230422,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230425,,HP,CA,CA,2023,Q2,Adult
222429911,22242991,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,Y,,LG5027585,,99.0,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,20230419.0,,20230421,20230421,DIR,657287,,FDA-CTU,,74.0,YR,,F,N,,,20230421,Y,PH,US,,2023,Q2,Elderly
222429911,22242991,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,Y,,LG5027585,,99.0,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20230419.0,,20230421,20230421,DIR,657287,,FDA-CTU,,74.0,YR,,F,N,,,20230421,Y,PH,US,,2023,Q2,Elderly
222429911,22242991,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,Y,,LG5027585,,99.0,,,,,2023,Q2,Therapy change,,2023,Q2,1,I,20230419.0,,20230421,20230421,DIR,657287,,FDA-CTU,,74.0,YR,,F,N,,,20230421,Y,PH,US,,2023,Q2,Elderly
222439861,22243986,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Angiodysplasia,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,,CA-AUROBINDO-AUR-APL-2023-031885,AUROBINDO,,76.0,YR,,M,Y,,,20230424,,PH,CA,CA,2023,Q2,Elderly
222439861,22243986,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Upper gastrointestinal haemorrhage,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,,CA-AUROBINDO-AUR-APL-2023-031885,AUROBINDO,,76.0,YR,,M,Y,,,20230424,,PH,CA,CA,2023,Q2,Elderly
222446081,22244608,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK(solution subcutaneous),,,U,,,,,,,Solution,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230414.0,20230424,20230424,EXP,,CA-AUROBINDO-AUR-APL-2023-032380,AUROBINDO,,33.0,YR,,F,Y,,,20230424,,HP,CA,CA,2023,Q2,Young Adult
222446081,22244608,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK(solution subcutaneous),,,U,,,,,,,Solution,,2023,Q2,Abdominal pain,,2023,Q2,1,I,,20230414.0,20230424,20230424,EXP,,CA-AUROBINDO-AUR-APL-2023-032380,AUROBINDO,,33.0,YR,,F,Y,,,20230424,,HP,CA,CA,2023,Q2,Young Adult
222446081,22244608,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK(solution subcutaneous),,,U,,,,,,,Solution,,2023,Q2,Nausea,,2023,Q2,1,I,,20230414.0,20230424,20230424,EXP,,CA-AUROBINDO-AUR-APL-2023-032380,AUROBINDO,,33.0,YR,,F,Y,,,20230424,,HP,CA,CA,2023,Q2,Young Adult
222459261,22245926,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 mg?subcutaneous,,,U,,UNKNOWN,,,2.4,MG,,/WK,2023,Q2,Hypotension,,2023,Q2,1,I,20220622.0,20230417.0,20230424,20230424,EXP,,PL-FreseniusKabi-FK202305038,FRESENIUS KABI,,76.0,YR,E,M,Y,108.0,KG,20230424,,MD,PL,PL,2023,Q2,Elderly
222466862,22246686,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Semaglutide B 3.0mg/ml PDS290 semaglutide 2.4 mg Blinded Semaglutide",,,U,,,,,,,Unknown,,2023,Q2,Renal failure,,2023,Q2,2,F,20221025.0,20230509.0,20230424,20230517,EXP,,FR-FreseniusKabi-FK202305149,FRESENIUS KABI,,71.0,YR,E,F,Y,68.0,KG,20230517,,HP,FR,FR,2023,Q2,Elderly
222474901,22247490,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 milligram,,,U,,,,,4.0,MG,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230414.0,20230425,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-032548,AUROBINDO,,56.0,YR,,M,Y,63.0,KG,20230425,,MD,CA,CA,2023,Q2,Adult
222474901,22247490,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 milligram,,,U,,,,,4.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230414.0,20230425,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-032548,AUROBINDO,,56.0,YR,,M,Y,63.0,KG,20230425,,MD,CA,CA,2023,Q2,Adult
222483492,22248349,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,ML,Injection,/WK,2023,Q2,Myocardial infarction,,2023,Q2,2,F,20220422.0,20230614.0,20230425,20230622,EXP,,US-ROCHE-3087250,ROCHE,,53.0,YR,,F,Y,90.81,KG,20230622,,MD,US,,2023,Q2,Adult
222483492,22248349,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,ML,Injection,/WK,2023,Q2,Chest pain,,2023,Q2,2,F,20220422.0,20230614.0,20230425,20230622,EXP,,US-ROCHE-3087250,ROCHE,,53.0,YR,,F,Y,90.81,KG,20230622,,MD,US,,2023,Q2,Adult
222483492,22248349,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,ML,Injection,/WK,2023,Q2,Cytokine release syndrome,,2023,Q2,2,F,20220422.0,20230614.0,20230425,20230622,EXP,,US-ROCHE-3087250,ROCHE,,53.0,YR,,F,Y,90.81,KG,20230622,,MD,US,,2023,Q2,Adult
222530421,22253042,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2023,Q2,Atrioventricular block first degree,,2023,Q2,1,I,,20230412.0,20230426,20230426,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-04346,ALKEM,,46.0,YR,,M,Y,,,20230426,,HP,AU,AU,2023,Q2,Adult
222530421,22253042,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2023,Q2,Trifascicular block,,2023,Q2,1,I,,20230412.0,20230426,20230426,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-04346,ALKEM,,46.0,YR,,M,Y,,,20230426,,HP,AU,AU,2023,Q2,Adult
222530421,22253042,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2023,Q2,Cardiomyopathy,,2023,Q2,1,I,,20230412.0,20230426,20230426,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2023-04346,ALKEM,,46.0,YR,,M,Y,,,20230426,,HP,AU,AU,2023,Q2,Adult
222532491,22253249,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,C-reactive protein increased,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032457,AUROBINDO,,19.0,YR,,F,Y,,,20230426,,HP,CA,CA,2023,Q2,Youth
222532491,22253249,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Ankylosing spondylitis,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032457,AUROBINDO,,19.0,YR,,F,Y,,,20230426,,HP,CA,CA,2023,Q2,Youth
222532491,22253249,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032457,AUROBINDO,,19.0,YR,,F,Y,,,20230426,,HP,CA,CA,2023,Q2,Youth
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Depression,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222532701,22253270,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230424.0,20230426,20230426,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230426,,MD,CA,CA,2023,Q2,Adult
222534041,22253404,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (solution subcutaneous)",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (solution subcutaneous)",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Loss of consciousness,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (solution subcutaneous)",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Fatigue,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (solution subcutaneous)",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,Wrong technique in product usage process,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222534041,22253404,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (solution subcutaneous)",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230414.0,20230426,20230426,EXP,,CA-AUROBINDO-AUR-APL-2023-032365,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20230426,,HP,CA,CA,2023,Q2,Elderly
222545952,22254595,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg,,,,,,,,3.0,MG,,,2023,Q2,Myalgia,,2023,Q2,2,F,,20230518.0,20230426,20230523,EXP,,ES-BAYER-2023A051913,BAYER,,83.0,YR,E,M,Y,,,20230523,,HP,ES,ES,2023,Q2,Elderly
222545952,22254595,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg,,,,,,,,3.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,2,F,,20230518.0,20230426,20230523,EXP,,ES-BAYER-2023A051913,BAYER,,83.0,YR,E,M,Y,,,20230523,,HP,ES,ES,2023,Q2,Elderly
222545952,22254595,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg,,,,,,,,3.0,MG,,,2023,Q2,Dyspnoea,,2023,Q2,2,F,,20230518.0,20230426,20230523,EXP,,ES-BAYER-2023A051913,BAYER,,83.0,YR,E,M,Y,,,20230523,,HP,ES,ES,2023,Q2,Elderly
222545952,22254595,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg,,,,,,,,3.0,MG,,,2023,Q2,Renal impairment,,2023,Q2,2,F,,20230518.0,20230426,20230523,EXP,,ES-BAYER-2023A051913,BAYER,,83.0,YR,E,M,Y,,,20230523,,HP,ES,ES,2023,Q2,Elderly
222635341,22263534,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 0.5 mg, solution for injection in pre-filled pen, In long term",,,,,,,,,,,,2023,Q2,Hypokalaemia,,2023,Q2,1,I,20230309.0,20230418.0,20230428,20230428,EXP,FR-AFSSAPS-TO2023000536,FR-Accord-355674,ACCORD,,76.0,YR,E,F,Y,67.0,KG,20230428,,MD,FR,FR,2023,Q2,Elderly
222635341,22263534,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 0.5 mg, solution for injection in pre-filled pen, In long term",,,,,,,,,,,,2023,Q2,Hyponatraemia,,2023,Q2,1,I,20230309.0,20230418.0,20230428,20230428,EXP,FR-AFSSAPS-TO2023000536,FR-Accord-355674,ACCORD,,76.0,YR,E,F,Y,67.0,KG,20230428,,MD,FR,FR,2023,Q2,Elderly
222635341,22263534,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 0.5 mg, solution for injection in pre-filled pen, In long term",,,,,,,,,,,,2023,Q2,Lipase increased,,2023,Q2,1,I,20230309.0,20230418.0,20230428,20230428,EXP,FR-AFSSAPS-TO2023000536,FR-Accord-355674,ACCORD,,76.0,YR,E,F,Y,67.0,KG,20230428,,MD,FR,FR,2023,Q2,Elderly
222650012,22265001,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,3.0,MG,,,2023,Q2,Hypernatraemia,,2023,Q2,2,F,,20230518.0,20230428,20230526,EXP,,JP-AstraZeneca-2023A096720,ASTRAZENECA,"Sugiyama J, Ryuge A, Mitsubayashi K, Ito M, Matsumoto N, Takeuchi R, Azuma K, Hachiya A, Asano M, Nakamura T. Dapagliflozin induced hypernatremia via osmotic diuresis: a case report. CEN Case Reports 2023;1-5.",65.0,YR,,F,Y,77.0,KG,20230526,,HP,JP,,2023,Q2,Elderly
222654561,22265456,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, qd",,,,,,,,,,,QD,2023,Q2,Therapy interrupted,,2023,Q2,1,I,20230321.0,20230323.0,20230428,20230428,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0300716,MYOVANT SCIENCES,,75.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Elderly
222657221,22265722,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,3.0 mg/ml,,,Y,,,,,,,Unknown,/WK,2023,Q2,Drug eruption,,2023,Q2,1,I,20220911.0,20230419.0,20230428,20230428,EXP,,DE-JNJFOC-20230444235,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,104.0,KG,20230428,,MD,DE,DE,2023,Q2,Elderly
222657221,22265722,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,3.0 mg/ml,,,Y,,,,,,,Unknown,/WK,2023,Q2,Drug eruption,,2023,Q2,1,I,20220911.0,20230419.0,20230428,20230428,EXP,,DE-JNJFOC-20230444235,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,104.0,KG,20230428,,MD,DE,DE,2023,Q2,Elderly
222657221,22265722,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,3.0 mg/ml,,,Y,,,,,,,Unknown,/WK,2023,Q2,Drug eruption,,2023,Q2,1,I,20220911.0,20230419.0,20230428,20230428,EXP,,DE-JNJFOC-20230444235,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,104.0,KG,20230428,,MD,DE,DE,2023,Q2,Elderly
222666791,22266679,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20230424.0,20230428,20230428,EXP,,NVSC2023IE094764,NOVARTIS,"Kearney N, Hughes R, Kirby B. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures-experiences from a specialty clinic. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023;1-9",27.0,YR,,F,Y,132.3,KG,20230428,,HP,IE,IE,2023,Q2,Young Adult
222666791,22266679,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,1,I,,20230424.0,20230428,20230428,EXP,,NVSC2023IE094764,NOVARTIS,"Kearney N, Hughes R, Kirby B. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures-experiences from a specialty clinic. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023;1-9",27.0,YR,,F,Y,132.3,KG,20230428,,HP,IE,IE,2023,Q2,Young Adult
222666791,22266679,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hidradenitis,,2023,Q2,1,I,,20230424.0,20230428,20230428,EXP,,NVSC2023IE094764,NOVARTIS,"Kearney N, Hughes R, Kirby B. Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures-experiences from a specialty clinic. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023;1-9",27.0,YR,,F,Y,132.3,KG,20230428,,HP,IE,IE,2023,Q2,Young Adult
222666901,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,20230201.0,20230420.0,20230428,20230428,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Elderly
222666901,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20230201.0,20230420.0,20230428,20230428,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Elderly
222666901,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,1,I,20230201.0,20230420.0,20230428,20230428,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Elderly
222666901,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hot flush,,2023,Q2,1,I,20230201.0,20230420.0,20230428,20230428,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Elderly
222668981,22266898,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.25,MG,Injection,/WK,2023,Q2,Lactic acidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.25,MG,Injection,/WK,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.25,MG,Injection,/WK,2023,Q2,Electrolyte imbalance,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.75,MG,Injection,/WK,2023,Q2,Lactic acidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.75,MG,Injection,/WK,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.75,MG,Injection,/WK,2023,Q2,Electrolyte imbalance,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.5,MG,Injection,/WK,2023,Q2,Lactic acidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.5,MG,Injection,/WK,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,0.5,MG,Injection,/WK,2023,Q2,Electrolyte imbalance,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,1.0,MG,Injection,/WK,2023,Q2,Lactic acidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,1.0,MG,Injection,/WK,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222668981,22266898,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,2.5,MG,Y,,202206bcl1,,,1.0,MG,Injection,/WK,2023,Q2,Electrolyte imbalance,,2023,Q2,1,I,20230328.0,20230427.0,20230428,20230428,EXP,,CN-AstraZeneca-2023A099473,ASTRAZENECA,,23673.0,DY,,F,Y,62.0,KG,20230428,,MD,CN,,2023,Q2,Elderly
222678031,22267803,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2023,Q2,Euglycaemic diabetic ketoacidosis,,2023,Q2,1,I,,20230425.0,20230430,20230430,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-233753",BOEHRINGER INGELHEIM,"Chaudhry A, Roels C, Lee J. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery. Canadian Journal of Diabetes. 2022;46(8): 843-850. doi:10.1016/j.jcjd.2022.06.007.",70.0,YR,E,M,Y,88.0,KG,20230430,,MD,CA,CA,2023,Q2,Elderly
222678031,22267803,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2023,Q2,Coronary artery disease,,2023,Q2,1,I,,20230425.0,20230430,20230430,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-233753",BOEHRINGER INGELHEIM,"Chaudhry A, Roels C, Lee J. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery. Canadian Journal of Diabetes. 2022;46(8): 843-850. doi:10.1016/j.jcjd.2022.06.007.",70.0,YR,E,M,Y,88.0,KG,20230430,,MD,CA,CA,2023,Q2,Elderly
222697122,22269712,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,strength: 0.25/0.5 mg,,,,,,,,0.25,MG,,,2023,Q2,Drug ineffective,,2023,Q2,2,F,20230206.0,20230508.0,20230501,20230519,EXP,,CA-Accord-355265,ACCORD,,54.0,YR,A,F,Y,,,20230519,,PH,CA,CA,2023,Q2,Adult
222697122,22269712,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,strength: 0.25/0.5 mg,,,,,,,,0.25,MG,,,2023,Q2,Dizziness,,2023,Q2,2,F,20230206.0,20230508.0,20230501,20230519,EXP,,CA-Accord-355265,ACCORD,,54.0,YR,A,F,Y,,,20230519,,PH,CA,CA,2023,Q2,Adult
222697122,22269712,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,strength: 0.25/0.5 mg,,,,,,,,0.25,MG,,,2023,Q2,Concomitant disease aggravated,,2023,Q2,2,F,20230206.0,20230508.0,20230501,20230519,EXP,,CA-Accord-355265,ACCORD,,54.0,YR,A,F,Y,,,20230519,,PH,CA,CA,2023,Q2,Adult
222697122,22269712,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,strength: 0.25/0.5 mg,,,,,,,,0.25,MG,,,2023,Q2,Feeling abnormal,,2023,Q2,2,F,20230206.0,20230508.0,20230501,20230519,EXP,,CA-Accord-355265,ACCORD,,54.0,YR,A,F,Y,,,20230519,,PH,CA,CA,2023,Q2,Adult
222697122,22269712,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,strength: 0.25/0.5 mg,,,,,,,,0.25,MG,,,2023,Q2,Headache,,2023,Q2,2,F,20230206.0,20230508.0,20230501,20230519,EXP,,CA-Accord-355265,ACCORD,,54.0,YR,A,F,Y,,,20230519,,PH,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Therapy cessation,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Tension headache,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222699361,22269936,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,209637.0,,,,,2023,Q2,Pancreatitis,,2023,Q2,1,I,,20230418.0,20230501,20230501,EXP,CA-HEALTHCANVIG-E2B-06200174,CA-NOVOPROD-1055544,NOVO NORDISK,,59.0,YR,,M,Y,,,20230501,,CN,CA,CA,2023,Q2,Adult
222700611,22270061,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",502.629,MG,Y,U,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Cholecystitis,,2023,Q2,1,I,20230405.0,20230419.0,20230501,20230501,EXP,,DE-NOVOPROD-1054149,NOVO NORDISK,,67.0,YR,,M,Y,101.0,KG,20230501,,MD,DE,DE,2023,Q2,Elderly
222700611,22270061,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",502.629,MG,Y,U,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Bile duct stone,,2023,Q2,1,I,20230405.0,20230419.0,20230501,20230501,EXP,,DE-NOVOPROD-1054149,NOVO NORDISK,,67.0,YR,,M,Y,101.0,KG,20230501,,MD,DE,DE,2023,Q2,Elderly
222700611,22270061,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",502.629,MG,Y,U,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Pancreatitis,,2023,Q2,1,I,20230405.0,20230419.0,20230501,20230501,EXP,,DE-NOVOPROD-1054149,NOVO NORDISK,,67.0,YR,,M,Y,101.0,KG,20230501,,MD,DE,DE,2023,Q2,Elderly
222706362,22270636,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20230331.0,20230502.0,20230501,20230508,EXP,,HU-NOVOPROD-1056889,NOVO NORDISK,,67.0,YR,,M,Y,75.0,KG,20230508,,MD,HU,HU,2023,Q2,Elderly
222733312,22273331,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Neck pain,,2023,Q2,2,F,20230408.0,20230518.0,20230502,20230530,EXP,,CA-Accord-355931,ACCORD,,77.0,YR,E,M,Y,82.7,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
222742281,22274228,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 milligram, qw",,,,,,,,0.5,MG,,/WK,2023,Q2,Blood ketone body increased,,2023,Q2,1,I,20230328.0,20230422.0,20230502,20230502,EXP,,CN-009507513-2304CHN009708,MERCK,,42.0,YR,,F,Y,83.5,KG,20230502,,HP,CN,CN,2023,Q2,Adult
222761881,22276188,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg/mL,,,U,,,,,,,,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg/mL,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg/mL,,,U,,,,,,,,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg/mL,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.0 mg/mL,,,U,,,,,,,,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.0 mg/mL,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.27 mg/mL,,,U,,,,,,,,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.27 mg/mL,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222761881,22276188,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230425.0,20230502,20230502,EXP,,GB-JNJFOC-20230504310,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230503,,MD,GB,GB,2023,Q2,Adult
222767434,22276743,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,Once per day",,,,,,,213051.0,,,Tablet,,2023,Q2,Ischaemic cardiomyopathy,,2023,Q2,4,F,20230412.0,20230511.0,20230503,20230516,EXP,,US-NOVOPROD-1058334,NOVO NORDISK,,74.0,YR,,M,Y,84.0,KG,20230516,,MD,US,US,2023,Q2,Elderly
222767434,22276743,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,Once per day",,,,,,,213051.0,,,Tablet,,2023,Q2,Tachycardia,,2023,Q2,4,F,20230412.0,20230511.0,20230503,20230516,EXP,,US-NOVOPROD-1058334,NOVO NORDISK,,74.0,YR,,M,Y,84.0,KG,20230516,,MD,US,US,2023,Q2,Elderly
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Emotional disorder,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Nightmare,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Pain,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Irritability,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Nausea,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Therapeutic response unexpected,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Agitation,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Cold sweat,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Headache,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Hot flush,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Mental disorder,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Hepatic enzyme increased,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Gastrointestinal pain,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Patient dissatisfaction with treatment,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Abdominal pain,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Fatigue,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Constipation,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Drug withdrawal syndrome,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Arrhythmia,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222773831,22277383,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Food craving,,2023,Q2,1,I,,20230419.0,20230503,20230503,EXP,,CA-AUROBINDO-AUR-APL-2023-033053,AUROBINDO,,60.0,YR,,F,Y,,,20230503,,HP,CA,CA,2023,Q2,Adult
222792681,22279268,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q2,Appendicitis perforated,,2023,Q2,1,I,20230129.0,,20230502,20230502,DIR,658483,,FDA-CTU,,50.0,YR,,F,N,54.9,KG,20230502,N,CN,US,,2023,Q2,Adult
222794321,22279432,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hidradenitis,,2023,Q2,1,I,,20230428.0,20230503,20230503,EXP,,IE-MYLANLABS-2023M1046434,MYLAN,Kearney N.; Hughes R.; Kirby B. et al... Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic.. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,,F,Y,132.3,KG,20230503,,HP,IE,IE,2023,Q2,Young Adult
222794321,22279432,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20230428.0,20230503,20230503,EXP,,IE-MYLANLABS-2023M1046434,MYLAN,Kearney N.; Hughes R.; Kirby B. et al... Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic.. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,,F,Y,132.3,KG,20230503,,HP,IE,IE,2023,Q2,Young Adult
222794321,22279432,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,1,I,,20230428.0,20230503,20230503,EXP,,IE-MYLANLABS-2023M1046434,MYLAN,Kearney N.; Hughes R.; Kirby B. et al... Treatment of hidradenitis suppurativa with brodalumab in biologic treatment failures - experiences from a specialty clinic.. Clinical and Experimental Dermatology. 2023;1-9,27.0,YR,,F,Y,132.3,KG,20230503,,HP,IE,IE,2023,Q2,Young Adult
222808011,22280801,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230466358,JOHNSON AND JOHNSON,,58.0,YR,A,F,Y,99.0,KG,20230504,,PH,CA,CA,2023,Q2,Adult
222808011,22280801,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230466358,JOHNSON AND JOHNSON,,58.0,YR,A,F,Y,99.0,KG,20230504,,PH,CA,CA,2023,Q2,Adult
222808011,22280801,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230466358,JOHNSON AND JOHNSON,,58.0,YR,A,F,Y,99.0,KG,20230504,,PH,CA,CA,2023,Q2,Adult
222808011,22280801,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230466358,JOHNSON AND JOHNSON,,58.0,YR,A,F,Y,99.0,KG,20230504,,PH,CA,CA,2023,Q2,Adult
222808011,22280801,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,General physical health deterioration,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230466358,JOHNSON AND JOHNSON,,58.0,YR,A,F,Y,99.0,KG,20230504,,PH,CA,CA,2023,Q2,Adult
222816401,22281640,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,unk,,,,,,,2023,Q2,Macular oedema,,2023,Q2,1,I,20220412.0,20230426.0,20230504,20230504,EXP,,"PL-REGENERON PHARMACEUTICALS, INC.-2023-061073",REGENERON,,67.0,YR,,M,Y,,,20230504,,HP,PL,PL,2023,Q2,Elderly
222816401,22281640,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,unk,,,,,,,2023,Q2,Macular oedema,,2023,Q2,1,I,20220412.0,20230426.0,20230504,20230504,EXP,,"PL-REGENERON PHARMACEUTICALS, INC.-2023-061073",REGENERON,,67.0,YR,,M,Y,,,20230504,,HP,PL,PL,2023,Q2,Elderly
222816401,22281640,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,unk,,,,,,,2023,Q2,Macular oedema,,2023,Q2,1,I,20220412.0,20230426.0,20230504,20230504,EXP,,"PL-REGENERON PHARMACEUTICALS, INC.-2023-061073",REGENERON,,67.0,YR,,M,Y,,,20230504,,HP,PL,PL,2023,Q2,Elderly
222825451,22282545,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Meniere's disease,,2023,Q2,1,I,,20230428.0,20230504,20230504,EXP,,CA-AstraZeneca-2023A102650,ASTRAZENECA,,75.0,YR,,F,Y,,,20230504,,MD,CA,,2023,Q2,Elderly
222825451,22282545,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Meniere's disease,,2023,Q2,1,I,,20230428.0,20230504,20230504,EXP,,CA-AstraZeneca-2023A102650,ASTRAZENECA,,75.0,YR,,F,Y,,,20230504,,MD,CA,,2023,Q2,Elderly
222848371,22284837,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,5035283,,99.0,,,,QW,2023,Q2,Burning sensation,,2023,Q2,1,I,20230502.0,,20230503,20230503,DIR,658738,,FDA-CTU,,49.0,YR,,F,N,,,20230503,N,,US,,2023,Q2,Adult
222848371,22284837,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,5035283,,99.0,,,,QW,2023,Q2,Rash,,2023,Q2,1,I,20230502.0,,20230503,20230503,DIR,658738,,FDA-CTU,,49.0,YR,,F,N,,,20230503,N,,US,,2023,Q2,Adult
222848371,22284837,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,5035283,,99.0,,,,QW,2023,Q2,Pruritus,,2023,Q2,1,I,20230502.0,,20230503,20230503,DIR,658738,,FDA-CTU,,49.0,YR,,F,N,,,20230503,N,,US,,2023,Q2,Adult
222893811,22289381,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q2,Foetal exposure during pregnancy,,2023,Q2,1,I,20230430.0,,20230504,20230504,DIR,658873,,FDA-CTU,,35.0,YR,,F,N,94.5,KG,20230504,Y,CN,US,,2023,Q2,Adult
222893811,22289381,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q2,Abortion spontaneous,,2023,Q2,1,I,20230430.0,,20230504,20230504,DIR,658873,,FDA-CTU,,35.0,YR,,F,N,94.5,KG,20230504,Y,CN,US,,2023,Q2,Adult
222893811,22289381,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q2,Exposure during pregnancy,,2023,Q2,1,I,20230430.0,,20230504,20230504,DIR,658873,,FDA-CTU,,35.0,YR,,F,N,94.5,KG,20230504,Y,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Feeling abnormal,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Crying,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Hypoaesthesia,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Suicidal ideation,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Middle insomnia,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Chest pain,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Paraesthesia,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Panic attack,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Anxiety,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Palpitations,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Restlessness,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222917201,22291720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once a week;?,,,Y,Y,,,,,,,999,2023,Q2,Fear,,2023,Q2,1,I,20230413.0,,20230505,20230505,DIR,658960,,FDA-CTU,,40.0,YR,,F,N,63.9,KG,20230505,N,CN,US,,2023,Q2,Adult
222989161,22298916,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,Y,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Ketoacidosis,,2023,Q2,1,I,20230424.0,20230428.0,20230509,20230509,EXP,,GB-NOVOPROD-1060984,NOVO NORDISK,,56.0,YR,,M,Y,100.0,KG,20230509,,PH,GB,GB,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Product formulation issue,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Weight decreased,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Vomiting,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Malaise,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Hypophagia,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Drug hypersensitivity,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
222994311,22299431,1,PS,METHYLCOBALAMIN\SEMAGLUTIDE,METHYLCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25 ml;?Frequency : Weekly;?,,,Y,D,,20230626.0,99.0,,,,QW,2023,Q2,Intentional product misuse,,2023,Q2,1,I,20230424.0,,20230508,20230508,DIR,659274,,FDA-CTU,,40.0,YR,,F,N,63.0,KG,20230508,Y,CN,US,,2023,Q2,Adult
223019971,22301997,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2023,Q2,Renal impairment,,2023,Q2,1,I,,20230502.0,20230510,20230510,EXP,,ES-AstraZeneca-2023A101374,ASTRAZENECA,Gutierrez A. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. Unknown 2021;,83.0,YR,,M,Y,,,20230510,,MD,ES,,2023,Q2,Elderly
223019971,22301997,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230502.0,20230510,20230510,EXP,,ES-AstraZeneca-2023A101374,ASTRAZENECA,Gutierrez A. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. Unknown 2021;,83.0,YR,,M,Y,,,20230510,,MD,ES,,2023,Q2,Elderly
223019971,22301997,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230502.0,20230510,20230510,EXP,,ES-AstraZeneca-2023A101374,ASTRAZENECA,Gutierrez A. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. Unknown 2021;,83.0,YR,,M,Y,,,20230510,,MD,ES,,2023,Q2,Elderly
223019971,22301997,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230502.0,20230510,20230510,EXP,,ES-AstraZeneca-2023A101374,ASTRAZENECA,Gutierrez A. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. Unknown 2021;,83.0,YR,,M,Y,,,20230510,,MD,ES,,2023,Q2,Elderly
223039261,22303926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,,,2023,Q2,Renal impairment,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,ES-MYLANLABS-2023M1048043,MYLAN,Ana Guti?rrez. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. unknown. 2021,83.0,YR,,M,Y,,,20230510,,HP,ES,ES,2023,Q2,Elderly
223039261,22303926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,ES-MYLANLABS-2023M1048043,MYLAN,Ana Guti?rrez. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. unknown. 2021,83.0,YR,,M,Y,,,20230510,,HP,ES,ES,2023,Q2,Elderly
223039261,22303926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,ES-MYLANLABS-2023M1048043,MYLAN,Ana Guti?rrez. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. unknown. 2021,83.0,YR,,M,Y,,,20230510,,HP,ES,ES,2023,Q2,Elderly
223039261,22303926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,ES-MYLANLABS-2023M1048043,MYLAN,Ana Guti?rrez. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS. unknown. 2021,83.0,YR,,M,Y,,,20230510,,HP,ES,ES,2023,Q2,Elderly
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Movement disorder,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Alanine aminotransferase increased,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Pain,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Aspartate aminotransferase increased,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Abdominal distension,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Hepatic enzyme increased,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Back pain,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Blood alkaline phosphatase increased,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223047601,22304760,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q2,Vomiting,,2023,Q2,1,I,20230331.0,,20230509,20230509,DIR,659506,,FDA-CTU,,44.0,YR,,F,N,101.25,KG,20230509,Y,CN,US,,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223051801,22305180,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230504.0,20230510,20230510,EXP,,CA-MYLANLABS-2023M1048581,MYLAN,,51.0,YR,,F,Y,,,20230510,,HP,CA,CA,2023,Q2,Adult
223062021,22306202,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,U,,,,,3.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230428.0,20230511,20230511,EXP,,ES-AUROBINDO-AUR-APL-2023-034972,AUROBINDO,Ana Guti?rrez.. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS.. 2021,83.0,YR,,M,Y,,,20230511,,HP,ES,ES,2023,Q2,Elderly
223062021,22306202,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,U,,,,,3.0,MG,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230428.0,20230511,20230511,EXP,,ES-AUROBINDO-AUR-APL-2023-034972,AUROBINDO,Ana Guti?rrez.. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS.. 2021,83.0,YR,,M,Y,,,20230511,,HP,ES,ES,2023,Q2,Elderly
223062021,22306202,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,U,,,,,3.0,MG,,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230428.0,20230511,20230511,EXP,,ES-AUROBINDO-AUR-APL-2023-034972,AUROBINDO,Ana Guti?rrez.. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS.. 2021,83.0,YR,,M,Y,,,20230511,,HP,ES,ES,2023,Q2,Elderly
223062021,22306202,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,U,,,,,3.0,MG,,,2023,Q2,Renal impairment,,2023,Q2,1,I,,20230428.0,20230511,20230511,EXP,,ES-AUROBINDO-AUR-APL-2023-034972,AUROBINDO,Ana Guti?rrez.. NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER:FIGHTING LOCALLY ADVANCED PROSTATE CANCER 20 YEARS AFTER DIAGNOSIS.. 2021,83.0,YR,,M,Y,,,20230511,,HP,ES,ES,2023,Q2,Elderly
223122941,22312294,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Premature delivery,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Pre-eclampsia,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Maternal exposure before pregnancy,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223144893,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Cardiovascular disorder,,2023,Q2,3,F,20230218.0,20230621.0,20230512,20230628,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230628,,MD,HR,,2023,Q2,Adult
223144893,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Hypoxia,,2023,Q2,3,F,20230218.0,20230621.0,20230512,20230628,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230628,,MD,HR,,2023,Q2,Adult
223144893,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q2,Pericardial effusion,,2023,Q2,3,F,20230218.0,20230621.0,20230512,20230628,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230628,,MD,HR,,2023,Q2,Adult
223153051,22315305,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,999999.0,,,,,2023,Q2,Hepatic failure,,2023,Q2,1,I,20230505.0,,20230511,20230511,DIR,659832,,FDA-CTU,,29.0,YR,,M,N,78.75,KG,20230511,Y,CN,US,,2023,Q2,Young Adult
223153061,22315306,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223180431,22318043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg,,,Y,,05017954002221,,209637.0,,,,,2023,Q2,Hypotension,,2023,Q2,1,I,20230408.0,20230504.0,20230515,20230515,EXP,,GB-NOVOPROD-1061460,NOVO NORDISK,,28.0,YR,,F,Y,,,20230512,,CN,GB,GB,2023,Q2,Young Adult
223210421,22321042,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223225281,22322528,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.0 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.0 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.27 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223225281,22322528,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.27 mg/mL,,,U,U,,,209637.0,,,Solution for injection,,2023,Q2,Ventricular tachycardia,,2023,Q2,1,I,,20230503.0,20230516,20230516,EXP,,GB-NOVOPROD-1061437,NOVO NORDISK,,63.0,YR,,F,Y,,,20230516,,MD,GB,GB,2023,Q2,Adult
223229432,22322943,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,Once per week",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2023,Q2,Cholelithiasis,,2023,Q2,2,F,20230310.0,20230516.0,20230516,20230529,EXP,,ZA-NOVOPROD-1061850,NOVO NORDISK,,56.0,YR,,F,Y,96.0,KG,20230529,,MD,ZA,ZA,2023,Q2,Adult
223231131,22323113,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,N,,,99.0,,,,,2023,Q2,Illness,,2023,Q2,1,I,20230509.0,,20230512,20230512,DIR,660034,,FDA-CTU,,40.0,YR,,F,N,65.7,KG,20230512,N,CN,US,,2023,Q2,Adult
223250531,22325053,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2023,Q2,Septic shock,,2023,Q2,1,I,20230424.0,,20230514,20230514,DIR,660145,,FDA-CTU,,70.0,YR,,F,N,,,20230514,N,MD,US,,2023,Q2,Elderly
223250531,22325053,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2023,Q2,Necrotising fasciitis,,2023,Q2,1,I,20230424.0,,20230514,20230514,DIR,660145,,FDA-CTU,,70.0,YR,,F,N,,,20230514,N,MD,US,,2023,Q2,Elderly
223306651,22330665,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223315731,22331573,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,N,N,167879,,99.0,,,,QW,2023,Q2,Intercepted product prescribing error,,2023,Q2,1,I,20230512.0,,20230516,20230516,DIR,660351,,FDA-CTU,,27.0,YR,,F,N,97.65,KG,20230516,Y,CN,US,,2023,Q2,Young Adult
223315731,22331573,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,N,N,167879,,99.0,,,,QW,2023,Q2,Product prescribing error,,2023,Q2,1,I,20230512.0,,20230516,20230516,DIR,660351,,FDA-CTU,,27.0,YR,,F,N,97.65,KG,20230516,Y,CN,US,,2023,Q2,Young Adult
223315731,22331573,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Intercepted product prescribing error,,2023,Q2,1,I,20230512.0,,20230516,20230516,DIR,660351,,FDA-CTU,,27.0,YR,,F,N,97.65,KG,20230516,Y,CN,US,,2023,Q2,Young Adult
223315731,22331573,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Product prescribing error,,2023,Q2,1,I,20230512.0,,20230516,20230516,DIR,660351,,FDA-CTU,,27.0,YR,,F,N,97.65,KG,20230516,Y,CN,US,,2023,Q2,Young Adult
223405172,22340517,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,2,F,20230301.0,20230605.0,20230518,20230612,PER,,US-UROVANT SCIENCES GMBH-202305-URV-000831,UROVANT SCIENCES,,79.0,YR,,M,Y,89.796,KG,20230612,,CN,US,US,2023,Q2,Elderly
223420671,22342067,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Death,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-069532,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223424371,22342437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Hospitalisation,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-070559,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223424371,22342437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Septic shock,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-070559,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223424371,22342437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Upper gastrointestinal haemorrhage,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-070559,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223424371,22342437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Hypovolaemic shock,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-070559,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223424371,22342437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-070559,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,149.0,KG,20230519,,HP,CA,CA,2023,Q2,Elderly
223433341,22343334,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,209637.0,,,,,2023,Q2,Glycosylated haemoglobin increased,,2023,Q2,1,I,,20230508.0,20230519,20230519,EXP,,US-NOVOPROD-1064785,NOVO NORDISK,Daiena Shahid. Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. Endocrine Practice. 2023;29:S23-S24,33.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Young Adult
223433341,22343334,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,209637.0,,,,,2023,Q2,Pre-eclampsia,,2023,Q2,1,I,,20230508.0,20230519,20230519,EXP,,US-NOVOPROD-1064785,NOVO NORDISK,Daiena Shahid. Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. Endocrine Practice. 2023;29:S23-S24,33.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Young Adult
223433341,22343334,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,209637.0,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230508.0,20230519,20230519,EXP,,US-NOVOPROD-1064785,NOVO NORDISK,Daiena Shahid. Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. Endocrine Practice. 2023;29:S23-S24,33.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Young Adult
223433341,22343334,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,209637.0,,,,,2023,Q2,Premature delivery,,2023,Q2,1,I,,20230508.0,20230519,20230519,EXP,,US-NOVOPROD-1064785,NOVO NORDISK,Daiena Shahid. Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. Endocrine Practice. 2023;29:S23-S24,33.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Young Adult
223456611,22345661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Nephropathy toxic,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Nausea,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Asthenia,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Nephropathy toxic,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Nausea,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Asthenia,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223456611,22345661,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mcg qw,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230506.0,20230519,20230519,EXP,,BG-NOVOPROD-1063284,NOVO NORDISK,"Gorcheva, Desislava I., Lozanov, Lachezar B.,. Potential Risks of GLP-1RA and SGLT-2i Treatment. Endocrinologia. 2023;XXVIII",56.0,YR,,F,Y,,,20230519,,HP,BG,BG,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223462821,22346282,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230515.0,20230519,20230519,EXP,,CA-BAUSCH-BL-2023-007471,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230519,,CN,CA,CA,2023,Q2,Adult
223464711,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Pneumothorax,,2023,Q2,1,I,,20230516.0,20230519,20230519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Elderly
223464711,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Hypoglycaemic coma,,2023,Q2,1,I,,20230516.0,20230519,20230519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Elderly
223464711,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230516.0,20230519,20230519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Elderly
223464711,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230516.0,20230519,20230519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Elderly
223464711,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Rib fracture,,2023,Q2,1,I,,20230516.0,20230519,20230519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Elderly
223481001,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,unk,,,U,,,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230518.0,20230522,20230522,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230522,,PH,CA,CA,2023,Q2,Elderly
223481001,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,unk,,,U,,,,,,,,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,,20230518.0,20230522,20230522,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230522,,PH,CA,CA,2023,Q2,Elderly
223481001,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,unk,,,U,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230518.0,20230522,20230522,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230522,,PH,CA,CA,2023,Q2,Elderly
223481001,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,unk,,,U,,,,,,,,,2023,Q2,Wrong product administered,,2023,Q2,1,I,,20230518.0,20230522,20230522,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230522,,PH,CA,CA,2023,Q2,Elderly
223481251,22348125,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,restarted now at patients request,,,Y,U,,,209637.0,,,Solution for injection,,2023,Q2,Intestinal obstruction,,2023,Q2,1,I,20230318.0,20230511.0,20230522,20230522,EXP,,GB-NOVOPROD-1065707,NOVO NORDISK,,72.0,YR,,F,Y,138.0,KG,20230522,,MD,GB,GB,2023,Q2,Elderly
223481251,22348125,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25mcg once weekly,,,Y,U,,,209637.0,,,Solution for injection,,2023,Q2,Intestinal obstruction,,2023,Q2,1,I,20230318.0,20230511.0,20230522,20230522,EXP,,GB-NOVOPROD-1065707,NOVO NORDISK,,72.0,YR,,F,Y,138.0,KG,20230522,,MD,GB,GB,2023,Q2,Elderly
223530151,22353015,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 mg, qw",,,Y,,,,209637.0,0.25,MG,Solution for injection,/WK,2023,Q2,Mesenteric vein thrombosis,,2023,Q2,1,I,20220812.0,20230511.0,20230523,20230523,EXP,,GB-NOVOPROD-1065696,NOVO NORDISK,,76.0,YR,,F,Y,89.0,KG,20230523,,MD,GB,GB,2023,Q2,Elderly
223530151,22353015,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 mg, qw",,,Y,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q2,Mesenteric vein thrombosis,,2023,Q2,1,I,20220812.0,20230511.0,20230523,20230523,EXP,,GB-NOVOPROD-1065696,NOVO NORDISK,,76.0,YR,,F,Y,89.0,KG,20230523,,MD,GB,GB,2023,Q2,Elderly
223530181,22353018,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,take one daily,,,,,,,,,,Solution for injection,,2023,Q2,Dizziness,,2023,Q2,1,I,20230325.0,20230511.0,20230523,20230523,EXP,GB-MHRA-TPP41695729C4757292YC1683703456265,GB-NOVOPROD-1063996,NOVO NORDISK,,64.0,YR,,M,Y,93.0,KG,20230523,,HP,GB,GB,2023,Q2,Adult
223530181,22353018,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,take one daily,,,,,,,,,,Solution for injection,,2023,Q2,Rash erythematous,,2023,Q2,1,I,20230325.0,20230511.0,20230523,20230523,EXP,GB-MHRA-TPP41695729C4757292YC1683703456265,GB-NOVOPROD-1063996,NOVO NORDISK,,64.0,YR,,M,Y,93.0,KG,20230523,,HP,GB,GB,2023,Q2,Adult
223530181,22353018,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,take one daily,,,,,,,,,,Solution for injection,,2023,Q2,Vision blurred,,2023,Q2,1,I,20230325.0,20230511.0,20230523,20230523,EXP,GB-MHRA-TPP41695729C4757292YC1683703456265,GB-NOVOPROD-1063996,NOVO NORDISK,,64.0,YR,,M,Y,93.0,KG,20230523,,HP,GB,GB,2023,Q2,Adult
223550321,22355032,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg,,,,,,,,0.25,MG,Injection,,2023,Q2,Dysgeusia,,2023,Q2,1,I,20230518.0,20230520.0,20230523,20230523,PER,,US-PFIZER INC-202300198427,PFIZER,,57.0,YR,,F,Y,79.378,KG,20230523,,CN,US,US,2023,Q2,Adult
223671912,22367191,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2023,Q2,Live birth,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2023,Q2,Urticaria,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2023,Q2,Drug hypersensitivity,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Illness,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Migraine,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Product prescribing error,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Nausea,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Hunger,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700771,22370077,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 week,,,U,,,,,,,Solution for injection,,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230515.0,20230526,20230526,EXP,CA-HEALTHCANVIG-E2B_06208804,CA-NOVOPROD-1066689,NOVO NORDISK,,53.0,YR,,F,Y,,,20230526,,CN,CA,CA,2023,Q2,Adult
223700981,22370098,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,,,2023,Q2,Orthostatic hypotension,,2023,Q2,1,I,,20230517.0,20230526,20230526,EXP,,US-NOVOPROD-1067392,NOVO NORDISK,,29.0,YR,,F,Y,,,20230526,,MD,US,US,2023,Q2,Young Adult
223700981,22370098,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,,,2023,Q2,Syncope,,2023,Q2,1,I,,20230517.0,20230526,20230526,EXP,,US-NOVOPROD-1067392,NOVO NORDISK,,29.0,YR,,F,Y,,,20230526,,MD,US,US,2023,Q2,Young Adult
223700981,22370098,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,,,2023,Q2,Dizziness,,2023,Q2,1,I,,20230517.0,20230526,20230526,EXP,,US-NOVOPROD-1067392,NOVO NORDISK,,29.0,YR,,F,Y,,,20230526,,MD,US,US,2023,Q2,Young Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Back pain,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Dehydration,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Dyspnoea,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Insurance issue,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Memory impairment,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Spontaneous bacterial peritonitis,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Treatment noncompliance,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Ammonia abnormal,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Ascites,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Urinary tract infection,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Varices oesophageal,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Somnolence,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Inability to afford medication,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Diarrhoea,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Product use issue,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Cellulitis,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Condition aggravated,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Asthenia,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Hepatic encephalopathy,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223745992,22374599,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 or 0.5 mg/Dos, 2 mg/1.5 ml",,,,,,,,0.5,MG,,/WK,2023,Q2,Hepatic lesion,,2023,Q2,2,F,20210101.0,20230616.0,20230526,20230620,EXP,,US-BAUSCH-BL-2021-001929,BAUSCH AND LOMB,,58.0,YR,,F,Y,97.0,KG,20230620,,CN,US,US,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Lichenification,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Rheumatoid arthritis,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Ulcer,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Peripheral swelling,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Pain,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Hyperkeratosis,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Skin ulcer,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Hypoaesthesia,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Oedema,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Keloid scar,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Oedema peripheral,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Haemoglobin decreased,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Inflammation,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Polyuria,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Haematocrit decreased,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Mean cell haemoglobin decreased,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Musculoskeletal stiffness,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Papilloma,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Mouth ulceration,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223760501,22376050,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Tension,,2023,Q2,1,I,,20230519.0,20230527,20230527,EXP,CA-MHPD-E2B_06198391,CA-Accord-359651,ACCORD,,50.0,YR,A,M,Y,145.0,KG,20230527,,HP,CA,CA,2023,Q2,Adult
223769411,22376941,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Product storage error,,2023,Q2,1,I,20230523.0,20230524.0,20230529,20230529,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-074685,BRISTOL MYERS SQUIBB,,54.0,YR,A,F,Y,,,20230529,,CN,US,US,2023,Q2,Adult
223771791,22377179,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230516.0,20230529,20230529,EXP,CA- HEALTHCANVIG-001031987,CA-NOVOPROD-1067754,NOVO NORDISK,,66.0,YR,,M,Y,,,20230529,,HP,CA,CA,2023,Q2,Elderly
223771791,22377179,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,,20230516.0,20230529,20230529,EXP,CA- HEALTHCANVIG-001031987,CA-NOVOPROD-1067754,NOVO NORDISK,,66.0,YR,,M,Y,,,20230529,,HP,CA,CA,2023,Q2,Elderly
223771791,22377179,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230516.0,20230529,20230529,EXP,CA- HEALTHCANVIG-001031987,CA-NOVOPROD-1067754,NOVO NORDISK,,66.0,YR,,M,Y,,,20230529,,HP,CA,CA,2023,Q2,Elderly
223771791,22377179,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Renal tubular necrosis,,2023,Q2,1,I,,20230516.0,20230529,20230529,EXP,CA- HEALTHCANVIG-001031987,CA-NOVOPROD-1067754,NOVO NORDISK,,66.0,YR,,M,Y,,,20230529,,HP,CA,CA,2023,Q2,Elderly
223771791,22377179,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230516.0,20230529,20230529,EXP,CA- HEALTHCANVIG-001031987,CA-NOVOPROD-1067754,NOVO NORDISK,,66.0,YR,,M,Y,,,20230529,,HP,CA,CA,2023,Q2,Elderly
223772091,22377209,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 mg, qw",,,Y,U,,,209637.0,0.25,MG,Solution for injection,/WK,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230517.0,20230529,20230529,EXP,,GB-NOVOPROD-1066261,NOVO NORDISK,,60.0,YR,,F,Y,,,20230529,,MD,GB,GB,2023,Q2,Adult
223772091,22377209,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.5 mg, qw",,,Y,U,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230517.0,20230529,20230529,EXP,,GB-NOVOPROD-1066261,NOVO NORDISK,,60.0,YR,,F,Y,,,20230529,,MD,GB,GB,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Abdominal pain,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Food intolerance,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Oropharyngeal discomfort,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Accidental overdose,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Dehydration,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797281,22379728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.5 mg instead of 0.25 mg,,,U,,,,209637.0,,,,,2023,Q2,Product administration error,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069527,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;19:135-136",45.0,YR,,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Food intolerance,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Accidental overdose,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Hiccups,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Asthenia,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Food intolerance,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Accidental overdose,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Hiccups,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Asthenia,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223797291,22379729,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.66mg,,,U,,,,209637.0,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230515.0,20230529,20230529,EXP,,US-NOVOPROD-1069510,NOVO NORDISK,"Wiener, Brian G.;Gnirke, Marlis;Vassallo, Susi;Smith, Silas W.;Su, Mark K.. Gluts of GLP-1: A Case Series of Semaglutide Overdose Through Administration Errors. Journal of Medical Toxicology. 2023;63-168",53.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223823951,22382395,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Granulomatosis with polyangiitis,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,NVSC2023CA119763,NOVARTIS,,66.0,YR,,M,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223823951,22382395,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Hepatic cirrhosis,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,NVSC2023CA119763,NOVARTIS,,66.0,YR,,M,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223823951,22382395,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,NVSC2023CA119763,NOVARTIS,,66.0,YR,,M,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223823951,22382395,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,NVSC2023CA119763,NOVARTIS,,66.0,YR,,M,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Flank pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Sleep disorder,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Cough,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Bone pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Rales,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Restless legs syndrome,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,COVID-19,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Fall,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Flank pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Blood pressure increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Sleep disorder,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Weight increased,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Cough,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Bone pain,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Rales,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,Restless legs syndrome,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,COVID-19,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223835501,22383550,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230525.0,20230530,20230530,EXP,,CA-PFIZER INC-202300202371,PFIZER,,65.0,YR,,F,Y,,,20230530,,HP,CA,CA,2023,Q2,Elderly
223850451,22385045,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q2,Panic attack,,2023,Q2,1,I,20230502.0,,20230528,20230528,DIR,661609,,FDA-CTU,,36.0,YR,,F,N,91.8,KG,20230528,N,CN,US,,2023,Q2,Adult
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Joint swelling,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Weight increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Sleep disorder,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Fall,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Cough,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Restless legs syndrome,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,COVID-19,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Blood pressure increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Rales,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Bone pain,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,SARS-CoV-2 test positive,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Muscular weakness,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Flank pain,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223869531,22386953,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,UNK,,,,,Solution,,2023,Q2,Gait disturbance,,2023,Q2,1,I,,20230523.0,20230531,20230531,EXP,,NVSC2023CA118330,NOVARTIS,,65.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Elderly
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Ageusia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Affective disorder,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Vitamin B12 decreased,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Hallucination,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Depression,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Nightmare,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Sleep talking,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Anosmia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Urinary tract infection,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Renal pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Neck injury,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Mobility decreased,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Back pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Road traffic accident,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Muscle twitching,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Sensory loss,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Dizziness,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Pollakiuria,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,General physical health deterioration,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Middle insomnia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Decreased appetite,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Abnormal dreams,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223875681,22387568,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q2,Anger,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119727,NOVARTIS,,55.0,YR,,M,Y,145.0,KG,20230531,,CN,CA,CA,2023,Q2,Adult
223879671,22387967,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution subcutaneous,,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,CA-MHPD-E2B_06255381,CA-Accord-359986,ACCORD,,66.0,YR,E,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223879671,22387967,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution subcutaneous,,,,,,,,,,,,2023,Q2,Hepatic cirrhosis,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,CA-MHPD-E2B_06255381,CA-Accord-359986,ACCORD,,66.0,YR,E,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223879671,22387967,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution subcutaneous,,,,,,,,,,,,2023,Q2,Treatment failure,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,CA-MHPD-E2B_06255381,CA-Accord-359986,ACCORD,,66.0,YR,E,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223879671,22387967,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,solution subcutaneous,,,,,,,,,,,,2023,Q2,Granulomatosis with polyangiitis,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,CA-MHPD-E2B_06255381,CA-Accord-359986,ACCORD,,66.0,YR,E,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223880222,22388022,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Hypertension,,2023,Q2,2,F,20230621.0,20230620.0,20230531,20230628,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-076401,BRISTOL MYERS SQUIBB,,87.0,YR,E,F,Y,,,20230628,,HP,US,US,2023,Q2,Elderly
223880222,22388022,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Cardiac failure,,2023,Q2,2,F,20230621.0,20230620.0,20230531,20230628,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-076401,BRISTOL MYERS SQUIBB,,87.0,YR,E,F,Y,,,20230628,,HP,US,US,2023,Q2,Elderly
223880222,22388022,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Condition aggravated,,2023,Q2,2,F,20230621.0,20230620.0,20230531,20230628,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-076401,BRISTOL MYERS SQUIBB,,87.0,YR,E,F,Y,,,20230628,,HP,US,US,2023,Q2,Elderly
223880222,22388022,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Mitral valve disease,,2023,Q2,2,F,20230621.0,20230620.0,20230531,20230628,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-076401,BRISTOL MYERS SQUIBB,,87.0,YR,E,F,Y,,,20230628,,HP,US,US,2023,Q2,Elderly
223888401,22388840,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119562,NOVARTIS,,66.0,YR,,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223888401,22388840,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Renal tubular necrosis,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119562,NOVARTIS,,66.0,YR,,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223888401,22388840,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119562,NOVARTIS,,66.0,YR,,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223888401,22388840,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119562,NOVARTIS,,66.0,YR,,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223888401,22388840,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,NVSC2023CA119562,NOVARTIS,,66.0,YR,,M,Y,,,20230531,,HP,CA,CA,2023,Q2,Elderly
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Emotional disorder,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Patient dissatisfaction with treatment,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Fatigue,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Nightmare,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Drug titration error,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Irritability,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Nausea,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Hot flush,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Cold sweat,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Therapeutic response unexpected,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Food craving,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Agitation,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Arrhythmia,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Hepatic enzyme increased,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Headache,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Abdominal pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Drug withdrawal syndrome,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Mental disorder,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Constipation,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223894071,22389407,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,Solution,,2023,Q2,Gastrointestinal pain,,2023,Q2,1,I,,20230524.0,20230531,20230531,EXP,,CA-MYLANLABS-2023M1055821,MYLAN,,60.0,YR,,F,Y,,,20230531,,CN,CA,CA,2023,Q2,Adult
223943051,22394305,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 milligram 1,,,,,202210BCC1,,,0.25,MG,Injection,,2023,Q2,Haemorrhage subcutaneous,,2023,Q2,1,I,20230324.0,20230527.0,20230601,20230601,EXP,,CN-AMGEN-CHNSP2023092478,AMGEN,,73.0,YR,E,F,Y,60.0,KG,20230601,,HP,CN,CN,2023,Q2,Elderly
223943051,22394305,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 milligram 1,,,,,202210BCC1,,,0.25,MG,Injection,,2023,Q2,Dizziness,,2023,Q2,1,I,20230324.0,20230527.0,20230601,20230601,EXP,,CN-AMGEN-CHNSP2023092478,AMGEN,,73.0,YR,E,F,Y,60.0,KG,20230601,,HP,CN,CN,2023,Q2,Elderly
223943051,22394305,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 milligram 1,,,,,202210BCC1,,,0.25,MG,Injection,,2023,Q2,Injection site reaction,,2023,Q2,1,I,20230324.0,20230527.0,20230601,20230601,EXP,,CN-AMGEN-CHNSP2023092478,AMGEN,,73.0,YR,E,F,Y,60.0,KG,20230601,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Haemorrhage subcutaneous,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Hyperhidrosis,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Injection site reaction,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Spinal osteoarthritis,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Ecchymosis,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Vomiting,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Vertebral foraminal stenosis,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Injection site induration,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Dizziness,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
223986431,22398643,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QD",0.25,MG,Y,,202210BCC1,,,0.25,MG,Injection,QD,2023,Q2,Vertigo,,2023,Q2,1,I,20230324.0,20230527.0,20230602,20230602,EXP,,CN-SA-2023SA167699,SANOFI AVENTIS,,73.0,YR,E,F,Y,60.0,KG,20230602,,HP,CN,CN,2023,Q2,Elderly
224002161,22400216,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,10 UNK ONCE A WEEK SUBCUTANEOUS,,,N,D,?,,99.0,,,,999,2023,Q2,Blood creatine abnormal,,2023,Q2,1,I,20230301.0,,20230601,20230601,DIR,662096,,FDA-CTU,,37.0,YR,,F,N,81.9,KG,20230601,N,HP,US,,2023,Q2,Adult
224002161,22400216,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,10 UNK ONCE A WEEK SUBCUTANEOUS,,,N,D,?,,99.0,,,,999,2023,Q2,Glomerular filtration rate decreased,,2023,Q2,1,I,20230301.0,,20230601,20230601,DIR,662096,,FDA-CTU,,37.0,YR,,F,N,81.9,KG,20230601,N,HP,US,,2023,Q2,Adult
224002161,22400216,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,10 UNK ONCE A WEEK SUBCUTANEOUS,,,N,D,?,,99.0,,,,999,2023,Q2,Protein urine present,,2023,Q2,1,I,20230301.0,,20230601,20230601,DIR,662096,,FDA-CTU,,37.0,YR,,F,N,81.9,KG,20230601,N,HP,US,,2023,Q2,Adult
224002161,22400216,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,10 UNK ONCE A WEEK SUBCUTANEOUS,,,N,D,?,,99.0,,,,999,2023,Q2,Nephropathy,,2023,Q2,1,I,20230301.0,,20230601,20230601,DIR,662096,,FDA-CTU,,37.0,YR,,F,N,81.9,KG,20230601,N,HP,US,,2023,Q2,Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Nausea,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Malaise,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Night sweats,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Chest pain,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Cold sweat,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Illness,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Syncope,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Somnolence,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Tachycardia,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Postural orthostatic tachycardia syndrome,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Pallor,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Hypotension,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Flushing,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Adverse drug reaction,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
224002391,22400239,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,D,,,99.0,,,,,2023,Q2,Dizziness,,2023,Q2,1,I,20230526.0,,20230601,20230601,DIR,662113,,FDA-CTU,,33.0,YR,,F,N,50.85,KG,20230601,N,CN,US,,2023,Q2,Young Adult
225225951,22522595,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 mg,,,U,,,,,3.0,MG,,,2023,Q2,Renal impairment,,2023,Q2,1,I,,20230529.0,20230605,20230605,EXP,,NVSC2023ES123169,NOVARTIS,,83.0,YR,,M,Y,,,20230605,,HP,ES,ES,2023,Q2,Elderly
225225951,22522595,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 mg,,,U,,,,,3.0,MG,,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230529.0,20230605,20230605,EXP,,NVSC2023ES123169,NOVARTIS,,83.0,YR,,M,Y,,,20230605,,HP,ES,ES,2023,Q2,Elderly
225225951,22522595,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 mg,,,U,,,,,3.0,MG,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230529.0,20230605,20230605,EXP,,NVSC2023ES123169,NOVARTIS,,83.0,YR,,M,Y,,,20230605,,HP,ES,ES,2023,Q2,Elderly
225225951,22522595,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 mg,,,U,,,,,3.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230529.0,20230605,20230605,EXP,,NVSC2023ES123169,NOVARTIS,,83.0,YR,,M,Y,,,20230605,,HP,ES,ES,2023,Q2,Elderly
225303891,22530389,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Dermatitis bullous,,2023,Q2,1,I,20230424.0,,20230606,20230606,DIR,662552,,FDA-CTU,,67.0,YR,,F,N,86.0,KG,20230606,N,HP,US,,2023,Q2,Elderly
225303891,22530389,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Injection site erythema,,2023,Q2,1,I,20230424.0,,20230606,20230606,DIR,662552,,FDA-CTU,,67.0,YR,,F,N,86.0,KG,20230606,N,HP,US,,2023,Q2,Elderly
225303891,22530389,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Injection site swelling,,2023,Q2,1,I,20230424.0,,20230606,20230606,DIR,662552,,FDA-CTU,,67.0,YR,,F,N,86.0,KG,20230606,N,HP,US,,2023,Q2,Elderly
225303891,22530389,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Injection site mass,,2023,Q2,1,I,20230424.0,,20230606,20230606,DIR,662552,,FDA-CTU,,67.0,YR,,F,N,86.0,KG,20230606,N,HP,US,,2023,Q2,Elderly
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225315951,22531595,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230530.0,20230607,20230607,EXP,,CA-AstraZeneca-2023A127417,ASTRAZENECA,,51.0,YR,,F,Y,,,20230607,,MD,CA,,2023,Q2,Adult
225340621,22534062,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,dosage form: solution subcutaneous,,,U,,Unknown,,,,,,,2023,Q2,Erythema,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242692",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,86.0,KG,20230608,,MD,CA,CA,2023,Q2,Elderly
225340621,22534062,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,dosage form: solution subcutaneous,,,U,,Unknown,,,,,,,2023,Q2,Peripheral swelling,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242692",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,86.0,KG,20230608,,MD,CA,CA,2023,Q2,Elderly
225340621,22534062,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,dosage form: solution subcutaneous,,,U,,Unknown,,,,,,,2023,Q2,Infection,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242692",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,86.0,KG,20230608,,MD,CA,CA,2023,Q2,Elderly
225349891,22534989,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,D,,,99.0,,,,999,2023,Q2,Migraine,,2023,Q2,1,I,20230523.0,,20230607,20230607,DIR,662789,,FDA-CTU,,50.0,YR,,F,N,71.1,KG,20230607,N,CN,US,,2023,Q2,Adult
225349891,22534989,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,D,,,99.0,,,,999,2023,Q2,Colitis,,2023,Q2,1,I,20230523.0,,20230607,20230607,DIR,662789,,FDA-CTU,,50.0,YR,,F,N,71.1,KG,20230607,N,CN,US,,2023,Q2,Adult
225349891,22534989,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,D,,,99.0,,,,999,2023,Q2,Anorectal swelling,,2023,Q2,1,I,20230523.0,,20230607,20230607,DIR,662789,,FDA-CTU,,50.0,YR,,F,N,71.1,KG,20230607,N,CN,US,,2023,Q2,Adult
225349891,22534989,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,D,,,99.0,,,,999,2023,Q2,Bedridden,,2023,Q2,1,I,20230523.0,,20230607,20230607,DIR,662789,,FDA-CTU,,50.0,YR,,F,N,71.1,KG,20230607,N,CN,US,,2023,Q2,Adult
225354691,22535469,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Aggression,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225354691,22535469,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230607.0,20230608,20230608,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Adult
225375761,22537576,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (1/W)",,,U,,,,,1.0,MG,,/WK,2023,Q2,Pneumothorax,,2023,Q2,1,I,,20230601.0,20230608,20230608,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202306000684,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
225375761,22537576,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (1/W)",,,U,,,,,1.0,MG,,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230601.0,20230608,20230608,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202306000684,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
225375761,22537576,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (1/W)",,,U,,,,,1.0,MG,,/WK,2023,Q2,Rib fracture,,2023,Q2,1,I,,20230601.0,20230608,20230608,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202306000684,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
225375761,22537576,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (1/W)",,,U,,,,,1.0,MG,,/WK,2023,Q2,Hypoglycaemic coma,,2023,Q2,1,I,,20230601.0,20230608,20230608,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202306000684,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
225375761,22537576,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (1/W)",,,U,,,,,1.0,MG,,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230601.0,20230608,20230608,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202306000684,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230608,,CN,CA,CA,2023,Q2,Elderly
225378552,22537855,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,2,F,,20230607.0,20230608,20230613,EXP,,CA-BAUSCH-BL-2023-008809,BAUSCH AND LOMB,,66.0,YR,,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Elderly
225378552,22537855,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Renal tubular necrosis,,2023,Q2,2,F,,20230607.0,20230608,20230613,EXP,,CA-BAUSCH-BL-2023-008809,BAUSCH AND LOMB,,66.0,YR,,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Elderly
225378552,22537855,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,2,F,,20230607.0,20230608,20230613,EXP,,CA-BAUSCH-BL-2023-008809,BAUSCH AND LOMB,,66.0,YR,,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Elderly
225378552,22537855,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,2,F,,20230607.0,20230608,20230613,EXP,,CA-BAUSCH-BL-2023-008809,BAUSCH AND LOMB,,66.0,YR,,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Elderly
225378552,22537855,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,2,F,,20230607.0,20230608,20230613,EXP,,CA-BAUSCH-BL-2023-008809,BAUSCH AND LOMB,,66.0,YR,,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Elderly
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Acute kidney injury,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Dehydration,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,COVID-19,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Euglycaemic diabetic ketoacidosis,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Hyperkalaemia,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Diabetic ketoacidosis,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Leukaemoid reaction,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225875972,22587597,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,Unknown,,,1.0,MG,,QD,2023,Q2,Hyperamylasaemia,,2023,Q2,2,F,20221101.0,20230616.0,20230612,20230626,EXP,,JP-EMD Serono-9407247,EMD SERONO INC,,19.0,YR,A,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Youth
225907591,22590759,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1 weekly;?,,,,D,,,99.0,,,,999,2023,Q2,Therapeutic product effect decreased,,2023,Q2,1,I,20230609.0,,20230610,20230610,DIR,663135,,FDA-CTU,,43.0,YR,,M,N,99.45,KG,20230610,N,CN,US,,2023,Q2,Adult
225907591,22590759,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1 weekly;?,,,,D,,,99.0,,,,999,2023,Q2,Heart rate irregular,,2023,Q2,1,I,20230609.0,,20230610,20230610,DIR,663135,,FDA-CTU,,43.0,YR,,M,N,99.45,KG,20230610,N,CN,US,,2023,Q2,Adult
225907591,22590759,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1 weekly;?,,,,D,,,99.0,,,,999,2023,Q2,Product compounding quality issue,,2023,Q2,1,I,20230609.0,,20230610,20230610,DIR,663135,,FDA-CTU,,43.0,YR,,M,N,99.45,KG,20230610,N,CN,US,,2023,Q2,Adult
225907591,22590759,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1 weekly;?,,,,D,,,99.0,,,,999,2023,Q2,Heart rate increased,,2023,Q2,1,I,20230609.0,,20230610,20230610,DIR,663135,,FDA-CTU,,43.0,YR,,M,N,99.45,KG,20230610,N,CN,US,,2023,Q2,Adult
225929511,22592951,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q2,Thirst,,2023,Q2,1,I,20181004.0,20230302.0,20230613,20230613,EXP,GB-MHRA-ADR 27725278,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2023-02667,ALKEM,,37.0,YR,,F,Y,125.5,KG,20230613,,MD,GB,GB,2023,Q2,Adult
225931281,22593128,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,20230601.0,20230602.0,20230613,20230613,EXP,,GB-NOVOPROD-1076061,NOVO NORDISK,,53.0,YR,,,Y,,,20230613,,HP,GB,GB,2023,Q2,Adult
225951491,22595149,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Neutropenia,,2023,Q2,1,I,20230608.0,,20230612,20230612,DIR,663266,,FDA-CTU,,71.0,YR,,F,N,99.81,KG,20230612,N,,US,,2023,Q2,Elderly
225955931,22595593,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,NOT SPECIFIED,,2023,Q2,Oxygen saturation decreased,,2023,Q2,1,I,,20230605.0,20230613,20230613,EXP,,CA-FreseniusKabi-FK202308244,FRESENIUS KABI,,43.0,YR,A,F,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225955931,22595593,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,NOT SPECIFIED,,2023,Q2,Respiratory rate decreased,,2023,Q2,1,I,,20230605.0,20230613,20230613,EXP,,CA-FreseniusKabi-FK202308244,FRESENIUS KABI,,43.0,YR,A,F,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
226042601,22604260,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, qw (1mg once weekly-not able to administer due to supply issues)",,,,,,,,1.0,MG,,/WK,2023,Q2,Sedation complication,,2023,Q2,1,I,20221201.0,20230323.0,20230615,20230615,EXP,,AU-MYLANLABS-2023M1062226,MYLAN,,23.0,YR,,F,Y,175.0,KG,20230615,,PH,AU,AU,2023,Q2,Youth
226042601,22604260,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, qw (1mg once weekly-not able to administer due to supply issues)",,,,,,,,1.0,MG,,/WK,2023,Q2,Antipsychotic drug level increased,,2023,Q2,1,I,20221201.0,20230323.0,20230615,20230615,EXP,,AU-MYLANLABS-2023M1062226,MYLAN,,23.0,YR,,F,Y,175.0,KG,20230615,,PH,AU,AU,2023,Q2,Youth
226042601,22604260,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, qw (1mg once weekly-not able to administer due to supply issues)",,,,,,,,1.0,MG,,/WK,2023,Q2,Pneumonia,,2023,Q2,1,I,20221201.0,20230323.0,20230615,20230615,EXP,,AU-MYLANLABS-2023M1062226,MYLAN,,23.0,YR,,F,Y,175.0,KG,20230615,,PH,AU,AU,2023,Q2,Youth
226042601,22604260,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, qw (1mg once weekly-not able to administer due to supply issues)",,,,,,,,1.0,MG,,/WK,2023,Q2,Troponin I increased,,2023,Q2,1,I,20221201.0,20230323.0,20230615,20230615,EXP,,AU-MYLANLABS-2023M1062226,MYLAN,,23.0,YR,,F,Y,175.0,KG,20230615,,PH,AU,AU,2023,Q2,Youth
226075071,22607507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,qw,,,,,,,209637.0,,,,/WK,2023,Q2,Death,,2023,Q2,1,I,,20230607.0,20230616,20230616,EXP,,US-NOVOPROD-1076681,NOVO NORDISK,,38.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
226088171,22608817,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,4.0,MG,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230606.0,20230616,20230616,EXP,,CA-TEVA-2023-CA-2896482,TEVA,,56.0,YR,A,M,Y,63.0,KG,20230616,,MD,CA,CA,2023,Q2,Adult
226088171,22608817,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,4.0,MG,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230606.0,20230616,20230616,EXP,,CA-TEVA-2023-CA-2896482,TEVA,,56.0,YR,A,M,Y,63.0,KG,20230616,,MD,CA,CA,2023,Q2,Adult
226101711,22610171,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?OTHER ROUTE : subcutaneously;?,,,Y,D,Not provided,20230616.0,99.0,,,,999,2023,Q2,Incorrect route of product administration,,2023,Q2,1,I,20230501.0,,20230615,20230615,DIR,663643,,FDA-CTU,,54.0,YR,,F,N,64.35,KG,20230615,Y,CN,US,,2023,Q2,Adult
226101711,22610171,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?OTHER ROUTE : subcutaneously;?,,,Y,D,Not provided,20230616.0,99.0,,,,999,2023,Q2,Wrong technique in device usage process,,2023,Q2,1,I,20230501.0,,20230615,20230615,DIR,663643,,FDA-CTU,,54.0,YR,,F,N,64.35,KG,20230615,Y,CN,US,,2023,Q2,Adult
226101711,22610171,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?OTHER ROUTE : subcutaneously;?,,,Y,D,Not provided,20230616.0,99.0,,,,999,2023,Q2,Injection site necrosis,,2023,Q2,1,I,20230501.0,,20230615,20230615,DIR,663643,,FDA-CTU,,54.0,YR,,F,N,64.35,KG,20230615,Y,CN,US,,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226158001,22615800,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,Solution for injection,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,CA,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,1.25,MG,Unknown,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,125.0,ML,Unknown,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,/WK,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Unknown,,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Stress,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Nasal congestion,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Dyspnoea exertional,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Respiration abnormal,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Upper respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Flank pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Nasopharyngitis,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Prolonged expiration,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Heart sounds,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Influenza,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Asthma,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Chest discomfort,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Injury,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Insomnia,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Depressed mood,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Appetite disorder,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Malaise,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Productive cough,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Angina pectoris,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Lower respiratory tract infection,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Rales,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Fall,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Depressive symptom,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226164101,22616410,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNKNOWN,,,,,"UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN,UNK",,,,,Solution subcutaneous,,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230605.0,20230619,20230619,EXP,,CA-Hikma Pharmaceuticals USA Inc.-CA-H14001-23-02034,HIKMA,,61.0,YR,,F,Y,,,20230619,,HP,CA,,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Parkinson's disease,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Loss of consciousness,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Off label use,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Urinary tract infection,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Fall,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Back pain,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Hypoaesthesia,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Hypertension,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,250.0,UG,Unknown,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Parkinson's disease,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Loss of consciousness,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Off label use,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Urinary tract infection,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Fall,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Back pain,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Hypoaesthesia,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Hypertension,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226170891,22617089,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q2,Pain in extremity,,2023,Q2,1,I,,20230612.0,20230620,20230620,EXP,,CA-JNJFOC-20230635639,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,107.0,KG,20230620,,HP,CA,CA,2023,Q2,Adult
226197221,22619722,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q2,Aggression,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226197221,22619722,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230616.0,20230620,20230620,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Aggression,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226206201,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230610.0,20230620,20230620,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226224421,22622442,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230511.0,20230621,20230621,PER,,US-STRIDES ARCOLAB LIMITED-2023SP007236,STRIDES,"Ouellette S, Frias G, Shah R, Alamgir M, Wassef C.. Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports.. J-Drugs-Dermatol. 2023;22(4):413-416.",74.0,YR,,M,Y,,,20230621,,HP,US,US,2023,Q2,Elderly
226224421,22622442,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230511.0,20230621,20230621,PER,,US-STRIDES ARCOLAB LIMITED-2023SP007236,STRIDES,"Ouellette S, Frias G, Shah R, Alamgir M, Wassef C.. Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports.. J-Drugs-Dermatol. 2023;22(4):413-416.",74.0,YR,,M,Y,,,20230621,,HP,US,US,2023,Q2,Elderly
226224691,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230612.0,20230621,20230621,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20230621,,HP,CA,CA,2023,Q2,Elderly
226224691,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230612.0,20230621,20230621,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20230621,,HP,CA,CA,2023,Q2,Elderly
226224691,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q2,Renal tubular necrosis,,2023,Q2,1,I,,20230612.0,20230621,20230621,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20230621,,HP,CA,CA,2023,Q2,Elderly
226224691,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230612.0,20230621,20230621,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20230621,,HP,CA,CA,2023,Q2,Elderly
226224691,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q2,Anaemia,,2023,Q2,1,I,,20230612.0,20230621,20230621,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20230621,,HP,CA,CA,2023,Q2,Elderly
226258301,22625830,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230616.0,20230621,20230621,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20230621,,CN,CA,CA,2023,Q2,Adult
226258301,22625830,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230616.0,20230621,20230621,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20230621,,CN,CA,CA,2023,Q2,Adult
226258301,22625830,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230616.0,20230621,20230621,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20230621,,CN,CA,CA,2023,Q2,Adult
226258301,22625830,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230616.0,20230621,20230621,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20230621,,CN,CA,CA,2023,Q2,Adult
226260021,22626002,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1.5 INJECTION ONCE A WEK INTRAMUSCULAR,,,N,D,212941,20240404.0,99.0,,,,999,2023,Q2,Wrong product administered,,2023,Q2,1,I,20230510.0,,20230619,20230619,DIR,663998,,FDA-CTU,,40.0,YR,,F,N,112.5,KG,20230619,N,CN,US,,2023,Q2,Adult
226260021,22626002,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Wrong product administered,,2023,Q2,1,I,20230510.0,,20230619,20230619,DIR,663998,,FDA-CTU,,40.0,YR,,F,N,112.5,KG,20230619,N,CN,US,,2023,Q2,Adult
226314211,22631421,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Aggression,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226314211,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226316381,22631638,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Illness,,2023,Q2,1,I,,20230613.0,20230623,20230623,EXP,,NVSC2023CA136055,NOVARTIS,,58.0,YR,,F,Y,,,20230620,,CN,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Blood cholesterol increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Stress,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Poor quality sleep,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,,,,,,2023,Q2,Transient ischaemic attack,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Blood cholesterol increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Stress,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Poor quality sleep,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg,,,,,,,,,,,,2023,Q2,Transient ischaemic attack,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Blood cholesterol increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Stress,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Poor quality sleep,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226326361,22632636,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1.0 mg,,,,,,,,,,,,2023,Q2,Transient ischaemic attack,,2023,Q2,1,I,,20230614.0,20230623,20230623,EXP,CA- HEALTHCANVIG-E2B_06310296,CA-NOVOPROD-1080535,NOVO NORDISK,,47.0,YR,,F,Y,,,20230623,,HP,CA,CA,2023,Q2,Adult
226347312,22634731,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg or 0.5 mg SQ Q 7,,,U,,,,,,,,,2023,Q2,Skin infection,,2023,Q2,2,F,20230517.0,20230620.0,20230623,20230629,EXP,,NVSC2023US124030,NOVARTIS,,49.0,YR,,F,Y,,,20230629,,MD,US,US,2023,Q2,Adult
226347312,22634731,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg or 0.5 mg SQ Q 7,,,U,,,,,,,,,2023,Q2,Pain,,2023,Q2,2,F,20230517.0,20230620.0,20230623,20230629,EXP,,NVSC2023US124030,NOVARTIS,,49.0,YR,,F,Y,,,20230629,,MD,US,US,2023,Q2,Adult
226367891,22636789,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q2,Hepatic cirrhosis,,2023,Q2,1,I,,20230614.0,20230626,20230626,EXP,CA-MHPD-E2B_06222171,CA-Accord-362817,ACCORD,,66.0,YR,E,M,Y,,,20230624,,HP,CA,CA,2023,Q2,Elderly
226367891,22636789,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q2,Off label use,,2023,Q2,1,I,,20230614.0,20230626,20230626,EXP,CA-MHPD-E2B_06222171,CA-Accord-362817,ACCORD,,66.0,YR,E,M,Y,,,20230624,,HP,CA,CA,2023,Q2,Elderly
226367891,22636789,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q2,Granulomatosis with polyangiitis,,2023,Q2,1,I,,20230614.0,20230626,20230626,EXP,CA-MHPD-E2B_06222171,CA-Accord-362817,ACCORD,,66.0,YR,E,M,Y,,,20230624,,HP,CA,CA,2023,Q2,Elderly
226367891,22636789,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230614.0,20230626,20230626,EXP,CA-MHPD-E2B_06222171,CA-Accord-362817,ACCORD,,66.0,YR,E,M,Y,,,20230624,,HP,CA,CA,2023,Q2,Elderly
226375401,22637540,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20221130.0,20230626,20230626,PER,,US-APOTEX-2022AP016501,APOTEX,"Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient. The Journal of Heart and Lung Transplantation. 2022;00",76.0,YR,,M,Y,,,20230626,,MD,US,US,2023,Q2,Elderly
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Middle insomnia,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Faeces discoloured,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Faeces hard,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Abdominal pain lower,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Eating disorder,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226390871,22639087,1,PS,PYRIDOXINE\SEMAGLUTIDE,PYRIDOXINE\SEMAGLUTIDE,1,Other,ONCE A WEEK INJECTION INTO SKIN ,,,Y,D,,,99.0,,,,999,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230619.0,,20230623,20230623,DIR,664640,,FDA-CTU,,37.0,YR,,F,N,99.0,KG,20230623,N,CN,US,,2023,Q2,Adult
226406731,22640673,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20220801.0,20220812.0,20230626,20230626,PER,,US-Accord-274042,ACCORD,,56.0,YR,A,M,Y,143.3,KG,20230626,,CN,US,US,2023,Q2,Adult
226450581,22645058,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION WEEKLY SUBCUTANEOUS?,,,Y,D,,,99.0,,,,999,2023,Q2,Nephrolithiasis,,2023,Q2,1,I,20230601.0,,20230624,20230624,DIR,664688,,FDA-CTU,,60.0,YR,,M,N,107.55,KG,20230624,Y,CN,US,,2023,Q2,Adult
226451801,22645180,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,Y,D,,,99.0,,,,,2023,Q2,Palpitations,,2023,Q2,1,I,20230517.0,,20230626,20230626,DIR,664775,,FDA-CTU,,40.0,YR,,F,N,78.75,KG,20230626,N,CN,US,,2023,Q2,Adult
226451801,22645180,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,Y,D,,,99.0,,,,,2023,Q2,Panic attack,,2023,Q2,1,I,20230517.0,,20230626,20230626,DIR,664775,,FDA-CTU,,40.0,YR,,F,N,78.75,KG,20230626,N,CN,US,,2023,Q2,Adult
226457721,22645772,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q2,Aggression,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Psychotic disorder,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226457721,22645772,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,209637.0,,,Solution for injection,,2023,Q2,Aggression,,2023,Q2,1,I,,20230615.0,20230627,20230627,EXP,CA-HEALTHCANVIG-06307631,CA-NOVOPROD-1080863,NOVO NORDISK,,42.0,YR,,M,Y,,,20230627,,CN,CA,CA,2023,Q2,Adult
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Vomiting projectile,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Dehydration,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Prescribed overdose,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Insurance issue,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Product use in unapproved indication,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226460431,22646043,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : every 7 days;?,,,Y,D,148373,20230705.0,99.0,,,Injection,999,2023,Q2,Feeding disorder,,2023,Q2,1,I,20230606.0,,20230626,20230626,DIR,664859,,FDA-CTU,,74.0,YR,,F,N,67.5,KG,20230626,N,CN,US,,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Dyspepsia,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Immune-mediated enterocolitis,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226491771,22649177,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2023,Q2,Gastritis,,2023,Q2,1,I,20220812.0,20230622.0,20230628,20230628,EXP,IT-MINISAL02-929539,IT-009507513-2306ITA011855,MERCK,,71.0,YR,,M,Y,89.0,KG,20230628,,MD,IT,IT,2023,Q2,Elderly
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Loss of personal independence in daily activities,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Wheezing,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Hypoacusis,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226507171,22650717,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,,20230620.0,20230628,20230628,EXP,,CA-APOTEX-2023AP009371,APOTEX,,51.0,YR,,F,Y,,,20230628,,CN,CA,CA,2023,Q2,Adult
226528411,22652841,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Renal tubular necrosis,,2023,Q2,1,I,,20230621.0,20230629,20230629,EXP,,CA-APOTEX-2023AP009429,APOTEX,,66.0,YR,,M,Y,,,20230629,,HP,CA,CA,2023,Q2,Elderly
226528411,22652841,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,,20230621.0,20230629,20230629,EXP,,CA-APOTEX-2023AP009429,APOTEX,,66.0,YR,,M,Y,,,20230629,,HP,CA,CA,2023,Q2,Elderly
226528411,22652841,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230621.0,20230629,20230629,EXP,,CA-APOTEX-2023AP009429,APOTEX,,66.0,YR,,M,Y,,,20230629,,HP,CA,CA,2023,Q2,Elderly
226528411,22652841,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Chest pain,,2023,Q2,1,I,,20230621.0,20230629,20230629,EXP,,CA-APOTEX-2023AP009429,APOTEX,,66.0,YR,,M,Y,,,20230629,,HP,CA,CA,2023,Q2,Elderly
226528411,22652841,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230621.0,20230629,20230629,EXP,,CA-APOTEX-2023AP009429,APOTEX,,66.0,YR,,M,Y,,,20230629,,HP,CA,CA,2023,Q2,Elderly
226538351,22653835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,1.0,MG,,,,,,,,,,2023,Q2,Drug eruption,,2023,Q2,1,I,20230315.0,20230617.0,20230629,20230629,EXP,IT-MINISAL02-924141,IT-Accord-363726,ACCORD,,63.0,YR,,F,Y,,,20230628,,MD,IT,IT,2023,Q2,Adult
226538351,22653835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,1.0,MG,,,,,,,,,,2023,Q2,Drug reaction with eosinophilia and systemic symptoms,,2023,Q2,1,I,20230315.0,20230617.0,20230629,20230629,EXP,IT-MINISAL02-924141,IT-Accord-363726,ACCORD,,63.0,YR,,F,Y,,,20230628,,MD,IT,IT,2023,Q2,Adult
226538351,22653835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,1.0,MG,,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,20230315.0,20230617.0,20230629,20230629,EXP,IT-MINISAL02-924141,IT-Accord-363726,ACCORD,,63.0,YR,,F,Y,,,20230628,,MD,IT,IT,2023,Q2,Adult
226538351,22653835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,1.0,MG,,,,,,,,,,2023,Q2,Sensory loss,,2023,Q2,1,I,20230315.0,20230617.0,20230629,20230629,EXP,IT-MINISAL02-924141,IT-Accord-363726,ACCORD,,63.0,YR,,F,Y,,,20230628,,MD,IT,IT,2023,Q2,Adult
226538351,22653835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,1.0,MG,,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,1,I,20230315.0,20230617.0,20230629,20230629,EXP,IT-MINISAL02-924141,IT-Accord-363726,ACCORD,,63.0,YR,,F,Y,,,20230628,,MD,IT,IT,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Palpitations,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Increased appetite,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Gastrointestinal sounds abnormal,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Presyncope,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Chills,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Tremor,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Flushing,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Anal incontinence,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Feeling cold,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Burning sensation,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Feeling jittery,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Asthenia,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Cold sweat,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226544621,22654462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.1 Injection(s);?OTHER FREQUENCY : Once per week;?,,,N,D,1,20230619.0,99.0,,,Injection,999,2023,Q2,Micturition urgency,,2023,Q2,1,I,20230501.0,,20230628,20230628,DIR,665180,,FDA-CTU,,41.0,YR,,F,N,81.0,KG,20230628,Y,CN,US,,2023,Q2,Adult
226576341,22657634,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",8.16,MG,Y,,,,215256.0,0.24,MG,Solution for injection,/WK,2023,Q2,Gallbladder disorder,,2023,Q2,1,I,20211020.0,20230620.0,20230630,20230630,EXP,,US-NOVOPROD-1081720,NOVO NORDISK,,54.0,YR,,F,Y,71.0,KG,20230630,,MD,US,US,2023,Q2,Adult
226576341,22657634,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.16,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q2,Gallbladder disorder,,2023,Q2,1,I,20211020.0,20230620.0,20230630,20230630,EXP,,US-NOVOPROD-1081720,NOVO NORDISK,,54.0,YR,,F,Y,71.0,KG,20230630,,MD,US,US,2023,Q2,Adult
226576341,22657634,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,8.16,MG,Y,,,,215256.0,,,Solution for injection,,2023,Q2,Gallbladder disorder,,2023,Q2,1,I,20211020.0,20230620.0,20230630,20230630,EXP,,US-NOVOPROD-1081720,NOVO NORDISK,,54.0,YR,,F,Y,71.0,KG,20230630,,MD,US,US,2023,Q2,Adult
226646661,22664666,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,N,D,,,99.0,,,,999,2023,Q2,Gallbladder disorder,,2023,Q2,1,I,20230622.0,,20230630,20230630,DIR,665402,,FDA-CTU,,32.0,YR,,F,N,67.5,KG,20230630,N,CN,US,,2023,Q2,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Heart rate increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Groin abscess,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Cough,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Cortisol decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Laryngitis bacterial,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Ligament sprain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Headache,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Movement disorder,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,COVID-19,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Blood pressure diastolic decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Insulin-like growth factor increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Drug ineffective,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Drug resistance,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Intervertebral disc protrusion,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Subcutaneous abscess,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Sciatic nerve injury,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Body temperature decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Heart rate decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Sinusitis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Nasal congestion,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Oropharyngeal pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Blood pressure increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Blood cholesterol abnormal,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Back injury,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Blood growth hormone increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Off label use,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Stress,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Infectious mononucleosis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Muscle spasms,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Illness,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Facial pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Abdominal pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Anxiety,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,52,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2023,Q3,Back pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Heart rate increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Groin abscess,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Cough,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Cortisol decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Laryngitis bacterial,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Ligament sprain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Headache,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Movement disorder,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,COVID-19,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Blood pressure diastolic decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Insulin-like growth factor increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Drug ineffective,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Drug resistance,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Intervertebral disc protrusion,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Nasopharyngitis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Subcutaneous abscess,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Sciatic nerve injury,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Body temperature decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Heart rate decreased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Sinusitis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Nasal congestion,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Oropharyngeal pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Blood pressure increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Blood cholesterol abnormal,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Back injury,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Blood growth hormone increased,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Off label use,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Stress,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Infectious mononucleosis,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Muscle spasms,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Illness,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Facial pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Abdominal pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Anxiety,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1436788042,14367880,53,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QD",,,U,,,,,,,,QD,2023,Q3,Back pain,,2023,Q3,42,F,20151225.0,20230907.0,20180109,20230915,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20230915,,CN,CA,CA,2023,Q3,Young Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Procedural pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Feeling abnormal,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Bell's palsy,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Anxiety,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Pyrexia,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Foreign body sensation in eyes,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Back pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site bruising,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Contusion,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site swelling,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Sputum discoloured,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Fatigue,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Malaise,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Decreased appetite,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Discomfort,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Anaphylactic reaction,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Illness,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Cough,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Dyspnoea,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Tinnitus,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Asthma,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Mobility decreased,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Tinnitus,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Throat clearing,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Oropharyngeal pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Headache,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Symptom recurrence,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Lacrimation increased,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site swelling,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Paralysis,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Dizziness,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Asthenia,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site bruising,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Productive cough,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Asthenia,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Eyelid ptosis,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Throat clearing,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Limb discomfort,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Upper-airway cough syndrome,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Sputum discoloured,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Weight increased,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Eye haemorrhage,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Asthma,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Lipoma,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Symptom recurrence,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Hypoaesthesia,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Dizziness,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injury,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Aphthous ulcer,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Urinary incontinence,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Hypertensive crisis,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,COVID-19,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Fall,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Sinus congestion,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Loss of consciousness,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Vaccination site pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Lethargy,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Chills,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Paranasal sinus discomfort,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Oxygen saturation decreased,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Injection site pain,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
1475009819,14750098,48,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW",,,U,,UNKNOWN,,,,,,/WK,2023,Q3,Weight decreased,,2023,Q3,19,F,20171205.0,20230731.0,20180412,20230809,EXP,,CA-ROCHE-2104193,ROCHE,,63.0,YR,,F,Y,,,20230809,,CN,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
175684666,17568466,51,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230814.0,20200320,20230817,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Second primary malignancy,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Constipation,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Pain,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Neoplasm malignant,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Rib fracture,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Headache,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Blood pressure increased,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Migraine,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Hypersensitivity,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Weight increased,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Oropharyngeal pain,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Restless legs syndrome,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Cough,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Musculoskeletal chest pain,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,COVID-19,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Insomnia,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Hypertonic bladder,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Vomiting,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Hepatic cancer,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Fatigue,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Depression,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Fall,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Heart valve incompetence,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Malaise,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Limb injury,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
1792066921,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q3,Pyrexia,,2023,Q3,21,F,20200201.0,20230803.0,20200621,20230810,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20230810,,CN,CA,CA,2023,Q3,Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Oropharyngeal pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Muscle spasms,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Back pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Insulin-like growth factor increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Nasal congestion,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Groin abscess,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Drug resistance,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Laryngitis bacterial,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Sinusitis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Illness,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Blood growth hormone increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Back injury,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Blood cholesterol abnormal,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Off label use,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Sciatic nerve injury,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Infectious mononucleosis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Body temperature decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Subcutaneous abscess,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Stress,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Anxiety,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Heart rate increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Abdominal pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Heart rate decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Intervertebral disc protrusion,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Cortisol decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Movement disorder,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Ligament sprain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Blood pressure increased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Cough,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Headache,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,COVID-19,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Blood pressure diastolic decreased,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Facial pain,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
179322653,17932265,47,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW (1 every 1 weeks)",,,U,,,,,,,,/WK,2023,Q3,Drug ineffective for unapproved indication,,2023,Q3,3,F,,20230712.0,20200623,20230717,EXP,,NVSC2020CA172766,NOVARTIS,,27.0,YR,,F,Y,,,20230717,,CN,CA,CA,2023,Q3,Young Adult
182591896,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2023,Q3,Myasthenia gravis,,2023,Q3,6,F,20200826.0,20230905.0,20200911,20230905,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20230906,,HP,DK,DK,2023,Q3,Elderly
182591896,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2023,Q3,Myocarditis,,2023,Q3,6,F,20200826.0,20230905.0,20200911,20230905,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20230906,,HP,DK,DK,2023,Q3,Elderly
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Influenza,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Heart sounds,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Angina pectoris,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Wheezing,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Insomnia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Appetite disorder,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Pyrexia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Injury,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Chest discomfort,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Chest pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Weight decreased,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Stress,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Nasal congestion,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Depressed mood,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Flank pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Rales,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Asthma,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Respiration abnormal,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Dyspnoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Malaise,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Productive cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Prolonged expiration,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Depressive symptom,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Fall,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Influenza,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Heart sounds,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Angina pectoris,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Wheezing,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Insomnia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Appetite disorder,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Pyrexia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Injury,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest discomfort,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Weight decreased,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Stress,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasal congestion,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressed mood,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Flank pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Rales,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Asthma,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Malaise,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Productive cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressive symptom,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Fall,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Influenza,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Injury,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Stress,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Rales,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Asthma,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Malaise,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Fall,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Influenza,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Heart sounds,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Angina pectoris,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Wheezing,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Appetite disorder,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Pyrexia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Injury,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Chest discomfort,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Chest pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Weight decreased,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Stress,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nasal congestion,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Depressed mood,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Flank pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Rales,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthma,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Respiration abnormal,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Dyspnoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Malaise,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Productive cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Prolonged expiration,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Depressive symptom,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Fall,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Influenza,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Heart sounds,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Angina pectoris,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Wheezing,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Insomnia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Appetite disorder,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Pyrexia,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Injury,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Chest discomfort,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Chest pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Weight decreased,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Stress,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Nasal congestion,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Depressed mood,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Flank pain,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Rales,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Asthma,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Respiration abnormal,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Dyspnoea,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Malaise,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Productive cough,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Prolonged expiration,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Depressive symptom,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Fall,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
182657238,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,8,F,,20230807.0,20200915,20230816,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Necrotising fasciitis,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Deformity,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Nerve injury,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Sepsis,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Fournier's gangrene,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Anal incontinence,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Renal tubular necrosis,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Scrotal abscess,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Septic shock,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Renal failure,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Stress,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
183315193,18331519,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Scar,,2023,Q3,3,F,20160213.0,20230830.0,20200930,20230907,EXP,,US-AstraZeneca-2020SF25232,ASTRAZENECA,,17123.0,DY,,M,Y,113.9,KG,20230907,,LW,US,,2023,Q3,Elderly
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Temperature intolerance,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,White blood cell count decreased,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Liver function test abnormal,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Musculoskeletal stiffness,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Progressive multiple sclerosis,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Neuralgia,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Anal incontinence,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Wrong technique in product usage process,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Fatigue,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Lumbar radiculopathy,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Fall,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Drug monitoring procedure incorrectly performed,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Loss of bladder sensation,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Urinary tract infection,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
1910650312,19106503,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2023,Q3,Intervertebral disc degeneration,,2023,Q3,12,F,20210405.0,20230918.0,20210407,20230926,PER,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20230926,,CN,US,US,2023,Q3,Adult
194320013,19432001,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,3.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,20181002.0,20230807.0,20210617,20230813,EXP,,JP-ABBVIE-19P-087-2886963-00,ABBVIE,,57.0,YR,,M,Y,57.0,KG,20230813,,MD,JP,JP,2023,Q3,Adult
194320013,19432001,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,3.0,MG,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,20181002.0,20230807.0,20210617,20230813,EXP,,JP-ABBVIE-19P-087-2886963-00,ABBVIE,,57.0,YR,,M,Y,57.0,KG,20230813,,MD,JP,JP,2023,Q3,Adult
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Peripheral swelling,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Atrioventricular block,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Gait disturbance,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Skin depigmentation,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Cellulitis,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Arthritis,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Off label use,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Psoriatic arthropathy,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Carpal tunnel syndrome,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Psoriasis,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
196851989,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q3,Feeling hot,,2023,Q3,9,F,20200927.0,20230823.0,20210811,20230830,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20230830,,CN,CA,CA,2023,Q3,Elderly
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,139,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,U,,,,,,,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,140,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,141,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,142,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,143,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Fall,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rales,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Asthma,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Injury,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Influenza,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Malaise,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Stress,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Cough,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
199676586,19967658,144,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 ml, QW",,,U,,,,,1.25,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,6,F,,20230820.0,20211019,20230826,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202356404,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,4,F,,20230811.0,20211228,20230826,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20230826,,HP,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Wheezing,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Asthma,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202392557,20239255,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2023,Q3,Depression,,2023,Q3,7,F,,20230814.0,20211228,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20230818,,MD,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Hypoacusis,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Wheezing,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Diabetes mellitus,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Dyspnoea,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Asthma,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202440625,20244062,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Depression,,2023,Q3,5,F,,20230626.0,20211228,20230704,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20230704,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
202669079,20266907,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,9,F,,20230717.0,20211231,20230719,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230719,,CN,CA,CA,2023,Q3,Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Off label use,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Off label use,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2031300113,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q3,Off label use,,2023,Q3,13,F,,20230715.0,20220109,20230731,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230729,,MD,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Body temperature increased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myoglobinuria,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Muscle spasms,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Product prescribing error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Micturition frequency decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urinary retention,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Drug interaction,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urine flow decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Drug titration error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myopathy,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Off label use,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Renal failure,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myalgia,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Chills,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urine output decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Headache,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Body temperature increased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myoglobinuria,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Muscle spasms,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Product prescribing error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Micturition frequency decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urinary retention,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Drug interaction,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urine flow decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Drug titration error,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myopathy,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Off label use,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Renal failure,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Myalgia,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Chills,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Urine output decreased,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
2034676817,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2023,Q3,Headache,,2023,Q3,17,F,,20230727.0,20220118,20230731,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Dr hab. n. med. Jaroslaw Woron; dr hab. N. med Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20230731,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Body temperature increased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myoglobinuria,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myopathy,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug interaction,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Serotonin syndrome,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Rhabdomyolysis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urinary retention,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product administered,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Hyperhidrosis,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction medication error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product prescribing error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Drug titration error,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Headache,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Chills,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Myalgia,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine output decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Urine flow decreased,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Muscle spasms,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Renal failure,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
204119879,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2023,Q3,Contraindicated product prescribed,,2023,Q3,9,F,,20230717.0,20220201,20230725,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20230725,,HP,PL,PL,2023,Q3,Young Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
209251033,20925103,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230724.0,20220607,20230803,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Therapeutic response shortened,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Shoulder fracture,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Foot fracture,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
210078865,21007886,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown; solution subcutaneous,,,,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,5,F,,20230713.0,20220627,20230721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-15062,SAMSUNG BIOEPIS,,66.0,YR,E,M,Y,154.0,KG,20230721,,HP,CA,CA,2023,Q3,Elderly
212259184,21225918,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,4,F,,20230718.0,20220818,20230727,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230727,,HP,CA,CA,2023,Q3,Adult
212259184,21225918,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,4,F,,20230718.0,20220818,20230727,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230727,,HP,CA,CA,2023,Q3,Adult
212259184,21225918,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q3,Intentional product use issue,,2023,Q3,4,F,,20230718.0,20220818,20230727,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230727,,HP,CA,CA,2023,Q3,Adult
212259184,21225918,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,4,F,,20230718.0,20220818,20230727,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230727,,HP,CA,CA,2023,Q3,Adult
212259184,21225918,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Solution subcutaneous, unknown",,,,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,4,F,,20230718.0,20220818,20230727,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-20160,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,84.0,KG,20230727,,HP,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Psoriatic arthropathy,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Needle issue,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Arthralgia,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Musculoskeletal stiffness,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Insomnia,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Musculoskeletal pain,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Tenderness,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Atrial fibrillation,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Joint swelling,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Cholelithiasis,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Accidental exposure to product,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Psoriasis,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Injection site haemorrhage,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Back pain,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
212483733,21248373,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2023,Q3,Exposure to SARS-CoV-2,,2023,Q3,3,F,20211111.0,20230705.0,20220824,20230708,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20230708,,MD,CA,CA,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Dizziness,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Stress,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Blood cholesterol increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Memory impairment,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Hypertension,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Poor quality sleep,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q3,Transient ischaemic attack,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Dizziness,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Stress,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Blood cholesterol increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Memory impairment,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Hypertension,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Poor quality sleep,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q3,Transient ischaemic attack,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Dizziness,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Stress,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Blood cholesterol increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Memory impairment,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Hypertension,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Poor quality sleep,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q3,Transient ischaemic attack,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Dizziness,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Stress,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Blood cholesterol increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Memory impairment,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Hypertension,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Poor quality sleep,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q3,Transient ischaemic attack,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Dizziness,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Stress,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Blood cholesterol increased,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Memory impairment,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Hypertension,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Poor quality sleep,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
213030495,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q3,Transient ischaemic attack,,2023,Q3,5,F,,20230901.0,20220907,20230905,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20230905,,HP,CA,,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Influenza,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Stress,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Pyrexia,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Appetite disorder,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Flank pain,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Injury,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Insomnia,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Rhinorrhoea,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Upper respiratory tract infection,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Nasal congestion,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depressed mood,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Malaise,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Chest discomfort,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Respiration abnormal,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Prolonged expiration,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Nasopharyngitis,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Cough,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Angina pectoris,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Lower respiratory tract infection,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Rales,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Productive cough,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depressive symptom,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Chest pain,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Heart sounds,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea exertional,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,219,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Fall,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Influenza,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Stress,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Pyrexia,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Appetite disorder,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Flank pain,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Injury,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Insomnia,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Weight decreased,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasal congestion,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressed mood,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Malaise,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest discomfort,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Wheezing,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Cough,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Angina pectoris,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Rales,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Productive cough,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Asthma,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressive symptom,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest pain,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Heart sounds,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
216754197,21675419,220,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, 1 every 1 week (dosage form;solution subcutaneous,route;intravenous not otherwise sp",,,U,,,,,1.25,MG,,/WK,2023,Q3,Fall,,2023,Q3,7,F,,20230908.0,20221202,20230913,EXP,,CA-ORGANON-2002CAN010574,ORGANON,,61.0,YR,,F,Y,,,20230913,,HP,CA,CA,2023,Q3,Adult
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Weight increased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Aortic arteriosclerosis,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Weight decreased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood pressure systolic increased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood pressure diastolic decreased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Oxygen saturation decreased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood pressure fluctuation,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood glucose increased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood pressure increased,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
217823003,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2023,Q3,Blood pressure diastolic abnormal,,2023,Q3,3,F,,20230921.0,20221227,20230923,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20230923,,HP,CA,,2023,Q3,Elderly
218635813,21863581,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Bile duct stone,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Cholangitis,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Bile duct stone,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Cholangitis,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Bile duct stone,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Cholangitis,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Bile duct stone,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,9660.0,MG,Y,N,,,213051.0,,,Tablet,,2023,Q3,Cholangitis,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Bile duct stone,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218635813,21863581,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",9660.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Cholangitis,,2023,Q3,3,F,20221220.0,20230710.0,20230116,20230717,EXP,,GB-NOVOPROD-1010020,NOVO NORDISK,,86.0,YR,,M,Y,88.0,KG,20230717,,MD,GB,GB,2023,Q3,Elderly
218980292,21898029,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, OW",,,,,,,,0.5,MG,,/WK,2023,Q3,Abdominal pain,,2023,Q3,2,F,,20230904.0,20230123,20230905,EXP,,CA-BAYER-2023A007959,BAYER,,73.0,YR,E,M,Y,,,20230905,,CN,CA,CA,2023,Q3,Elderly
218980292,21898029,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,2,F,,20230904.0,20230123,20230905,EXP,,CA-BAYER-2023A007959,BAYER,,73.0,YR,E,M,Y,,,20230905,,CN,CA,CA,2023,Q3,Elderly
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
219322053,21932205,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230626.0,20230131,20230707,EXP,,CA-AstraZeneca-2021A862428,ASTRAZENECA,,51.0,YR,,F,Y,,,20230707,,MD,CA,,2023,Q3,Adult
220065483,22006548,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, WE, 1 every 1 week",,,,,,,,,,,/WK,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, WE, 1 every 1 week",,,,,,,,,,,/WK,2023,Q3,Substance use,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, WE, 1 every 1 week",,,,,,,,,,,/WK,2023,Q3,Product dose omission issue,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, WE, 1 every 1 week",,,,,,,,,,,/WK,2023,Q3,Aggression,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, WE, 1 every 1 week",,,,,,,,,,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Substance use,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Aggression,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220065483,22006548,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,,20230920.0,20230217,20230928,EXP,,CA-JNJFOC-20230137575,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230928,,PH,CA,CA,2023,Q3,Adult
220465983,22046598,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, qd",7028.0,MG,D,,,,213051.0,7.0,MG,Tablet,QD,2023,Q3,Cholelithiasis,,2023,Q3,3,F,20221224.0,20230712.0,20230228,20230718,EXP,,CZ-NOVOPROD-1025875,NOVO NORDISK,,66.0,YR,,M,Y,99.0,KG,20230718,,MD,CZ,CZ,2023,Q3,Elderly
220465983,22046598,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 mg, qd",7028.0,MG,D,,,,213051.0,7.0,MG,Tablet,QD,2023,Q3,Cholecystitis acute,,2023,Q3,3,F,20221224.0,20230712.0,20230228,20230718,EXP,,CZ-NOVOPROD-1025875,NOVO NORDISK,,66.0,YR,,M,Y,99.0,KG,20230718,,MD,CZ,CZ,2023,Q3,Elderly
220702653,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",0.25,MG,Y,,,,,0.5,MG,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",0.25,MG,Y,,,,,0.5,MG,,/WK,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",0.25,MG,Y,,,,,0.5,MG,,/WK,2023,Q3,Vomiting,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",0.25,MG,Y,,,,,0.5,MG,,/WK,2023,Q3,Nausea,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",0.25,MG,Y,,,,,0.5,MG,,QD,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",0.25,MG,Y,,,,,0.5,MG,,QD,2023,Q3,Hypoglycaemia,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",0.25,MG,Y,,,,,0.5,MG,,QD,2023,Q3,Vomiting,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
220702653,22070265,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QD",0.25,MG,Y,,,,,0.5,MG,,QD,2023,Q3,Nausea,,2023,Q3,3,F,20220303.0,20230704.0,20230307,20230707,EXP,CA-SA-SAC20230306000805,CA-SA-2023SA073605,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20230707,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222423443,22242344,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,3,F,,20230811.0,20230422,20230824,EXP,,CA-AUROBINDO-AUR-APL-2023-031358,AUROBINDO,,51.0,YR,,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Asthenia,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Injection site bruising,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Pain,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Thinking abnormal,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Fatigue,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Hepatic cancer metastatic,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Pain in extremity,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Off label use,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Therapeutic response delayed,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Neoplasm malignant,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222429735,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK 4MG/3ML INJ.PEN,,,,,,,,,,Injection,,2023,Q3,Psoriasis,,2023,Q3,5,F,20220101.0,20230717.0,20230424,20230721,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20230721,,HP,CA,CA,2023,Q3,Young Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222532702,22253270,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Dosage form: Not specified",,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,2,F,,20230821.0,20230426,20230823,EXP,,CA-ORGANON-O2110CAN002274,ORGANON,,51.0,YR,,F,Y,,,20230823,,MD,CA,CA,2023,Q3,Adult
222666902,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,2,F,20230201.0,20230420.0,20230428,20230906,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230906,,CN,US,US,2023,Q3,Elderly
222666902,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,2,F,20230201.0,20230420.0,20230428,20230906,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230906,,CN,US,US,2023,Q3,Elderly
222666902,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Nasopharyngitis,,2023,Q3,2,F,20230201.0,20230420.0,20230428,20230906,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230906,,CN,US,US,2023,Q3,Elderly
222666902,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Hot flush,,2023,Q3,2,F,20230201.0,20230420.0,20230428,20230906,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20230906,,CN,US,US,2023,Q3,Elderly
222767436,22276743,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,Once per day",,,,,,,213051.0,7.0,MG,Tablet,QD,2023,Q3,Tachycardia,,2023,Q3,6,F,20230412.0,20230814.0,20230503,20230822,EXP,,US-NOVOPROD-1058334,NOVO NORDISK,,74.0,YR,,M,Y,84.0,KG,20230822,,MD,US,US,2023,Q3,Elderly
222767436,22276743,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7.0,mg,Once per day",,,,,,,213051.0,7.0,MG,Tablet,QD,2023,Q3,Ischaemic cardiomyopathy,,2023,Q3,6,F,20230412.0,20230814.0,20230503,20230822,EXP,,US-NOVOPROD-1058334,NOVO NORDISK,,74.0,YR,,M,Y,84.0,KG,20230822,,MD,US,US,2023,Q3,Elderly
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Feeding disorder,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Constipation,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Early satiety,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Muscle atrophy,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223015667,22301566,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,7,F,20230301.0,20230805.0,20230510,20230811,PER,,US-ELI_LILLY_AND_COMPANY-US202305003831,ELI LILLY AND CO,,46.0,YR,,,Y,,,20230811,,CN,US,US,2023,Q3,Adult
223144894,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q3,Pericardial effusion,,2023,Q3,4,F,20230218.0,20230717.0,20230512,20230724,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230724,,MD,HR,,2023,Q3,Adult
223144894,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q3,Cardiovascular disorder,,2023,Q3,4,F,20230218.0,20230717.0,20230512,20230724,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230724,,MD,HR,,2023,Q3,Adult
223144894,22314489,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q3,Hypoxia,,2023,Q3,4,F,20230218.0,20230717.0,20230512,20230724,EXP,,HR-Eisai Medical Research-EC-2023-134982,EISAI,,61.0,YR,A,F,Y,88.0,KG,20230724,,MD,HR,,2023,Q3,Adult
223180793,22318079,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg,,,Y,,04042023,,209637.0,0.5,MG,,,2023,Q3,Counterfeit product administered,,2023,Q3,3,F,20230201.0,20230713.0,20230515,20230719,EXP,,US-NOVOPROD-1060259,NOVO NORDISK,,35.0,YR,,F,Y,97.959,KG,20230719,,MD,US,US,2023,Q3,Adult
223180793,22318079,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg,,,Y,,04042023,,209637.0,0.5,MG,,,2023,Q3,Maternal exposure during pregnancy,,2023,Q3,3,F,20230201.0,20230713.0,20230515,20230719,EXP,,US-NOVOPROD-1060259,NOVO NORDISK,,35.0,YR,,F,Y,97.959,KG,20230719,,MD,US,US,2023,Q3,Adult
223180793,22318079,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg,,,Y,,04042023,,209637.0,0.5,MG,,,2023,Q3,Abortion spontaneous,,2023,Q3,3,F,20230201.0,20230713.0,20230515,20230719,EXP,,US-NOVOPROD-1060259,NOVO NORDISK,,35.0,YR,,F,Y,97.959,KG,20230719,,MD,US,US,2023,Q3,Adult
223481002,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, QW",,,U,,,,,1.0,MG,,/WK,2023,Q3,Diabetic ketoacidosis,,2023,Q3,2,F,20230110.0,20230825.0,20230522,20230901,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230901,,PH,CA,CA,2023,Q3,Elderly
223481002,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, QW",,,U,,,,,1.0,MG,,/WK,2023,Q3,Hyperglycaemia,,2023,Q3,2,F,20230110.0,20230825.0,20230522,20230901,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230901,,PH,CA,CA,2023,Q3,Elderly
223481002,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, QW",,,U,,,,,1.0,MG,,/WK,2023,Q3,Wrong product administered,,2023,Q3,2,F,20230110.0,20230825.0,20230522,20230901,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230901,,PH,CA,CA,2023,Q3,Elderly
223481002,22348100,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, QW",,,U,,,,,1.0,MG,,/WK,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,20230110.0,20230825.0,20230522,20230901,EXP,,CA-SA-2023SA154850,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20230901,,PH,CA,CA,2023,Q3,Elderly
223769412,22376941,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Product storage error,,2023,Q3,2,F,20230523.0,20230918.0,20230529,20230918,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-074685,BRISTOL MYERS SQUIBB,,54.0,YR,A,F,Y,,,20230918,,CN,US,US,2023,Q3,Adult
225354692,22535469,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q3,Aggression,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,dosage form: SOLUTION SUBCUTANEOUS,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q3,Substance use,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Aggression,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225354692,22535469,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Substance use,,2023,Q3,2,F,,20230814.0,20230608,20230818,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-242681",BOEHRINGER INGELHEIM,,42.0,YR,A,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Eye pruritus,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Sepsis,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Chronic sinusitis,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Disorientation,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Diffuse large B-cell lymphoma,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Ocular hyperaemia,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Acute respiratory failure,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
225415652,22541565,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg or 0.5 mg dose,,,,,,,,,,,,2023,Q3,Rhinorrhoea,,2023,Q3,2,F,20230101.0,20230810.0,20230609,20230815,EXP,,US-AMGEN-USASP2023097214,AMGEN,,74.0,YR,E,F,Y,98.2,KG,20230815,,MD,US,US,2023,Q3,Elderly
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Substance use,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Aggression,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Product use in unapproved indication,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Substance use,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Aggression,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226206202,22620620,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Product use in unapproved indication,,2023,Q3,2,F,,20230810.0,20230620,20230818,PER,,CA-OTSUKA-2023_015943,OTSUKA,,42.0,YR,,M,Y,,,20230818,,CN,CA,CA,2023,Q3,Adult
226425812,22642581,9,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Unknown,,,,U,,,,,,,,,2023,Q3,Diverticulitis,,2023,Q3,2,F,20221015.0,20230822.0,20230627,20230825,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-246290",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,72.5,KG,20230825,,MD,JP,JP,2023,Q3,Elderly
226569264,22656926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Nasal congestion,,2023,Q3,4,F,20230623.0,20230816.0,20230630,20230821,PER,,NVSC2023US148839,NOVARTIS,,32.0,YR,,F,Y,129.2,KG,20230821,,CN,US,US,2023,Q3,Young Adult
226569264,22656926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Chills,,2023,Q3,4,F,20230623.0,20230816.0,20230630,20230821,PER,,NVSC2023US148839,NOVARTIS,,32.0,YR,,F,Y,129.2,KG,20230821,,CN,US,US,2023,Q3,Young Adult
226569264,22656926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Rhinorrhoea,,2023,Q3,4,F,20230623.0,20230816.0,20230630,20230821,PER,,NVSC2023US148839,NOVARTIS,,32.0,YR,,F,Y,129.2,KG,20230821,,CN,US,US,2023,Q3,Young Adult
226569264,22656926,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Influenza like illness,,2023,Q3,4,F,20230623.0,20230816.0,20230630,20230821,PER,,NVSC2023US148839,NOVARTIS,,32.0,YR,,F,Y,129.2,KG,20230821,,CN,US,US,2023,Q3,Young Adult
226605352,22660535,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,U,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q3,Syncope,,2023,Q3,2,F,20230528.0,20230705.0,20230630,20230714,EXP,,US-NOVOPROD-1083194,NOVO NORDISK,,66.0,YR,,F,Y,,,20230714,,CN,US,US,2023,Q3,Elderly
226605352,22660535,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,U,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q3,Seizure,,2023,Q3,2,F,20230528.0,20230705.0,20230630,20230714,EXP,,US-NOVOPROD-1083194,NOVO NORDISK,,66.0,YR,,F,Y,,,20230714,,CN,US,US,2023,Q3,Elderly
226605352,22660535,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,U,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q3,Counterfeit product administered,,2023,Q3,2,F,20230528.0,20230705.0,20230630,20230714,EXP,,US-NOVOPROD-1083194,NOVO NORDISK,,66.0,YR,,F,Y,,,20230714,,CN,US,US,2023,Q3,Elderly
226605352,22660535,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,U,,,,209637.0,0.5,MG,Solution for injection,/WK,2023,Q3,Extra dose administered,,2023,Q3,2,F,20230528.0,20230705.0,20230630,20230714,EXP,,US-NOVOPROD-1083194,NOVO NORDISK,,66.0,YR,,F,Y,,,20230714,,CN,US,US,2023,Q3,Elderly
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Road traffic accident,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Sensory loss,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Hallucination,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Depression,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Neck injury,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Vitamin B12 decreased,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Middle insomnia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Ageusia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Anosmia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,General physical health deterioration,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Muscle twitching,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Decreased appetite,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Drug titration error,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Mobility decreased,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Back pain,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Nightmare,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Affective disorder,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Anger,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Dizziness,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Abnormal dreams,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Pollakiuria,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Sleep talking,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Renal pain,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226707291,22670729,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q3,Arthralgia,,2023,Q3,1,I,,20230626.0,20230705,20230705,EXP,,CA-APOTEX-2023AP009666,APOTEX,,55.0,YR,,M,Y,145.0,KG,20230705,,HP,CA,CA,2023,Q3,Adult
226726431,22672643,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,,,,,,2.0,MG,,999,2023,Q3,Cholecystitis acute,,2023,Q3,1,I,20230704.0,,20230704,20230704,DIR,665644,,FDA-CTU,,79.0,YR,,M,N,82.0,KG,20230704,N,PH,US,,2023,Q3,Elderly
226726431,22672643,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,,,,,,2.0,MG,,999,2023,Q3,Mental status changes,,2023,Q3,1,I,20230704.0,,20230704,20230704,DIR,665644,,FDA-CTU,,79.0,YR,,M,N,82.0,KG,20230704,N,PH,US,,2023,Q3,Elderly
226731621,22673162,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Upper gastrointestinal haemorrhage,,2023,Q3,1,I,,20230629.0,20230705,20230705,EXP,,CA-PFIZER INC-202300237464,PFIZER,,73.0,YR,,F,Y,118.0,KG,20230705,,HP,CA,CA,2023,Q3,Elderly
226731621,22673162,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Gastric ulcer,,2023,Q3,1,I,,20230629.0,20230705,20230705,EXP,,CA-PFIZER INC-202300237464,PFIZER,,73.0,YR,,F,Y,118.0,KG,20230705,,HP,CA,CA,2023,Q3,Elderly
226752591,22675259,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Diabetic complication,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671404,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,126.0,KG,20230706,,PH,CA,CA,2023,Q3,Adult
226752591,22675259,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Blood ketone body,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671404,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,126.0,KG,20230706,,PH,CA,CA,2023,Q3,Adult
226752591,22675259,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Staphylococcal sepsis,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671404,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,126.0,KG,20230706,,PH,CA,CA,2023,Q3,Adult
226752591,22675259,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Euglycaemic diabetic ketoacidosis,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671404,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,126.0,KG,20230706,,PH,CA,CA,2023,Q3,Adult
226752591,22675259,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pulmonary oedema,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671404,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,126.0,KG,20230706,,PH,CA,CA,2023,Q3,Adult
226763791,22676379,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,219998,,99.0,20.0,IU,,999,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665736,,FDA-CTU,,47.0,YR,,F,N,,,20230705,Y,PH,US,,2023,Q3,Adult
226763791,22676379,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,219998,,99.0,20.0,IU,,999,2023,Q3,Wrong technique in product usage process,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665736,,FDA-CTU,,47.0,YR,,F,N,,,20230705,Y,PH,US,,2023,Q3,Adult
226763791,22676379,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,219998,,99.0,20.0,IU,,999,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665736,,FDA-CTU,,47.0,YR,,F,N,,,20230705,Y,PH,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Constipation,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Cholelithiasis,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226773501,22677350,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2023,Q3,Cholecystectomy,,2023,Q3,1,I,20230703.0,,20230705,20230705,DIR,665758,,FDA-CTU,,39.0,YR,,F,N,142.0,KG,20230705,N,,US,,2023,Q3,Adult
226782271,22678227,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Aggression,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Off label use,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Aggression,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782271,22678227,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230628.0,20230706,20230706,EXP,,CA-JNJFOC-20230671550,JOHNSON AND JOHNSON,,42.0,YR,A,M,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782411,22678241,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Walking disability,,2023,Q3,1,I,,20230705.0,20230706,20230706,EXP,,CA-BAUSCH-BL-2023-010234,BAUSCH AND LOMB,,58.0,YR,,F,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226782411,22678241,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Illness,,2023,Q3,1,I,,20230705.0,20230706,20230706,EXP,,CA-BAUSCH-BL-2023-010234,BAUSCH AND LOMB,,58.0,YR,,F,Y,,,20230706,,CN,CA,CA,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Peripheral coldness,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Palpitations,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827901,22682790,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Constipation,,2023,Q3,1,I,,,20230706,20230706,DIR,665911,,FDA-CTU,,40.0,YR,,F,N,107.1,KG,20230706,Y,CN,US,,2023,Q3,Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Panic attack,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Heart rate increased,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Insomnia,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Palpitations,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Anxiety,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once weekly;?,,,N,D,,,99.0,,,,999,2023,Q3,Hypertension,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Panic attack,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Heart rate increased,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Insomnia,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Palpitations,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Anxiety,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226827931,22682793,5,SS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,20230623.0,,20230706,20230706,DIR,665899,,FDA-CTU,,31.0,YR,,F,N,69.75,KG,20230706,N,CN,US,,2023,Q3,Young Adult
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Malaise,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Lacunar infarction,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Pain in extremity,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Unhealthy lifestyle,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Physical deconditioning,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Glaucoma,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Asthenia,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Muscular weakness,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Cataract,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Thirst,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Cerebral atrophy,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Arthralgia,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Sarcopenia,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Vertigo,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Injection site induration,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Diabetic nephropathy,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Breast cancer,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Dementia,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Angina pectoris,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Diabetic neuropathy,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Treatment noncompliance,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226899422,22689942,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,,2023,Q3,Off label use,,2023,Q3,2,F,20230301.0,20230712.0,20230711,20230724,EXP,,JP-EMD Serono-2023460110,EMD SERONO INC,,79.0,YR,E,F,Y,52.0,KG,20230724,,HP,JP,JP,2023,Q3,Elderly
226911461,22691146,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,1,I,,20230704.0,20230711,20230711,EXP,,CA-PFIZER INC-202300241632,PFIZER,,59.0,YR,,M,Y,82.0,KG,20230711,,HP,CA,CA,2023,Q3,Adult
226931881,22693188,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Depression,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226931881,22693188,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226931881,22693188,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226931881,22693188,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226931881,22693188,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226931881,22693188,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,20220826.0,,20230711,20230711,DIR,666289,,FDA-CTU,,56.0,YR,,M,N,123.75,KG,20230711,N,CN,US,,2023,Q3,Adult
226942373,22694237,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 weeks,,,U,,,,,1.0,MG,Subcutaneous Injection,/WK,2023,Q3,Aggression,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 weeks,,,U,,,,,1.0,MG,Subcutaneous Injection,/WK,2023,Q3,Substance use,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 weeks,,,U,,,,,1.0,MG,Subcutaneous Injection,/WK,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 weeks,,,U,,,,,1.0,MG,Subcutaneous Injection,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 weeks,,,U,,,,,1.0,MG,Subcutaneous Injection,/WK,2023,Q3,Product dose omission issue,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Aggression,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Substance use,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Product dose omission issue,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,35,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Aggression,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,35,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Substance use,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,35,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Psychotic disorder,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,35,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226942373,22694237,35,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Subcutaneous Injection,,2023,Q3,Product dose omission issue,,2023,Q3,3,F,,20230908.0,20230711,20230913,EXP,,CA-009507513-2307CAN004244,MERCK,,42.0,YR,,M,Y,,,20230913,,CN,CA,CA,2023,Q3,Adult
226963411,22696341,7,C,Semaglutide [Ozempic] ,,2,,,,,,,,,,,,,,2023,Q3,Renal failure,,2023,Q3,1,I,20230708.0,,20230711,20230711,DIR,666386,,FDA-CTU,,76.0,YR,,M,N,94.0,KG,20230711,Y,CN,US,,2023,Q3,Elderly
226963411,22696341,7,C,Semaglutide [Ozempic] ,,2,,,,,,,,,,,,,,2023,Q3,Pneumonia legionella,,2023,Q3,1,I,20230708.0,,20230711,20230711,DIR,666386,,FDA-CTU,,76.0,YR,,M,N,94.0,KG,20230711,Y,CN,US,,2023,Q3,Elderly
226963411,22696341,7,C,Semaglutide [Ozempic] ,,2,,,,,,,,,,,,,,2023,Q3,Pneumonitis,,2023,Q3,1,I,20230708.0,,20230711,20230711,DIR,666386,,FDA-CTU,,76.0,YR,,M,N,94.0,KG,20230711,Y,CN,US,,2023,Q3,Elderly
226963411,22696341,7,C,Semaglutide [Ozempic] ,,2,,,,,,,,,,,,,,2023,Q3,Pleural effusion,,2023,Q3,1,I,20230708.0,,20230711,20230711,DIR,666386,,FDA-CTU,,76.0,YR,,M,N,94.0,KG,20230711,Y,CN,US,,2023,Q3,Elderly
226963411,22696341,7,C,Semaglutide [Ozempic] ,,2,,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20230708.0,,20230711,20230711,DIR,666386,,FDA-CTU,,76.0,YR,,M,N,94.0,KG,20230711,Y,CN,US,,2023,Q3,Elderly
226982812,22698281,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Aggression,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Substance use,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,1.0,MG,Solution,/WK,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Aggression,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Substance use,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Aggression,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Substance use,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226982812,22698281,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230830.0,20230712,20230830,EXP,,CA-BAUSCH-BL-2023-010247,BAUSCH AND LOMB,,42.0,YR,,M,Y,,,20230830,,CN,CA,CA,2023,Q3,Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Hallucination,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Emotional distress,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Dehydration,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Muscular weakness,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Fear of death,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Hospitalisation,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,unknown (dose increased),,,Y,,,,215256.0,,,,,2023,Q3,Panic reaction,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Hallucination,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Emotional distress,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Dehydration,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Muscular weakness,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Fear of death,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Hospitalisation,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
226994601,22699460,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,215256.0,,,,,2023,Q3,Panic reaction,,2023,Q3,1,I,20221101.0,20230703.0,20230713,20230713,EXP,,GB-NOVOPROD-1087997,NOVO NORDISK,,34.0,YR,,M,Y,,,20230713,,CN,GB,GB,2023,Q3,Young Adult
227054621,22705462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.5 INJECTIONS ONCE WEEKLY SUBCUTANEOUS?,,,Y,D,,,99.0,,,Injection,999,2023,Q3,Muscle contractions involuntary,,2023,Q3,1,I,20230508.0,,20230713,20230713,DIR,666673,,FDA-CTU,,37.0,YR,,F,N,76.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227054621,22705462,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,,,,,,2023,Q3,Muscle contractions involuntary,,2023,Q3,1,I,20230508.0,,20230713,20230713,DIR,666673,,FDA-CTU,,37.0,YR,,F,N,76.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227056411,22705641,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,,20230301.0,99.0,,,,999,2023,Q3,Self-injurious ideation,,2023,Q3,1,I,20230318.0,,20230713,20230713,DIR,666646,,FDA-CTU,,45.0,YR,,F,N,85.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227056411,22705641,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,,20230301.0,99.0,,,,999,2023,Q3,Intrusive thoughts,,2023,Q3,1,I,20230318.0,,20230713,20230713,DIR,666646,,FDA-CTU,,45.0,YR,,F,N,85.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227056411,22705641,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,,20230301.0,99.0,,,,999,2023,Q3,Depressed mood,,2023,Q3,1,I,20230318.0,,20230713,20230713,DIR,666646,,FDA-CTU,,45.0,YR,,F,N,85.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227056411,22705641,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : once a week;?,,,Y,D,,20230301.0,99.0,,,,999,2023,Q3,Fear,,2023,Q3,1,I,20230318.0,,20230713,20230713,DIR,666646,,FDA-CTU,,45.0,YR,,F,N,85.5,KG,20230713,N,CN,US,,2023,Q3,Adult
227102271,22710227,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Dose Description : 0.25 mg, QD (in the morning)",,,,,,,,0.25,MG,Unknown,QD,2023,Q3,Agranulocytosis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227102271,22710227,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Dose Description : 0.25 mg, QD (in the morning)",,,,,,,,0.25,MG,Unknown,QD,2023,Q3,Haemolysis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227124262,22712426,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,,1.0,MG,Solution,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,,1.0,MG,Solution,,2023,Q3,Substance use,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,,1.0,MG,Solution,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,,1.0,MG,Solution,,2023,Q3,Aggression,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Weeks,,,U,,,,,1.0,MG,Solution,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Substance use,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Aggression,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227124262,22712426,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230828.0,20230717,20230910,EXP,CA-MHPD-E2B_06307631,CA-Accord-366639,ACCORD,,42.0,YR,A,M,Y,,,20230908,,CN,CA,CA,2023,Q3,Adult
227147101,22714710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,Y,,,,209637.0,,,Solution for injection,,2023,Q3,Endometrial cancer metastatic,,2023,Q3,1,I,20221001.0,20230707.0,20230718,20230718,EXP,,US-NOVOPROD-1089679,NOVO NORDISK,,64.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227147101,22714710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,Y,,,,209637.0,,,Solution for injection,,2023,Q3,Counterfeit product administered,,2023,Q3,1,I,20221001.0,20230707.0,20230718,20230718,EXP,,US-NOVOPROD-1089679,NOVO NORDISK,,64.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227147101,22714710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,Y,,,,209637.0,,,Solution for injection,,2023,Q3,Product use in unapproved indication,,2023,Q3,1,I,20221001.0,20230707.0,20230718,20230718,EXP,,US-NOVOPROD-1089679,NOVO NORDISK,,64.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227162821,22716282,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q3,Tooth extraction,,2023,Q3,1,I,,20230706.0,20230718,20230718,EXP,CA-MHPD-E2B_06297222,CA-Accord-367000,ACCORD,,62.0,YR,A,F,Y,,,20230718,,HP,CA,CA,2023,Q3,Adult
227162821,22716282,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230706.0,20230718,20230718,EXP,CA-MHPD-E2B_06297222,CA-Accord-367000,ACCORD,,62.0,YR,A,F,Y,,,20230718,,HP,CA,CA,2023,Q3,Adult
227162821,22716282,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q3,Carpal tunnel decompression,,2023,Q3,1,I,,20230706.0,20230718,20230718,EXP,CA-MHPD-E2B_06297222,CA-Accord-367000,ACCORD,,62.0,YR,A,F,Y,,,20230718,,HP,CA,CA,2023,Q3,Adult
227165403,22716540,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Cerebrovascular accident,,2023,Q3,3,F,20230309.0,20230913.0,20230718,20230914,EXP,,US-ROCHE-3387975,ROCHE,,78.0,YR,,F,Y,67.1,KG,20230914,,MD,US,,2023,Q3,Elderly
227165403,22716540,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Urinary bladder haemorrhage,,2023,Q3,3,F,20230309.0,20230913.0,20230718,20230914,EXP,,US-ROCHE-3387975,ROCHE,,78.0,YR,,F,Y,67.1,KG,20230914,,MD,US,,2023,Q3,Elderly
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Nausea,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Abdominal distension,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Vomiting,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Product compounding quality issue,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Weight decreased,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Gastroenteritis viral,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227169491,22716949,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,WEEKLY?,,,Y,D,,,99.0,,,,QW,2023,Q3,Dehydration,,2023,Q3,1,I,20230624.0,,20230717,20230717,DIR,667023,,FDA-CTU,,51.0,YR,,M,N,173.25,KG,20230717,N,HP,US,,2023,Q3,Adult
227174732,22717473,26,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,26,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,26,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Aggression,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,26,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Substance use,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,26,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Aggression,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Substance use,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227174732,22717473,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230905.0,20230718,20230913,EXP,,CA-AstraZeneca-2023A163189,ASTRAZENECA,,42.0,YR,,M,Y,,,20230913,,MD,CA,,2023,Q3,Adult
227182111,22718211,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,3.0,MG,,,2023,Q3,Renal failure,,2023,Q3,1,I,,20230713.0,20230718,20230718,EXP,,SG-AstraZeneca-2023A161207,ASTRAZENECA,,48.0,YR,,M,Y,,,20230718,,MD,SG,,2023,Q3,Adult
227238791,22723879,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,TWICE WEEKLY SUBCUTANEOUS,,,Y,D,417835,20230930.0,99.0,,,,999,2023,Q3,Hospitalisation,,2023,Q3,1,I,20230501.0,,20230718,20230718,DIR,667199,,FDA-CTU,,42.0,YR,,F,N,90.0,KG,20230718,Y,CN,US,,2023,Q3,Adult
227243211,22724321,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,Tablet,,2023,Q3,Urine output increased,,2023,Q3,1,I,,20230710.0,20230719,20230719,EXP,,JP-MALLINCKRODT-MNK202303211,MALLINCKRODT,,63.0,YR,A,F,Y,,,20230719,,HP,JP,JP,2023,Q3,Adult
227243211,22724321,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,Tablet,,2023,Q3,Haemothorax,,2023,Q3,1,I,,20230710.0,20230719,20230719,EXP,,JP-MALLINCKRODT-MNK202303211,MALLINCKRODT,,63.0,YR,A,F,Y,,,20230719,,HP,JP,JP,2023,Q3,Adult
227243211,22724321,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,Tablet,,2023,Q3,Pneumothorax,,2023,Q3,1,I,,20230710.0,20230719,20230719,EXP,,JP-MALLINCKRODT-MNK202303211,MALLINCKRODT,,63.0,YR,A,F,Y,,,20230719,,HP,JP,JP,2023,Q3,Adult
227270342,22727034,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,,/WK,2023,Q3,Suicidal ideation,,2023,Q3,2,F,20230708.0,20230726.0,20230720,20230803,EXP,,US-JNJFOC-20230728548,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,,,20230803,,HP,US,US,2023,Q3,Adult
227270351,22727035,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Renal tubular necrosis,,2023,Q3,1,I,,20230713.0,20230720,20230720,EXP,,CA-APOTEX-2023AP010547,APOTEX,,68.0,YR,,M,Y,112.0,KG,20230720,,HP,CA,CA,2023,Q3,Elderly
227282392,22728239,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Therapeutic response shortened,,2023,Q3,2,F,20230716.0,20230724.0,20230720,20230728,PER,,US-SA-2023SA219691,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20230728,,MD,US,US,2023,Q3,Adult
227282392,22728239,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Accidental exposure to product,,2023,Q3,2,F,20230716.0,20230724.0,20230720,20230728,PER,,US-SA-2023SA219691,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20230728,,MD,US,US,2023,Q3,Adult
227282392,22728239,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Rash,,2023,Q3,2,F,20230716.0,20230724.0,20230720,20230728,PER,,US-SA-2023SA219691,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20230728,,MD,US,US,2023,Q3,Adult
227282392,22728239,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,2,F,20230716.0,20230724.0,20230720,20230728,PER,,US-SA-2023SA219691,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20230728,,MD,US,US,2023,Q3,Adult
227293561,22729356,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230216.0,20230720,20230720,PER,,US-NOVOPROD-1035319,NOVO NORDISK,,57.0,YR,,M,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293561,22729356,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q3,Dehydration,,2023,Q3,1,I,,20230216.0,20230720,20230720,PER,,US-NOVOPROD-1035319,NOVO NORDISK,,57.0,YR,,M,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293601,22729360,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,209637.0,,,,,2023,Q3,Electric shock sensation,,2023,Q3,1,I,20230428.0,20230501.0,20230720,20230720,PER,,US-NOVOPROD-1060070,NOVO NORDISK,,65.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Elderly
227293601,22729360,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,209637.0,,,,,2023,Q3,Hypoaesthesia,,2023,Q3,1,I,20230428.0,20230501.0,20230720,20230720,PER,,US-NOVOPROD-1060070,NOVO NORDISK,,65.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Elderly
227293601,22729360,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,209637.0,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,20230428.0,20230501.0,20230720,20230720,PER,,US-NOVOPROD-1060070,NOVO NORDISK,,65.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Elderly
227293601,22729360,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,,,,,209637.0,,,,,2023,Q3,Nervous system disorder,,2023,Q3,1,I,20230428.0,20230501.0,20230720,20230720,PER,,US-NOVOPROD-1060070,NOVO NORDISK,,65.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Elderly
227293661,22729366,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.6 ml/1.5mg,,,U,,,,209637.0,,,,,2023,Q3,Weight fluctuation,,2023,Q3,1,I,,20230417.0,20230720,20230720,PER,,US-NOVOPROD-1059036,NOVO NORDISK,,24.0,YR,,,Y,,,20230720,,CN,US,US,2023,Q3,Young Adult
227293671,22729367,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,Solution for injection,,2023,Q3,Dry mouth,,2023,Q3,1,I,20230101.0,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1069776,NOVO NORDISK,,40.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293671,22729367,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,Solution for injection,,2023,Q3,Abdominal distension,,2023,Q3,1,I,20230101.0,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1069776,NOVO NORDISK,,40.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293671,22729367,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,Solution for injection,,2023,Q3,Fatigue,,2023,Q3,1,I,20230101.0,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1069776,NOVO NORDISK,,40.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293671,22729367,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,Solution for injection,,2023,Q3,Nausea,,2023,Q3,1,I,20230101.0,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1069776,NOVO NORDISK,,40.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293671,22729367,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,Solution for injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,20230101.0,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1069776,NOVO NORDISK,,40.0,YR,,F,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293681,22729368,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q3,Dry mouth,,2023,Q3,1,I,,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1068127,NOVO NORDISK,,40.0,YR,,,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293681,22729368,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1068127,NOVO NORDISK,,40.0,YR,,,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293681,22729368,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1068127,NOVO NORDISK,,40.0,YR,,,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293681,22729368,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q3,Abdominal distension,,2023,Q3,1,I,,20230519.0,20230720,20230720,PER,,US-NOVOPROD-1068127,NOVO NORDISK,,40.0,YR,,,Y,,,20230720,,CN,US,US,2023,Q3,Adult
227293701,22729370,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.4 mL, qw",1.2,ML,Y,,,,209637.0,0.4,ML,,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,20221001.0,20230210.0,20230720,20230720,PER,,US-NOVOPROD-1024045,NOVO NORDISK,,32.0,YR,,F,Y,86.168,KG,20230720,,MD,US,US,2023,Q3,Young Adult
227293701,22729370,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.4 mL, qw",1.2,ML,Y,,,,209637.0,0.4,ML,,/WK,2023,Q3,Nausea,,2023,Q3,1,I,20221001.0,20230210.0,20230720,20230720,PER,,US-NOVOPROD-1024045,NOVO NORDISK,,32.0,YR,,F,Y,86.168,KG,20230720,,MD,US,US,2023,Q3,Young Adult
227293701,22729370,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.4 mL, qw",1.2,ML,Y,,,,209637.0,0.4,ML,,/WK,2023,Q3,Counterfeit product administered,,2023,Q3,1,I,20221001.0,20230210.0,20230720,20230720,PER,,US-NOVOPROD-1024045,NOVO NORDISK,,32.0,YR,,F,Y,86.168,KG,20230720,,MD,US,US,2023,Q3,Young Adult
227293701,22729370,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.4 mL, qw",1.2,ML,Y,,,,209637.0,0.4,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,20221001.0,20230210.0,20230720,20230720,PER,,US-NOVOPROD-1024045,NOVO NORDISK,,32.0,YR,,F,Y,86.168,KG,20230720,,MD,US,US,2023,Q3,Young Adult
227349681,22734968,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,,,2023,Q3,Depression suicidal,,2023,Q3,1,I,20210410.0,20230711.0,20230721,20230721,EXP,,GB-NOVOPROD-1091100,NOVO NORDISK,,33.0,YR,,M,Y,160.0,KG,20230721,,CN,GB,GB,2023,Q3,Young Adult
227355162,22735516,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Substance use,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Aggression,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Substance use,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Aggression,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, q.wk.",,,U,,,,,,,Solution for injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, q.wk.",,,U,,,,,,,Solution for injection,,2023,Q3,Product dose omission issue,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, q.wk.",,,U,,,,,,,Solution for injection,,2023,Q3,Substance use,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, q.wk.",,,U,,,,,,,Solution for injection,,2023,Q3,Psychotic disorder,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227355162,22735516,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK UNK, q.wk.",,,U,,,,,,,Solution for injection,,2023,Q3,Aggression,,2023,Q3,2,F,,20230817.0,20230721,20230828,EXP,,CA-APOTEX-2023AP010477,APOTEX,,42.0,YR,,M,Y,,,20230828,,CN,CA,CA,2023,Q3,Adult
227409231,22740923,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",7.857,MG,Y,N,,,215256.0,1.0,MG,Solution for injection,/WK,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,20230612.0,20230711.0,20230724,20230724,EXP,,US-NOVOPROD-1090349,NOVO NORDISK,,51.0,YR,,F,Y,78.0,KG,20230724,,MD,US,US,2023,Q3,Adult
227409231,22740923,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",7.857,MG,Y,N,,,215256.0,0.5,MG,Solution for injection,/WK,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,20230612.0,20230711.0,20230724,20230724,EXP,,US-NOVOPROD-1090349,NOVO NORDISK,,51.0,YR,,F,Y,78.0,KG,20230724,,MD,US,US,2023,Q3,Adult
227409301,22740930,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 DF QD,,,,,UNKNOWN,,,,,Solution for injection,,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,,20230712.0,20230724,20230724,EXP,GB-MHRA-TPP24273302C124611YC1688985744946,GB-NOVOPROD-1092783,NOVO NORDISK,,44.0,YR,,M,Y,100.0,KG,20230724,,MD,GB,GB,2023,Q3,Adult
227426911,22742691,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Granulomatosis with polyangiitis,,2023,Q3,1,I,,20230714.0,20230724,20230724,EXP,,CA-TEVA-2023-CA-2908021,TEVA,,66.0,YR,E,M,Y,,,20230724,,HP,CA,CA,2023,Q3,Elderly
227426911,22742691,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hepatic cirrhosis,,2023,Q3,1,I,,20230714.0,20230724,20230724,EXP,,CA-TEVA-2023-CA-2908021,TEVA,,66.0,YR,E,M,Y,,,20230724,,HP,CA,CA,2023,Q3,Elderly
227426911,22742691,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230714.0,20230724,20230724,EXP,,CA-TEVA-2023-CA-2908021,TEVA,,66.0,YR,E,M,Y,,,20230724,,HP,CA,CA,2023,Q3,Elderly
227426911,22742691,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,,20230714.0,20230724,20230724,EXP,,CA-TEVA-2023-CA-2908021,TEVA,,66.0,YR,E,M,Y,,,20230724,,HP,CA,CA,2023,Q3,Elderly
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,COVID-19,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Immune system disorder,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227440122,22744012,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,COVID-19,,2023,Q3,2,F,,20230718.0,20230724,20230725,EXP,,CA-AMGEN-CANSP2023126229,AMGEN,,60.0,YR,A,F,Y,77.0,KG,20230725,,HP,CA,CA,2023,Q3,Adult
227456732,22745673,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution for injection/infusion,,2023,Q3,Pneumonia,,2023,Q3,2,F,,20230728.0,20230725,20230801,EXP,,CA-JNJFOC-20230745746,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,77.0,KG,20230801,,HP,CA,CA,2023,Q3,Adult
227456732,22745673,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution for injection/infusion,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230728.0,20230725,20230801,EXP,,CA-JNJFOC-20230745746,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,77.0,KG,20230801,,HP,CA,CA,2023,Q3,Adult
227456732,22745673,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution for injection/infusion,,2023,Q3,COVID-19,,2023,Q3,2,F,,20230728.0,20230725,20230801,EXP,,CA-JNJFOC-20230745746,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,77.0,KG,20230801,,HP,CA,CA,2023,Q3,Adult
227456732,22745673,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution for injection/infusion,,2023,Q3,Immune system disorder,,2023,Q3,2,F,,20230728.0,20230725,20230801,EXP,,CA-JNJFOC-20230745746,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,77.0,KG,20230801,,HP,CA,CA,2023,Q3,Adult
227456732,22745673,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution for injection/infusion,,2023,Q3,Pain,,2023,Q3,2,F,,20230728.0,20230725,20230801,EXP,,CA-JNJFOC-20230745746,JOHNSON AND JOHNSON,,60.0,YR,A,F,Y,77.0,KG,20230801,,HP,CA,CA,2023,Q3,Adult
227510401,22751040,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230716.0,20230726,20230726,EXP,,CA-TEVA-2023-CA-2909103,TEVA,,66.0,YR,E,M,Y,,,20230726,,HP,CA,CA,2023,Q3,Elderly
227510401,22751040,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Granulomatosis with polyangiitis,,2023,Q3,1,I,,20230716.0,20230726,20230726,EXP,,CA-TEVA-2023-CA-2909103,TEVA,,66.0,YR,E,M,Y,,,20230726,,HP,CA,CA,2023,Q3,Elderly
227510401,22751040,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Hepatic cirrhosis,,2023,Q3,1,I,,20230716.0,20230726,20230726,EXP,,CA-TEVA-2023-CA-2909103,TEVA,,66.0,YR,E,M,Y,,,20230726,,HP,CA,CA,2023,Q3,Elderly
227510401,22751040,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Treatment failure,,2023,Q3,1,I,,20230716.0,20230726,20230726,EXP,,CA-TEVA-2023-CA-2909103,TEVA,,66.0,YR,E,M,Y,,,20230726,,HP,CA,CA,2023,Q3,Elderly
227526321,22752632,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,Injection,,2023,Q3,Nausea,,2023,Q3,1,I,20230426.0,,20230726,20230726,DIR,FDA-CDER-CTU-2023-54592,,FDA-CTU,,65.0,YR,,F,N,72.57,KG,20230724,Y,CN,US,,2023,Q3,Elderly
227526321,22752632,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,Injection,,2023,Q3,Endometrial cancer,,2023,Q3,1,I,20230426.0,,20230726,20230726,DIR,FDA-CDER-CTU-2023-54592,,FDA-CTU,,65.0,YR,,F,N,72.57,KG,20230724,Y,CN,US,,2023,Q3,Elderly
227556961,22755696,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 milligram, qd",,,,,,,,0.25,MG,,QD,2023,Q3,Off label use,,2023,Q3,1,I,20220501.0,20230717.0,20230727,20230727,EXP,,DE-AMGEN-DEUSP2023125089,AMGEN,"Allgaier,R. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Drugs in R and D. 2023;23(2):93-98",62.0,YR,A,,Y,,,20230727,,HP,DE,DE,2023,Q3,Adult
227556961,22755696,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.25 milligram, qd",,,,,,,,0.25,MG,,QD,2023,Q3,Haemolysis,,2023,Q3,1,I,20220501.0,20230717.0,20230727,20230727,EXP,,DE-AMGEN-DEUSP2023125089,AMGEN,"Allgaier,R. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Drugs in R and D. 2023;23(2):93-98",62.0,YR,A,,Y,,,20230727,,HP,DE,DE,2023,Q3,Adult
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Liver injury,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Shock,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Toxic encephalopathy,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Acute respiratory failure,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227562981,22756298,1,PS,NADIDE\SEMAGLUTIDE,NADIDE\SEMAGLUTIDE,1,Intramuscular,Frequency : Weekly;?,,,Y,D,06062023,20231020.0,99.0,,,Injection,QW,2023,Q3,Unresponsive to stimuli,,2023,Q3,1,I,20230709.0,,20230726,20230726,DIR,668219,,FDA-CTU,,65.0,YR,,F,N,72.0,KG,20230726,N,CN,US,,2023,Q3,Elderly
227566321,22756632,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg SC Once Weekly,,,,,,,,1.0,MG,,/WK,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg SC Once Weekly,,,,,,,,1.0,MG,,/WK,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg SC Once Weekly,,,,,,,,1.0,MG,,/WK,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg SC Once Weekly,,,,,,,,1.0,MG,,/WK,2023,Q3,Nausea,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227566321,22756632,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1mg SC Once Weekly,,,,,,,,1.0,MG,,/WK,2023,Q3,Off label use,,2023,Q3,1,I,20230701.0,20230722.0,20230727,20230727,EXP,GB-MHRA-MIDB-bbe6a0bf-12c5-4386-87ac-b9ff674d9b7d,GB-PFIZER INC-202300257258,PFIZER,,66.0,YR,,F,Y,117.0,KG,20230727,,PH,GB,GB,2023,Q3,Elderly
227575761,22757576,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q3,Small intestinal obstruction,,2023,Q3,1,I,20230720.0,,20230727,20230727,DIR,668270,,FDA-CTU,,51.0,YR,,F,N,67.5,KG,20230727,N,CN,US,,2023,Q3,Adult
227575761,22757576,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q3,Crohn's disease,,2023,Q3,1,I,20230720.0,,20230727,20230727,DIR,668270,,FDA-CTU,,51.0,YR,,F,N,67.5,KG,20230727,N,CN,US,,2023,Q3,Adult
227575761,22757576,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q3,Intestinal stenosis,,2023,Q3,1,I,20230720.0,,20230727,20230727,DIR,668270,,FDA-CTU,,51.0,YR,,F,N,67.5,KG,20230727,N,CN,US,,2023,Q3,Adult
227593071,22759307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Gallbladder disorder,,2023,Q3,1,I,20230625.0,20230717.0,20230728,20230728,EXP,,KR-NOVOPROD-1092976,NOVO NORDISK,,85.0,YR,,M,Y,72.0,KG,20230728,,MD,KR,KR,2023,Q3,Elderly
227645691,22764569,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,209637.0,,,,,2023,Q3,Depressed mood,,2023,Q3,1,I,20230215.0,20230720.0,20230731,20230731,EXP,,GB-NOVOPROD-1096943,NOVO NORDISK,,61.0,YR,,F,Y,68.0,KG,20230731,,CN,GB,GB,2023,Q3,Adult
227645691,22764569,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,209637.0,,,,,2023,Q3,Medication error,,2023,Q3,1,I,20230215.0,20230720.0,20230731,20230731,EXP,,GB-NOVOPROD-1096943,NOVO NORDISK,,61.0,YR,,F,Y,68.0,KG,20230731,,CN,GB,GB,2023,Q3,Adult
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dehydration,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Euglycaemic diabetic ketoacidosis,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227651581,22765158,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,,20230724.0,20230731,20230731,EXP,,CA-JNJFOC-20230759013,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,78.0,KG,20230731,,PH,CA,CA,2023,Q3,Elderly
227676461,22767646,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,99.0,,,,QW,2023,Q3,Suicidal ideation,,2023,Q3,1,I,20230728.0,,20230729,20230729,DIR,668523,,FDA-CTU,,25.0,YR,,F,N,84.6,KG,20230729,N,CN,US,,2023,Q3,Young Adult
227680641,22768064,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Eczema,,2023,Q3,1,I,20230101.0,20230726.0,20230731,20230731,PER,,US-SA-2023SA230550,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230731,,MD,US,US,2023,Q3,Youth
227723232,22772323,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,,,2023,Q3,Blood pressure increased,,2023,Q3,2,F,20230727.0,20230802.0,20230801,20230806,EXP,,NVSJ2023JP011949,NOVARTIS,,44.0,YR,,M,Y,,,20230807,,PH,JP,JP,2023,Q3,Adult
227723232,22772323,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg,,,U,,,,,0.25,MG,,,2023,Q3,Contraindicated product administered,,2023,Q3,2,F,20230727.0,20230802.0,20230801,20230806,EXP,,NVSJ2023JP011949,NOVARTIS,,44.0,YR,,M,Y,,,20230807,,PH,JP,JP,2023,Q3,Adult
227820961,22782096,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,2.4,MG,,999,2023,Q3,Appendicitis,,2023,Q3,1,I,20230802.0,,20230802,20230802,DIR,668953,,FDA-CTU,,38.0,YR,,M,N,174.0,KG,20230802,N,PH,US,,2023,Q3,Adult
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hypotension,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227835161,22783516,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dialysis,,2023,Q3,1,I,,20230802.0,20230803,20230803,EXP,,CA-BAUSCH-BL-2023-011799,BAUSCH AND LOMB,,75.0,YR,,F,Y,,,20230803,,PH,CA,CA,2023,Q3,Elderly
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Sinusitis,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Hepatic pain,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Palpitations,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Blood pressure systolic increased,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,White blood cell count increased,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Renal pain,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Discoloured vomit,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Breast mass,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Hepatic enzyme increased,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Nephrolithiasis,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Blood glucose abnormal,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Head injury,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Abdominal distension,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Illness,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Gait disturbance,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Injection site pain,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Hypercholesterolaemia,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227836331,22783633,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Dosage form  - Not Specified,,,,,,,,,,,,2023,Q3,Coma,,2023,Q3,1,I,,20230731.0,20230803,20230803,EXP,,CA-FreseniusKabi-FK202311774,FRESENIUS KABI,,53.0,YR,A,F,Y,,,20230803,,HP,CA,CA,2023,Q3,Adult
227896501,22789650,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Hyperkalaemia,,2023,Q3,1,I,20221005.0,20230730.0,20230804,20230804,EXP,,GB-MYLANLABS-2023M1081326,MYLAN,,54.0,YR,,M,Y,95.0,KG,20230804,,HP,GB,GB,2023,Q3,Adult
227896501,22789650,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20221005.0,20230730.0,20230804,20230804,EXP,,GB-MYLANLABS-2023M1081326,MYLAN,,54.0,YR,,M,Y,95.0,KG,20230804,,HP,GB,GB,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Hepatic necrosis,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227966121,22796612,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q3,Completed suicide,,2023,Q3,1,I,,20230801.0,20230808,20230808,EXP,,NL-SANDOZ-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20230808,,MD,NL,NL,2023,Q3,Adult
227990081,22799008,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, Semaglutide B 3.0mg/ml PDS290 semaglutide 2.4 mg Blinded Semaglutide",,,U,,,,,,,,,2023,Q3,Renal failure,,2023,Q3,1,I,20221025.0,20230724.0,20230808,20230808,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-402370,RANBAXY,,71.0,YR,,F,Y,68.0,KG,20230808,,HP,FR,FR,2023,Q3,Elderly
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Vasoplegia syndrome,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Intentional overdose,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Hyperlactacidaemia,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Suicide attempt,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228007013,22800701,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/kg),,,U,,,,,14.0,MG,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,3,F,,20230811.0,20230808,20230821,EXP,,NL-BAUSCH-BL-2023-011732,BAUSCH AND LOMB,"Workum J, Keyany A, Jaspers T. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology Reports. 2023 JUL 17;11:141-144. doi:10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Alanine aminotransferase increased,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Overdose,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Aspartate aminotransferase increased,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Lactic acidosis,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Suicide attempt,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Distributive shock,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228027442,22802744,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets,,,D,,UNKNOWN,,,14.0,MG,Tablets,,2023,Q3,Hepatic necrosis,,2023,Q3,2,F,,20230804.0,20230809,20230816,EXP,,NL-Unichem Pharmaceuticals (USA) Inc-UCM202308-001048,UNICHEM,,55.0,YR,A,F,Y,125.0,KG,20230816,,HP,NL,,2023,Q3,Adult
228028731,22802873,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230801.0,20230809,20230809,EXP,,NL-ORGANON-O2308NLD000287,ORGANON,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports.. 2023;11:141-4",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228028731,22802873,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230801.0,20230809,20230809,EXP,,NL-ORGANON-O2308NLD000287,ORGANON,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports.. 2023;11:141-4",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228028731,22802873,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230801.0,20230809,20230809,EXP,,NL-ORGANON-O2308NLD000287,ORGANON,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports.. 2023;11:141-4",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228030101,22803010,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,COVID-19,,2023,Q3,1,I,,20230728.0,20230809,20230809,EXP,CA-MHPD-E2B_06346911,CA-Accord-370926,ACCORD,,59.0,YR,A,F,Y,77.0,KG,20230809,,HP,CA,CA,2023,Q3,Adult
228030101,22803010,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Pneumonia,,2023,Q3,1,I,,20230728.0,20230809,20230809,EXP,CA-MHPD-E2B_06346911,CA-Accord-370926,ACCORD,,59.0,YR,A,F,Y,77.0,KG,20230809,,HP,CA,CA,2023,Q3,Adult
228030101,22803010,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Coma,,2023,Q3,1,I,,20230728.0,20230809,20230809,EXP,CA-MHPD-E2B_06346911,CA-Accord-370926,ACCORD,,59.0,YR,A,F,Y,77.0,KG,20230809,,HP,CA,CA,2023,Q3,Adult
228042471,22804247,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,,D,,,,0.25,MG,,999,2023,Q3,Pancreatitis acute,,2023,Q3,1,I,20230720.0,,20230808,20230808,DIR,669687,,FDA-CTU,,65.0,YR,,F,N,106.5,KG,20230808,N,HP,US,,2023,Q3,Elderly
228056631,22805663,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milligram, qd",,,Y,U,,,,3.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230802.0,20230809,20230809,EXP,,US-MYLANLABS-2023M1083501,MYLAN,"Chahal N, Zarka J, Simonson M. SLOW DOWN AND THINK ABOUT IT: DIFFERENTIATING CAUSES OF GASTROPARESIS IN PATIENTS WITH DIABETES. J-Gen-Intern-Med 2023;38 (Suppl. 2):S533.",66.0,YR,,M,Y,,,20230809,,HP,US,US,2023,Q3,Elderly
228056631,22805663,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"7 milligram, qd",,,Y,U,,,,7.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230802.0,20230809,20230809,EXP,,US-MYLANLABS-2023M1083501,MYLAN,"Chahal N, Zarka J, Simonson M. SLOW DOWN AND THINK ABOUT IT: DIFFERENTIATING CAUSES OF GASTROPARESIS IN PATIENTS WITH DIABETES. J-Gen-Intern-Med 2023;38 (Suppl. 2):S533.",66.0,YR,,M,Y,,,20230809,,HP,US,US,2023,Q3,Elderly
228062291,22806229,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230731.0,20230809,20230809,EXP,,NL-PRINSTON PHARMACEUTICAL INC.-2023PRN00370,PRINSTON PHARMACEUTICAL,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol. Rep. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228062291,22806229,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Hepatic necrosis,,2023,Q3,1,I,,20230731.0,20230809,20230809,EXP,,NL-PRINSTON PHARMACEUTICAL INC.-2023PRN00370,PRINSTON PHARMACEUTICAL,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol. Rep. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228062291,22806229,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230731.0,20230809,20230809,EXP,,NL-PRINSTON PHARMACEUTICAL INC.-2023PRN00370,PRINSTON PHARMACEUTICAL,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol. Rep. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228062291,22806229,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Completed suicide,,2023,Q3,1,I,,20230731.0,20230809,20230809,EXP,,NL-PRINSTON PHARMACEUTICAL INC.-2023PRN00370,PRINSTON PHARMACEUTICAL,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol. Rep. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228062291,22806229,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Overdose,,2023,Q3,1,I,,20230731.0,20230809,20230809,EXP,,NL-PRINSTON PHARMACEUTICAL INC.-2023PRN00370,PRINSTON PHARMACEUTICAL,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol. Rep. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Panic attack,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Depression,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Hypophagia,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Therapy cessation,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228095051,22809505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 10 Units;?OTHER FREQUENCY : Once a week;?OTHER ROUTE : Subcutaneous injection;?,,,N,D,219526,20240522.0,99.0,10.0,IU,,999,2023,Q3,Anxiety,,2023,Q3,1,I,20230720.0,,20230809,20230809,DIR,669865,,FDA-CTU,,57.0,YR,,F,N,83.25,KG,20230809,N,CN,US,,2023,Q3,Adult
228102021,22810202,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Chest pain,,2023,Q3,1,I,,20230731.0,20230810,20230810,EXP,,CA-TEVA-2023-CA-2913384,TEVA,,66.0,YR,E,M,Y,,,20230810,,HP,CA,CA,2023,Q3,Elderly
228102021,22810202,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Renal tubular necrosis,,2023,Q3,1,I,,20230731.0,20230810,20230810,EXP,,CA-TEVA-2023-CA-2913384,TEVA,,66.0,YR,E,M,Y,,,20230810,,HP,CA,CA,2023,Q3,Elderly
228102021,22810202,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Anaemia,,2023,Q3,1,I,,20230731.0,20230810,20230810,EXP,,CA-TEVA-2023-CA-2913384,TEVA,,66.0,YR,E,M,Y,,,20230810,,HP,CA,CA,2023,Q3,Elderly
228102021,22810202,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,,20230731.0,20230810,20230810,EXP,,CA-TEVA-2023-CA-2913384,TEVA,,66.0,YR,E,M,Y,,,20230810,,HP,CA,CA,2023,Q3,Elderly
228102021,22810202,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230731.0,20230810,20230810,EXP,,CA-TEVA-2023-CA-2913384,TEVA,,66.0,YR,E,M,Y,,,20230810,,HP,CA,CA,2023,Q3,Elderly
228121251,22812125,4,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,209637.0,,,,,2023,Q3,Hyperkalaemia,,2023,Q3,1,I,20221005.0,20230730.0,20230811,20230811,EXP,,GB-NOVOPROD-1098350,NOVO NORDISK,,54.0,YR,,M,Y,95.0,KG,20230811,,HP,GB,GB,2023,Q3,Adult
228121251,22812125,4,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,D,,,,209637.0,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20221005.0,20230730.0,20230811,20230811,EXP,,GB-NOVOPROD-1098350,NOVO NORDISK,,54.0,YR,,M,Y,95.0,KG,20230811,,HP,GB,GB,2023,Q3,Adult
228129961,22812996,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Hyperkalaemia,,2023,Q3,1,I,20221005.0,20230730.0,20230811,20230811,EXP,,GB-AUROBINDO-AUR-APL-2023-051909,AUROBINDO,,54.0,YR,,M,Y,95.0,KG,20230811,,HP,GB,GB,2023,Q3,Adult
228129961,22812996,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20221005.0,20230730.0,20230811,20230811,EXP,,GB-AUROBINDO-AUR-APL-2023-051909,AUROBINDO,,54.0,YR,,M,Y,95.0,KG,20230811,,HP,GB,GB,2023,Q3,Adult
228150852,22815085,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,2,F,20230808.0,20230810.0,20230811,20230816,PER,,US-ABBVIE-5363726,ABBVIE,,57.0,YR,,F,Y,,,20230816,,HP,US,US,2023,Q3,Adult
228150852,22815085,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Head discomfort,,2023,Q3,2,F,20230808.0,20230810.0,20230811,20230816,PER,,US-ABBVIE-5363726,ABBVIE,,57.0,YR,,F,Y,,,20230816,,HP,US,US,2023,Q3,Adult
228150852,22815085,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Visual field defect,,2023,Q3,2,F,20230808.0,20230810.0,20230811,20230816,PER,,US-ABBVIE-5363726,ABBVIE,,57.0,YR,,F,Y,,,20230816,,HP,US,US,2023,Q3,Adult
228184752,22818475,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Abdominal hernia,,2023,Q3,2,F,20200701.0,20230801.0,20230814,20230825,EXP,,CA-002147023-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230825,,MD,CA,CA,2023,Q3,Elderly
228184752,22818475,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Meningioma,,2023,Q3,2,F,20200701.0,20230801.0,20230814,20230825,EXP,,CA-002147023-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230825,,MD,CA,CA,2023,Q3,Elderly
228184752,22818475,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Abdominal hernia,,2023,Q3,2,F,20200701.0,20230801.0,20230814,20230825,EXP,,CA-002147023-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230825,,MD,CA,CA,2023,Q3,Elderly
228186891,22818689,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Heparin-induced thrombocytopenia,,2023,Q3,1,I,20230623.0,20230811.0,20230814,20230814,EXP,,FR-SANDOZ-SDZ2023FR013078,SANDOZ,,73.0,YR,,M,Y,,,20230814,,HP,FR,FR,2023,Q3,Elderly
228186891,22818689,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Heparin-induced thrombocytopenia,,2023,Q3,1,I,20230623.0,20230811.0,20230814,20230814,EXP,,FR-SANDOZ-SDZ2023FR013078,SANDOZ,,73.0,YR,,M,Y,,,20230814,,HP,FR,FR,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Dialysis,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Hypotension,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228191671,22819167,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011797,APOTEX,,75.0,YR,,F,Y,,,20230814,,PH,CA,CA,2023,Q3,Elderly
228205061,22820506,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : weekly;?,,,,,,,,0.5,MG,,999,2023,Q3,Cholelithiasis,,2023,Q3,1,I,20230810.0,,20230812,20230812,DIR,670212,,FDA-CTU,,64.0,YR,,M,N,92.0,KG,20230812,N,PH,US,,2023,Q3,Adult
228205061,22820506,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : weekly;?,,,,,,,,0.5,MG,,999,2023,Q3,Gallbladder enlargement,,2023,Q3,1,I,20230810.0,,20230812,20230812,DIR,670212,,FDA-CTU,,64.0,YR,,M,N,92.0,KG,20230812,N,PH,US,,2023,Q3,Adult
228205061,22820506,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : weekly;?,,,,,,,,0.5,MG,,999,2023,Q3,Intra-abdominal fluid collection,,2023,Q3,1,I,20230810.0,,20230812,20230812,DIR,670212,,FDA-CTU,,64.0,YR,,M,N,92.0,KG,20230812,N,PH,US,,2023,Q3,Adult
228205061,22820506,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : weekly;?,,,,,,,,0.5,MG,,999,2023,Q3,Cholecystitis acute,,2023,Q3,1,I,20230810.0,,20230812,20230812,DIR,670212,,FDA-CTU,,64.0,YR,,M,N,92.0,KG,20230812,N,PH,US,,2023,Q3,Adult
228212761,22821276,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Suicidal ideation,,2023,Q3,1,I,20230812.0,,20230813,20230813,DIR,670243,,FDA-CTU,,59.0,YR,,M,N,87.75,KG,20230813,N,CN,US,,2023,Q3,Adult
228212761,22821276,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Therapy interrupted,,2023,Q3,1,I,20230812.0,,20230813,20230813,DIR,670243,,FDA-CTU,,59.0,YR,,M,N,87.75,KG,20230813,N,CN,US,,2023,Q3,Adult
228212761,22821276,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,Y,,,99.0,,,,,2023,Q3,Drug rechallenge positive,,2023,Q3,1,I,20230812.0,,20230813,20230813,DIR,670243,,FDA-CTU,,59.0,YR,,M,N,87.75,KG,20230813,N,CN,US,,2023,Q3,Adult
228218571,22821857,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230731.0,20230814,20230814,EXP,,NL-BEXIMCO-2023BEX00039,BEXIMCO PHARMACEUTICALS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228218571,22821857,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Overdose,,2023,Q3,1,I,,20230731.0,20230814,20230814,EXP,,NL-BEXIMCO-2023BEX00039,BEXIMCO PHARMACEUTICALS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228218571,22821857,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Hepatic necrosis,,2023,Q3,1,I,,20230731.0,20230814,20230814,EXP,,NL-BEXIMCO-2023BEX00039,BEXIMCO PHARMACEUTICALS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228218571,22821857,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230731.0,20230814,20230814,EXP,,NL-BEXIMCO-2023BEX00039,BEXIMCO PHARMACEUTICALS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228218571,22821857,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/kg),,,D,,,,,,,Tablet,,2023,Q3,Completed suicide,,2023,Q3,1,I,,20230731.0,20230814,20230814,EXP,,NL-BEXIMCO-2023BEX00039,BEXIMCO PHARMACEUTICALS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230809,,HP,NL,NL,2023,Q3,Adult
228266261,22826626,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Illness,,2023,Q3,1,I,,20230803.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011818,APOTEX,,58.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
228266261,22826626,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Walking disability,,2023,Q3,1,I,,20230803.0,20230816,20230816,EXP,,CA-APOTEX-2023AP011818,APOTEX,,58.0,YR,,F,Y,,,20230816,,CN,CA,CA,2023,Q3,Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Asthenia,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Palpitations,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Tinnitus,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Urine output decreased,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Vision blurred,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Presyncope,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Dizziness,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Headache,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228268841,22826884,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 4 Injection(s);?Frequency : Weekly;?,,,Y,D,213602,20240425.0,99.0,,,Injection,QW,2023,Q3,Heart rate increased,,2023,Q3,1,I,20230728.0,,20230815,20230815,DIR,670422,,FDA-CTU,,31.0,YR,,F,N,66.15,KG,20230815,N,CN,US,,2023,Q3,Young Adult
228269751,22826975,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Clostridium test positive,,2023,Q3,1,I,,20230806.0,20230816,20230816,EXP,,CA-TEVA-2023-CA-2915973,TEVA,,56.0,YR,A,F,Y,,,20230816,,PH,CA,CA,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Hepatic necrosis,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228283321,22828332,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,U,,UNK,,,420.0,MG,,,2023,Q3,Overdose,,2023,Q3,1,I,,20230802.0,20230816,20230816,EXP,,NL-LAURUS LABS LIMITED-2023LAU000068,LAURUS LABS LIMITED,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230816,,HP,NL,NL,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Frequent bowel movements,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Asthenia,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Vertigo,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Colitis ulcerative,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Off label use,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,Intentional product use issue,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228304221,22830422,30,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q3,COVID-19,,2023,Q3,1,I,,20230809.0,20230817,20230817,EXP,,CA-JNJFOC-20230829644,JOHNSON AND JOHNSON,,42.0,YR,A,F,Y,118.0,KG,20230817,,HP,CA,CA,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Overdose,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228310501,22831050,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,UNK,,,420.0,MG,Tablets,,2023,Q3,Hepatic necrosis,,2023,Q3,1,I,,20230804.0,20230817,20230817,EXP,,NL-NOVAST LABORATORIES INC.-2023NOV000297,NOVAST,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep.. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230817,,HP,NL,NL,2023,Q3,Adult
228323361,22832336,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,Y,,,,,,,,2023,Q3,Panic attack,,2023,Q3,1,I,20230810.0,,20230816,20230816,DIR,670620,,FDA-CTU,,34.0,YR,,F,N,67.95,KG,20230816,N,CN,US,,2023,Q3,Young Adult
228323361,22832336,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,Y,,,,,,,,2023,Q3,Suicidal ideation,,2023,Q3,1,I,20230810.0,,20230816,20230816,DIR,670620,,FDA-CTU,,34.0,YR,,F,N,67.95,KG,20230816,N,CN,US,,2023,Q3,Young Adult
228323361,22832336,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,Y,,,,,,,,2023,Q3,Intrusive thoughts,,2023,Q3,1,I,20230810.0,,20230816,20230816,DIR,670620,,FDA-CTU,,34.0,YR,,F,N,67.95,KG,20230816,N,CN,US,,2023,Q3,Young Adult
228323981,22832398,7,C,SEMAGLUTIDE ((LEVURE/SACCHAROMYCES CEREVISIAE)),,2,,,,,D,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230101.0,20230811.0,20230817,20230817,EXP,FR-AFSSAPS-TO2023001280,"FR-Ipsen Biopharmaceuticals, Inc.-2023-19388",IPSEN,,79.0,YR,E,F,Y,,,20230817,,PH,FR,FR,2023,Q3,Elderly
228323981,22832398,7,C,SEMAGLUTIDE ((LEVURE/SACCHAROMYCES CEREVISIAE)),,2,,,,,D,,,,,,,,,2023,Q3,Haematoma,,2023,Q3,1,I,20230101.0,20230811.0,20230817,20230817,EXP,FR-AFSSAPS-TO2023001280,"FR-Ipsen Biopharmaceuticals, Inc.-2023-19388",IPSEN,,79.0,YR,E,F,Y,,,20230817,,PH,FR,FR,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Tension,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Osteoarthritis,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Osteoarthritis,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Renal disorder,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Insomnia,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228324021,22832402,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.50,,,,,,,,,,,,2023,Q3,Fluid retention,,2023,Q3,1,I,20190101.0,20230808.0,20230817,20230817,EXP,,"CO-Ipsen Biopharmaceuticals, Inc.-2023-19004",IPSEN,,72.0,YR,E,M,Y,,,20230817,,CN,CO,CO,2023,Q3,Elderly
228332802,22833280,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q3,Wrist fracture,,2023,Q3,2,F,20230731.0,20230807.0,20230817,20230818,EXP,,US-NOVOPROD-1101287,NOVO NORDISK,,57.0,YR,,F,Y,,,20230818,,CN,US,US,2023,Q3,Adult
228332802,22833280,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q3,Road traffic accident,,2023,Q3,2,F,20230731.0,20230807.0,20230817,20230818,EXP,,US-NOVOPROD-1101287,NOVO NORDISK,,57.0,YR,,F,Y,,,20230818,,CN,US,US,2023,Q3,Adult
228332802,22833280,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q3,Counterfeit product administered,,2023,Q3,2,F,20230731.0,20230807.0,20230817,20230818,EXP,,US-NOVOPROD-1101287,NOVO NORDISK,,57.0,YR,,F,Y,,,20230818,,CN,US,US,2023,Q3,Adult
228333021,22833302,3,C,Semaglutide 1 mg,,2,,,,,,,,,,,,,,2023,Q3,Swelling face,,2023,Q3,1,I,20220328.0,,20230816,20230816,DIR,670755,,FDA-CTU,,64.0,YR,,M,N,105.3,KG,20230816,N,PH,US,,2023,Q3,Adult
228333021,22833302,3,C,Semaglutide 1 mg,,2,,,,,,,,,,,,,,2023,Q3,Swollen tongue,,2023,Q3,1,I,20220328.0,,20230816,20230816,DIR,670755,,FDA-CTU,,64.0,YR,,M,N,105.3,KG,20230816,N,PH,US,,2023,Q3,Adult
228333021,22833302,3,C,Semaglutide 1 mg,,2,,,,,,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,1,I,20220328.0,,20230816,20230816,DIR,670755,,FDA-CTU,,64.0,YR,,M,N,105.3,KG,20230816,N,PH,US,,2023,Q3,Adult
228333021,22833302,3,C,Semaglutide 1 mg,,2,,,,,,,,,,,,,,2023,Q3,Oropharyngeal pain,,2023,Q3,1,I,20220328.0,,20230816,20230816,DIR,670755,,FDA-CTU,,64.0,YR,,M,N,105.3,KG,20230816,N,PH,US,,2023,Q3,Adult
228333021,22833302,3,C,Semaglutide 1 mg,,2,,,,,,,,,,,,,,2023,Q3,Tongue injury,,2023,Q3,1,I,20220328.0,,20230816,20230816,DIR,670755,,FDA-CTU,,64.0,YR,,M,N,105.3,KG,20230816,N,PH,US,,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Depression,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Asthma,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228334781,22833478,27,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230808.0,20230817,20230817,EXP,,CA-PFIZER INC-202100985739,PFIZER,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228343951,22834395,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230814.0,20230817,20230817,EXP,,CA-BAUSCH-BL-2023-012393,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20230817,,MD,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Asthma,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Appetite disorder,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Angina pectoris,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Respiration abnormal,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Wheezing,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Heart sounds,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Pyrexia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Chest discomfort,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Influenza,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Nasal congestion,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Injury,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Depressive symptom,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Malaise,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Productive cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Rales,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Chest pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Depressed mood,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Prolonged expiration,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q3,Flank pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Asthma,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Appetite disorder,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Angina pectoris,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Wheezing,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Heart sounds,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Pyrexia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest discomfort,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Influenza,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasal congestion,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Injury,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressive symptom,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Malaise,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Productive cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Rales,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Chest pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Depressed mood,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q3,Flank pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Asthma,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Appetite disorder,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Angina pectoris,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Respiration abnormal,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Wheezing,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Heart sounds,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Pyrexia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Chest discomfort,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Influenza,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Nasal congestion,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Injury,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Depressive symptom,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Malaise,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Productive cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Rales,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Chest pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Depressed mood,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Prolonged expiration,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q3,Flank pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthma,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Appetite disorder,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Angina pectoris,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Respiration abnormal,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Wheezing,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Heart sounds,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Pyrexia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Chest discomfort,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Influenza,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nasal congestion,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Injury,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Depressive symptom,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Malaise,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Productive cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Rales,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Chest pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Depressed mood,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Prolonged expiration,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Flank pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Asthma,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Appetite disorder,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Angina pectoris,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Respiration abnormal,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Wheezing,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Heart sounds,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Pyrexia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Stress,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Chest discomfort,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Influenza,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Nasal congestion,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Injury,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Depressive symptom,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Malaise,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Productive cough,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Fall,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Rales,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Chest pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Depressed mood,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Prolonged expiration,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228345521,22834552,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q3,Flank pain,,2023,Q3,1,I,,20230807.0,20230817,20230817,EXP,,CA-BAUSCHBL-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20230817,,CN,CA,CA,2023,Q3,Adult
228370561,22837056,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,SEMAGLUTIDA (9375A),,,,,UNKNOWN,,,1.0,MG,,,2023,Q3,Pancreatitis acute,,2023,Q3,1,I,20230110.0,20230808.0,20230818,20230818,EXP,ES-AEMPS-1404097,ES-TEVA-2023-ES-2917355,TEVA,,61.0,YR,A,M,Y,,,20230818,,MD,ES,ES,2023,Q3,Adult
228371522,22837152,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Therapeutic response decreased,,2023,Q3,2,F,20230501.0,20230811.0,20230818,20230823,PER,,US-SA-2023SA248640,SANOFI AVENTIS,,33.0,YR,A,M,Y,138.3,KG,20230823,,MD,US,US,2023,Q3,Young Adult
228371522,22837152,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,2,F,20230501.0,20230811.0,20230818,20230823,PER,,US-SA-2023SA248640,SANOFI AVENTIS,,33.0,YR,A,M,Y,138.3,KG,20230823,,MD,US,US,2023,Q3,Young Adult
228371522,22837152,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Rash macular,,2023,Q3,2,F,20230501.0,20230811.0,20230818,20230823,PER,,US-SA-2023SA248640,SANOFI AVENTIS,,33.0,YR,A,M,Y,138.3,KG,20230823,,MD,US,US,2023,Q3,Young Adult
228371522,22837152,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Abdominal discomfort,,2023,Q3,2,F,20230501.0,20230811.0,20230818,20230823,PER,,US-SA-2023SA248640,SANOFI AVENTIS,,33.0,YR,A,M,Y,138.3,KG,20230823,,MD,US,US,2023,Q3,Young Adult
228383061,22838306,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Colitis ischaemic,,2023,Q3,1,I,20230816.0,,20230817,20230817,DIR,670779,,FDA-CTU,,70.0,YR,,F,N,134.0,KG,20230817,N,PH,US,,2023,Q3,Elderly
228420482,22842048,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230808.0,20230821.0,20230821,20230824,EXP,,IL-ROCHE-3403981,ROCHE,,56.0,YR,,M,Y,,,20230824,,MD,IL,,2023,Q3,Adult
228420482,22842048,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,2,F,20230808.0,20230821.0,20230821,20230824,EXP,,IL-ROCHE-3403981,ROCHE,,56.0,YR,,M,Y,,,20230824,,MD,IL,,2023,Q3,Adult
228420482,22842048,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,2,F,20230808.0,20230821.0,20230821,20230824,EXP,,IL-ROCHE-3403981,ROCHE,,56.0,YR,,M,Y,,,20230824,,MD,IL,,2023,Q3,Adult
228426792,22842679,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",15022.0,MG,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Hepatic failure,,2023,Q3,2,F,20230701.0,20230818.0,20230821,20230823,EXP,,MX-NOVOPROD-1100369,NOVO NORDISK,,73.0,YR,,M,Y,83.0,KG,20230823,,MD,MX,MX,2023,Q3,Elderly
228426792,22842679,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",15022.0,MG,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Jaundice,,2023,Q3,2,F,20230701.0,20230818.0,20230821,20230823,EXP,,MX-NOVOPROD-1100369,NOVO NORDISK,,73.0,YR,,M,Y,83.0,KG,20230823,,MD,MX,MX,2023,Q3,Elderly
228426792,22842679,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",15022.0,MG,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q3,Septic shock,,2023,Q3,2,F,20230701.0,20230818.0,20230821,20230823,EXP,,MX-NOVOPROD-1100369,NOVO NORDISK,,73.0,YR,,M,Y,83.0,KG,20230823,,MD,MX,MX,2023,Q3,Elderly
228428411,22842841,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2023,Q3,Acute myocardial infarction,,2023,Q3,1,I,20230121.0,20230810.0,20230821,20230821,EXP,,CA-HLS Therapeutics Inc.-2023AMR000049,AMARIN,,63.0,YR,A,M,Y,99.0,KG,20230818,,CN,CA,CA,2023,Q3,Adult
228431214,22843121,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q3,Colitis,,2023,Q3,4,F,20230811.0,20230914.0,20230821,20230921,PER,,US-Eisai Medical Research-EC-2023-147022,EISAI,,54.0,YR,A,M,Y,80.3,KG,20230921,,MD,US,,2023,Q3,Adult
228437821,22843782,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Lung operation,,2023,Q3,1,I,,20230816.0,20230821,20230821,EXP,,CA-SA-2023SA253341,SANOFI AVENTIS,,55.0,YR,A,F,Y,68.0,KG,20230821,,PH,CA,CA,2023,Q3,Adult
228437821,22843782,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Gene mutation,,2023,Q3,1,I,,20230816.0,20230821,20230821,EXP,,CA-SA-2023SA253341,SANOFI AVENTIS,,55.0,YR,A,F,Y,68.0,KG,20230821,,PH,CA,CA,2023,Q3,Adult
228437821,22843782,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Lung neoplasm malignant,,2023,Q3,1,I,,20230816.0,20230821,20230821,EXP,,CA-SA-2023SA253341,SANOFI AVENTIS,,55.0,YR,A,F,Y,68.0,KG,20230821,,PH,CA,CA,2023,Q3,Adult
228437821,22843782,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2023,Q3,Cough,,2023,Q3,1,I,,20230816.0,20230821,20230821,EXP,,CA-SA-2023SA253341,SANOFI AVENTIS,,55.0,YR,A,F,Y,68.0,KG,20230821,,PH,CA,CA,2023,Q3,Adult
228440111,22844011,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Indicus Pharma-000969,INDICUS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,,,20230821,,HP,NL,NL,2023,Q3,Adult
228440111,22844011,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Indicus Pharma-000969,INDICUS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,,,20230821,,HP,NL,NL,2023,Q3,Adult
228440111,22844011,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Indicus Pharma-000969,INDICUS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,,,20230821,,HP,NL,NL,2023,Q3,Adult
228440111,22844011,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Indicus Pharma-000969,INDICUS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,,,20230821,,HP,NL,NL,2023,Q3,Adult
228440111,22844011,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Indicus Pharma-000969,INDICUS,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,,,20230821,,HP,NL,NL,2023,Q3,Adult
228444981,22844498,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Inventia-000656,INVENTIA HEALTHCARE,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228444981,22844498,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Inventia-000656,INVENTIA HEALTHCARE,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228444981,22844498,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Inventia-000656,INVENTIA HEALTHCARE,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228444981,22844498,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Inventia-000656,INVENTIA HEALTHCARE,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228444981,22844498,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230806.0,20230821,20230821,EXP,,NL-Inventia-000656,INVENTIA HEALTHCARE,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144.",55.0,YR,A,F,Y,125.0,KG,20230821,,HP,NL,NL,2023,Q3,Adult
228457981,22845798,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, daily",,,,,,,,,,,QD,2023,Q3,Dizziness,,2023,Q3,1,I,,20230817.0,20230821,20230821,EXP,GB-MHRA-TPP5516541C2189717YC1691678359888,GB-ELI_LILLY_AND_COMPANY-GB202308010530,ELI LILLY AND CO,,69.0,YR,,M,Y,92.0,KG,20230821,,CN,GB,GB,2023,Q3,Elderly
228457981,22845798,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, daily",,,,,,,,,,,QD,2023,Q3,Confusional state,,2023,Q3,1,I,,20230817.0,20230821,20230821,EXP,GB-MHRA-TPP5516541C2189717YC1691678359888,GB-ELI_LILLY_AND_COMPANY-GB202308010530,ELI LILLY AND CO,,69.0,YR,,M,Y,92.0,KG,20230821,,CN,GB,GB,2023,Q3,Elderly
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Off label use,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Weight increased,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Bone pain,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Blood pressure fluctuation,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Pain,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,COVID-19,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228469201,22846920,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230816.0,20230822,20230822,EXP,,CA-JNJFOC-20230844187,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,106.0,KG,20230822,,HP,CA,CA,2023,Q3,Adult
228470961,22847096,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milligram, Daily",,,Y,,,,,3.0,MG,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230808.0,20230822,20230822,EXP,,US-AUROBINDO-AUR-APL-2023-053325,AUROBINDO,"Chahal N, Zarka J, Simonson M.. SLOW DOWN AND THINK ABOUT IT: DIFFERENTIATING CAUSES OF GASTROPARESIS IN PATIENTS WITH DIABETES. J-Gen-Intern-Med. 2023;38 (Suppl. 2):S533",66.0,YR,,M,Y,,,20230822,,HP,US,US,2023,Q3,Elderly
228470961,22847096,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"7 milligram, Daily",,,Y,,,,,7.0,MG,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230808.0,20230822,20230822,EXP,,US-AUROBINDO-AUR-APL-2023-053325,AUROBINDO,"Chahal N, Zarka J, Simonson M.. SLOW DOWN AND THINK ABOUT IT: DIFFERENTIATING CAUSES OF GASTROPARESIS IN PATIENTS WITH DIABETES. J-Gen-Intern-Med. 2023;38 (Suppl. 2):S533",66.0,YR,,M,Y,,,20230822,,HP,US,US,2023,Q3,Elderly
228497601,22849760,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 Milligram Daily;,,,Y,,,,,3.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230814.0,20230822,20230822,EXP,,US-TEVA-2023-US-2918565,TEVA,,66.0,YR,E,M,Y,,,20230822,,HP,US,US,2023,Q3,Elderly
228497601,22849760,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,7 Milligram Daily;,,,Y,,,,,7.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230814.0,20230822,20230822,EXP,,US-TEVA-2023-US-2918565,TEVA,,66.0,YR,E,M,Y,,,20230822,,HP,US,US,2023,Q3,Elderly
228557981,22855798,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,NOT SPECIFIED,/WK,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312677,FRESENIUS KABI,,85.0,YR,E,M,Y,117.0,KG,20230823,,CN,CA,CA,2023,Q3,Elderly
228557981,22855798,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,NOT SPECIFIED,/WK,2023,Q3,Thrombocytopenia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312677,FRESENIUS KABI,,85.0,YR,E,M,Y,117.0,KG,20230823,,CN,CA,CA,2023,Q3,Elderly
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Psoriatic arthropathy,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Oral herpes,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hemiparesis,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Musculoskeletal stiffness,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Influenza,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565141,22856514,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Joint swelling,,2023,Q3,1,I,,20230818.0,20230823,20230823,EXP,,CA-Orion Corporation ORION PHARMA-23_00025257,ORION,,52.0,YR,A,F,Y,,,20230823,,HP,CA,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Product use in unapproved indication,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Abdominal distension,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Drug effect less than expected,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Hypersomnia,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Abdominal rigidity,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Dizziness,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Asthenia,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Eructation,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228565351,22856535,1,PS,LEVOCARNITINE\SEMAGLUTIDE,LEVOCARNITINE\SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Weekly;?,,,Y,D,Unk,,99.0,,,,999,2023,Q3,Flatulence,,2023,Q3,1,I,20230710.0,,20230821,20230821,DIR,671312,,FDA-CTU,,52.0,YR,,F,N,112.5,KG,20230821,N,CN,US,,2023,Q3,Adult
228587111,22858711,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Crohn's disease,,2023,Q3,1,I,20190226.0,20230821.0,20230824,20230824,EXP,,CA-TAKEDA-2019TUS064485,TAKEDA,,35.0,YR,,M,Y,,,20230824,,MD,CA,CA,2023,Q3,Adult
228587111,22858711,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,20190226.0,20230821.0,20230824,20230824,EXP,,CA-TAKEDA-2019TUS064485,TAKEDA,,35.0,YR,,M,Y,,,20230824,,MD,CA,CA,2023,Q3,Adult
228587111,22858711,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Therapeutic reaction time decreased,,2023,Q3,1,I,20190226.0,20230821.0,20230824,20230824,EXP,,CA-TAKEDA-2019TUS064485,TAKEDA,,35.0,YR,,M,Y,,,20230824,,MD,CA,CA,2023,Q3,Adult
228635001,22863500,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, unknown",,,U,,,,,1.0,MG,,,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,,20230818.0,20230825,20230825,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202308011304,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230825,,CN,DE,DE,2023,Q3,Elderly
228635001,22863500,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 mg, unknown",,,U,,,,,1.0,MG,,,2023,Q3,Neuroendocrine carcinoma of the skin,,2023,Q3,1,I,,20230818.0,20230825,20230825,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202308011304,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230825,,CN,DE,DE,2023,Q3,Elderly
228637861,22863786,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Muscle tightness,,2023,Q3,1,I,,20230817.0,20230825,20230825,PER,,US-ALKERMES INC.-ALK-2023-003458,ALKERMES,,60.0,YR,,F,Y,,,20230825,,MD,US,US,2023,Q3,Adult
228637861,22863786,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Arthralgia,,2023,Q3,1,I,,20230817.0,20230825,20230825,PER,,US-ALKERMES INC.-ALK-2023-003458,ALKERMES,,60.0,YR,,F,Y,,,20230825,,MD,US,US,2023,Q3,Adult
228657481,22865748,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Illness,,2023,Q3,1,I,,20230811.0,20230825,20230825,EXP,,CA-AUROBINDO-AUR-APL-2023-054754,AUROBINDO,,58.0,YR,,F,Y,,,20230825,,CN,CA,CA,2023,Q3,Adult
228657481,22865748,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Walking disability,,2023,Q3,1,I,,20230811.0,20230825,20230825,EXP,,CA-AUROBINDO-AUR-APL-2023-054754,AUROBINDO,,58.0,YR,,F,Y,,,20230825,,CN,CA,CA,2023,Q3,Adult
228658341,22865834,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,3.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230816.0,20230825,20230825,EXP,,US-MICRO LABS LIMITED-ML2023-04858,MICRO LABS,,66.0,YR,E,M,Y,,,20230825,,HP,US,,2023,Q3,Elderly
228658341,22865834,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,7.0,MG,,QD,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230816.0,20230825,20230825,EXP,,US-MICRO LABS LIMITED-ML2023-04858,MICRO LABS,,66.0,YR,E,M,Y,,,20230825,,HP,US,,2023,Q3,Elderly
228660401,22866040,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q3,Allodynia,,2023,Q3,1,I,20230818.0,,20230824,20230824,DIR,671736,,FDA-CTU,,35.0,YR,,F,N,88.2,KG,20230824,N,CN,US,,2023,Q3,Adult
228660401,22866040,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q3,Blister,,2023,Q3,1,I,20230818.0,,20230824,20230824,DIR,671736,,FDA-CTU,,35.0,YR,,F,N,88.2,KG,20230824,N,CN,US,,2023,Q3,Adult
228692421,22869242,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,Y,,Unknown,,,3.0,MG,UNK,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230816.0,20230826,20230826,EXP,,US-GRANULES-US-2023GRALIT00215,GRANULES INDIA,Chahal N.Slow Down and Think About It: Differentiating Causes of Gastroparesis In Patients With Diabetes.Journal of General Internal Medicine.JUL-2023;38:S533,66.0,YR,E,M,Y,,,20230826,,HP,US,US,2023,Q3,Elderly
228692421,22869242,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,Y,,,,,7.0,MG,UNK,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230816.0,20230826,20230826,EXP,,US-GRANULES-US-2023GRALIT00215,GRANULES INDIA,Chahal N.Slow Down and Think About It: Differentiating Causes of Gastroparesis In Patients With Diabetes.Journal of General Internal Medicine.JUL-2023;38:S533,66.0,YR,E,M,Y,,,20230826,,HP,US,US,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dialysis,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypotension,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228694761,22869476,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230811.0,20230826,20230826,EXP,,CA-AUROBINDO-AUR-APL-2023-054664,AUROBINDO,,75.0,YR,,F,Y,,,20230826,,PH,CA,CA,2023,Q3,Elderly
228709692,22870969,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q3,Nephrolithiasis,,2023,Q3,2,F,20230811.0,20230828.0,20230828,20230830,EXP,,US-ABBVIE-5378810,ABBVIE,,53.0,YR,,F,Y,90.718,KG,20230830,,CN,US,US,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228769591,22876959,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012566,APOTEX,,51.0,YR,,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228778141,22877814,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230817.0,20230829,20230829,EXP,,CA-APOTEX-2023AP012537,APOTEX,,51.0,YR,,F,Y,,,20230829,,MD,CA,CA,2023,Q3,Adult
228788871,22878887,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,unknown,,,0.5,MG,,,2023,Q3,Bronchiolitis,,2023,Q3,1,I,,20230821.0,20230829,20230829,EXP,,CA-FreseniusKabi-FK202313123,FRESENIUS KABI,,32.0,YR,A,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Young Adult
228788871,22878887,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,unknown,,,0.5,MG,,,2023,Q3,Product use issue,,2023,Q3,1,I,,20230821.0,20230829,20230829,EXP,,CA-FreseniusKabi-FK202313123,FRESENIUS KABI,,32.0,YR,A,F,Y,,,20230829,,HP,CA,CA,2023,Q3,Young Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Muscular weakness,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Implant site pain,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Pain in extremity,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Scar pain,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 INJECTION ONCE WEEKLY SUBCUTANEOUS?,,,,D,,,99.0,,,,999,2023,Q3,Therapy cessation,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Muscular weakness,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Implant site pain,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Scar pain,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228797391,22879739,5,C,SEMAGLUTIDE + VITAMIN B ,,2,,,,,,,,,,,,,,2023,Q3,Therapy cessation,,2023,Q3,1,I,20230806.0,,20230828,20230828,DIR,672047,,FDA-CTU,,37.0,YR,,F,N,69.75,KG,20230828,N,CN,US,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Hypoacusis,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Sleep disorder due to a general medical condition,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228841391,22884139,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Wheezing,,2023,Q3,1,I,,20230822.0,20230830,20230830,EXP,,CA-AstraZeneca-2023A195186,ASTRAZENECA,,51.0,YR,,F,Y,,,20230830,,MD,CA,,2023,Q3,Adult
228862361,22886236,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,U,,,209637.0,,,,,2023,Q3,Migraine,,2023,Q3,1,I,,20230820.0,20230831,20230831,EXP,,GB-NOVOPROD-1106374,NOVO NORDISK,,36.0,YR,,F,Y,,,20230831,,CN,GB,GB,2023,Q3,Adult
228888361,22888836,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,NOT SPECIFIED,,2023,Q3,Upper gastrointestinal haemorrhage,,2023,Q3,1,I,,20230828.0,20230831,20230831,EXP,,CA-FreseniusKabi-FK202313325,FRESENIUS KABI,,73.0,YR,E,F,Y,118.0,KG,20230831,,HP,CA,CA,2023,Q3,Elderly
228888361,22888836,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,NOT SPECIFIED,,2023,Q3,Gastric ulcer,,2023,Q3,1,I,,20230828.0,20230831,20230831,EXP,,CA-FreseniusKabi-FK202313325,FRESENIUS KABI,,73.0,YR,E,F,Y,118.0,KG,20230831,,HP,CA,CA,2023,Q3,Elderly
228896451,22889645,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,Solution,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,Solution,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,Solution,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,Solution,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,Solution,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228896451,22889645,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230830.0,20230831,20230831,EXP,,CA-BAUSCH-BL-2023-013107,BAUSCH AND LOMB,,48.0,YR,,M,Y,113.0,KG,20230831,,CN,CA,CA,2023,Q3,Adult
228994601,22899460,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,Y,,Unknown,,,3.0,MG,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230821.0,20230904,20230904,EXP,,US-EPICPHARMA-US-2023EPCLIT01336,EPIC PHARM,N Chahal.Slow down and think about it: differentiating causes of gastroparesis in patients with diabetes.Journal of General Internal Medicine.JUL-2023;38 (Suppl. 2):S533,66.0,YR,A,M,Y,,,20230904,,HP,US,US,2023,Q3,Elderly
228994601,22899460,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,Y,,,,,7.0,MG,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,,20230821.0,20230904,20230904,EXP,,US-EPICPHARMA-US-2023EPCLIT01336,EPIC PHARM,N Chahal.Slow down and think about it: differentiating causes of gastroparesis in patients with diabetes.Journal of General Internal Medicine.JUL-2023;38 (Suppl. 2):S533,66.0,YR,A,M,Y,,,20230904,,HP,US,US,2023,Q3,Elderly
229077181,22907718,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 VILE ONCE A WEEK SUBCUTANEOUS,,,N,D,,,99.0,,,,QW,2023,Q3,Panic attack,,2023,Q3,1,I,20230829.0,,20230904,20230904,DIR,672668,,FDA-CTU,,27.0,YR,,F,N,84.15,KG,20230904,Y,CN,US,,2023,Q3,Young Adult
229077181,22907718,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 VILE ONCE A WEEK SUBCUTANEOUS,,,N,D,,,99.0,,,,QW,2023,Q3,Anxiety,,2023,Q3,1,I,20230829.0,,20230904,20230904,DIR,672668,,FDA-CTU,,27.0,YR,,F,N,84.15,KG,20230904,Y,CN,US,,2023,Q3,Young Adult
229077181,22907718,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 VILE ONCE A WEEK SUBCUTANEOUS,,,N,D,,,99.0,,,,QW,2023,Q3,Suicidal ideation,,2023,Q3,1,I,20230829.0,,20230904,20230904,DIR,672668,,FDA-CTU,,27.0,YR,,F,N,84.15,KG,20230904,Y,CN,US,,2023,Q3,Young Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Oral herpes,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Joint swelling,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Influenza,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Pain,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Musculoskeletal stiffness,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Hemiparesis,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229115731,22911573,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Poultice,,2023,Q3,Psoriatic arthropathy,,2023,Q3,1,I,,20230825.0,20230906,20230906,EXP,CA-MHPD-E2B_06412615,CA-Accord-376139,ACCORD,,52.0,YR,,F,Y,,,20230906,,HP,CA,CA,2023,Q3,Adult
229128901,22912890,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,Unknown,,,,,,,2023,Q3,Anaphylactic shock,,2023,Q3,1,I,20230808.0,20230904.0,20230906,20230906,EXP,FR-AFSSAPS-RE2023000775,FR-PFIZER INC-202300292152,PFIZER,,68.0,YR,,M,Y,89.0,KG,20230906,,PH,FR,FR,2023,Q3,Elderly
229153851,22915385,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, q.wk.",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 milligram, q.wk.",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Off label use,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 milligram, q.wk.",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Vomiting,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 milligram, q.wk.",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Nausea,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 milligram, q.wk.",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Insomnia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229153851,22915385,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 milligram, q.wk.",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q3,Asthenia,,2023,Q3,1,I,,20230829.0,20230907,20230907,EXP,,CA-APOTEX-2023AP013217,APOTEX,,48.0,YR,,M,Y,113.0,KG,20230907,,HP,CA,CA,2023,Q3,Adult
229179641,22917964,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229179641,22917964,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Lipids increased,,2023,Q3,1,I,20230101.0,20230830.0,20230907,20230907,PER,,US-JNJFOC-20230870510,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,69.008,KG,20230907,,MD,US,US,2023,Q3,Young Adult
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Memory impairment,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Head injury,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Anal incontinence,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Constipation,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229232721,22923272,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230907.0,20230908,20230908,EXP,,CA-ABBVIE-5398034,ABBVIE,,77.0,YR,,F,Y,113.0,KG,20230908,,PH,CA,CA,2023,Q3,Elderly
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Fibrin D dimer increased,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Pain,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Contusion,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Joint swelling,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Ear infection,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Oropharyngeal pain,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Spinal pain,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Cough,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Haemoglobin decreased,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Rhinorrhoea,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Influenza like illness,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Muscle tightness,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Lower respiratory tract infection,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Blood iron decreased,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Fatigue,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Ill-defined disorder,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229247111,22924711,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, 1 every 1 weeks",,,,,,,,,,,/WK,2023,Q3,Thrombosis,,2023,Q3,1,I,,20230905.0,20230908,20230908,EXP,,CA-PFIZER INC-202300294196,PFIZER,,48.0,YR,,F,Y,,,20230908,,HP,CA,CA,2023,Q3,Adult
229272811,22927281,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 dosage form; 14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,,,,,,,,Tablet,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230831.0,20230911,20230911,EXP,,NL-STRIDES ARCOLAB LIMITED-2023SP014137,STRIDES,"Workum JD, Keyany A, Jaspers TCC.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.. Toxicol-Rep.. 2023;11:141-144.",55.0,YR,,F,Y,,,20230911,,HP,NL,NL,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Blood pressure increased,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Nausea,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Dysstasia,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Vomiting projectile,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229308741,22930874,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,1 injection one shot a week intramuscular?,,,N,D,08222023@12,20231006.0,,,,,999,2023,Q3,Speech disorder,,2023,Q3,1,I,20230902.0,,20230909,20230909,DIR,673400,,FDA-CTU,,45.0,YR,,F,N,89.1,KG,20230909,N,CN,US,,2023,Q3,Adult
229310551,22931055,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?OTHER ROUTE : Injected in abdomen near naval;?,,,N,D,,,99.0,,,,999,2023,Q3,Parosmia,,2023,Q3,1,I,20230717.0,,20230910,20230910,DIR,673425,,FDA-CTU,,56.0,YR,,F,N,,,20230910,N,CN,US,,2023,Q3,Adult
229310551,22931055,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?OTHER ROUTE : Injected in abdomen near naval;?,,,N,D,,,99.0,,,,999,2023,Q3,Abdominal rigidity,,2023,Q3,1,I,20230717.0,,20230910,20230910,DIR,673425,,FDA-CTU,,56.0,YR,,F,N,,,20230910,N,CN,US,,2023,Q3,Adult
229310551,22931055,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Other,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?OTHER ROUTE : Injected in abdomen near naval;?,,,N,D,,,99.0,,,,999,2023,Q3,Dysgeusia,,2023,Q3,1,I,20230717.0,,20230910,20230910,DIR,673425,,FDA-CTU,,56.0,YR,,F,N,,,20230910,N,CN,US,,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pancreatitis necrotising,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229324581,22932458,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230911.0,20230912,20230912,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-260529",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,130.0,KG,20230912,,PH,CA,CA,2023,Q3,Adult
229401081,22940108,15,C,SEMAGLUTIDE ((LEVURE/SACCHAROMYCES CEREVISIAE)),,2,,,,,U,,,,,,,,,2023,Q3,Anaphylactic shock,,2023,Q3,1,I,20230808.0,20230906.0,20230913,20230913,EXP,FR-AFSSAPS-RE2023000775,FR-FreseniusKabi-FK202313994,FRESENIUS KABI,,68.0,YR,E,M,Y,89.0,KG,20230913,,PH,FR,FR,2023,Q3,Elderly
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Blood pressure fluctuation,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Pain,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Bone pain,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,COVID-19,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229491781,22949178,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,1,I,,20230911.0,20230915,20230915,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-24509,SAMSUNG BIOEPIS,,51.0,YR,A,F,Y,106.0,KG,20230915,,HP,CA,CA,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Suicide attempt,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Vasoplegia syndrome,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229494071,22949407,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,,,,420.0,MG,,,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230831.0,20230915,20230915,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-407933,RANBAXY,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicology  Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20230915,,HP,NL,NL,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Nausea,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Vomiting,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Constipation,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Dehydration,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Fatigue,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Sepsis,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,Lactic acidosis,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229495631,22949563,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q3,White blood cell count increased,,2023,Q3,1,I,20230910.0,,20230914,20230914,DIR,673963,,FDA-CTU,,49.0,YR,,F,N,107.6,KG,20230914,N,PH,US,,2023,Q3,Adult
229535531,22953553,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230912.0,20230918,20230918,EXP,,GB-MYLANLABS-2023M1097961,MYLAN,,66.0,YR,,,Y,,,20230918,,CN,GB,GB,2023,Q3,Elderly
229535531,22953553,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230912.0,20230918,20230918,EXP,,GB-MYLANLABS-2023M1097961,MYLAN,,66.0,YR,,,Y,,,20230918,,CN,GB,GB,2023,Q3,Elderly
229563271,22956327,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Dose: 0.5 mg likely,,,U,,,,209637.0,,,,,2023,Q3,Suicidal ideation,,2023,Q3,1,I,20230101.0,20230907.0,20230919,20230919,EXP,,CA-NOVOPROD-1114268,NOVO NORDISK,,40.0,YR,,F,Y,,,20230919,,MD,CA,CA,2023,Q3,Adult
229570151,22957015,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Heart rate irregular,,2023,Q3,1,I,20230911.0,,20230916,20230916,DIR,FDA-CDER-CTU-2023-68453,,FDA-CTU,,37.0,MON,,M,N,,,20230916,Y,CN,US,,2023,Q3,Adult
229570151,22957015,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Myocardial infarction,,2023,Q3,1,I,20230911.0,,20230916,20230916,DIR,FDA-CDER-CTU-2023-68453,,FDA-CTU,,37.0,MON,,M,N,,,20230916,Y,CN,US,,2023,Q3,Adult
229570151,22957015,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Product quality issue,,2023,Q3,1,I,20230911.0,,20230916,20230916,DIR,FDA-CDER-CTU-2023-68453,,FDA-CTU,,37.0,MON,,M,N,,,20230916,Y,CN,US,,2023,Q3,Adult
229580361,22958036,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,,,,/WK,2023,Q3,Fatigue,,2023,Q3,1,I,20230809.0,20230907.0,20230919,20230919,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20230918,,MD,US,US,2023,Q3,Adult
229580361,22958036,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,,,,/WK,2023,Q3,Nausea,,2023,Q3,1,I,20230809.0,20230907.0,20230919,20230919,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20230918,,MD,US,US,2023,Q3,Adult
229580361,22958036,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,,,,/WK,2023,Q3,White blood cell count decreased,,2023,Q3,1,I,20230809.0,20230907.0,20230919,20230919,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20230918,,MD,US,US,2023,Q3,Adult
229580361,22958036,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,,,,/WK,2023,Q3,Platelet count decreased,,2023,Q3,1,I,20230809.0,20230907.0,20230919,20230919,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20230918,,MD,US,US,2023,Q3,Adult
229580361,22958036,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,,,,/WK,2023,Q3,Lymphopenia,,2023,Q3,1,I,20230809.0,20230907.0,20230919,20230919,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20230918,,MD,US,US,2023,Q3,Adult
229611371,22961137,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?,,,,,,,,,,Injection,999,2023,Q3,Gastroenteritis viral,,2023,Q3,1,I,20230824.0,,20230919,20230919,DIR,674454,,FDA-CTU,,52.0,YR,,M,N,113.85,KG,20230919,N,CN,US,,2023,Q3,Adult
229611371,22961137,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?,,,,,,,,,,Injection,999,2023,Q3,Fatigue,,2023,Q3,1,I,20230824.0,,20230919,20230919,DIR,674454,,FDA-CTU,,52.0,YR,,M,N,113.85,KG,20230919,N,CN,US,,2023,Q3,Adult
229611371,22961137,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : 1x week;?,,,,,,,,,,Injection,999,2023,Q3,Weight decreased,,2023,Q3,1,I,20230824.0,,20230919,20230919,DIR,674454,,FDA-CTU,,52.0,YR,,M,N,113.85,KG,20230919,N,CN,US,,2023,Q3,Adult
229640991,22964099,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,ASKU,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230912.0,20230921,20230921,EXP,,GB-SANDOZ INC.-SDZ2023GB028508,SANDOZ,,66.0,YR,,,Y,,,20230921,,CN,GB,GB,2023,Q3,Elderly
229640991,22964099,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,ASKU,,,,,,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230912.0,20230921,20230921,EXP,,GB-SANDOZ INC.-SDZ2023GB028508,SANDOZ,,66.0,YR,,,Y,,,20230921,,CN,GB,GB,2023,Q3,Elderly
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Hepatic necrosis,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Intentional overdose,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Drug interaction,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Hepatic ischaemia,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,14mg of 30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q3,Vasoplegia syndrome,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Toxicity to various agents,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Hepatic necrosis,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Intentional overdose,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Drug interaction,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Hepatic ischaemia,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229658352,22965835,9,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q3,Vasoplegia syndrome,,2023,Q3,2,F,,20230922.0,20230921,20230930,EXP,,NL-TEVA-2023-NL-2927697,TEVA,,55.0,YR,A,F,Y,,,20230930,,HP,NL,NL,2023,Q3,Adult
229663031,22966303,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"ASKU,ASKU",,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230912.0,20230921,20230921,EXP,,GB-TEVA-2023-GB-2926923,TEVA,,66.0,YR,E,,Y,,,20230921,,CN,GB,GB,2023,Q3,Elderly
229663031,22966303,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"ASKU,ASKU",,,,,,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230912.0,20230921,20230921,EXP,,GB-TEVA-2023-GB-2926923,TEVA,,66.0,YR,E,,Y,,,20230921,,CN,GB,GB,2023,Q3,Elderly
229677641,22967764,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 vial once a week subcutaneous,,,Y,D,181306,20230708.0,99.0,,,,999,2023,Q3,Therapy cessation,,2023,Q3,1,I,,,20230920,20230920,DIR,674622,,FDA-CTU,,35.0,YR,,F,N,72.0,KG,20230920,N,CN,US,,2023,Q3,Adult
229677641,22967764,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4 vial once a week subcutaneous,,,Y,D,181306,20230708.0,99.0,,,,999,2023,Q3,Dyskinesia,,2023,Q3,1,I,,,20230920,20230920,DIR,674622,,FDA-CTU,,35.0,YR,,F,N,72.0,KG,20230920,N,CN,US,,2023,Q3,Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Eructation,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Bedridden,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Feeding disorder,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Vomiting,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Product compounding quality issue,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Anal incontinence,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Weight decreased,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229681241,22968124,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 6 Injection(s);?OTHER FREQUENCY : 1x per week;?,,,N,Y,233615,20240722.0,99.0,,,,999,2023,Q3,Product formulation issue,,2023,Q3,1,I,20230908.0,,20230920,20230920,DIR,674757,,FDA-CTU,,33.0,YR,,F,N,77.85,KG,20230920,N,CN,US,,2023,Q3,Young Adult
229698471,22969847,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Substance use,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Aggression,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q3,Substance use,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q3,Aggression,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698471,22969847,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230914.0,20230922,20230922,EXP,,CA-TEVA-2023-CA-2927503,TEVA,,42.0,YR,A,M,Y,,,20230922,,CN,CA,CA,2023,Q3,Adult
229698521,22969852,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230912.0,20230922,20230922,EXP,,GB-AUROBINDO-AUR-APL-2023-059010,AUROBINDO,,66.0,YR,,,Y,,,20230922,,CN,GB,GB,2023,Q3,Elderly
229698521,22969852,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230912.0,20230922,20230922,EXP,,GB-AUROBINDO-AUR-APL-2023-059010,AUROBINDO,,66.0,YR,,,Y,,,20230922,,CN,GB,GB,2023,Q3,Elderly
229704811,22970481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230920.0,,20230921,20230921,DIR,674786,,FDA-CTU,,41.0,YR,,F,N,90.5,KG,20230921,Y,,US,,2023,Q3,Adult
229704811,22970481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Infusion related reaction,,2023,Q3,1,I,20230920.0,,20230921,20230921,DIR,674786,,FDA-CTU,,41.0,YR,,F,N,90.5,KG,20230921,Y,,US,,2023,Q3,Adult
229704811,22970481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,1,I,20230920.0,,20230921,20230921,DIR,674786,,FDA-CTU,,41.0,YR,,F,N,90.5,KG,20230921,Y,,US,,2023,Q3,Adult
229709121,22970912,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,ASKU,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230912.0,20230922,20230922,EXP,,GB-MICRO LABS LIMITED-ML2023-05322,MICRO LABS,,66.0,YR,E,,Y,,,20230922,,CN,GB,,2023,Q3,Elderly
229709121,22970912,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,ASKU,,,,,,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230912.0,20230922,20230922,EXP,,GB-MICRO LABS LIMITED-ML2023-05322,MICRO LABS,,66.0,YR,E,,Y,,,20230922,,CN,GB,,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Condition aggravated,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Product temperature excursion issue,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Interferon gamma release assay positive,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,JC polyomavirus test positive,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Lower urinary tract symptoms,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Labelled drug-drug interaction issue,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229754001,22975400,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qwk",,,,,,,,0.5,MG,,/WK,2023,Q3,Mononeuropathy multiplex,,2023,Q3,1,I,20220822.0,20230911.0,20230924,20230924,EXP,,IT-AMGEN INC.-ITANI2022230257,AMGEN,,65.0,YR,E,M,Y,,,20230924,,MD,IT,IT,2023,Q3,Elderly
229760401,22976040,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.5,MG,Solution for injection,,2023,Q3,Rhabdomyolysis,,2023,Q3,1,I,20230608.0,20230913.0,20230925,20230925,EXP,SE-SEMPA-2023-012244,SE-Accord-367725,ACCORD,,72.0,YR,E,M,Y,98.0,KG,20230925,,MD,SE,SE,2023,Q3,Elderly
229761761,22976176,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230920.0,20230921.0,20230925,20230925,PER,,US-ABBVIE-5419826,ABBVIE,,40.0,YR,,F,Y,90.264,KG,20230925,,HP,US,US,2023,Q3,Adult
229761761,22976176,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,1,I,20230920.0,20230921.0,20230925,20230925,PER,,US-ABBVIE-5419826,ABBVIE,,40.0,YR,,F,Y,90.264,KG,20230925,,HP,US,US,2023,Q3,Adult
229782911,22978291,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,Tablet,1X,2023,Q3,Intentional overdose,,2023,Q3,1,I,,20230912.0,20230925,20230925,EXP,,NL-MICRO LABS LIMITED-ML2023-05373,MICRO LABS,,55.0,YR,A,F,Y,125.0,KG,20230925,,MD,NL,,2023,Q3,Adult
229782911,22978291,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,Tablet,1X,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230912.0,20230925,20230925,EXP,,NL-MICRO LABS LIMITED-ML2023-05373,MICRO LABS,,55.0,YR,A,F,Y,125.0,KG,20230925,,MD,NL,,2023,Q3,Adult
229782911,22978291,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,Tablet,1X,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230912.0,20230925,20230925,EXP,,NL-MICRO LABS LIMITED-ML2023-05373,MICRO LABS,,55.0,YR,A,F,Y,125.0,KG,20230925,,MD,NL,,2023,Q3,Adult
229782911,22978291,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,D,,,,,,,Tablet,1X,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230912.0,20230925,20230925,EXP,,NL-MICRO LABS LIMITED-ML2023-05373,MICRO LABS,,55.0,YR,A,F,Y,125.0,KG,20230925,,MD,NL,,2023,Q3,Adult
229870541,22987054,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230913.0,20230926,20230926,EXP,,NL-GRANULES-NL-2023GRALIT00239,GRANULES INDIA,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report .Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230926,,HP,NL,NL,2023,Q3,Adult
229870541,22987054,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230913.0,20230926,20230926,EXP,,NL-GRANULES-NL-2023GRALIT00239,GRANULES INDIA,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report .Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230926,,HP,NL,NL,2023,Q3,Adult
229870541,22987054,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230913.0,20230926,20230926,EXP,,NL-GRANULES-NL-2023GRALIT00239,GRANULES INDIA,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report .Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230926,,HP,NL,NL,2023,Q3,Adult
229870541,22987054,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Overdose,,2023,Q3,1,I,,20230913.0,20230926,20230926,EXP,,NL-GRANULES-NL-2023GRALIT00239,GRANULES INDIA,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report .Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230926,,HP,NL,NL,2023,Q3,Adult
229870541,22987054,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230913.0,20230926,20230926,EXP,,NL-GRANULES-NL-2023GRALIT00239,GRANULES INDIA,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report .Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230926,,HP,NL,NL,2023,Q3,Adult
229882981,22988298,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,UNK,,,,,,,2023,Q3,Kidney infection,,2023,Q3,1,I,,20230914.0,20230926,20230926,EXP,,GB-LAURUS LABS LIMITED-2023LAU000085,LAURUS LABS LIMITED,,66.0,YR,,,Y,,,20230926,,CN,GB,GB,2023,Q3,Elderly
229882981,22988298,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,UNK,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20230914.0,20230926,20230926,EXP,,GB-LAURUS LABS LIMITED-2023LAU000085,LAURUS LABS LIMITED,,66.0,YR,,,Y,,,20230926,,CN,GB,GB,2023,Q3,Elderly
229983691,22998369,30,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,30,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,30,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2023,Q3,Aggression,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,30,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,30,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2023,Q3,Substance use,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Psychotic disorder,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Aggression,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
229983691,22998369,31,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q3,Substance use,,2023,Q3,1,I,,20230918.0,20230928,20230928,EXP,,CA-TEVA-2023-CA-2929008,TEVA,,42.0,YR,A,M,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230006131,23000613,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q3,Impaired gastric emptying,,2023,Q3,1,I,20230626.0,,20230927,20230927,DIR,675577,,FDA-CTU,,49.0,YR,,F,N,64.8,KG,20230927,N,CN,US,,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Influenza,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Fluid retention,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Illness,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Asthenia,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Off label use,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Fatigue,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230012181,23001218,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Solution,,2023,Q3,Muscle spasms,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-AUROBINDO-AUR-APL-2023-060759,AUROBINDO,,59.0,YR,,F,Y,,,20230928,,CN,CA,CA,2023,Q3,Adult
230078791,23007879,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Abdominal hernia,,2023,Q3,1,I,20200701.0,20230802.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230929,,MD,CA,CA,2023,Q3,Elderly
230078791,23007879,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Abdominal hernia,,2023,Q3,1,I,20200701.0,20230802.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230929,,MD,CA,CA,2023,Q3,Elderly
230078791,23007879,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Meningioma,,2023,Q3,1,I,20200701.0,20230802.0,20230929,20230929,EXP,,CA-SANDOZ INC.-NVSC2023CA139239,SANDOZ,,72.0,YR,,F,Y,69.9,KG,20230929,,MD,CA,CA,2023,Q3,Elderly
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Vomiting,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Nausea,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Blood magnesium decreased,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Abdominal pain,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,White blood cell count increased,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Shift to the left,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230083751,23008375,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,08302318A2,20231228.0,99.0,0.05,ML,,999,2023,Q3,Blood potassium decreased,,2023,Q3,1,I,20230927.0,,20230928,20230928,DIR,675689,,FDA-CTU,,62.0,YR,,F,N,86.6,KG,20230928,N,PH,US,,2023,Q3,Adult
230086151,23008615,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : Weekly;?,,,N,D,,,99.0,,,Injection,999,2023,Q3,Vomiting,,2023,Q3,1,I,20230926.0,,20230928,20230928,DIR,675722,,FDA-CTU,,70.0,YR,,M,N,76.5,KG,20230928,N,CN,US,,2023,Q3,Elderly
230086151,23008615,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : Weekly;?,,,N,D,,,99.0,,,Injection,999,2023,Q3,Abdominal pain,,2023,Q3,1,I,20230926.0,,20230928,20230928,DIR,675722,,FDA-CTU,,70.0,YR,,M,N,76.5,KG,20230928,N,CN,US,,2023,Q3,Elderly
230086151,23008615,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : Weekly;?,,,N,D,,,99.0,,,Injection,999,2023,Q3,Eructation,,2023,Q3,1,I,20230926.0,,20230928,20230928,DIR,675722,,FDA-CTU,,70.0,YR,,M,N,76.5,KG,20230928,N,CN,US,,2023,Q3,Elderly
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Visual acuity reduced,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Photopsia,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Blindness unilateral,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Vitreous haemorrhage,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Retinal ischaemia,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Vitreous floaters,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Macular degeneration,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230088151,23008815,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,N,,,,,,,,2023,Q3,Tinnitus,,2023,Q3,1,I,20230825.0,,20230928,20230928,DIR,675746,,FDA-CTU,,57.0,YR,,M,N,87.75,KG,20230928,N,CN,US,,2023,Q3,Adult
230099341,23009934,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,D,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,,20230919.0,20230929,20230929,EXP,,NL-EPICPHARMA-NL-2023EPCLIT01435,EPIC PHARM,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report.Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230929,,HP,NL,NL,2023,Q3,Adult
230099341,23009934,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,D,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Distributive shock,,2023,Q3,1,I,,20230919.0,20230929,20230929,EXP,,NL-EPICPHARMA-NL-2023EPCLIT01435,EPIC PHARM,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report.Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230929,,HP,NL,NL,2023,Q3,Adult
230099341,23009934,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,D,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Overdose,,2023,Q3,1,I,,20230919.0,20230929,20230929,EXP,,NL-EPICPHARMA-NL-2023EPCLIT01435,EPIC PHARM,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report.Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230929,,HP,NL,NL,2023,Q3,Adult
230099341,23009934,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,D,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230919.0,20230929,20230929,EXP,,NL-EPICPHARMA-NL-2023EPCLIT01435,EPIC PHARM,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report.Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230929,,HP,NL,NL,2023,Q3,Adult
230099341,23009934,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 Tablets,,,D,,Unknown,,,14.0,MG,Tablet,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20230919.0,20230929,20230929,EXP,,NL-EPICPHARMA-NL-2023EPCLIT01435,EPIC PHARM,Jessica D. Workum.Methylene blue as treatment for vasoplegic shock in severe metformin  overdose: A case report.Toxicology Reports.17-JUL-2023;11:141-144,55.0,YR,A,F,Y,125.0,KG,20230929,,HP,NL,NL,2023,Q3,Adult
230132321,23013232,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,COVID-19,,2023,Q3,1,I,,20230922.0,20230930,20230930,EXP,,CA-TEVA-2023-CA-2930277,TEVA,,59.0,YR,A,F,Y,77.0,KG,20230930,,HP,CA,CA,2023,Q3,Adult
230132321,23013232,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230922.0,20230930,20230930,EXP,,CA-TEVA-2023-CA-2930277,TEVA,,59.0,YR,A,F,Y,77.0,KG,20230930,,HP,CA,CA,2023,Q3,Adult
230132321,23013232,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,1,I,,20230922.0,20230930,20230930,EXP,,CA-TEVA-2023-CA-2930277,TEVA,,59.0,YR,A,F,Y,77.0,KG,20230930,,HP,CA,CA,2023,Q3,Adult
230132321,23013232,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q3,Coma,,2023,Q3,1,I,,20230922.0,20230930,20230930,EXP,,CA-TEVA-2023-CA-2930277,TEVA,,59.0,YR,A,F,Y,77.0,KG,20230930,,HP,CA,CA,2023,Q3,Adult
230149931,23014993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,2.0,MG,,999,2023,Q3,Weight decreased,,2023,Q3,1,I,20230925.0,,20230929,20230929,DIR,675819,,FDA-CTU,,80.0,YR,,M,N,61.24,KG,20230929,N,PH,US,,2023,Q3,Elderly
230149931,23014993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,2.0,MG,,999,2023,Q3,Therapy change,,2023,Q3,1,I,20230925.0,,20230929,20230929,DIR,675819,,FDA-CTU,,80.0,YR,,M,N,61.24,KG,20230929,N,PH,US,,2023,Q3,Elderly
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Rales,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Pyrexia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Fall,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressive symptom,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Weight decreased,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Flank pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Productive cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Heart sounds,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Injury,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Insomnia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Wheezing,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasal congestion,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Influenza,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest discomfort,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Asthma,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Angina pectoris,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Stress,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Appetite disorder,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressed mood,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Malaise,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rales,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Pyrexia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Fall,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressive symptom,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Weight decreased,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Flank pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Productive cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Heart sounds,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Injury,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Insomnia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Wheezing,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasal congestion,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Influenza,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest discomfort,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Asthma,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Angina pectoris,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Stress,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Appetite disorder,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressed mood,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Malaise,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rales,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Pyrexia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Fall,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressive symptom,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Weight decreased,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Flank pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Productive cough,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Heart sounds,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Injury,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Insomnia,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Wheezing,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasal congestion,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Influenza,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest discomfort,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Asthma,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest pain,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Angina pectoris,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Stress,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Appetite disorder,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressed mood,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
177196116,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Malaise,,2023,Q4,6,F,,20220922.0,20200428,20231207,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20231207,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Weight increased,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Pyrexia,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Second primary malignancy,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Oropharyngeal pain,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Vomiting,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Heart valve incompetence,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Cough,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Hypertonic bladder,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Headache,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Constipation,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Fatigue,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Pain,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Migraine,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Hepatic cancer,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Malaise,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Limb injury,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Musculoskeletal chest pain,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Product dose omission issue,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Rib fracture,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Depression,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Insomnia,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Neoplasm malignant,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Fall,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Hypersensitivity,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Restless legs syndrome,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,COVID-19,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
1792066922,17920669,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2023,Q4,Blood pressure increased,,2023,Q4,22,F,20200201.0,20231106.0,20200621,20231110,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20231110,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Flank pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Rales,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Stress,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Productive cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Influenza,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Insomnia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Fall,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Asthma,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Injury,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Malaise,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Chest pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Wheezing,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
181801448,18180144,93,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231012.0,20200821,20231107,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20231107,,CN,CA,CA,2023,Q4,Adult
182591897,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2023,Q4,Myocarditis,,2023,Q4,7,F,20200826.0,20231101.0,20200911,20231101,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20231102,,HP,DK,DK,2023,Q4,Elderly
182591897,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2023,Q4,Myasthenia gravis,,2023,Q4,7,F,20200826.0,20231101.0,20200911,20231101,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20231102,,HP,DK,DK,2023,Q4,Elderly
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressive symptom,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest discomfort,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Pyrexia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Rales,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Injury,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Fall,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Heart sounds,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressed mood,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Asthma,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Influenza,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Productive cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Malaise,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Appetite disorder,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Insomnia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Stress,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Flank pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Weight decreased,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Angina pectoris,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Wheezing,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,61,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressive symptom,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest discomfort,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Pyrexia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Rales,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Injury,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Fall,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Heart sounds,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressed mood,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Asthma,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Influenza,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Productive cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Malaise,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Appetite disorder,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Insomnia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Stress,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Flank pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Weight decreased,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Angina pectoris,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Wheezing,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,62,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,63,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Rales,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Injury,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Fall,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Asthma,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Influenza,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Malaise,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Stress,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182657239,18265723,64,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20231213.0,20200915,20231220,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20231220,,CN,CA,CA,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dysphagia,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Intervertebral discitis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Monocyte count increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Ulcer,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin B12 increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,C-reactive protein increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Post cholecystectomy syndrome,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood uric acid increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dry eye,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Red blood cell sedimentation rate increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Red blood cell count decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hyperhidrosis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Syncope,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Adrenal insufficiency,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Multiple sclerosis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Glomerular filtration rate increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Spinal disorder,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Granulocyte count increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cholecystitis acute,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Depressed mood,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Demyelination,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dry mouth,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Progressive multifocal leukoencephalopathy,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood immunoglobulin A increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Electric shock,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rheumatoid factor increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Neuropathy peripheral,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint noise,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood test abnormal,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Balance disorder,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Infusion related reaction,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dactylitis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Urticaria,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,White blood cell count increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug hypersensitivity,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood alkaline phosphatase increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cognitive disorder,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,White blood cells urine positive,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Temperature intolerance,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Coordination abnormal,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Depression,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Throat irritation,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Neutrophil count increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Miosis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood urea increased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Throat clearing,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin B12 deficiency,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin D deficiency,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Therapeutic response decreased,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Post-traumatic stress disorder,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
182734399,18273439,88,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,9,F,,20230921.0,20200916,20231002,EXP,,CA-AstraZeneca-2020SF15177,ASTRAZENECA,,50.0,YR,,F,Y,110.7,KG,20231002,,MD,CA,,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,94,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 milliliter, q.wk.",,,U,,,,,125.0,ML,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Chest pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Influenza,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Stress,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Wheezing,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Insomnia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Fall,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Productive cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Asthma,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Malaise,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Injury,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Flank pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,96,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Rales,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183019478,18301947,97,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, q.wk.",,,U,,,,,,,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,8,F,,20231207.0,20200923,20231215,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Treatment failure,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Glaucoma,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Delirium,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Dementia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Drug effect less than expected,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Mood swings,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Blood pressure systolic increased,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Gene mutation,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Drug intolerance,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Eye inflammation,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Asthenia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Rash,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Decreased appetite,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Amnesia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Hypertension,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Deafness neurosensory,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Eye pain,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Serum amyloid A protein increased,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Pneumonia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Fatigue,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Skin disorder,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Vascular cognitive impairment,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Myalgia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Muscular weakness,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Fatigue,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Arthralgia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Agitation,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Ill-defined disorder,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Conjunctivitis,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Chills,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Lethargy,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Cryopyrin associated periodic syndrome,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Paranoia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Urticaria,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Bronchitis,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Autoinflammatory disease,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Ocular hyperaemia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Ocular discomfort,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Drug ineffective,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Arthralgia,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Illness,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
183655334,18365533,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Joint swelling,,2023,Q4,4,F,,20230927.0,20201009,20231005,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,86.0,YR,,M,Y,,,20231005,,CN,CA,CA,2023,Q4,Elderly
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Hypoacusis,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Asthma,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Diabetes mellitus,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Depression,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Dyspnoea,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Wheezing,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
191402625,19140262,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,5,F,,20231208.0,20210415,20231218,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20231218,,MD,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Toothache,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Intervertebral disc protrusion,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Agitation,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Osteoarthritis,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Cholelithiasis,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Multiple sclerosis relapse,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Influenza,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Constipation,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
194212554,19421255,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Infusion related reaction,,2023,Q4,4,F,,20231002.0,20210615,20231012,EXP,,CA-PFIZER INC-2021641512,PFIZER,,51.0,YR,,F,Y,89.0,KG,20231012,,HP,CA,CA,2023,Q4,Adult
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Anaemia,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Arthritis,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Carpal tunnel syndrome,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cellulitis,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cardiac valve thickening,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Skin depigmentation,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Nerve compression,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Psoriatic arthropathy,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Psoriasis,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Feeling hot,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
1968519810,19685198,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Brachioradial pruritus,,2023,Q4,10,F,20200927.0,20231130.0,20210811,20231208,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20231208,,CN,CA,CA,2023,Q4,Elderly
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,85,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
198816074,19881607,86,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231211.0,20210925,20231215,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Off label use,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Off label use,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Off label use,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2031300114,20313001,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,14,F,,20231122.0,20220109,20231202,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231202,,MD,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Product prescribing error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Drug titration error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Myopathy,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Myalgia,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Urine output decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Micturition frequency decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Urinary retention,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Muscle spasms,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Myoglobinuria,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Body temperature increased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Off label use,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Chills,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Headache,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Renal failure,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Drug interaction,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,,,,,0.5,MG,Injection,/WK,2023,Q4,Urine flow decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Product prescribing error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Contraindicated product administered,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Drug titration error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Product use in unapproved indication,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Myopathy,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Myalgia,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Contraindicated product prescribed,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Urine output decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Micturition frequency decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Urinary retention,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Muscle spasms,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Myoglobinuria,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Body temperature increased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Off label use,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Serotonin syndrome,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Rhabdomyolysis,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Chills,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Hyperhidrosis,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Headache,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Renal failure,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Drug interaction,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2034676818,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,Injection,,2023,Q4,Urine flow decreased,,2023,Q4,18,F,,20231204.0,20220118,20231206,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,"Woron Jaroslaw, Marcin Siwek. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE - PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20231206,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myopathy,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine output decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urine flow decreased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myalgia,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Myoglobinuria,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Muscle spasms,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product prescribed,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Headache,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Body temperature increased,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Chills,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Renal failure,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product use in unapproved indication,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Urinary retention,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Product prescribing error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Serotonin syndrome,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Drug titration error,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Hyperhidrosis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
2041198710,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,U,U,Unknown,,,0.5,MG,,/WK,2023,Q4,Rhabdomyolysis,,2023,Q4,10,F,,20231122.0,20220201,20231129,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20231129,,HP,PL,PL,2023,Q4,Young Adult
204821324,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Chronic kidney disease,,2023,Q4,4,F,,20231025.0,20220216,20231103,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20231103,,MD,US,US,2023,Q4,Adult
204821324,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Genotype drug resistance test positive,,2023,Q4,4,F,,20231025.0,20220216,20231103,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20231103,,MD,US,US,2023,Q4,Adult
204821324,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,4,F,,20231025.0,20220216,20231103,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20231103,,MD,US,US,2023,Q4,Adult
204821324,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,4,F,,20231025.0,20220216,20231103,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20231103,,MD,US,US,2023,Q4,Adult
205231932,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q4,Weight increased,,2023,Q4,2,F,,20231103.0,20220227,20231113,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20231113,,MD,US,US,2023,Q4,Adult
205231932,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q4,Genotype drug resistance test positive,,2023,Q4,2,F,,20231103.0,20220227,20231113,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20231113,,MD,US,US,2023,Q4,Adult
205231932,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q4,Chronic kidney disease,,2023,Q4,2,F,,20231103.0,20220227,20231113,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20231113,,MD,US,US,2023,Q4,Adult
205231932,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q4,Hepatitis B,,2023,Q4,2,F,,20231103.0,20220227,20231113,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20231113,,MD,US,US,2023,Q4,Adult
205231932,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2023,Q4,Decreased appetite,,2023,Q4,2,F,,20231103.0,20220227,20231113,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20231113,,MD,US,US,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,107,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,U,,,,125.0,ML,Unknown,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,108,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Unknown,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
206906023,20690602,109,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231023.0,20220408,20231107,EXP,,CA-PFIZER INC-2020147397,MYLAN,,61.0,YR,,F,Y,,,20231107,,HP,CA,CA,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Memory impairment,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Transient ischaemic attack,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Blood cholesterol increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Poor quality sleep,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Hypertension,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2023,Q4,Stress,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Memory impairment,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Transient ischaemic attack,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Blood cholesterol increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Poor quality sleep,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Hypertension,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2023,Q4,Stress,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Memory impairment,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Transient ischaemic attack,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Blood cholesterol increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Poor quality sleep,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Hypertension,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2023,Q4,Stress,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Memory impairment,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Transient ischaemic attack,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Blood cholesterol increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Poor quality sleep,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Hypertension,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,,,,,2023,Q4,Stress,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Memory impairment,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Transient ischaemic attack,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Blood cholesterol increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Poor quality sleep,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Dizziness,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Hypertension,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
213030496,21303049,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,MG,,,2023,Q4,Stress,,2023,Q4,6,F,,20231129.0,20220907,20231205,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20231205,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Red blood cell sedimentation rate increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood immunoglobulin A increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood test abnormal,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Multiple sclerosis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin B12 deficiency,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Throat clearing,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Granulocyte count increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Progressive multifocal leukoencephalopathy,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rheumatoid factor increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Aspartate aminotransferase,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Depression,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Red blood cell count decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Neuropathy peripheral,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Coordination abnormal,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Throat irritation,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood alkaline phosphatase increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,White blood cells urine positive,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Post-traumatic stress disorder,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Electric shock,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,White blood cell count increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin B12 increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Miosis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Spinal disorder,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Demyelination,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Balance disorder,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Temperature intolerance,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood urea increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Urticaria,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Syncope,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vitamin D deficiency,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,C-reactive protein increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cholecystitis acute,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Neutrophil count increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dry mouth,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Ulcer,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dry eye,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dysphagia,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cognitive disorder,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint noise,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Post cholecystectomy syndrome,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dactylitis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood uric acid increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug hypersensitivity,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Therapeutic response decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Adrenal insufficiency,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Monocyte count increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hyperhidrosis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Infusion related reaction,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose decreased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Glomerular filtration rate increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,White blood cells urine positive,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Intervertebral discitis,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
215194974,21519497,29,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,4,F,,20231120.0,20221028,20231124,EXP,,CA-ROCHE-3202752,ROCHE,,50.0,YR,,F,Y,110.0,KG,20231124,,HP,CA,,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Rash,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,C-reactive protein increased,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Alanine aminotransferase increased,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Pain in extremity,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Colon cancer stage II,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Platelet count decreased,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Heart rate increased,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Cough,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Peripheral swelling,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Swelling,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
216323495,21632349,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, QW (at a strength of 0.25 to 0.5 mg)",,,U,,,,,,,,/WK,2023,Q4,Muscle spasms,,2023,Q4,5,F,20230821.0,20231023.0,20221123,20231031,EXP,,PHHY2019CA014011,NOVARTIS,,52.0,YR,,F,Y,,,20231031,,CN,CA,CA,2023,Q4,Adult
217448414,21744841,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cardiogenic shock,,2023,Q4,4,F,20220819.0,20231020.0,20221219,20231031,EXP,,FR-JNJFOC-20221239097,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,97.0,KG,20231031,,MD,FR,FR,2023,Q4,Elderly
217448414,21744841,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Respiratory failure,,2023,Q4,4,F,20220819.0,20231020.0,20221219,20231031,EXP,,FR-JNJFOC-20221239097,JOHNSON AND JOHNSON,,65.0,YR,E,M,Y,97.0,KG,20231031,,MD,FR,FR,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Diabetes mellitus,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222129262,22212926,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,2,F,,20221107.0,20230414,20231018,EXP,,CA-Covis Pharma GmbH-2023COV00888,COVIS PHARMA,,70.0,YR,E,M,Y,,,20231018,,MD,CA,CA,2023,Q4,Elderly
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Asthenia,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Therapeutic response delayed,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Psoriasis,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Pain in extremity,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Off label use,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Fatigue,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Neoplasm malignant,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Injection site bruising,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Thinking abnormal,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Pain,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222429736,22242973,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 DF, UNK 4MG/3ML INJ.PEN",,,,,,,,,,Injection,,2023,Q4,Hepatic cancer metastatic,,2023,Q4,6,F,20220101.0,20231020.0,20230424,20231030,EXP,,CA-PFIZER INC-202200850939,PFIZER,,34.0,YR,,F,Y,,,20231030,,HP,CA,CA,2023,Q4,Young Adult
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Hot flush,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Rotator cuff syndrome,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
222666903,22266690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,3,F,20230201.0,20231021.0,20230428,20231103,PER,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200428,MYOVANT SCIENCES,,68.0,YR,,M,Y,,,20231103,,CN,US,US,2023,Q4,Elderly
223464712,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q4,Pneumothorax,,2023,Q4,2,F,,20231013.0,20230519,20231016,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20231016,,HP,CA,CA,2023,Q4,Elderly
223464712,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q4,Weight decreased,,2023,Q4,2,F,,20231013.0,20230519,20231016,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20231016,,HP,CA,CA,2023,Q4,Elderly
223464712,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q4,Rib fracture,,2023,Q4,2,F,,20231013.0,20230519,20231016,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20231016,,HP,CA,CA,2023,Q4,Elderly
223464712,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q4,Fall,,2023,Q4,2,F,,20231013.0,20230519,20231016,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20231016,,HP,CA,CA,2023,Q4,Elderly
223464712,22346471,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2023,Q4,Hypoglycaemic coma,,2023,Q4,2,F,,20231013.0,20230519,20231016,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-238062",BOEHRINGER INGELHEIM,,72.0,YR,E,M,Y,,,20231016,,HP,CA,CA,2023,Q4,Elderly
223627265,22362726,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q4,Hepatic function abnormal,,2023,Q4,5,F,20221024.0,20231023.0,20230524,20231025,EXP,,NVSJ2022JP101157,NOVARTIS,,36.0,YR,,F,Y,68.3,KG,20231026,,MD,JP,JP,2023,Q4,Adult
223627265,22362726,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q4,Disease recurrence,,2023,Q4,5,F,20221024.0,20231023.0,20230524,20231025,EXP,,NVSJ2022JP101157,NOVARTIS,,36.0,YR,,F,Y,68.3,KG,20231026,,MD,JP,JP,2023,Q4,Adult
223627265,22362726,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q4,Familial mediterranean fever,,2023,Q4,5,F,20221024.0,20231023.0,20230524,20231025,EXP,,NVSJ2022JP101157,NOVARTIS,,36.0,YR,,F,Y,68.3,KG,20231026,,MD,JP,JP,2023,Q4,Adult
223627265,22362726,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q4,C-reactive protein increased,,2023,Q4,5,F,20221024.0,20231023.0,20230524,20231025,EXP,,NVSJ2022JP101157,NOVARTIS,,36.0,YR,,F,Y,68.3,KG,20231026,,MD,JP,JP,2023,Q4,Adult
223627265,22362726,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q4,Anaemia,,2023,Q4,5,F,20221024.0,20231023.0,20230524,20231025,EXP,,NVSJ2022JP101157,NOVARTIS,,36.0,YR,,F,Y,68.3,KG,20231026,,MD,JP,JP,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Foreign body sensation in eyes,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Feeling abnormal,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Bell's palsy,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Limb discomfort,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Injection site swelling,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Paralysis,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Sputum discoloured,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Oxygen saturation decreased,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Anxiety,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Hypertensive crisis,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Lethargy,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Sinus congestion,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Injection site bruising,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Upper-airway cough syndrome,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Dizziness,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Vaccination site pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Illness,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Symptom recurrence,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Back pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Tinnitus,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Urinary incontinence,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Lipoma,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Hypoaesthesia,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Chills,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Mobility decreased,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Decreased appetite,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,COVID-19,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Throat clearing,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Anaphylactic reaction,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Contusion,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Fatigue,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Paranasal sinus discomfort,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Oropharyngeal pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Asthenia,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Eye haemorrhage,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Injection site pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Eyelid ptosis,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Procedural pain,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Lacrimation increased,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Discomfort,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Aphthous ulcer,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Headache,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
225198403,22519840,57,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, weekly",,,,,,,,,,,/WK,2023,Q4,Weight increased,,2023,Q4,3,F,,20230919.0,20230605,20231002,EXP,,CA-PFIZER INC-202300205797,PFIZER,,63.0,YR,,F,Y,,,20231002,,MD,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,103,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly  |  Daily Dose Unit : Dosage forms  |  Unit Dose Unit : Dosage forms",,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,104,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest discomfort,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Flank pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressive symptom,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Appetite disorder,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Influenza,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Stress,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Angina pectoris,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Heart sounds,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Injury,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Chest pain,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Fall,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Rales,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Insomnia,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Cough,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Depressed mood,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Wheezing,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasal congestion,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226158003,22615800,105,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),125 ml,,,,,UNKNOWN,,,,,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,3,F,,20231205.0,20230619,20231220,EXP,,CA-HIKMA PHARMACEUTICALS USA INC.-CA-H14001-23-02032,HIKMA,,61.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Product dose omission issue,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Aggression,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Substance use,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,D,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Psychotic disorder,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,Solution for injection,,2023,Q4,Product dose omission issue,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,Solution for injection,,2023,Q4,Aggression,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,Solution for injection,,2023,Q4,Substance use,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,Solution for injection,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226197223,22619722,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,Solution for injection,,2023,Q4,Psychotic disorder,,2023,Q4,3,F,,20230929.0,20230620,20231003,EXP,CA-SA-SAC20230616001488,CA-SA-2023SA185858,SANOFI AVENTIS,,42.0,YR,A,M,Y,,,20231003,,HP,CA,CA,2023,Q4,Adult
226224692,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q4,Diarrhoea,,2023,Q4,2,F,20221218.0,20231030.0,20230621,20231110,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20231110,,HP,CA,CA,2023,Q4,Elderly
226224692,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q4,Anaemia,,2023,Q4,2,F,20221218.0,20231030.0,20230621,20231110,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20231110,,HP,CA,CA,2023,Q4,Elderly
226224692,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q4,Renal tubular necrosis,,2023,Q4,2,F,20221218.0,20231030.0,20230621,20231110,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20231110,,HP,CA,CA,2023,Q4,Elderly
226224692,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q4,Chest pain,,2023,Q4,2,F,20221218.0,20231030.0,20230621,20231110,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20231110,,HP,CA,CA,2023,Q4,Elderly
226224692,22622469,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2023,Q4,Acute kidney injury,,2023,Q4,2,F,20221218.0,20231030.0,20230621,20231110,EXP,,CA-JNJFOC-20230631877,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20231110,,HP,CA,CA,2023,Q4,Elderly
226258303,22625830,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q4,Substance use,,2023,Q4,3,F,,20230929.0,20230621,20231006,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
226258303,22625830,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q4,Aggression,,2023,Q4,3,F,,20230929.0,20230621,20231006,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
226258303,22625830,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q4,Psychotic behaviour,,2023,Q4,3,F,,20230929.0,20230621,20231006,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
226258303,22625830,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,3,F,,20230929.0,20230621,20231006,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
226258303,22625830,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2023,Q4,Product dose omission issue,,2023,Q4,3,F,,20230929.0,20230621,20231006,EXP,,CA-ABBVIE-5299251,ABBVIE,,42.0,YR,,M,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Aggression,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Product dose omission issue,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Aggression,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226314212,22631421,17,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Product dose omission issue,,2023,Q4,2,F,,20231019.0,20230623,20231027,EXP,,NVSC2023CA136078,NOVARTIS,,42.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Adult
226951622,22695162,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,209637.0,,,Solution for injection,,2023,Q4,Peripheral vascular disorder,,2023,Q4,2,F,20230329.0,20231005.0,20230712,20231016,EXP,PT-INFARMED-J202306-948,PT-NOVOPROD-1087040,NOVO NORDISK,,66.0,YR,,F,Y,88.0,KG,20231016,,PH,PT,PT,2023,Q4,Elderly
226951622,22695162,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qw",,,Y,,,,209637.0,,,Solution for injection,,2023,Q4,Peripheral vascular disorder,,2023,Q4,2,F,20230329.0,20231005.0,20230712,20231016,EXP,PT-INFARMED-J202306-948,PT-NOVOPROD-1087040,NOVO NORDISK,,66.0,YR,,F,Y,88.0,KG,20231016,,PH,PT,PT,2023,Q4,Elderly
227491365,22749136,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7,,,,,,,,,,,QD,2023,Q4,Dehydration,,2023,Q4,5,F,20230720.0,20231130.0,20230725,20231205,EXP,,US-JNJFOC-20230746691,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,156.5,KG,20231205,,MD,US,US,2023,Q4,Adult
227491365,22749136,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dehydration,,2023,Q4,5,F,20230720.0,20231130.0,20230725,20231205,EXP,,US-JNJFOC-20230746691,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,156.5,KG,20231205,,MD,US,US,2023,Q4,Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Endocrine disorder,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Oropharyngeal pain,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Headache,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dry throat,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Throat irritation,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Cough,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Vomiting,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Illness,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pain,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Iron deficiency,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Tooth disorder,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Attention deficit hyperactivity disorder,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Infusion related reaction,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Acne cystic,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Acne,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Infertility,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pharyngeal erythema,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227545962,22754596,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nausea,,2023,Q4,2,F,,20231213.0,20230727,20231222,EXP,,CA-APOTEX-2023AP010787,APOTEX,,30.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Young Adult
227720404,22772040,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",21.5,MG,D,,,,215256.0,0.5,MG,Solution for injection,/WK,2023,Q4,Obstructive pancreatitis,,2023,Q4,4,F,20230614.0,20231010.0,20230801,20231018,EXP,,CA-NOVOPROD-1094838,NOVO NORDISK,,82.0,YR,,M,Y,108.0,KG,20231018,,MD,CA,CA,2023,Q4,Elderly
227720404,22772040,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",21.5,MG,D,,,,215256.0,0.5,MG,Solution for injection,/WK,2023,Q4,Bile duct stone,,2023,Q4,4,F,20230614.0,20231010.0,20230801,20231018,EXP,,CA-NOVOPROD-1094838,NOVO NORDISK,,82.0,YR,,M,Y,108.0,KG,20231018,,MD,CA,CA,2023,Q4,Elderly
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Hypoaesthesia,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Paralysis,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Lipoma,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Lacrimation increased,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Chills,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Paranasal sinus discomfort,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Injection site pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Feeling abnormal,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Bell's palsy,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Oropharyngeal pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Decreased appetite,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Injection site discomfort,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Oxygen saturation decreased,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Vaccination site pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Fatigue,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Eyelid ptosis,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Injection site swelling,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Sinus congestion,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Aphthous ulcer,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Eye haemorrhage,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Limb discomfort,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Throat clearing,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Lethargy,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Discomfort,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Back pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Illness,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Symptom recurrence,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Injection site bruising,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Dizziness,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Myalgia,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,COVID-19,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Urinary incontinence,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Injury,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Anxiety,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Hypertensive crisis,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Contusion,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Cough,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Foreign body sensation in eyes,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Weight increased,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Asthenia,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Procedural pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Headache,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Upper-airway cough syndrome,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Pain,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Fall,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Tinnitus,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Anaphylactic reaction,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Sputum discoloured,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Mobility decreased,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
227804512,22780451,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,2,F,,20231012.0,20230803,20231017,EXP,,CA-ROCHE-3397166,ROCHE,,63.0,YR,,F,Y,,,20231017,,HP,CA,,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Red blood cell count decreased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood chloride increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood cholesterol increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Albumin globulin ratio increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Mean cell haemoglobin increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood cholesterol increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Protein total decreased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Low density lipoprotein increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Mean platelet volume increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood calcium increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Basal cell carcinoma,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Carbon dioxide increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Mean cell haemoglobin concentration increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Albumin globulin ratio increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
228806384,22880638,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Low density lipoprotein increased,,2023,Q4,4,F,20230619.0,20231215.0,20230829,20231219,EXP,,US-ABBVIE-5384814,ABBVIE,,58.0,YR,,F,Y,81.19,KG,20231219,,CN,US,US,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,149,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,150,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Fall,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Malaise,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Influenza,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Flank pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Wheezing,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Injury,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Rales,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Insomnia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Stress,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Productive cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Asthma,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,151,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution,,2023,Q4,Chest pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Influenza,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Rales,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Stress,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229004604,22900460,152,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,4,F,,20231116.0,20230904,20231127,EXP,,CA-SANDOZ INC.-NVSC2020CA225240,SANDOZ,,61.0,YR,,F,Y,,,20231127,,CN,CA,CA,2023,Q4,Adult
229128902,22912890,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,Unknown,,,,,,,2023,Q4,Anaphylactic shock,,2023,Q4,2,F,20230808.0,20231121.0,20230906,20231124,EXP,FR-AFSSAPS-RE2023000775,FR-PFIZER INC-202300292152,PFIZER,,68.0,YR,,M,Y,89.0,KG,20231124,,PH,FR,FR,2023,Q4,Elderly
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Swelling,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Arthritis,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Rash papular,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Peripheral swelling,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Skin irritation,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Pruritus,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Injection site bruising,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Accidental exposure to product,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Skin discolouration,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Sensitive skin,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Arthralgia,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Exposure via skin contact,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Joint swelling,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Gait disturbance,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Ocular hyperaemia,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Injection site swelling,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Conjunctivitis,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Rash erythematous,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229160384,22916038,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,,/WK,2023,Q4,Pain,,2023,Q4,4,F,20230101.0,20231024.0,20230907,20231101,PER,,US-SA-2023SA269387,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20231101,,MD,US,US,2023,Q4,Adult
229330852,22933085,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1mg/0.75 ml,,,,,,,,,,Injection,,2023,Q4,Haematemesis,,2023,Q4,2,F,20230901.0,20230925.0,20230912,20231005,EXP,,US-JNJFOC-20230910456,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,113.5,KG,20231005,,MD,US,US,2023,Q4,Adult
229330852,22933085,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1mg/0.75 ml,,,,,,,,,,Injection,,2023,Q4,Nausea,,2023,Q4,2,F,20230901.0,20230925.0,20230912,20231005,EXP,,US-JNJFOC-20230910456,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,113.5,KG,20231005,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,Nausea,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,Fatigue,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,White blood cell count decreased,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,Platelet count decreased,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,Off label use,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229580362,22958036,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1mg,,,,,,,,1.0,MG,,/WK,2023,Q4,Lymphopenia,,2023,Q4,2,F,20230808.0,20230907.0,20230919,20231220,PER,,"US-PROVENTION BIO, INC.-US-PRAG-23-00066",PROVENTION BIO,,38.0,YR,,M,Y,89.0,KG,20231220,,MD,US,US,2023,Q4,Adult
229822652,22982265,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",18018.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2023,Q4,Acute kidney injury,,2023,Q4,2,F,20230913.0,20230927.0,20230926,20231006,EXP,,DE-NOVOPROD-1117214,NOVO NORDISK,,74.0,YR,,M,Y,79.0,KG,20231006,,MD,DE,DE,2023,Q4,Elderly
229822652,22982265,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",18018.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2023,Q4,Porcelain gallbladder,,2023,Q4,2,F,20230913.0,20230927.0,20230926,20231006,EXP,,DE-NOVOPROD-1117214,NOVO NORDISK,,74.0,YR,,M,Y,79.0,KG,20231006,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,White blood cell count decreased,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,Acute stress disorder,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,C-reactive protein abnormal,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,Pancytopenia,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,Sepsis,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229896285,22989628,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,U,,,,,1.0,MG,,,2023,Q4,Dermatitis atopic,,2023,Q4,5,F,20230920.0,20231211.0,20230927,20231215,EXP,,DE-SA-2023SA292049,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20231215,,MD,DE,DE,2023,Q4,Elderly
229955383,22995538,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Malignant genitourinary tract neoplasm,,2023,Q4,3,F,20230918.0,20231031.0,20230927,20231102,EXP,,NVSC2023CA206830,NOVARTIS,,69.0,YR,,M,Y,,,20231102,,MD,CA,CA,2023,Q4,Elderly
229955383,22995538,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20230918.0,20231031.0,20230927,20231102,EXP,,NVSC2023CA206830,NOVARTIS,,69.0,YR,,M,Y,,,20231102,,MD,CA,CA,2023,Q4,Elderly
229955383,22995538,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Malignant neoplasm progression,,2023,Q4,3,F,20230918.0,20231031.0,20230927,20231102,EXP,,NVSC2023CA206830,NOVARTIS,,69.0,YR,,M,Y,,,20231102,,MD,CA,CA,2023,Q4,Elderly
230191011,23019101,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Jaundice,,2023,Q4,1,I,,20230921.0,20231003,20231003,EXP,CA- HEALTHCANVIG-001048730,CA-NOVOPROD-1120793,NOVO NORDISK,,68.0,YR,,F,Y,102.0,KG,20231003,,PH,CA,CA,2023,Q4,Elderly
230201081,23020108,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,,,,,,,,,999,2023,Q4,Arthralgia,,2023,Q4,1,I,20230921.0,,20231002,20231002,DIR,676070,,FDA-CTU,,31.0,YR,,F,N,101.7,KG,20231002,N,CN,US,,2023,Q4,Young Adult
230201081,23020108,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,,,,,,,,,999,2023,Q4,Pain,,2023,Q4,1,I,20230921.0,,20231002,20231002,DIR,676070,,FDA-CTU,,31.0,YR,,F,N,101.7,KG,20231002,N,CN,US,,2023,Q4,Young Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Psychomotor hyperactivity,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Nightmare,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Mania,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Feeling abnormal,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Suffocation feeling,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Formication,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230203511,23020351,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Hallucination,,2023,Q4,1,I,20230927.0,,20231002,20231002,DIR,676132,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230210561,23021056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230926.0,,20231002,20231002,DIR,676130,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230210561,23021056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q4,Malaise,,2023,Q4,1,I,20230926.0,,20231002,20231002,DIR,676130,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230210561,23021056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q4,Nausea,,2023,Q4,1,I,20230926.0,,20231002,20231002,DIR,676130,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230210561,23021056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q4,Impaired gastric emptying,,2023,Q4,1,I,20230926.0,,20231002,20231002,DIR,676130,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230210561,23021056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,99.0,,,,QW,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,20230926.0,,20231002,20231002,DIR,676130,,FDA-CTU,,59.0,YR,,F,N,72.0,KG,20231002,N,CN,US,,2023,Q4,Adult
230223621,23022362,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg weekly,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20230926.0,20231003,20231003,EXP,,US-AstraZeneca-2023A219261,ASTRAZENECA,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co- Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice 2022;0(0):1-5.,64.0,YR,,F,Y,80.0,KG,20231003,,PH,US,,2023,Q4,Adult
230223621,23022362,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg weekly,,,,,,,,,,,,2023,Q4,Dehydration,,2023,Q4,1,I,,20230926.0,20231003,20231003,EXP,,US-AstraZeneca-2023A219261,ASTRAZENECA,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co- Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice 2022;0(0):1-5.,64.0,YR,,F,Y,80.0,KG,20231003,,PH,US,,2023,Q4,Adult
230223621,23022362,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg weekly,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,1,I,,20230926.0,20231003,20231003,EXP,,US-AstraZeneca-2023A219261,ASTRAZENECA,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co- Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice 2022;0(0):1-5.,64.0,YR,,F,Y,80.0,KG,20231003,,PH,US,,2023,Q4,Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Pain,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Cellulitis,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Depressive symptom,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Abscess,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Idiopathic intracranial hypertension,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230234911,23023491,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,,,,,,0.5,MG,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20230919.0,20231003,20231003,EXP,,CA-SANDOZ INC.-SDZ2023CA033925,SANDOZ,,26.0,YR,,F,Y,,,20231003,,MD,CA,CA,2023,Q4,Young Adult
230244081,23024408,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Renal tubular necrosis,,2023,Q4,1,I,,20230925.0,20231004,20231004,EXP,,CA-AUROBINDO-AUR-APL-2023-061030,AUROBINDO,,68.0,YR,,M,Y,112.0,KG,20231003,,HP,CA,CA,2023,Q4,Elderly
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Arterial stenosis,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Low density lipoprotein decreased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Myocardial infarction,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Arteriosclerosis coronary artery,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Prothrombin time prolonged,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Breath sounds abnormal,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Renal impairment,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Blood triglycerides increased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Mean platelet volume decreased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Ejection fraction decreased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Mitral valve calcification,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Platelet count decreased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Lymphadenopathy mediastinal,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Neuropathy peripheral,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Ischaemic cardiomyopathy,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Coronary artery dilatation,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Oedema peripheral,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Cardiac dysfunction,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230257902,23025790,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW (pen, 0.25mg or 0.5mg)",,,U,,,,,0.25,MG,Injection,/WK,2023,Q4,Blood creatinine increased,,2023,Q4,2,F,20230421.0,20231020.0,20231004,20231030,EXP,,NVSC2023US210581,NOVARTIS,,60.0,YR,,M,Y,137.8,KG,20231031,,CN,US,US,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Asthma,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Fall,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Lipoma,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Asthenia,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Sputum discoloured,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Oxygen saturation decreased,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Lethargy,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Aphthous ulcer,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Chills,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Fatigue,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Contusion,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Eyelid ptosis,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Illness,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Urinary incontinence,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Sinus congestion,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Tinnitus,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Foreign body sensation in eyes,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Pyrexia,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Feeling abnormal,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Bell's palsy,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Injection site pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Paralysis,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Procedural pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Cough,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Decreased appetite,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Anxiety,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Headache,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Eye haemorrhage,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Dyspnoea,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Productive cough,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Hypertensive crisis,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Injection site swelling,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Throat clearing,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Discomfort,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Anaphylactic reaction,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,COVID-19,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Injury,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Paranasal sinus discomfort,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Dizziness,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Injection site bruising,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Limb discomfort,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Symptom recurrence,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Back pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Oropharyngeal pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Lacrimation increased,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Weight increased,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Vaccination site pain,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Mobility decreased,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Upper-airway cough syndrome,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230260724,23026072,61,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, QW (1 every 1 weeks)",,,U,,UNKNOWN,,,,,,/WK,2023,Q4,Hypoaesthesia,,2023,Q4,4,F,,20231212.0,20231004,20231222,EXP,,CA-ROCHE-3431333,ROCHE,,63.0,YR,,F,Y,,,20231222,,HP,CA,CA,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Distributive shock,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Lactic acidosis,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230264431,23026443,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,30 tablets of semaglutide 14 mg (420 mg or 3.4 mg/ kg),,,,,,,,,,,,2023,Q4,Hepatic necrosis,,2023,Q4,1,I,,20231002.0,20231004,20231004,EXP,,NL-SANDOZ INC.-SDZ2023NL009965,SANDOZ,"Workum DJ, Keyany A, Jaspers CCT.. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Elsevier Toxicology Reports. 2023;11:141-44",55.0,YR,,F,Y,125.0,KG,20231004,,MD,NL,NL,2023,Q4,Adult
230274781,23027478,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20230920.0,20231004,20231004,EXP,,CA-TEVA-2023-CA-2933239,TEVA,,62.0,YR,A,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Adult
230274781,23027478,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230920.0,20231004,20231004,EXP,,CA-TEVA-2023-CA-2933239,TEVA,,62.0,YR,A,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Adult
230274781,23027478,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Tooth extraction,,2023,Q4,1,I,,20230920.0,20231004,20231004,EXP,,CA-TEVA-2023-CA-2933239,TEVA,,62.0,YR,A,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Adult
230274781,23027478,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Carpal tunnel decompression,,2023,Q4,1,I,,20230920.0,20231004,20231004,EXP,,CA-TEVA-2023-CA-2933239,TEVA,,62.0,YR,A,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Cough,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Blood iron decreased,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Muscle tightness,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Ear infection,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Fibrin D dimer increased,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Contusion,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Ill-defined disorder,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Haemoglobin decreased,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Oropharyngeal pain,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Influenza like illness,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Thrombosis,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Pain,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Spinal pain,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230350801,23035080,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK 1 every 1 Weeks,,,,,,,,,,Solution for injection,,2023,Q4,Fatigue,,2023,Q4,1,I,,20230927.0,20231005,20231005,EXP,,CA-SANDOZ INC.-SDZ2023CA037966,SANDOZ,,48.0,YR,,F,Y,,,20231005,,CN,CA,CA,2023,Q4,Adult
230362991,23036299,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,U,,,209637.0,,,,,2023,Q4,Colitis,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230362991,23036299,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,U,,,209637.0,,,,,2023,Q4,Medication error,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230362991,23036299,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK(dose was lowered after 6 days),,,Y,U,,,209637.0,,,,,2023,Q4,Colitis,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230362991,23036299,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK(dose was lowered after 6 days),,,Y,U,,,209637.0,,,,,2023,Q4,Medication error,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230362991,23036299,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK(higher dose),,,Y,U,,,209637.0,,,,,2023,Q4,Colitis,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230362991,23036299,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK(higher dose),,,Y,U,,,209637.0,,,,,2023,Q4,Medication error,,2023,Q4,1,I,20230703.0,20230926.0,20231006,20231006,EXP,,GB-NOVOPROD-1122879,NOVO NORDISK,,58.0,YR,,F,Y,,,20231006,,CN,GB,GB,2023,Q4,Adult
230369341,23036934,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q4,Breast mass,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-SANDOZ INC.-SDZ2023CA036267,SANDOZ,,36.0,YR,,F,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
230369341,23036934,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q4,Breast abscess,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-SANDOZ INC.-SDZ2023CA036267,SANDOZ,,36.0,YR,,F,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
230369341,23036934,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2023,Q4,Product use issue,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-SANDOZ INC.-SDZ2023CA036267,SANDOZ,,36.0,YR,,F,Y,,,20231006,,CN,CA,CA,2023,Q4,Adult
230378241,23037824,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : .175;?OTHER QUANTITY : 1 Injection(s);?,,,N,D,,,99.0,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,20230919.0,,20231005,20231005,DIR,676590,,FDA-CTU,,50.0,YR,,F,N,,,20231005,Y,CN,US,,2023,Q4,Adult
230378241,23037824,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : .175;?OTHER QUANTITY : 1 Injection(s);?,,,N,D,,,99.0,,,,,2023,Q4,Headache,,2023,Q4,1,I,20230919.0,,20231005,20231005,DIR,676590,,FDA-CTU,,50.0,YR,,F,N,,,20231005,Y,CN,US,,2023,Q4,Adult
230378241,23037824,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : .175;?OTHER QUANTITY : 1 Injection(s);?,,,N,D,,,99.0,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,20230919.0,,20231005,20231005,DIR,676590,,FDA-CTU,,50.0,YR,,F,N,,,20231005,Y,CN,US,,2023,Q4,Adult
230378371,23037837,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,,,,,,0.0,MG,,999,2023,Q4,Depression,,2023,Q4,1,I,20231005.0,,20231005,20231005,DIR,676535,,FDA-CTU,,45.0,YR,,F,N,79.65,KG,20231005,N,,US,,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Weight increased,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Cyst,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Back pain,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Sleep apnoea syndrome,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Limb operation,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Off label use,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Malaise,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Intentional product use issue,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Nasal congestion,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Pain in extremity,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230380621,23038062,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Carpal tunnel decompression,,2023,Q4,1,I,,20230926.0,20231006,20231006,EXP,,CA-APOTEX-2023AP014439,APOTEX,,46.0,YR,,F,Y,100.0,KG,20231006,,HP,CA,CA,2023,Q4,Adult
230439481,23043948,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.5,MG,,/WK,2023,Q4,Meniscopathy,,2023,Q4,1,I,20220416.0,20231004.0,20231009,20231009,EXP,,ES-ABBVIE-5438796,ABBVIE,,57.0,YR,,M,Y,,,20231009,,MD,ES,ES,2023,Q4,Adult
230460105,23046010,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Sepsis,,2023,Q4,5,F,20230729.0,20231020.0,20231009,20231025,EXP,,NVSC2023CA169372,NOVARTIS,,69.0,YR,,M,Y,,,20231025,,MD,CA,CA,2023,Q4,Elderly
230460105,23046010,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,5,F,20230729.0,20231020.0,20231009,20231025,EXP,,NVSC2023CA169372,NOVARTIS,,69.0,YR,,M,Y,,,20231025,,MD,CA,CA,2023,Q4,Elderly
230466791,23046679,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Deafness unilateral,,2023,Q4,1,I,20230501.0,20231002.0,20231009,20231009,EXP,,US-ABBVIE-5434439,ABBVIE,,50.0,YR,,F,Y,,,20231009,,CN,US,US,2023,Q4,Adult
230466791,23046679,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Ear discomfort,,2023,Q4,1,I,20230501.0,20231002.0,20231009,20231009,EXP,,US-ABBVIE-5434439,ABBVIE,,50.0,YR,,F,Y,,,20231009,,CN,US,US,2023,Q4,Adult
230491381,23049138,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.25,MG,,QW,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,20230131.0,,20231005,20231005,DIR,FDA-CDER-CTU-2023-73860,,FDA-CTU,,58.0,YR,,M,N,106.59,KG,20231005,Y,MD,US,,2023,Q4,Adult
230491381,23049138,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.25,MG,,QW,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20230131.0,,20231005,20231005,DIR,FDA-CDER-CTU-2023-73860,,FDA-CTU,,58.0,YR,,M,N,106.59,KG,20231005,Y,MD,US,,2023,Q4,Adult
230497391,23049739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q4,Ileus,,2023,Q4,1,I,20230821.0,,20231007,20231007,DIR,676718,,FDA-CTU,,67.0,YR,,F,N,119.7,KG,20231007,N,MD,US,,2023,Q4,Elderly
230497391,23049739,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,,,,1.0,MG,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20230821.0,,20231007,20231007,DIR,676718,,FDA-CTU,,67.0,YR,,F,N,119.7,KG,20231007,N,MD,US,,2023,Q4,Elderly
230504821,23050482,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,20231022.0,99.0,,,,QW,2023,Q4,Alopecia,,2023,Q4,1,I,20230909.0,,20231009,20231009,DIR,676843,,FDA-CTU,,52.0,YR,,F,N,71.1,KG,20231009,N,CN,US,,2023,Q4,Adult
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Sleep disorder,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rales,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Bone pain,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Flank pain,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Restless legs syndrome,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230545121,23054512,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Middle insomnia,,2023,Q4,1,I,,20231007.0,20231011,20231011,EXP,,CA-ROCHE-3436145,ROCHE,,65.0,YR,,F,Y,,,20231011,,HP,CA,,2023,Q4,Elderly
230569611,23056961,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,Unknown,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,1,I,,20231005.0,20231012,20231012,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265203",BOEHRINGER INGELHEIM,"LEE J, NOOR F, BARUA A, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164: doi:10.1016/j.chest.2023.07.1645.",57.0,YR,A,M,Y,,,20231012,,HP,US,US,2023,Q4,Adult
230569611,23056961,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,Unknown,,,,,,,2023,Q4,Metastases to lung,,2023,Q4,1,I,,20231005.0,20231012,20231012,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265203",BOEHRINGER INGELHEIM,"LEE J, NOOR F, BARUA A, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164: doi:10.1016/j.chest.2023.07.1645.",57.0,YR,A,M,Y,,,20231012,,HP,US,US,2023,Q4,Adult
230569611,23056961,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,Unknown,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231005.0,20231012,20231012,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265203",BOEHRINGER INGELHEIM,"LEE J, NOOR F, BARUA A, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164: doi:10.1016/j.chest.2023.07.1645.",57.0,YR,A,M,Y,,,20231012,,HP,US,US,2023,Q4,Adult
230569611,23056961,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,Unknown,,,,,,,2023,Q4,Adenocarcinoma pancreas,,2023,Q4,1,I,,20231005.0,20231012,20231012,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265203",BOEHRINGER INGELHEIM,"LEE J, NOOR F, BARUA A, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164: doi:10.1016/j.chest.2023.07.1645.",57.0,YR,A,M,Y,,,20231012,,HP,US,US,2023,Q4,Adult
230569611,23056961,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,Unknown,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231005.0,20231012,20231012,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-265203",BOEHRINGER INGELHEIM,"LEE J, NOOR F, BARUA A, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164: doi:10.1016/j.chest.2023.07.1645.",57.0,YR,A,M,Y,,,20231012,,HP,US,US,2023,Q4,Adult
230624081,23062408,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231012.0,20231013,20231013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-146191,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20231013,,HP,US,US,2023,Q4,Adult
230630631,23063063,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution,,2023,Q4,Neuropathy peripheral,,2023,Q4,1,I,,20231003.0,20231013,20231013,EXP,CA-MHPD-001056363,CA-Accord-383202,ACCORD,,54.0,YR,A,M,Y,,,20231013,,MD,CA,CA,2023,Q4,Adult
230630631,23063063,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution,,2023,Q4,Onychoclasis,,2023,Q4,1,I,,20231003.0,20231013,20231013,EXP,CA-MHPD-001056363,CA-Accord-383202,ACCORD,,54.0,YR,A,M,Y,,,20231013,,MD,CA,CA,2023,Q4,Adult
230630631,23063063,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution,,2023,Q4,Psoriasis,,2023,Q4,1,I,,20231003.0,20231013,20231013,EXP,CA-MHPD-001056363,CA-Accord-383202,ACCORD,,54.0,YR,A,M,Y,,,20231013,,MD,CA,CA,2023,Q4,Adult
230646611,23064661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Depression,,2023,Q4,1,I,20231002.0,,20231013,20231013,DIR,677388,,FDA-CTU,,36.0,YR,,F,N,99.0,KG,20231013,N,CN,US,,2023,Q4,Adult
230646611,23064661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Feeling abnormal,,2023,Q4,1,I,20231002.0,,20231013,20231013,DIR,677388,,FDA-CTU,,36.0,YR,,F,N,99.0,KG,20231013,N,CN,US,,2023,Q4,Adult
230646611,23064661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,20231002.0,,20231013,20231013,DIR,677388,,FDA-CTU,,36.0,YR,,F,N,99.0,KG,20231013,N,CN,US,,2023,Q4,Adult
230646611,23064661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20231002.0,,20231013,20231013,DIR,677388,,FDA-CTU,,36.0,YR,,F,N,99.0,KG,20231013,N,CN,US,,2023,Q4,Adult
230646611,23064661,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Decreased appetite,,2023,Q4,1,I,20231002.0,,20231013,20231013,DIR,677388,,FDA-CTU,,36.0,YR,,F,N,99.0,KG,20231013,N,CN,US,,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Faeces discoloured,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Rash macular,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Back pain,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Hypoaesthesia,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Migraine,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Abdominal pain lower,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Hyperhidrosis,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Balance disorder,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Productive cough,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230651461,23065146,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Pollakiuria,,2023,Q4,1,I,,20230929.0,20231013,20231013,EXP,,NVSC2023CA183220,NOVARTIS,,42.0,YR,,F,Y,,,20231013,,CN,CA,CA,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood urea increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure decreased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hyperkalaemia,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Sinus tachycardia,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood potassium increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Blood urea increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Blood creatinine increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Blood pressure decreased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Hyperkalaemia,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Sinus tachycardia,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230666631,23066663,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,2.0,MG,,,2023,Q4,Blood potassium increased,,2023,Q4,1,I,,20231009.0,20231016,20231016,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-266004",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20231016,,MD,US,US,2023,Q4,Adult
230676431,23067643,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Cellulitis,,2023,Q4,1,I,,20231005.0,20231016,20231016,EXP,,CA-APOTEX-2023AP015024,APOTEX,,54.0,YR,,F,Y,109.0,KG,20231016,,HP,CA,CA,2023,Q4,Adult
230676431,23067643,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Oxygen saturation decreased,,2023,Q4,1,I,,20231005.0,20231016,20231016,EXP,,CA-APOTEX-2023AP015024,APOTEX,,54.0,YR,,F,Y,109.0,KG,20231016,,HP,CA,CA,2023,Q4,Adult
230676431,23067643,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Heart rate decreased,,2023,Q4,1,I,,20231005.0,20231016,20231016,EXP,,CA-APOTEX-2023AP015024,APOTEX,,54.0,YR,,F,Y,109.0,KG,20231016,,HP,CA,CA,2023,Q4,Adult
230694931,23069493,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q4,Ketoacidosis,,2023,Q4,1,I,20230101.0,20231006.0,20231016,20231016,EXP,,CN-009507513-2310CHN003106,MERCK,,40.0,YR,,F,Y,69.0,KG,20231016,,HP,CN,CN,2023,Q4,Adult
230694931,23069493,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230101.0,20231006.0,20231016,20231016,EXP,,CN-009507513-2310CHN003106,MERCK,,40.0,YR,,F,Y,69.0,KG,20231016,,HP,CN,CN,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Demyelination,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Hyperhidrosis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Drug hypersensitivity,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood alkaline phosphatase increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Glomerular filtration rate increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Vitamin B12 increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dactylitis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Post cholecystectomy syndrome,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Syncope,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Adrenal insufficiency,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Nausea,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood glucose decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Electric shock,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Joint noise,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Nasal congestion,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Balance disorder,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,C-reactive protein increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Vitamin D deficiency,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood uric acid increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Spinal disorder,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Monocyte count increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Granulocyte count increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Depressed mood,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Fall,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cough,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,White blood cell count increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dry eye,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Ulcer,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cough,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Therapeutic response decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Back pain,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Rheumatoid factor increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood test abnormal,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood urea increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dry mouth,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure systolic increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,White blood cells urine positive,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cholecystitis acute,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Throat clearing,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Throat irritation,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Therapeutic response decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Temperature intolerance,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Coordination abnormal,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Red blood cell sedimentation rate increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Hyperhidrosis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Red blood cell count decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood immunoglobulin A increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Miosis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Urticaria,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Infusion related reaction,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Cognitive disorder,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Progressive multifocal leukoencephalopathy,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dysphagia,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Vitamin B12 deficiency,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Neutrophil count increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Multiple sclerosis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Multiple sclerosis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Demyelination,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Pain,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Post-traumatic stress disorder,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure systolic decreased,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Intervertebral discitis,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230731942,23073194,92,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Neuropathy peripheral,,2023,Q4,2,F,,20231012.0,20231017,20231027,EXP,,CA-SANDOZ INC.-NVSC2023CA031975,SANDOZ,,51.0,YR,,F,Y,81.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
230741482,23074148,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Ankylosing spondylitis,,2023,Q4,2,F,,20231030.0,20231017,20231106,EXP,,CA-PFIZER INC-202300318284,PFIZER,,36.0,YR,,F,Y,,,20231106,,HP,CA,CA,2023,Q4,Adult
230741482,23074148,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Breast abscess,,2023,Q4,2,F,,20231030.0,20231017,20231106,EXP,,CA-PFIZER INC-202300318284,PFIZER,,36.0,YR,,F,Y,,,20231106,,HP,CA,CA,2023,Q4,Adult
230741482,23074148,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Breast mass,,2023,Q4,2,F,,20231030.0,20231017,20231106,EXP,,CA-PFIZER INC-202300318284,PFIZER,,36.0,YR,,F,Y,,,20231106,,HP,CA,CA,2023,Q4,Adult
230741482,23074148,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Product use issue,,2023,Q4,2,F,,20231030.0,20231017,20231106,EXP,,CA-PFIZER INC-202300318284,PFIZER,,36.0,YR,,F,Y,,,20231106,,HP,CA,CA,2023,Q4,Adult
230753951,23075395,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5045468,20240212.0,99.0,,,,999,2023,Q4,Nausea,,2023,Q4,1,I,20231016.0,,20231017,20231017,DIR,677727,,FDA-CTU,,46.0,YR,,M,N,,,20231017,Y,HP,US,,2023,Q4,Adult
230753951,23075395,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5045468,20240212.0,99.0,,,,999,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231016.0,,20231017,20231017,DIR,677727,,FDA-CTU,,46.0,YR,,M,N,,,20231017,Y,HP,US,,2023,Q4,Adult
230753951,23075395,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5045468,20240212.0,99.0,,,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20231016.0,,20231017,20231017,DIR,677727,,FDA-CTU,,46.0,YR,,M,N,,,20231017,Y,HP,US,,2023,Q4,Adult
230753951,23075395,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5045468,20240212.0,99.0,,,,999,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231016.0,,20231017,20231017,DIR,677727,,FDA-CTU,,46.0,YR,,M,N,,,20231017,Y,HP,US,,2023,Q4,Adult
230763841,23076384,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,ASKU,,,,,,,2023,Q4,Subdural haematoma,,2023,Q4,1,I,20230915.0,20231008.0,20231017,20231017,EXP,,GB-TEVA-2023-GB-2934844,TEVA,,56.0,YR,A,M,Y,,,20231017,,PH,GB,GB,2023,Q4,Adult
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Hypovolaemia,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Leukocytosis,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Acute kidney injury,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Muscular weakness,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Blood creatinine increased,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Dizziness,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Fall,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Dehydration,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Balance disorder,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Hypotension,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Hypophosphataemia,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Weight decreased,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230807381,23080738,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Dizziness,,2023,Q4,1,I,20221023.0,,20231018,20231018,DIR,FDA-CDER-CTU-2023-76438,,FDA-CTU,,74.0,YR,,M,N,89.0,KG,20230118,N,PH,US,,2023,Q4,Elderly
230827441,23082744,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2023,Q4,Cellulitis gangrenous,,2023,Q4,1,I,,20231007.0,20231019,20231019,EXP,FR-AFSSAPS-LY2023001507,FR-Accord-385005,ACCORD,,69.0,YR,E,M,Y,,,20231019,,PH,FR,FR,2023,Q4,Elderly
230829351,23082935,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : once weekly;?,,,D,D,,,,2.0,MG,,999,2023,Q4,Cholecystitis acute,,2023,Q4,1,I,20231018.0,,20231018,20231018,DIR,677940,,FDA-CTU,,41.0,YR,,F,N,85.6,KG,20231018,N,PH,US,,2023,Q4,Adult
230877181,23087718,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",141.448,MG,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Pancreatic carcinoma,,2023,Q4,1,I,20230722.0,20231009.0,20231020,20231020,EXP,FR-AFSSAPS-CF2023000487,FR-NOVOPROD-1126186,NOVO NORDISK,,75.0,YR,,F,Y,70.0,KG,20231020,,PH,FR,FR,2023,Q4,Elderly
230939831,23093983,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Skin mass,,2023,Q4,1,I,20230101.0,20231010.0,20231023,20231023,EXP,,BR-NOVOPROD-1126811,NOVO NORDISK,,64.0,YR,,M,Y,,,20231023,,CN,BR,BR,2023,Q4,Adult
230939831,23093983,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Intestinal obstruction,,2023,Q4,1,I,20230101.0,20231010.0,20231023,20231023,EXP,,BR-NOVOPROD-1126811,NOVO NORDISK,,64.0,YR,,M,Y,,,20231023,,CN,BR,BR,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Stomatitis,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Bronchitis,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Psoriasis,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Oral herpes,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Fluid replacement,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Muscle spasms,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Dyspepsia,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Menopause,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939901,23093990,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA- HEALTHCANVIG-E2B_06549251,CA-NOVOPROD-1128506,NOVO NORDISK,,49.0,YR,,F,Y,,,20231023,,CN,CA,CA,2023,Q4,Adult
230939931,23093993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Rib fracture,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA-HEALTHCANVIG-06544998,CA-NOVOPROD-1128360,NOVO NORDISK,,72.0,YR,,M,Y,,,20231023,,HP,CA,CA,2023,Q4,Elderly
230939931,23093993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Hypoglycaemic coma,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA-HEALTHCANVIG-06544998,CA-NOVOPROD-1128360,NOVO NORDISK,,72.0,YR,,M,Y,,,20231023,,HP,CA,CA,2023,Q4,Elderly
230939931,23093993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Pneumothorax,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA-HEALTHCANVIG-06544998,CA-NOVOPROD-1128360,NOVO NORDISK,,72.0,YR,,M,Y,,,20231023,,HP,CA,CA,2023,Q4,Elderly
230939931,23093993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Fall,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA-HEALTHCANVIG-06544998,CA-NOVOPROD-1128360,NOVO NORDISK,,72.0,YR,,M,Y,,,20231023,,HP,CA,CA,2023,Q4,Elderly
230939931,23093993,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,Solution for injection,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231011.0,20231023,20231023,EXP,CA-HEALTHCANVIG-06544998,CA-NOVOPROD-1128360,NOVO NORDISK,,72.0,YR,,M,Y,,,20231023,,HP,CA,CA,2023,Q4,Elderly
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lipoma,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rash,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Parosmia,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Skin disorder,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230953551,23095355,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,20230727.0,,20231020,20231020,DIR,678249,,FDA-CTU,,61.0,YR,,F,N,,,20231020,Y,CN,US,,2023,Q4,Adult
230976751,23097675,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Salmonellosis,,2023,Q4,1,I,,20231018.0,20231023,20231023,EXP,,CA-ROCHE-3442127,ROCHE,,71.0,YR,,F,Y,,,20231023,,HP,CA,,2023,Q4,Elderly
230976751,23097675,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231018.0,20231023,20231023,EXP,,CA-ROCHE-3442127,ROCHE,,71.0,YR,,F,Y,,,20231023,,HP,CA,,2023,Q4,Elderly
230982273,23098227,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,0.25,MG,Injection,,2023,Q4,Colitis,,2023,Q4,3,F,20230811.0,20231030.0,20231023,20231106,PER,,US-Eisai-EC-2023-147022,EISAI,,54.0,YR,A,M,Y,80.3,KG,20231106,,MD,US,US,2023,Q4,Adult
230987292,23098729,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2023,Q4,Anion gap increased,,2023,Q4,2,F,20230530.0,20231115.0,20231024,20231123,EXP,,CN-009507513-2310CHN008393,MERCK,,49.0,YR,,M,Y,70.0,KG,20231123,,MD,CN,CN,2023,Q4,Adult
230987292,23098729,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2023,Q4,Pneumonia,,2023,Q4,2,F,20230530.0,20231115.0,20231024,20231123,EXP,,CN-009507513-2310CHN008393,MERCK,,49.0,YR,,M,Y,70.0,KG,20231123,,MD,CN,CN,2023,Q4,Adult
230987292,23098729,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2023,Q4,Sinusitis,,2023,Q4,2,F,20230530.0,20231115.0,20231024,20231123,EXP,,CN-009507513-2310CHN008393,MERCK,,49.0,YR,,M,Y,70.0,KG,20231123,,MD,CN,CN,2023,Q4,Adult
231006011,23100601,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,MZF4D73,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230319.0,,20231020,20231020,DIR,FDA-CDER-CTU-2023-77891,,FDA-CTU,,69.0,YR,,M,N,,,20230330,N,PH,US,,2023,Q4,Elderly
231006011,23100601,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,MZF4D73,,,,,,,2023,Q4,Leukocytosis,,2023,Q4,1,I,20230319.0,,20231020,20231020,DIR,FDA-CDER-CTU-2023-77891,,FDA-CTU,,69.0,YR,,M,N,,,20230330,N,PH,US,,2023,Q4,Elderly
231006011,23100601,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,MZF4D73,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230319.0,,20231020,20231020,DIR,FDA-CDER-CTU-2023-77891,,FDA-CTU,,69.0,YR,,M,N,,,20230330,N,PH,US,,2023,Q4,Elderly
231006011,23100601,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,MZF4D73,,,,,,,2023,Q4,Eosinophilia,,2023,Q4,1,I,20230319.0,,20231020,20231020,DIR,FDA-CDER-CTU-2023-77891,,FDA-CTU,,69.0,YR,,M,N,,,20230330,N,PH,US,,2023,Q4,Elderly
231010401,23101040,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Strength: 1.7MG/0.75ML INJ,SOLN,PEN,0.75ML?Frequency : Weekly;?",,,,,,,,1.7,MG,,QW,2023,Q4,Chest pain,,2023,Q4,1,I,20230324.0,,20231021,20231021,DIR,FDA-CDER-CTU-2023-78060,,FDA-CTU,,35.0,YR,,F,N,126.0,KG,20230410,N,PH,US,,2023,Q4,Adult
231010401,23101040,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Strength: 1.7MG/0.75ML INJ,SOLN,PEN,0.75ML?Frequency : Weekly;?",,,,,,,,1.7,MG,,QW,2023,Q4,Vomiting,,2023,Q4,1,I,20230324.0,,20231021,20231021,DIR,FDA-CDER-CTU-2023-78060,,FDA-CTU,,35.0,YR,,F,N,126.0,KG,20230410,N,PH,US,,2023,Q4,Adult
231010401,23101040,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Strength: 1.7MG/0.75ML INJ,SOLN,PEN,0.75ML?Frequency : Weekly;?",,,,,,,,1.7,MG,,QW,2023,Q4,Nausea,,2023,Q4,1,I,20230324.0,,20231021,20231021,DIR,FDA-CDER-CTU-2023-78060,,FDA-CTU,,35.0,YR,,F,N,126.0,KG,20230410,N,PH,US,,2023,Q4,Adult
231016902,23101690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Eructation,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Colitis ischaemic,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Nausea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Diarrhoea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",6.5,MG,Y,U,,,209637.0,1.0,MG,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",6.5,MG,Y,U,,,209637.0,1.0,MG,,/WK,2023,Q4,Eructation,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",6.5,MG,Y,U,,,209637.0,1.0,MG,,/WK,2023,Q4,Colitis ischaemic,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",6.5,MG,Y,U,,,209637.0,1.0,MG,,/WK,2023,Q4,Nausea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",6.5,MG,Y,U,,,209637.0,1.0,MG,,/WK,2023,Q4,Diarrhoea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Eructation,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Colitis ischaemic,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Nausea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231016902,23101690,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",6.5,MG,Y,U,,,209637.0,0.5,MG,,/WK,2023,Q4,Diarrhoea,,2023,Q4,2,F,20230519.0,20231117.0,20231025,20231129,EXP,,US-NOVOPROD-1129045,NOVO NORDISK,,70.0,YR,,F,Y,79.3,KG,20231129,,HP,US,US,2023,Q4,Elderly
231027422,23102742,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,QD,2023,Q4,Live birth,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,QD,2023,Q4,Premature delivery,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,QD,2023,Q4,Pre-eclampsia,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,QD,2023,Q4,Blood glucose increased,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231027422,23102742,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,7.0,MG,,QD,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,2,F,,20231102.0,20231025,20231109,EXP,,JP-EMD Serono-9363940,EMD SERONO INC,,36.0,YR,A,F,Y,,,20231109,,HP,JP,JP,2023,Q4,Adult
231032831,23103283,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Frequency : Weekly;?,,,,,,,,0.5,MG,,QW,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,20230314.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78211,,FDA-CTU,,63.0,YR,,M,N,87.0,KG,20230404,N,PH,US,,2023,Q4,Adult
231032831,23103283,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Frequency : Weekly;?,,,,,,,,0.5,MG,,QW,2023,Q4,Hyperglycaemia,,2023,Q4,1,I,20230314.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78211,,FDA-CTU,,63.0,YR,,M,N,87.0,KG,20230404,N,PH,US,,2023,Q4,Adult
231032831,23103283,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Frequency : Weekly;?,,,,,,,,0.5,MG,,QW,2023,Q4,Therapy cessation,,2023,Q4,1,I,20230314.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78211,,FDA-CTU,,63.0,YR,,M,N,87.0,KG,20230404,N,PH,US,,2023,Q4,Adult
231032831,23103283,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Frequency : Weekly;?,,,,,,,,0.5,MG,,QW,2023,Q4,Vomiting,,2023,Q4,1,I,20230314.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78211,,FDA-CTU,,63.0,YR,,M,N,87.0,KG,20230404,N,PH,US,,2023,Q4,Adult
231034891,23103489,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Pancreatic carcinoma,,2023,Q4,1,I,20230403.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78127,,FDA-CTU,,78.0,YR,,M,N,70.0,KG,20230414,N,PH,US,,2023,Q4,Elderly
231039641,23103964,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20210818.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78269,,FDA-CTU,,56.0,YR,,M,N,83.9,KG,20211021,N,PH,US,,2023,Q4,Adult
231039641,23103964,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Acidosis,,2023,Q4,1,I,20210818.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78269,,FDA-CTU,,56.0,YR,,M,N,83.9,KG,20211021,N,PH,US,,2023,Q4,Adult
231039641,23103964,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,20210818.0,,20231022,20231022,DIR,FDA-CDER-CTU-2023-78269,,FDA-CTU,,56.0,YR,,M,N,83.9,KG,20211021,N,PH,US,,2023,Q4,Adult
231056901,23105690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2023,Q4,Cholecystectomy,,2023,Q4,1,I,20221111.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78467,,FDA-CTU,,78.0,YR,,M,N,102.0,KG,20230509,N,PH,US,,2023,Q4,Elderly
231056901,23105690,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2023,Q4,Pancreatitis,,2023,Q4,1,I,20221111.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78467,,FDA-CTU,,78.0,YR,,M,N,102.0,KG,20230509,N,PH,US,,2023,Q4,Elderly
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Product substitution issue,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Product quality issue,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Adverse food reaction,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Culture stool negative,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Adverse drug reaction,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Abdominal pain,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Gastrointestinal infection,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Eructation,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Anal incontinence,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231057101,23105710,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2023,Q4,Flatulence,,2023,Q4,1,I,20230324.0,,20231023,20231023,DIR,FDA-CDER-CTU-2023-78476,,FDA-CTU,,52.0,YR,,M,N,130.0,KG,20230509,N,PH,US,,2023,Q4,Adult
231068102,23106810,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Product dose omission issue,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Substance use,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,32,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Aggression,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Product dose omission issue,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Psychotic disorder,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Substance use,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231068102,23106810,33,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution,,2023,Q4,Aggression,,2023,Q4,2,F,,20231019.0,20231026,20231101,EXP,,CA-SANDOZ INC.-NVSC2023CA136078,SANDOZ,,42.0,YR,,M,Y,,,20231101,,CN,CA,CA,2023,Q4,Adult
231106981,23110698,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 milligram, Once Daily (qd)",,,U,,,,,14.0,MG,,QD,2023,Q4,Vascular device infection,,2023,Q4,1,I,20220203.0,20230319.0,20231026,20231026,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-414198,RANBAXY,,62.0,YR,,M,Y,113.0,KG,20231026,,MD,GB,GB,2023,Q4,Adult
231115451,23111545,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,Y,,,99.0,,,,QW,2023,Q4,Vomiting,,2023,Q4,1,I,20231017.0,,20231024,20231024,DIR,678612,,FDA-CTU,,41.0,YR,,F,N,73.8,KG,20231024,Y,CN,US,,2023,Q4,Adult
231115451,23111545,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,Y,,,99.0,,,,QW,2023,Q4,Liquid product physical issue,,2023,Q4,1,I,20231017.0,,20231024,20231024,DIR,678612,,FDA-CTU,,41.0,YR,,F,N,73.8,KG,20231024,Y,CN,US,,2023,Q4,Adult
231115451,23111545,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,Y,,,99.0,,,,QW,2023,Q4,Diarrhoea,,2023,Q4,1,I,20231017.0,,20231024,20231024,DIR,678612,,FDA-CTU,,41.0,YR,,F,N,73.8,KG,20231024,Y,CN,US,,2023,Q4,Adult
231115451,23111545,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,Y,,,99.0,,,,QW,2023,Q4,Abdominal discomfort,,2023,Q4,1,I,20231017.0,,20231024,20231024,DIR,678612,,FDA-CTU,,41.0,YR,,F,N,73.8,KG,20231024,Y,CN,US,,2023,Q4,Adult
231115451,23111545,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,Y,,,99.0,,,,QW,2023,Q4,Malaise,,2023,Q4,1,I,20231017.0,,20231024,20231024,DIR,678612,,FDA-CTU,,41.0,YR,,F,N,73.8,KG,20231024,Y,CN,US,,2023,Q4,Adult
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Hypertension,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Hyperlipidaemia,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231143431,23114343,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,1.0,MG,,,202211BEJ1,,,1.0,MG,Injection,/WK,2023,Q4,Hepatic steatosis,,2023,Q4,1,I,,20231020.0,20231027,20231027,EXP,,CN-AstraZeneca-2023A242496,ASTRAZENECA,,13989.0,DY,,F,Y,70.0,KG,20231027,,MD,CN,,2023,Q4,Elderly
231148881,23114888,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,U,,,,,,Unknown,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231018.0,20231027,20231027,EXP,,US-MYLANLABS-2023M1112413,MYLAN,"LEE J, NOOR F, BARUA AMIT, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest 2023;164 (Suppl.)(4):A2466-A2467.",57.0,YR,,M,Y,,,20231027,,HP,US,US,2023,Q4,Adult
231148881,23114888,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,U,,,,,,Unknown,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231018.0,20231027,20231027,EXP,,US-MYLANLABS-2023M1112413,MYLAN,"LEE J, NOOR F, BARUA AMIT, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest 2023;164 (Suppl.)(4):A2466-A2467.",57.0,YR,,M,Y,,,20231027,,HP,US,US,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oxygen saturation decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic abnormal,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Musculoskeletal stiffness,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Skin induration,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Disability assessment scale score increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Adrenal insufficiency,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Heart rate decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Platelet count decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Illness,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Heart rate increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oedema,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Feeling jittery,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Multiple fractures,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hepatic enzyme increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Gait disturbance,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Sinusitis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Spinal pain,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Feeling hot,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthropathy,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lacrimation increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Eye swelling,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Productive cough,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Malaise,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dysphonia,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Helicobacter infection,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure systolic abnormal,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cystitis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Movement disorder,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Kidney infection,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Osteoarthritis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood pressure diastolic decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Underdose,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cortisol decreased,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Neck pain,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthritis,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231150801,23115080,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Skin ulcer,,2023,Q4,1,I,,20231017.0,20231027,20231027,EXP,,CA-AMGEN-CANSL2023191704,AMGEN,,57.0,YR,A,F,Y,97.0,KG,20231027,,HP,CA,CA,2023,Q4,Adult
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Clostridium difficile infection,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Abdominal pain,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Chills,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Abdominal discomfort,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231193451,23119345,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,strength 0.25,,,U,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,20230101.0,20231020.0,20231028,20231028,EXP,,CA-SANDOZ INC.-SDZ2023CA047474,SANDOZ,,69.0,YR,,F,Y,,,20231028,,CN,CA,CA,2023,Q4,Elderly
231236561,23123656,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",14588.0,MG,,,,,213051.0,14.0,MG,Tablet,QD,2023,Q4,Cholecystitis acute,,2023,Q4,1,I,20230627.0,20231025.0,20231030,20231030,EXP,,RS-NOVOPROD-1105530,NOVO NORDISK,,64.0,YR,,M,Y,82.0,KG,20231030,,MD,RS,RS,2023,Q4,Adult
231275851,23127585,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,unknown,,,,,,,2023,Q4,Upper gastrointestinal haemorrhage,,2023,Q4,1,I,,20231025.0,20231031,20231031,EXP,,CA-SANDOZ INC.-SDZ2023CA047043,SANDOZ,,73.0,YR,,F,Y,118.0,KG,20231031,,HP,CA,CA,2023,Q4,Elderly
231275851,23127585,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,unknown,,,,,,,2023,Q4,Gastric ulcer,,2023,Q4,1,I,,20231025.0,20231031,20231031,EXP,,CA-SANDOZ INC.-SDZ2023CA047043,SANDOZ,,73.0,YR,,F,Y,118.0,KG,20231031,,HP,CA,CA,2023,Q4,Elderly
231281042,23128104,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, QW",,,U,,,,,0.25,MG,Solution for injection,/WK,2023,Q4,Ocular hyperaemia,,2023,Q4,2,F,,20231124.0,20231031,20231204,EXP,,CA-SA-2023SA330575,SANOFI AVENTIS,,75.0,YR,E,F,Y,92.0,KG,20231204,,CN,CA,CA,2023,Q4,Elderly
231303721,23130372,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,sunday,,,,,,,,,,,,2023,Q4,Leg amputation,,2023,Q4,1,I,20230317.0,20231023.0,20231031,20231031,EXP,,GB-AstraZeneca-2023A240148,ASTRAZENECA,,64.0,YR,,M,Y,,,20231031,,MD,GB,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Dehydration,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Headache,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Intentional overdose,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Vomiting,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231304291,23130429,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,LG5047010,20231118.0,99.0,0.25,MG,,QW,2023,Q4,Nausea,,2023,Q4,1,I,20231027.0,,20231030,20231030,DIR,679270,,FDA-CTU,,51.0,YR,,F,N,,,20231030,N,HP,US,,2023,Q4,Adult
231320232,23132023,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,2,F,,20231201.0,20231101,20231213,EXP,,PL-AUROBINDO-AUR-APL-2023-065788,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231213,,MD,PL,PL,2023,Q4,Young Adult
231320232,23132023,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,2,F,,20231201.0,20231101,20231213,EXP,,PL-AUROBINDO-AUR-APL-2023-065788,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231213,,MD,PL,PL,2023,Q4,Young Adult
231320232,23132023,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, Every Week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,2,F,,20231201.0,20231101,20231213,EXP,,PL-AUROBINDO-AUR-APL-2023-065788,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231213,,MD,PL,PL,2023,Q4,Young Adult
231320232,23132023,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, Every Week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,2,F,,20231201.0,20231101,20231213,EXP,,PL-AUROBINDO-AUR-APL-2023-065788,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231213,,MD,PL,PL,2023,Q4,Young Adult
231329211,23132921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Adenocarcinoma pancreas,,2023,Q4,1,I,,20231018.0,20231101,20231101,EXP,,US-drreddys-LIT/USA/23/0180914,DR REDDYS,"Lee J, Noor F, Barua A, Ahmad R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164(4):A2466-7. doi:10.1016/j.chest.2023.07.1645",57.0,YR,A,M,Y,,,20231101,,HP,US,US,2023,Q4,Adult
231329211,23132921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Metastases to lung,,2023,Q4,1,I,,20231018.0,20231101,20231101,EXP,,US-drreddys-LIT/USA/23/0180914,DR REDDYS,"Lee J, Noor F, Barua A, Ahmad R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164(4):A2466-7. doi:10.1016/j.chest.2023.07.1645",57.0,YR,A,M,Y,,,20231101,,HP,US,US,2023,Q4,Adult
231329211,23132921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231018.0,20231101,20231101,EXP,,US-drreddys-LIT/USA/23/0180914,DR REDDYS,"Lee J, Noor F, Barua A, Ahmad R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164(4):A2466-7. doi:10.1016/j.chest.2023.07.1645",57.0,YR,A,M,Y,,,20231101,,HP,US,US,2023,Q4,Adult
231329211,23132921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231018.0,20231101,20231101,EXP,,US-drreddys-LIT/USA/23/0180914,DR REDDYS,"Lee J, Noor F, Barua A, Ahmad R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION. Chest. 2023;164(4):A2466-7. doi:10.1016/j.chest.2023.07.1645",57.0,YR,A,M,Y,,,20231101,,HP,US,US,2023,Q4,Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Pancreatic enlargement,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Abdominal pain upper,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Pyrexia,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Hypopnoea,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Abdominal wall disorder,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Dyspepsia,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Headache,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Nausea,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Gastrointestinal oedema,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Oesophageal pain,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,10,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Pancreatic enlargement,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Abdominal pain upper,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Pyrexia,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Hypopnoea,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Abdominal wall disorder,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Dyspepsia,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Headache,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Nausea,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Gastrointestinal oedema,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Oesophageal pain,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231330095,23133009,11,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,5,F,,20231109.0,20231101,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-065628,AUROBINDO,"Woro? J, Siwek M.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci. Med. Prakt Psych. 2023;15(94):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Neck pain,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Ankylosing spondylitis,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Therapeutic response shortened,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypoaesthesia,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Discomfort,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Greater trochanteric pain syndrome,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood pressure increased,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Dyspepsia,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypokinesia,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Carpal tunnel syndrome,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Pain,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231339523,23133952,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,3,F,20231106.0,20231130.0,20231101,20231208,EXP,,NVSC2023CA230941,NOVARTIS,,50.0,YR,,F,Y,,,20231208,,MD,CA,CA,2023,Q4,Adult
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Gait disturbance,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Fatigue,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Pericardial effusion,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Blood pressure decreased,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231349101,23134910,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Vial;?OTHER FREQUENCY : Once per week;?,,,Y,D,LG6110363,20231118.0,99.0,,,,999,2023,Q4,Asthenia,,2023,Q4,1,I,20230801.0,,20231031,20231031,DIR,679462,,FDA-CTU,,68.0,YR,,F,N,69.75,KG,20231031,N,CN,US,,2023,Q4,Elderly
231389161,23138916,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,,250874,20240930.0,99.0,,,,999,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231030.0,,20231101,20231101,DIR,679623,,FDA-CTU,,35.0,YR,,F,N,108.0,KG,20231101,Y,CN,US,,2023,Q4,Adult
231389161,23138916,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?OTHER FREQUENCY : Once a week;?,,,Y,,250874,20240930.0,99.0,,,,999,2023,Q4,Product quality issue,,2023,Q4,1,I,20231030.0,,20231101,20231101,DIR,679623,,FDA-CTU,,35.0,YR,,F,N,108.0,KG,20231101,Y,CN,US,,2023,Q4,Adult
231393981,23139398,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231018.0,20231102,20231102,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415786,RANBAXY,"Lee J, Noor F, Barua A, Ahmad R. A rare case of euglycemic diabetic ketoacidosis in setting of sodium-glucose cotransporter 2 inhibitors use with undiagnosed metastatic pancreatic cancer and starvation. Chest. 2023;Oct; 164(S4):A2466-A2467",57.0,YR,,M,Y,,,20231102,,HP,US,US,2023,Q4,Adult
231393981,23139398,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Adenocarcinoma pancreas,,2023,Q4,1,I,,20231018.0,20231102,20231102,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-415786,RANBAXY,"Lee J, Noor F, Barua A, Ahmad R. A rare case of euglycemic diabetic ketoacidosis in setting of sodium-glucose cotransporter 2 inhibitors use with undiagnosed metastatic pancreatic cancer and starvation. Chest. 2023;Oct; 164(S4):A2466-A2467",57.0,YR,,M,Y,,,20231102,,HP,US,US,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Staphylococcal infection,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Illness,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231401593,23140159,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Migraine,,2023,Q4,3,F,,20231121.0,20231102,20231204,EXP,,US-ROCHE-3442893,ROCHE,,40.0,YR,,M,Y,211.56,KG,20231204,,MD,US,,2023,Q4,Adult
231428241,23142824,2,C,Wegovy (semaglutide) 0.25mg/0.5mL,,2,,,,,,,,,,,,,,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20231101.0,,20231102,20231102,DIR,679738,,FDA-CTU,,18.0,YR,,F,N,70.0,KG,20231102,N,PH,US,,2023,Q4,Youth
231428241,23142824,3,C,Wegovy (semaglutide) 0.5mg/0.5mL,,2,,,,,,,,,,,,,,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20231101.0,,20231102,20231102,DIR,679738,,FDA-CTU,,18.0,YR,,F,N,70.0,KG,20231102,N,PH,US,,2023,Q4,Youth
231428241,23142824,4,C,Wegovy (semaglutide) 1mg/0.5mL,,2,,,,,,,,,,,,,,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20231101.0,,20231102,20231102,DIR,679738,,FDA-CTU,,18.0,YR,,F,N,70.0,KG,20231102,N,PH,US,,2023,Q4,Youth
231428241,23142824,5,C,Wegovy (semaglutide) 1.7mg/0.5mL,,2,,,,,,,,,,,,,,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20231101.0,,20231102,20231102,DIR,679738,,FDA-CTU,,18.0,YR,,F,N,70.0,KG,20231102,N,PH,US,,2023,Q4,Youth
231428241,23142824,6,C,Wegovy (semaglutide) 2.4mg/0.5mL,,2,,,,,,,,,,,,,,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20231101.0,,20231102,20231102,DIR,679738,,FDA-CTU,,18.0,YR,,F,N,70.0,KG,20231102,N,PH,US,,2023,Q4,Youth
231437061,23143706,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, weekly",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,1,I,,20231024.0,20231103,20231103,EXP,,PL-INSUD PHARMA-2310PL07459,INSUD PHARMA,"Jaros?aw Woro?, Marcin Siwek. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231103,,MD,PL,PL,2023,Q4,Young Adult
231437061,23143706,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, weekly",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231024.0,20231103,20231103,EXP,,PL-INSUD PHARMA-2310PL07459,INSUD PHARMA,"Jaros?aw Woro?, Marcin Siwek. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231103,,MD,PL,PL,2023,Q4,Young Adult
231437061,23143706,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, weekly",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,1,I,,20231024.0,20231103,20231103,EXP,,PL-INSUD PHARMA-2310PL07459,INSUD PHARMA,"Jaros?aw Woro?, Marcin Siwek. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231103,,MD,PL,PL,2023,Q4,Young Adult
231437061,23143706,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, weekly",,,Y,,,,,1.0,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231024.0,20231103,20231103,EXP,,PL-INSUD PHARMA-2310PL07459,INSUD PHARMA,"Jaros?aw Woro?, Marcin Siwek. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu oty?o?ci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231103,,MD,PL,PL,2023,Q4,Young Adult
231441021,23144102,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Aphasia,,2023,Q4,1,I,20230401.0,20231030.0,20231103,20231103,EXP,FR-AFSSAPS-BX2023001861,FR-MYLANLABS-2023M1115063,MYLAN,,55.0,YR,,F,Y,96.0,KG,20231103,,PH,FR,FR,2023,Q4,Adult
231441021,23144102,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Diplopia,,2023,Q4,1,I,20230401.0,20231030.0,20231103,20231103,EXP,FR-AFSSAPS-BX2023001861,FR-MYLANLABS-2023M1115063,MYLAN,,55.0,YR,,F,Y,96.0,KG,20231103,,PH,FR,FR,2023,Q4,Adult
231441021,23144102,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20230401.0,20231030.0,20231103,20231103,EXP,FR-AFSSAPS-BX2023001861,FR-MYLANLABS-2023M1115063,MYLAN,,55.0,YR,,F,Y,96.0,KG,20231103,,PH,FR,FR,2023,Q4,Adult
231451271,23145127,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20231027.0,20231103,20231103,EXP,,CA-PFIZER INC-202300350636,PFIZER,,75.0,YR,,F,Y,92.0,KG,20231103,,MD,CA,CA,2023,Q4,Elderly
231451271,23145127,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231027.0,20231103,20231103,EXP,,CA-PFIZER INC-202300350636,PFIZER,,75.0,YR,,F,Y,92.0,KG,20231103,,MD,CA,CA,2023,Q4,Elderly
231454431,23145443,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,,,,,0.25,MG,,999,2023,Q4,Therapy cessation,,2023,Q4,1,I,20231006.0,,20231103,20231103,DIR,679865,,FDA-CTU,,63.0,YR,,F,N,127.35,KG,20231103,N,MD,US,,2023,Q4,Adult
231454431,23145443,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,,,,,0.25,MG,,999,2023,Q4,Therapy change,,2023,Q4,1,I,20231006.0,,20231103,20231103,DIR,679865,,FDA-CTU,,63.0,YR,,F,N,127.35,KG,20231103,N,MD,US,,2023,Q4,Adult
231454431,23145443,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,,,,,0.25,MG,,999,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,20231006.0,,20231103,20231103,DIR,679865,,FDA-CTU,,63.0,YR,,F,N,127.35,KG,20231103,N,MD,US,,2023,Q4,Adult
231454431,23145443,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,,,,,0.25,MG,,999,2023,Q4,Follicular thyroid cancer,,2023,Q4,1,I,20231006.0,,20231103,20231103,DIR,679865,,FDA-CTU,,63.0,YR,,F,N,127.35,KG,20231103,N,MD,US,,2023,Q4,Adult
231454431,23145443,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,,,,,0.25,MG,,999,2023,Q4,Weight decreased,,2023,Q4,1,I,20231006.0,,20231103,20231103,DIR,679865,,FDA-CTU,,63.0,YR,,F,N,127.35,KG,20231103,N,MD,US,,2023,Q4,Adult
231536711,23153671,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : 1 x per week;?,,,Y,D,249696,20241024.0,99.0,,,,999,2023,Q4,Intestinal obstruction,,2023,Q4,1,I,20231028.0,,20231106,20231106,DIR,680156,,FDA-CTU,,63.0,YR,,F,N,101.25,KG,20231106,Y,CN,US,,2023,Q4,Adult
231536711,23153671,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : 1 x per week;?,,,Y,D,249696,20241024.0,99.0,,,,999,2023,Q4,Gastrointestinal infection,,2023,Q4,1,I,20231028.0,,20231106,20231106,DIR,680156,,FDA-CTU,,63.0,YR,,F,N,101.25,KG,20231106,Y,CN,US,,2023,Q4,Adult
231591621,23159162,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,LG5045549,20240213.0,99.0,,,,999,2023,Q4,Drug dose titration not performed,,2023,Q4,1,I,20231020.0,,20231107,20231107,DIR,680283,,FDA-CTU,,47.0,YR,,F,N,,,20231107,N,HP,US,,2023,Q4,Adult
231591621,23159162,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,LG5045549,20240213.0,99.0,,,,999,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231020.0,,20231107,20231107,DIR,680283,,FDA-CTU,,47.0,YR,,F,N,,,20231107,N,HP,US,,2023,Q4,Adult
231591621,23159162,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,LG5045549,20240213.0,99.0,,,,999,2023,Q4,Product prescribing error,,2023,Q4,1,I,20231020.0,,20231107,20231107,DIR,680283,,FDA-CTU,,47.0,YR,,F,N,,,20231107,N,HP,US,,2023,Q4,Adult
231591621,23159162,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,LG5045549,20240213.0,99.0,,,,999,2023,Q4,Nausea,,2023,Q4,1,I,20231020.0,,20231107,20231107,DIR,680283,,FDA-CTU,,47.0,YR,,F,N,,,20231107,N,HP,US,,2023,Q4,Adult
231591621,23159162,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,D,LG5045549,20240213.0,99.0,,,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20231020.0,,20231107,20231107,DIR,680283,,FDA-CTU,,47.0,YR,,F,N,,,20231107,N,HP,US,,2023,Q4,Adult
231597761,23159776,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231030.0,20231108,20231108,EXP,,US-TEVA-2023-US-2942263,TEVA,,57.0,YR,A,M,Y,,,20231108,,HP,US,US,2023,Q4,Adult
231597761,23159776,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231030.0,20231108,20231108,EXP,,US-TEVA-2023-US-2942263,TEVA,,57.0,YR,A,M,Y,,,20231108,,HP,US,US,2023,Q4,Adult
231630722,23163072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week/1 mg, 1x/week",,,U,,,,,1.0,MG,,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week/1 mg, 1x/week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week/1 mg, 1x/week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week/1 mg, 1x/week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Fatigue,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week/1 mg, 1x/week",,,U,,,,,1.0,MG,,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week/0.25 mg, 1x/week",,,U,,,,,0.25,MG,,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week/0.25 mg, 1x/week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week/0.25 mg, 1x/week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week/0.25 mg, 1x/week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Fatigue,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231630722,23163072,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week/0.25 mg, 1x/week",,,U,,,,,0.25,MG,,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,2,F,,20231110.0,20231109,20231120,EXP,,FR-AUROBINDO-AUR-APL-2023-066784,AUROBINDO,,70.0,YR,,F,Y,69.0,KG,20231120,,CN,FR,FR,2023,Q4,Elderly
231631041,23163104,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2023,Q4,Pulmonary fibrosis,,2023,Q4,1,I,,20231030.0,20231109,20231109,EXP,,CA-TEVA-2023-CA-2942078,TEVA,,66.0,YR,E,,Y,,,20231109,,HP,CA,CA,2023,Q4,Elderly
231651361,23165136,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,20231108.0,,20231108,20231108,DIR,680502,,FDA-CTU,,49.0,YR,,F,N,120.6,KG,20231108,Y,CN,US,,2023,Q4,Adult
231652401,23165240,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,5048625,20240324.0,99.0,0.5,ML,,QW,2023,Q4,Skin discolouration,,2023,Q4,1,I,20231108.0,,20231108,20231108,DIR,680476,,FDA-CTU,,70.0,YR,,F,N,,,20231108,N,HP,US,,2023,Q4,Elderly
231652401,23165240,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,N,5048625,20240324.0,99.0,0.5,ML,,QW,2023,Q4,Pain of skin,,2023,Q4,1,I,20231108.0,,20231108,20231108,DIR,680476,,FDA-CTU,,70.0,YR,,F,N,,,20231108,N,HP,US,,2023,Q4,Elderly
231652441,23165244,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Appendicitis,,2023,Q4,1,I,20231102.0,,20231108,20231108,DIR,680505,,FDA-CTU,,50.0,YR,,F,N,74.7,KG,20231108,N,CN,US,,2023,Q4,Adult
231652441,23165244,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Illness,,2023,Q4,1,I,20231102.0,,20231108,20231108,DIR,680505,,FDA-CTU,,50.0,YR,,F,N,74.7,KG,20231108,N,CN,US,,2023,Q4,Adult
231652441,23165244,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,20231102.0,,20231108,20231108,DIR,680505,,FDA-CTU,,50.0,YR,,F,N,74.7,KG,20231108,N,CN,US,,2023,Q4,Adult
231664991,23166499,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20231006.0,20231106.0,20231109,20231109,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-159570,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,,,20231109,,HP,US,US,2023,Q4,Elderly
231691041,23169104,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20221101.0,20230126.0,20231110,20231110,PER,,US-Accord-298596,ACCORD,,73.0,YR,E,F,Y,,,20231110,,CN,US,US,2023,Q4,Elderly
231691041,23169104,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Rash pruritic,,2023,Q4,1,I,20221101.0,20230126.0,20231110,20231110,PER,,US-Accord-298596,ACCORD,,73.0,YR,E,F,Y,,,20231110,,CN,US,US,2023,Q4,Elderly
231694811,23169481,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,,/WK,2023,Q4,Fatigue,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,U,,,,209637.0,1.0,MG,,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,U,,,,209637.0,0.25,MG,,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,U,,,,209637.0,0.25,MG,,/WK,2023,Q4,Fatigue,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,U,,,,209637.0,0.25,MG,,/WK,2023,Q4,Loss of consciousness,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,U,,,,209637.0,0.25,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231694811,23169481,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, qw",,,U,,,,209637.0,0.25,MG,,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,,20231031.0,20231110,20231110,EXP,CA-HPFB-E2B_05830513,FR-NOVOPROD-1136978,NOVO NORDISK,,70.0,YR,,F,Y,69.0,KG,20231110,,CN,FR,CA,2023,Q4,Elderly
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Product administration error,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Oesophageal pain,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Contraindicated product administered,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Pancreatitis,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Headache,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week (first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Eructation,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Product administration error,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Oesophageal pain,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Contraindicated product administered,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Pancreatitis,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Headache,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Drug interaction,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231695002,23169500,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Eructation,,2023,Q4,2,F,,20231101.0,20231110,20231215,EXP,,PL-AUROBINDO-AUR-APL-2023-067307,AUROBINDO,Woron J.. Zapalenie trzustki jako konsekwencja skojarzenia sertraliny z produktami leczniczymi stosowanymi w nieoperacyjnym leczeniu otytosci.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-5,29.0,YR,,M,Y,,,20231215,,MD,PL,PL,2023,Q4,Young Adult
231733121,23173312,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,One injection,,,U,,,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231103.0,20231111,20231111,EXP,,NVSC2023FI238929,NOVARTIS,,55.0,YR,,M,Y,,,20231111,,PH,FI,FI,2023,Q4,Adult
231733121,23173312,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,One injection,,,U,,,,,,,,/WK,2023,Q4,Blood triglycerides increased,,2023,Q4,1,I,,20231103.0,20231111,20231111,EXP,,NVSC2023FI238929,NOVARTIS,,55.0,YR,,M,Y,,,20231111,,PH,FI,FI,2023,Q4,Adult
231733121,23173312,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,One injection,,,U,,,,,,,,/WK,2023,Q4,Blood pressure increased,,2023,Q4,1,I,,20231103.0,20231111,20231111,EXP,,NVSC2023FI238929,NOVARTIS,,55.0,YR,,M,Y,,,20231111,,PH,FI,FI,2023,Q4,Adult
231733121,23173312,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,One injection,,,U,,,,,,,,/WK,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,1,I,,20231103.0,20231111,20231111,EXP,,NVSC2023FI238929,NOVARTIS,,55.0,YR,,M,Y,,,20231111,,PH,FI,FI,2023,Q4,Adult
231733121,23173312,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,One injection,,,U,,,,,,,,/WK,2023,Q4,Swelling,,2023,Q4,1,I,,20231103.0,20231111,20231111,EXP,,NVSC2023FI238929,NOVARTIS,,55.0,YR,,M,Y,,,20231111,,PH,FI,FI,2023,Q4,Adult
231752211,23175221,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231102.0,20231113,20231113,EXP,,US-AUROBINDO-AUR-APL-2023-067763,AUROBINDO,"LEE J, NOOR F, BARUA AMIT, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION.. Chest. 2023;164 (Suppl.)(4):A2466-A2467",57.0,YR,,M,Y,,,20231113,,HP,US,US,2023,Q4,Adult
231752211,23175221,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231102.0,20231113,20231113,EXP,,US-AUROBINDO-AUR-APL-2023-067763,AUROBINDO,"LEE J, NOOR F, BARUA AMIT, AHMAD R. A RARE CASE OF EUGLYCEMIC DIABETIC KETOACIDOSIS IN SETTING OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS USE WITH UNDIAGNOSED METASTATIC PANCREATIC CANCER AND STARVATION.. Chest. 2023;164 (Suppl.)(4):A2466-A2467",57.0,YR,,M,Y,,,20231113,,HP,US,US,2023,Q4,Adult
231769221,23176922,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,,,,,,,,,,2023,Q4,Acute disseminated encephalomyelitis,,2023,Q4,1,I,20220801.0,20231030.0,20231113,20231113,EXP,,DE-SAMSUNG BIOEPIS-SB-2023-29639,SAMSUNG BIOEPIS,,57.0,YR,A,M,Y,,,20231113,,MD,DE,DE,2023,Q4,Adult
231769221,23176922,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,,,,,,,,,,2023,Q4,Brain oedema,,2023,Q4,1,I,20220801.0,20231030.0,20231113,20231113,EXP,,DE-SAMSUNG BIOEPIS-SB-2023-29639,SAMSUNG BIOEPIS,,57.0,YR,A,M,Y,,,20231113,,MD,DE,DE,2023,Q4,Adult
231773911,23177391,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw (1 mg, 1x/week)",,,U,U,,,,1.0,MG,Injection,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw (1 mg, 1x/week)",,,U,U,,,,1.0,MG,Injection,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw (1 mg, 1x/week)",,,U,U,,,,1.0,MG,Injection,/WK,2023,Q4,Loss of consciousness,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw (1 mg, 1x/week)",,,U,U,,,,1.0,MG,Injection,/WK,2023,Q4,Fatigue,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw (1 mg, 1x/week)",,,U,U,,,,1.0,MG,Injection,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, qw (0.25 mg, 1x/week)",,,U,U,,,,0.25,MG,Injection,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, qw (0.25 mg, 1x/week)",,,U,U,,,,0.25,MG,Injection,/WK,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, qw (0.25 mg, 1x/week)",,,U,U,,,,0.25,MG,Injection,/WK,2023,Q4,Loss of consciousness,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, qw (0.25 mg, 1x/week)",,,U,U,,,,0.25,MG,Injection,/WK,2023,Q4,Fatigue,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231773911,23177391,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, qw (0.25 mg, 1x/week)",,,U,U,,,,0.25,MG,Injection,/WK,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,,20231108.0,20231113,20231113,EXP,CA-HPFB-E2B_05830513,FR-MYLANLABS-2023M1119950,MYLAN,,70.0,YR,,F,Y,69.0,KG,20231113,,CN,FR,FR,2023,Q4,Elderly
231780101,23178010,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5046184,20240221.0,99.0,0.25,ML,,999,2023,Q4,Anxiety,,2023,Q4,1,I,20231110.0,,20231113,20231113,DIR,680863,,FDA-CTU,,54.0,YR,,F,N,,,20231113,N,HP,US,,2023,Q4,Adult
231780101,23178010,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,LG5046184,20240221.0,99.0,0.25,ML,,999,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,20231110.0,,20231113,20231113,DIR,680863,,FDA-CTU,,54.0,YR,,F,N,,,20231113,N,HP,US,,2023,Q4,Adult
231796962,23179696,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,0.25,MG,Injection,/WK,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231796962,23179696,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,0.25,MG,Injection,/WK,2023,Q4,Renal impairment,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231796962,23179696,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,0.25,MG,Injection,/WK,2023,Q4,Vomiting,,2023,Q4,2,F,20211001.0,20231121.0,20231114,20231201,EXP,,JP-EMD Serono-2023487217,EMD SERONO INC,,75.0,YR,E,M,Y,73.0,KG,20231201,,MD,JP,JP,2023,Q4,Elderly
231801921,23180192,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20231110.0,20231114,20231114,EXP,,CA-ROCHE-3456135,ROCHE,,75.0,YR,,F,Y,92.0,KG,20231114,,MD,CA,,2023,Q4,Elderly
231801921,23180192,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231110.0,20231114,20231114,EXP,,CA-ROCHE-3456135,ROCHE,,75.0,YR,,F,Y,92.0,KG,20231114,,MD,CA,,2023,Q4,Elderly
231804331,23180433,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231107.0,20231114,20231114,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-163434,BRISTOL MYERS SQUIBB,,62.0,YR,A,,Y,,,20231114,,MD,US,US,2023,Q4,Adult
231817961,23181796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Solution,,2023,Q4,Blood pressure systolic increased,,2023,Q4,1,I,,20231110.0,20231114,20231114,EXP,,CA-MYLANLABS-2023M1121334,MYLAN,,58.0,YR,,F,Y,120.0,KG,20231114,,HP,CA,CA,2023,Q4,Adult
231817961,23181796,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,Solution,,2023,Q4,Lung disorder,,2023,Q4,1,I,,20231110.0,20231114,20231114,EXP,,CA-MYLANLABS-2023M1121334,MYLAN,,58.0,YR,,F,Y,120.0,KG,20231114,,HP,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Blood cholesterol increased,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Transient ischaemic attack,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Hypertension,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231834971,23183497,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Memory impairment,,2023,Q4,1,I,,20231107.0,20231114,20231114,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202311003995,ELI LILLY AND CO,,47.0,YR,,F,Y,,,20231114,,CN,CA,CA,2023,Q4,Adult
231836771,23183677,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231101.0,20231114,20231114,EXP,,PL-B.Braun Medical Inc.-2148269,B BRAUN,"Woron J, Siwek M. Pancreatitis as a consequence of the association of sertraline with medicinal products used in ?the non-operative treatment of obesity. Psychopharmacology in practice. 2023;5:43-45.",29.0,YR,,M,Y,,,20231114,,MD,PL,PL,2023,Q4,Young Adult
231836771,23183677,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231101.0,20231114,20231114,EXP,,PL-B.Braun Medical Inc.-2148269,B BRAUN,"Woron J, Siwek M. Pancreatitis as a consequence of the association of sertraline with medicinal products used in ?the non-operative treatment of obesity. Psychopharmacology in practice. 2023;5:43-45.",29.0,YR,,M,Y,,,20231114,,MD,PL,PL,2023,Q4,Young Adult
231859941,23185994,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,for the first 2 weeks,,,U,,,,,0.25,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231106.0,20231115,20231115,EXP,,PL-LABORATORIOS LICONSA S.A.-2310PL07719,INSUD PHARMA,,29.0,YR,,M,Y,,,20231115,,MD,PL,PL,2023,Q4,Young Adult
231859941,23185994,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,1.0,MG,,,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231106.0,20231115,20231115,EXP,,PL-LABORATORIOS LICONSA S.A.-2310PL07719,INSUD PHARMA,,29.0,YR,,M,Y,,,20231115,,MD,PL,PL,2023,Q4,Young Adult
231906591,23190659,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,CA-MHPD-E2B_06551541,CA-Accord-389718,ACCORD,,58.0,YR,,M,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231906591,23190659,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q4,Joint effusion,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,CA-MHPD-E2B_06551541,CA-Accord-389718,ACCORD,,58.0,YR,,M,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231906591,23190659,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Poultice,,2023,Q4,Disease recurrence,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,CA-MHPD-E2B_06551541,CA-Accord-389718,ACCORD,,58.0,YR,,M,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231913561,23191356,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, 1/week",,,,,,,,1.0,MG,,/WK,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20230110.0,20231101.0,20231116,20231116,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-418040,RANBAXY,,61.0,YR,,M,Y,,,20231116,,MD,ES,ES,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920051,23192005,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946771,TEVA,,51.0,YR,A,F,Y,,,20231116,,MD,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231920661,23192066,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231106.0,20231116,20231116,EXP,,CA-TEVA-2023-CA-2946801,TEVA,,51.0,YR,A,F,Y,,,20231116,,HP,CA,CA,2023,Q4,Adult
231932001,23193200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Peripheral sensory neuropathy,,2023,Q4,1,I,20221129.0,,20231116,20231116,DIR,681370,,FDA-CTU,,66.0,YR,,F,N,90.9,KG,20231116,N,HP,US,,2023,Q4,Elderly
231932001,23193200,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Vitamin B12 increased,,2023,Q4,1,I,20221129.0,,20231116,20231116,DIR,681370,,FDA-CTU,,66.0,YR,,F,N,90.9,KG,20231116,N,HP,US,,2023,Q4,Elderly
231948311,23194831,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (for the first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231948311,23194831,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (for the first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Headache,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231948311,23194831,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (for the first 2 weeks)",,,Y,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231948311,23194831,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231948311,23194831,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Headache,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231948311,23194831,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram,,,Y,,,,,1.0,MG,,,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231107.0,20231117,20231117,EXP,,PL-AUROBINDO-AUR-APL-2023-068009,AUROBINDO,"Woron J, Siwek M.. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231117,,MD,PL,PL,2023,Q4,Young Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Sleep apnoea syndrome,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Abdominal discomfort,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Colectomy total,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Uveitis,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pouchitis,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthritis,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231955981,23195598,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Intestinal anastomosis,,2023,Q4,1,I,,20231106.0,20231117,20231117,EXP,CA-MHPD-E2B 06551027,CA-Accord-389606,ACCORD,,39.0,YR,A,M,Y,,,20231117,,HP,CA,CA,2023,Q4,Adult
231979871,23197987,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,,20231115.0,20231117,20231117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-165895,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,,,20231117,,CN,US,US,2023,Q4,Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Oesophageal pain,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Dyspepsia,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, Every Week (0.24 mg, per week, for the first 2 weeks)",,,,,,,,0.25,MG,,/WK,2023,Q4,Headache,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Oesophageal pain,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Gastrooesophageal reflux disease,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Dyspepsia,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232001081,23200108,8,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, Every Week",,,,,,,,1.0,MG,,/WK,2023,Q4,Headache,,2023,Q4,1,I,,20231108.0,20231118,20231118,EXP,,PL-AUROBINDO-AUR-APL-2023-068140,AUROBINDO,"Woro? J, Siwek M.. Pancreatitis as a consequence of associations of sertraline with products medicinal products used in the non-operative treatment of obesity.. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45",29.0,YR,,M,Y,,,20231118,,MD,PL,PL,2023,Q4,Young Adult
232026931,23202693,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, QW",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.25 mg, QW",,,U,,,,,1.25,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 mg, QW",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q4,Asthenia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 mg, QW",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 mg, QW",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 mg, QW",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232026931,23202693,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.5 mg, QW",,,U,,,,,1.5,MG,Solution for injection,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055157,SANDOZ,,48.0,YR,,M,Y,113.0,KG,20231120,,HP,CA,CA,2023,Q4,Adult
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Abdominal pain,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Dialysis,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041141,23204114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Lactic acidosis,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055150,SANDOZ,,75.0,YR,,F,Y,,,20231120,,PH,CA,CA,2023,Q4,Elderly
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Vision blurred,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Chest discomfort,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Chills,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Hypoaesthesia,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Head discomfort,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Dizziness,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232041821,23204182,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,99.0,,,,,2023,Q4,Tinnitus,,2023,Q4,1,I,20231105.0,,20231120,20231120,DIR,681827,,FDA-CTU,,29.0,YR,,F,N,90.0,KG,20231120,N,CN,US,,2023,Q4,Young Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232042281,23204228,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,Unknown,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-SANDOZ INC.-SDZ2023CA055141,SANDOZ,,51.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Staphylococcal bacteraemia,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthritis infective,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint debridement,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint irrigation,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Knee arthroplasty,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232067081,23206708,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Joint stiffness,,2023,Q4,1,I,,20231110.0,20231120,20231120,EXP,,CA-TEVA-2023-CA-2948547,TEVA,,63.0,YR,A,M,Y,129.0,KG,20231120,,PH,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,23,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232074531,23207453,24,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231117.0,20231120,20231120,EXP,,CA-SANDOZ INC.-NVSC2023CA026799,SANDOZ,,51.0,YR,,F,Y,,,20231120,,CN,CA,CA,2023,Q4,Adult
232076731,23207673,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2023,Q4,Off label use,,2023,Q4,1,I,,20231113.0,20231120,20231120,EXP,,JP-JNJFOC-20231144000,JOHNSON AND JOHNSON,"Masaaki MIYAKE, et al.; Department of Internal Medicine, Joetsu General Hospital. A case of obesity hypoventilation syndrome secondary to type 2 diabetes mellitus, which was treated with concomitant therapies of NPPV, SGLT2 inhibitor, and GLP-1 receptor agonist. Proceedings of the 153rd Shinetsu Regional Meeting of the Japanese Society of Internal Medicine; 2023.10.21; Niigata-shi, Niigata: 2023.",64.0,YR,A,F,Y,,,20231121,,MD,JP,JP,2023,Q4,Adult
232076731,23207673,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2023,Q4,Pickwickian syndrome,,2023,Q4,1,I,,20231113.0,20231120,20231120,EXP,,JP-JNJFOC-20231144000,JOHNSON AND JOHNSON,"Masaaki MIYAKE, et al.; Department of Internal Medicine, Joetsu General Hospital. A case of obesity hypoventilation syndrome secondary to type 2 diabetes mellitus, which was treated with concomitant therapies of NPPV, SGLT2 inhibitor, and GLP-1 receptor agonist. Proceedings of the 153rd Shinetsu Regional Meeting of the Japanese Society of Internal Medicine; 2023.10.21; Niigata-shi, Niigata: 2023.",64.0,YR,A,F,Y,,,20231121,,MD,JP,JP,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,18,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Asthma,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Wheezing,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232081971,23208197,19,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2023,Q4,Hypoacusis,,2023,Q4,1,I,,20231116.0,20231121,20231121,EXP,,CA-SANDOZ INC.-NVSC2022CA263463,SANDOZ,,51.0,YR,,F,Y,,,20231121,,CN,CA,CA,2023,Q4,Adult
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Blood alkaline phosphatase increased,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Alanine aminotransferase increased,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Palmar erythema,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Chromaturia,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Nausea,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Decreased appetite,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Faeces pale,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232128781,23212878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,2.0,MG,,QW,2023,Q4,Jaundice,,2023,Q4,1,I,20230927.0,,20231121,20231121,DIR,681957,,FDA-CTU,,70.0,YR,,F,N,102.0,KG,20231121,N,MD,US,,2023,Q4,Elderly
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Feeling abnormal,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Feeling of despair,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Mental disorder,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Prescribed overdose,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Therapy cessation,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Crying,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Movement disorder,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232142061,23214206,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,,,,,,2023,Q4,Panic attack,,2023,Q4,1,I,20231111.0,,20231121,20231121,DIR,681987,,FDA-CTU,,37.0,YR,,F,N,58.95,KG,20231121,N,CN,US,,2023,Q4,Adult
232196001,23219600,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q4,Blood pressure increased,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202311008431,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20231122,,CN,FI,FI,2023,Q4,Adult
232196001,23219600,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202311008431,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20231122,,CN,FI,FI,2023,Q4,Adult
232196001,23219600,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q4,Blood triglycerides increased,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202311008431,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20231122,,CN,FI,FI,2023,Q4,Adult
232196001,23219600,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q4,Swelling,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202311008431,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20231122,,CN,FI,FI,2023,Q4,Adult
232196001,23219600,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 dosage form, weekly (1/W)",,,,,,,,,,,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202311008431,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20231122,,CN,FI,FI,2023,Q4,Adult
232226041,23222604,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231108.0,20231123,20231123,EXP,,CA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-419794,RANBAXY,"Chaudhry A, Roels C, Lee J. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery. Can J Diab. 2022;46(8):843-850",70.0,YR,,M,Y,,,20231123,,MD,CA,CA,2023,Q4,Elderly
232245531,23224553,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,Y,,Unknown,,,,,,,2023,Q4,Lactic acidosis,,2023,Q4,1,I,,20221103.0,20231124,20231124,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2022-12641,ALKEM,"Halderman A.K, Kandarpa M.. AKI induced by oral semaglutide leading to metformin-induced lactic acidosis. Journal of the American Society of Nephrology. 2021;32:139",77.0,YR,,M,Y,,,20231124,,HP,US,US,2023,Q4,Elderly
232263151,23226315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Enteritis,,2023,Q4,1,I,20230724.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86050,,FDA-CTU,,75.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232263151,23226315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Intestinal obstruction,,2023,Q4,1,I,20230724.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86050,,FDA-CTU,,75.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232263151,23226315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Ileus,,2023,Q4,1,I,20230724.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86050,,FDA-CTU,,75.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232263151,23226315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Product quality issue,,2023,Q4,1,I,20230724.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86050,,FDA-CTU,,75.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232263151,23226315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Small intestinal obstruction,,2023,Q4,1,I,20230724.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86050,,FDA-CTU,,75.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232263161,23226316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWK SQ,,,,,,,,1.0,MG,,QW,2023,Q4,Pancreatitis acute,,2023,Q4,1,I,20220424.0,,20231121,20231121,DIR,FDA-CDER-CTU-2023-86051,,FDA-CTU,,66.0,YR,,M,N,,,20231114,N,HP,US,,2023,Q4,Elderly
232264281,23226428,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231120.0,20231124,20231124,EXP,,CA-PFIZER INC-202300385667,PFIZER,,49.0,YR,,F,Y,98.0,KG,20231124,,HP,CA,CA,2023,Q4,Adult
232264281,23226428,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Influenza A virus test positive,,2023,Q4,1,I,,20231120.0,20231124,20231124,EXP,,CA-PFIZER INC-202300385667,PFIZER,,49.0,YR,,F,Y,98.0,KG,20231124,,HP,CA,CA,2023,Q4,Adult
232284701,23228470,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, dosage form: not specified",,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20231120.0,20231125,20231125,EXP,,CA-BAXTER-2023BAX036478,BAXTER,,75.0,YR,,F,Y,92.0,KG,20231125,,MD,CA,CA,2023,Q4,Elderly
232284701,23228470,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, dosage form: not specified",,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231120.0,20231125,20231125,EXP,,CA-BAXTER-2023BAX036478,BAXTER,,75.0,YR,,F,Y,92.0,KG,20231125,,MD,CA,CA,2023,Q4,Elderly
232312351,23231235,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, qw",,,,,,,,0.25,MG,,/WK,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231120.0,20231127,20231127,EXP,,US-OTSUKA-2023_030442,OTSUKA,"Maini R, Milosavljevic J, Aleksic S. A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy. Journal of the Endocrine Society. 2023;7:A464",71.0,YR,,F,Y,,,20231127,,MD,US,US,2023,Q4,Elderly
232345582,23234558,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, unknown freq.",,,,,,,,0.25,MG,Formulation unknown,,2023,Q4,Renal tubular injury,,2023,Q4,2,F,,20231119.0,20231128,20231201,EXP,,US-ASTELLAS-2023EU004649,ASTELLAS,"Patel DB, Restrepo A, Kovvuru K, Velez JC, Kanduri SR.. A case of semaglutide-associated severe AKI in an immunocompromised patient. Journal of the American Society of Nephrology. 2023;34:426-7",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232345582,23234558,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, unknown freq.",,,,,,,,0.25,MG,Formulation unknown,,2023,Q4,Kidney fibrosis,,2023,Q4,2,F,,20231119.0,20231128,20231201,EXP,,US-ASTELLAS-2023EU004649,ASTELLAS,"Patel DB, Restrepo A, Kovvuru K, Velez JC, Kanduri SR.. A case of semaglutide-associated severe AKI in an immunocompromised patient. Journal of the American Society of Nephrology. 2023;34:426-7",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232345582,23234558,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,Formulation unknown,,2023,Q4,Renal tubular injury,,2023,Q4,2,F,,20231119.0,20231128,20231201,EXP,,US-ASTELLAS-2023EU004649,ASTELLAS,"Patel DB, Restrepo A, Kovvuru K, Velez JC, Kanduri SR.. A case of semaglutide-associated severe AKI in an immunocompromised patient. Journal of the American Society of Nephrology. 2023;34:426-7",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232345582,23234558,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,1.0,MG,Formulation unknown,,2023,Q4,Kidney fibrosis,,2023,Q4,2,F,,20231119.0,20231128,20231201,EXP,,US-ASTELLAS-2023EU004649,ASTELLAS,"Patel DB, Restrepo A, Kovvuru K, Velez JC, Kanduri SR.. A case of semaglutide-associated severe AKI in an immunocompromised patient. Journal of the American Society of Nephrology. 2023;34:426-7",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Therapy interrupted,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Constipation,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Labelled drug-drug interaction issue,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Gastrointestinal bacterial overgrowth,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Product use issue,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Intentional product use issue,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Insomnia,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Stress,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Nocturia,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Diverticulitis,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232346171,23234617,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Hunger,,2023,Q4,1,I,,20231117.0,20231128,20231128,EXP,CA-HEALTHCANVIG-06637063,CA-NOVOPROD-1143076,NOVO NORDISK,,62.0,YR,,F,Y,,,20231128,,CN,CA,CA,2023,Q4,Adult
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Pain,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Arthralgia,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Back pain,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Headache,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Feeling abnormal,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Abdominal pain,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232396291,23239629,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2023,Q4,Neck pain,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,FDA-CDER-CTU-2023-87067,,FDA-CTU,,82.0,YR,,F,N,101.7,KG,20231128,N,,US,,2023,Q4,Elderly
232401081,23240108,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : 1 time a week;?,,,N,D,,,99.0,,,,999,2023,Q4,Heart rate increased,,2023,Q4,1,I,20220810.0,,20231128,20231128,DIR,682629,,FDA-CTU,,49.0,YR,,F,N,89.1,KG,20231128,Y,CN,US,,2023,Q4,Adult
232401081,23240108,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : 1 time a week;?,,,N,D,,,99.0,,,,999,2023,Q4,Asthenia,,2023,Q4,1,I,20220810.0,,20231128,20231128,DIR,682629,,FDA-CTU,,49.0,YR,,F,N,89.1,KG,20231128,Y,CN,US,,2023,Q4,Adult
232401081,23240108,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER FREQUENCY : 1 time a week;?,,,N,D,,,99.0,,,,999,2023,Q4,Malaise,,2023,Q4,1,I,20220810.0,,20231128,20231128,DIR,682629,,FDA-CTU,,49.0,YR,,F,N,89.1,KG,20231128,Y,CN,US,,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Abnormal dreams,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Poor quality sleep,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Fluid retention,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Erythema,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dry skin,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pain,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Anxiety,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Fatigue,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,"Hallucination, auditory",,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Therapy cessation,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pruritus,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dyspepsia,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Depression,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Menopausal symptoms,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Somnolence,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Back pain,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Paraesthesia,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Disturbance in attention,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Tremor,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Feeling abnormal,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Illness,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Gastrointestinal sounds abnormal,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Arthritis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Weight increased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Lymphoedema,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Arteriosclerosis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Abdominal distension,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Neutrophil count decreased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Drug titration error,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nausea,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Haemoglobin decreased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Cough,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Breast cancer,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diffuse idiopathic skeletal hyperostosis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nocturia,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Breast pain,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nightmare,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dermatitis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Hypoaesthesia,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pain in extremity,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Headache,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Device related infection,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nervousness,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Rotator cuff syndrome,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Synovial cyst,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Oropharyngeal pain,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Flatulence,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Calcinosis,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Constipation,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Blood iron decreased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Serum ferritin decreased,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Skin exfoliation,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232435661,23243566,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Urinary retention,,2023,Q4,1,I,,20231121.0,20231130,20231130,EXP,,CA-APOTEX-2023AP016947,APOTEX,,62.0,YR,,F,Y,111.0,KG,20231130,,HP,CA,CA,2023,Q4,Adult
232484221,23248422,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,for the first 2 weeks,,,Y,,,,,0.25,MG,,,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232484221,23248422,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,for the first 2 weeks,,,Y,,,,,0.25,MG,,,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232484221,23248422,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,for the first 2 weeks,,,Y,,,,,0.25,MG,,,2023,Q4,Headache,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232484221,23248422,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,MG,,,2023,Q4,Oedematous pancreatitis,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232484221,23248422,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,MG,,,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232484221,23248422,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.0,MG,,,2023,Q4,Headache,,2023,Q4,1,I,,20231118.0,20231201,20231201,EXP,,PL-Accord-387655,ACCORD,"Woron J, Siwek M. Pancreatitis as a consequence of the combination of sertraline with medicinal products used in the non-surgical treatment of obesity. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2023;94(5):43-45.",29.0,YR,A,M,Y,,,20231130,,MD,PL,PL,2023,Q4,Young Adult
232486251,23248625,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Pancreatitis,,2023,Q4,1,I,,20231120.0,20231201,20231201,EXP,,US-NOVOPROD-1145614,NOVO NORDISK,"Marah Alsayed Hasan, MD. Acute Interstitial Nephritis- A Complication Of. Journal of the Endocrine Society. 2023;Volume 7:A387-A388",75.0,YR,,M,Y,,,20231201,,MD,US,US,2023,Q4,Elderly
232486251,23248625,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,209637.0,,,,,2023,Q4,Tubulointerstitial nephritis,,2023,Q4,1,I,,20231120.0,20231201,20231201,EXP,,US-NOVOPROD-1145614,NOVO NORDISK,"Marah Alsayed Hasan, MD. Acute Interstitial Nephritis- A Complication Of. Journal of the Endocrine Society. 2023;Volume 7:A387-A388",75.0,YR,,M,Y,,,20231201,,MD,US,US,2023,Q4,Elderly
232510651,23251065,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.25,MG,,/WK,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231120.0,20231201,20231201,EXP,,US-ABBVIE-5504757,ABBVIE,"Maini R, Milosavljevic J, Aleksic S. A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy. J Endocr Soc. 2023; 7(Suppl 1), A464-A464.",71.0,YR,,F,Y,,,20231201,,MD,US,US,2023,Q4,Elderly
232510651,23251065,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.25,MG,,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231120.0,20231201,20231201,EXP,,US-ABBVIE-5504757,ABBVIE,"Maini R, Milosavljevic J, Aleksic S. A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy. J Endocr Soc. 2023; 7(Suppl 1), A464-A464.",71.0,YR,,F,Y,,,20231201,,MD,US,US,2023,Q4,Elderly
232514841,23251484,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Unknown,/WK,2023,Q4,Off label use,,2023,Q4,1,I,,20231122.0,20231201,20231201,EXP,,US-MYLANLABS-2023M1126794,MYLAN,"Bomberg EM, Patel P, Bensignor MO, Fox CK. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc 2022; 6 (Suppl. 1) A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231201,,MD,US,US,2023,Q4,Youth
232514841,23251484,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Unknown,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231122.0,20231201,20231201,EXP,,US-MYLANLABS-2023M1126794,MYLAN,"Bomberg EM, Patel P, Bensignor MO, Fox CK. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc 2022; 6 (Suppl. 1) A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231201,,MD,US,US,2023,Q4,Youth
232514841,23251484,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Unknown,/WK,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231122.0,20231201,20231201,EXP,,US-MYLANLABS-2023M1126794,MYLAN,"Bomberg EM, Patel P, Bensignor MO, Fox CK. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc 2022; 6 (Suppl. 1) A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231201,,MD,US,US,2023,Q4,Youth
232522541,23252254,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Form Of Admin.: NOT SPECIFIED,,,,,,,,,,,,2023,Q4,Lower gastrointestinal haemorrhage,,2023,Q4,1,I,,20231127.0,20231201,20231201,EXP,,CA-FreseniusKabi-FK202319179,FRESENIUS KABI,,76.0,YR,E,M,Y,72.0,KG,20231201,,HP,CA,CA,2023,Q4,Elderly
232522541,23252254,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Form Of Admin.: NOT SPECIFIED,,,,,,,,,,,,2023,Q4,Diverticulitis intestinal haemorrhagic,,2023,Q4,1,I,,20231127.0,20231201,20231201,EXP,,CA-FreseniusKabi-FK202319179,FRESENIUS KABI,,76.0,YR,E,M,Y,72.0,KG,20231201,,HP,CA,CA,2023,Q4,Elderly
232525761,23252576,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 milligram (Initial dose),,,Y,U,,,,0.25,MG,Unknown,,2023,Q4,Kidney fibrosis,,2023,Q4,1,I,,20231123.0,20231201,20231201,EXP,,US-MYLANLABS-2023M1127095,MYLAN,"Patel DB, Restrepo A, Kovvuru K, Velez JCQ, Kanduri SR. A Case of Semaglutide-Associated Severe AKI in an Immunocompromised Patient. J-Am-Soc-Nephrol 2023; 34 426-427.",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232525761,23252576,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,Y,U,,,,1.0,MG,Unknown,,2023,Q4,Kidney fibrosis,,2023,Q4,1,I,,20231123.0,20231201,20231201,EXP,,US-MYLANLABS-2023M1127095,MYLAN,"Patel DB, Restrepo A, Kovvuru K, Velez JCQ, Kanduri SR. A Case of Semaglutide-Associated Severe AKI in an Immunocompromised Patient. J-Am-Soc-Nephrol 2023; 34 426-427.",61.0,YR,,F,Y,,,20231201,,HP,US,US,2023,Q4,Adult
232542261,23254226,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231120.0,20231202,20231202,EXP,CA-MHPD-E2B_06579479,CA-Accord-392468,ACCORD,,61.0,YR,A,F,Y,,,20231202,,HP,CA,CA,2023,Q4,Adult
232542261,23254226,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231120.0,20231202,20231202,EXP,CA-MHPD-E2B_06579479,CA-Accord-392468,ACCORD,,61.0,YR,A,F,Y,,,20231202,,HP,CA,CA,2023,Q4,Adult
232542261,23254226,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,,20231120.0,20231202,20231202,EXP,CA-MHPD-E2B_06579479,CA-Accord-392468,ACCORD,,61.0,YR,A,F,Y,,,20231202,,HP,CA,CA,2023,Q4,Adult
232542261,23254226,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20231120.0,20231202,20231202,EXP,CA-MHPD-E2B_06579479,CA-Accord-392468,ACCORD,,61.0,YR,A,F,Y,,,20231202,,HP,CA,CA,2023,Q4,Adult
232559361,23255936,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram weekly,,,U,U,,,,0.5,MG,,,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017810,STRIDES,"Bomberg EM, Patel P, Bensignor MO, Fox CK.. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc. 2022;6 (Suppl. 1):A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231204,,MD,US,US,2023,Q4,Youth
232559361,23255936,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram weekly,,,U,U,,,,0.5,MG,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017810,STRIDES,"Bomberg EM, Patel P, Bensignor MO, Fox CK.. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc. 2022;6 (Suppl. 1):A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231204,,MD,US,US,2023,Q4,Youth
232559361,23255936,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram weekly,,,U,U,,,,0.5,MG,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017810,STRIDES,"Bomberg EM, Patel P, Bensignor MO, Fox CK.. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc. 2022;6 (Suppl. 1):A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231204,,MD,US,US,2023,Q4,Youth
232559361,23255936,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram weekly,,,U,U,,,,0.5,MG,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017810,STRIDES,"Bomberg EM, Patel P, Bensignor MO, Fox CK.. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. J-Endocr-Soc. 2022;6 (Suppl. 1):A24-A25 abstr. PSUN124.",23.0,YR,,M,Y,291.6,KG,20231204,,MD,US,US,2023,Q4,Youth
232572261,23257226,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 milligram; Initial dose,,,,,,,,0.25,MG,,,2023,Q4,Kidney fibrosis,,2023,Q4,1,I,,20231123.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017927,STRIDES,"Patel DB, Restrepo A, Kovvuru K, Velez JCQ, Kanduri SR.. A Case of Semaglutide-Associated Severe AKI in an Immunocompromised Patient.. J-Am-Soc-Nephrol.. 2023;34:426-427.",61.0,YR,,F,Y,,,20231204,,HP,US,US,2023,Q4,Adult
232572261,23257226,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram,,,,,,,,1.0,MG,,,2023,Q4,Kidney fibrosis,,2023,Q4,1,I,,20231123.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017927,STRIDES,"Patel DB, Restrepo A, Kovvuru K, Velez JCQ, Kanduri SR.. A Case of Semaglutide-Associated Severe AKI in an Immunocompromised Patient.. J-Am-Soc-Nephrol.. 2023;34:426-427.",61.0,YR,,F,Y,,,20231204,,HP,US,US,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nausea,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Hunger,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Constipation,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Intentional product use issue,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Nocturia,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Insomnia,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Product use issue,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Gastrointestinal bacterial overgrowth,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Therapy interrupted,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diverticulitis,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Labelled drug-drug interaction issue,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Stress,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232573151,23257315,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231121.0,20231204,20231204,EXP,,CA-APOTEX-2023AP016950,APOTEX,,62.0,YR,,F,Y,,,20231204,,HP,CA,CA,2023,Q4,Adult
232574961,23257496,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,UNKNOWN,,,0.5,MG,,/WK,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-drreddys-LIT/USA/23/0187610,DR REDDYS,"Bomberg E, Patel P, Bensignor M, Fox C. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. Journal of the Endocrine Society. 2022;6 (SUPPL. 1):A24-25. doi:10.1210/jendso/bvac150.051",23.0,YR,A,M,Y,,,20231204,,HP,US,US,2023,Q4,Youth
232574961,23257496,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,UNKNOWN,,,0.5,MG,,/WK,2023,Q4,Drug interaction,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-drreddys-LIT/USA/23/0187610,DR REDDYS,"Bomberg E, Patel P, Bensignor M, Fox C. Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric Surgery. Journal of the Endocrine Society. 2022;6 (SUPPL. 1):A24-25. doi:10.1210/jendso/bvac150.051",23.0,YR,A,M,Y,,,20231204,,HP,US,US,2023,Q4,Youth
232588911,23258891,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Palpitations,,2023,Q4,1,I,20230710.0,,20231201,20231201,DIR,FDA-CDER-CTU-2023-88431,,FDA-CTU,,49.0,YR,,F,N,65.77,KG,20231201,N,CN,US,,2023,Q4,Adult
232588911,23258891,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,20230710.0,,20231201,20231201,DIR,FDA-CDER-CTU-2023-88431,,FDA-CTU,,49.0,YR,,F,N,65.77,KG,20231201,N,CN,US,,2023,Q4,Adult
232588911,23258891,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,20230710.0,,20231201,20231201,DIR,FDA-CDER-CTU-2023-88431,,FDA-CTU,,49.0,YR,,F,N,65.77,KG,20231201,N,CN,US,,2023,Q4,Adult
232617401,23261740,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 0.25 Mg, Solution for injection in pre-filled pen",,,,,,,,,,,,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,20231014.0,20231123.0,20231205,20231205,EXP,SE-SEMPA-2023-015335,SE-Accord-393144,ACCORD,,57.0,YR,A,M,Y,,,20231205,,MD,SE,SE,2023,Q4,Adult
232633361,23263336,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Alopecia,,2023,Q4,1,I,20231201.0,20231204.0,20231204,20231204,DIR,683314,,FDA-CTU,,62.0,YR,,M,N,103.5,KG,20231204,N,CN,US,,2023,Q4,Adult
232639241,23263924,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Therapy cessation,,2023,Q4,1,I,20230415.0,20231122.0,20231205,20231205,DIR,FDA-CDER-CTU-2023-88858,,FDA-CTU,,61.0,YR,,M,N,,,20231122,N,PH,US,,2023,Q4,Adult
232639241,23263924,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2023,Q4,Pancreatitis,,2023,Q4,1,I,20230415.0,20231122.0,20231205,20231205,DIR,FDA-CDER-CTU-2023-88858,,FDA-CTU,,61.0,YR,,M,N,,,20231122,N,PH,US,,2023,Q4,Adult
232652261,23265226,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,Y,,,,209637.0,,,,,2023,Q4,Counterfeit product administered,,2023,Q4,1,I,,20231128.0,20231206,20231206,EXP,,US-NOVOPROD-1146329,NOVO NORDISK,,32.0,YR,,F,Y,,,20231206,,MD,US,US,2023,Q4,Young Adult
232652261,23265226,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,Y,,,,209637.0,,,,,2023,Q4,Benign pancreatic neoplasm,,2023,Q4,1,I,,20231128.0,20231206,20231206,EXP,,US-NOVOPROD-1146329,NOVO NORDISK,,32.0,YR,,F,Y,,,20231206,,MD,US,US,2023,Q4,Young Adult
232674121,23267412,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : Units (Int^l?);?OTHER FREQUENCY : Once a week;?,,,,,,,99.0,,,,999,2023,Q4,Personal relationship issue,,2023,Q4,1,I,20230909.0,20231205.0,20231205,20231205,DIR,683503,,FDA-CTU,,53.0,YR,,F,N,104.85,KG,20231205,N,CN,US,,2023,Q4,Adult
232674121,23267412,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : Units (Int^l?);?OTHER FREQUENCY : Once a week;?,,,,,,,99.0,,,,999,2023,Q4,Mood altered,,2023,Q4,1,I,20230909.0,20231205.0,20231205,20231205,DIR,683503,,FDA-CTU,,53.0,YR,,F,N,104.85,KG,20231205,N,CN,US,,2023,Q4,Adult
232674121,23267412,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER STRENGTH : Units (Int^l?);?OTHER FREQUENCY : Once a week;?,,,,,,,99.0,,,,999,2023,Q4,Mental disorder,,2023,Q4,1,I,20230909.0,20231205.0,20231205,20231205,DIR,683503,,FDA-CTU,,53.0,YR,,F,N,104.85,KG,20231205,N,CN,US,,2023,Q4,Adult
232676221,23267622,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,U,,,,,,Solution for injection,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231201.0,20231206,20231206,EXP,,CA-MYLANLABS-2023M1129181,MYLAN,,43.0,YR,,F,Y,,,20231206,,HP,CA,CA,2023,Q4,Adult
232676221,23267622,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,U,,,,,,Solution for injection,,2023,Q4,Subcutaneous abscess,,2023,Q4,1,I,,20231201.0,20231206,20231206,EXP,,CA-MYLANLABS-2023M1129181,MYLAN,,43.0,YR,,F,Y,,,20231206,,HP,CA,CA,2023,Q4,Adult
232676221,23267622,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,U,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231201.0,20231206,20231206,EXP,,CA-MYLANLABS-2023M1129181,MYLAN,,43.0,YR,,F,Y,,,20231206,,HP,CA,CA,2023,Q4,Adult
232676221,23267622,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,U,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231201.0,20231206,20231206,EXP,,CA-MYLANLABS-2023M1129181,MYLAN,,43.0,YR,,F,Y,,,20231206,,HP,CA,CA,2023,Q4,Adult
232676221,23267622,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,U,,,,,,Solution for injection,,2023,Q4,Groin abscess,,2023,Q4,1,I,,20231201.0,20231206,20231206,EXP,,CA-MYLANLABS-2023M1129181,MYLAN,,43.0,YR,,F,Y,,,20231206,,HP,CA,CA,2023,Q4,Adult
232708771,23270877,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous-dosage form,,,U,,Unknown,,,,,Solution for injection,,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232708771,23270877,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous-dosage form,,,U,,Unknown,,,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232708771,23270877,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,0.5,MG,Solution for injection,/WK,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232708771,23270877,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,0.5,MG,Solution for injection,/WK,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232723981,23272398,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2023,Q4,Proteinuria,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232723981,23272398,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2023,Q4,Focal segmental glomerulosclerosis,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232723981,23272398,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, Weekly",,,U,,,,,1.0,MG,,,2023,Q4,Proteinuria,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232723981,23272398,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, Weekly",,,U,,,,,1.0,MG,,,2023,Q4,Focal segmental glomerulosclerosis,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232723981,23272398,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 milligram, Weekly",,,U,,,,,2.0,MG,,,2023,Q4,Proteinuria,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232723981,23272398,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 milligram, Weekly",,,U,,,,,2.0,MG,,,2023,Q4,Focal segmental glomerulosclerosis,,2023,Q4,1,I,,20231122.0,20231207,20231207,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-422249,RANBAXY,"Khan J, Juncos LA, Ali U, Bukhari SW, Khalid M, Khan N. Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS). J Am Soc Nephrol. 2023;34:247/TH-PO564",55.0,YR,,F,Y,,,20231207,,HP,US,US,2023,Q4,Adult
232728531,23272853,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : 1x week;?,,,N,D,,,99.0,,,,999,2023,Q4,Intestinal obstruction,,2023,Q4,1,I,20230923.0,20231206.0,20231206,20231206,DIR,683661,,FDA-CTU,,56.0,YR,,F,N,76.5,KG,20231206,N,CN,US,,2023,Q4,Adult
232728531,23272853,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : 1x week;?,,,N,D,,,99.0,,,,999,2023,Q4,Post procedural complication,,2023,Q4,1,I,20230923.0,20231206.0,20231206,20231206,DIR,683661,,FDA-CTU,,56.0,YR,,F,N,76.5,KG,20231206,N,CN,US,,2023,Q4,Adult
232728531,23272853,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : 1x week;?,,,N,D,,,99.0,,,,999,2023,Q4,Product compounding quality issue,,2023,Q4,1,I,20230923.0,20231206.0,20231206,20231206,DIR,683661,,FDA-CTU,,56.0,YR,,F,N,76.5,KG,20231206,N,CN,US,,2023,Q4,Adult
232728531,23272853,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : 1x week;?,,,N,D,,,99.0,,,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20230923.0,20231206.0,20231206,20231206,DIR,683661,,FDA-CTU,,56.0,YR,,F,N,76.5,KG,20231206,N,CN,US,,2023,Q4,Adult
232805771,23280577,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,,,,,,0.5,MG,,,2023,Q4,Product use issue,,2023,Q4,1,I,,20230301.0,20231211,20231211,EXP,,CA-SANDOZ INC.-SDZ2023CA066093,SANDOZ,,32.0,YR,,F,Y,,,20231211,,CN,CA,CA,2023,Q4,Young Adult
232805771,23280577,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,,,,,,0.5,MG,,,2023,Q4,Bronchiolitis,,2023,Q4,1,I,,20230301.0,20231211,20231211,EXP,,CA-SANDOZ INC.-SDZ2023CA066093,SANDOZ,,32.0,YR,,F,Y,,,20231211,,CN,CA,CA,2023,Q4,Young Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Stress,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Asthma,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressed mood,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Insomnia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Pyrexia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Angina pectoris,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Injury,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Nasal congestion,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Influenza,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Appetite disorder,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Wheezing,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Fall,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Flank pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Productive cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Weight decreased,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Malaise,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Depressive symptom,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Heart sounds,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Chest discomfort,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2023,Q4,Rales,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Stress,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Asthma,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressed mood,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Insomnia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Pyrexia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Angina pectoris,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Injury,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasal congestion,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Influenza,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Appetite disorder,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Wheezing,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Fall,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Flank pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Productive cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Weight decreased,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Malaise,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressive symptom,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Heart sounds,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest discomfort,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rales,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Stress,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Asthma,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressed mood,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Insomnia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Prolonged expiration,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Pyrexia,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Angina pectoris,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Injury,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Nasal congestion,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Respiration abnormal,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Influenza,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Appetite disorder,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Wheezing,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Fall,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Flank pain,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Productive cough,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Weight decreased,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Malaise,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Depressive symptom,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Heart sounds,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Chest discomfort,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232812472,23281247,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2023,Q4,Rales,,2023,Q4,2,F,,20220922.0,20231211,20231218,EXP,,CA-SANDOZ INC.-NVSC2020CA111078,SANDOZ,,61.0,YR,,F,Y,,,20231218,,CN,CA,CA,2023,Q4,Adult
232863131,23286313,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,20.0,MG,,/WK,2023,Q4,Diarrhoea,,2023,Q4,1,I,20231112.0,20231130.0,20231212,20231212,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-175496,BRISTOL MYERS SQUIBB,,41.0,YR,A,M,Y,90.72,KG,20231212,,CN,US,US,2023,Q4,Adult
232863131,23286313,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,20.0,MG,,/WK,2023,Q4,Dyschezia,,2023,Q4,1,I,20231112.0,20231130.0,20231212,20231212,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-175496,BRISTOL MYERS SQUIBB,,41.0,YR,A,M,Y,90.72,KG,20231212,,CN,US,US,2023,Q4,Adult
232868271,23286827,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?,,,Y,Y,N/a,20231226.0,99.0,,,Injection,,2023,Q4,Cystitis,,2023,Q4,1,I,20230301.0,20231209.0,20231209,20231209,DIR,684029,,FDA-CTU,,54.0,YR,,F,N,67.5,KG,20231209,N,CN,US,,2023,Q4,Adult
232868271,23286827,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1 Injection(s);?,,,Y,Y,N/a,20231226.0,99.0,,,Injection,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20230301.0,20231209.0,20231209,20231209,DIR,684029,,FDA-CTU,,54.0,YR,,F,N,67.5,KG,20231209,N,CN,US,,2023,Q4,Adult
232891111,23289111,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.25,MG,,/WK,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231204.0,20231212,20231212,EXP,,US-MEITHEAL-2023MPLIT00190,MEITHEAL PHARMACEUTICALS,"Maini R, et al.A Case Of Diabetic Ketoacidosis After Initiation Of Decitabine And Venetoclax Chemotherapy.Journal of the Endocrine Society.05-oct-2023;7 (1):A464",71.0,YR,E,F,Y,,,20231212,,HP,US,US,2023,Q4,Elderly
232902091,23290209,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2023,Q4,Necrotising myositis,,2023,Q4,1,I,,20231204.0,20231213,20231213,EXP,,PK-Umedica-000462,UMEDICA LABS,"Altaf F, Bhatt V, Qasim A, Qureshi ZA, Rajan V, Moore S, Elkin R. Necrotizing Autoimmune Myopathy: A Case Report on Statin-Induced Rhabdomyolysis. Cureus. 2023 Nov 19;15(11):e49065. doi: 10.7759/cureus.49065. PMID: 38024077; PMCID: PMC10660882.",42.0,YR,A,F,Y,,,20231208,,HP,PK,,2023,Q4,Adult
232930591,23293059,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232930591,23293059,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232930591,23293059,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232930591,23293059,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232930591,23293059,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232930591,23293059,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231207.0,20231213,20231213,EXP,,CA-PFIZER INC-202300439764,PFIZER,,43.0,YR,,F,Y,,,20231213,,HP,CA,CA,2023,Q4,Adult
232939841,23293984,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231213.0,20231213,20231213,EXP,,NL-SANDOZ INC.-SDZ2023NL067741,SANDOZ,,55.0,YR,,F,Y,125.0,KG,20231213,,HP,NL,NL,2023,Q4,Adult
232939841,23293984,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,,20231213.0,20231213,20231213,EXP,,NL-SANDOZ INC.-SDZ2023NL067741,SANDOZ,,55.0,YR,,F,Y,125.0,KG,20231213,,HP,NL,NL,2023,Q4,Adult
232939841,23293984,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (420 mg or 3.4 mg/ kg),,,D,,,,,,,Tablet,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20231213.0,20231213,20231213,EXP,,NL-SANDOZ INC.-SDZ2023NL067741,SANDOZ,,55.0,YR,,F,Y,125.0,KG,20231213,,HP,NL,NL,2023,Q4,Adult
232959551,23295955,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dizziness postural,,2023,Q4,1,I,20231213.0,20231213.0,20231213,20231213,DIR,684525,,FDA-CTU,,54.0,YR,,F,N,98.0,KG,20231213,N,MD,US,,2023,Q4,Adult
232959551,23295955,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyskinesia,,2023,Q4,1,I,20231213.0,20231213.0,20231213,20231213,DIR,684525,,FDA-CTU,,54.0,YR,,F,N,98.0,KG,20231213,N,MD,US,,2023,Q4,Adult
232959551,23295955,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Staring,,2023,Q4,1,I,20231213.0,20231213.0,20231213,20231213,DIR,684525,,FDA-CTU,,54.0,YR,,F,N,98.0,KG,20231213,N,MD,US,,2023,Q4,Adult
232959551,23295955,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Muscle twitching,,2023,Q4,1,I,20231213.0,20231213.0,20231213,20231213,DIR,684525,,FDA-CTU,,54.0,YR,,F,N,98.0,KG,20231213,N,MD,US,,2023,Q4,Adult
232979381,23297938,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Heart rate increased,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Myalgia,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Visual impairment,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,,,2023,Q4,Heart rate increased,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,,,2023,Q4,Myalgia,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,,,2023,Q4,Visual impairment,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979381,23297938,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION?SUBCUTANEOUS,,,U,,,,,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018469,BAUSCH AND LOMB,,46.0,YR,,F,Y,79.0,KG,20231214,,CN,CA,CA,2023,Q4,Adult
232979391,23297939,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232979391,23297939,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232979391,23297939,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232979391,23297939,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232984901,23298490,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets g (420 mg or 3.4 mg/ ?kg),,,D,,,,,14.0,MG,Tablet,,2023,Q4,Distributive shock,,2023,Q4,1,I,,20231206.0,20231214,20231214,EXP,,NL-Harman-000040,HARMAN FINOCHEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144. doi: 10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,,,20231211,,MD,NL,,2023,Q4,Adult
232984901,23298490,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets g (420 mg or 3.4 mg/ ?kg),,,D,,,,,14.0,MG,Tablet,,2023,Q4,Metabolic acidosis,,2023,Q4,1,I,,20231206.0,20231214,20231214,EXP,,NL-Harman-000040,HARMAN FINOCHEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144. doi: 10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,,,20231211,,MD,NL,,2023,Q4,Adult
232984901,23298490,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets g (420 mg or 3.4 mg/ ?kg),,,D,,,,,14.0,MG,Tablet,,2023,Q4,Hyperlactacidaemia,,2023,Q4,1,I,,20231206.0,20231214,20231214,EXP,,NL-Harman-000040,HARMAN FINOCHEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144. doi: 10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,,,20231211,,MD,NL,,2023,Q4,Adult
232984901,23298490,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets g (420 mg or 3.4 mg/ ?kg),,,D,,,,,14.0,MG,Tablet,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231206.0,20231214,20231214,EXP,,NL-Harman-000040,HARMAN FINOCHEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144. doi: 10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,,,20231211,,MD,NL,,2023,Q4,Adult
232984901,23298490,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,30 tablets g (420 mg or 3.4 mg/ ?kg),,,D,,,,,14.0,MG,Tablet,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20231206.0,20231214,20231214,EXP,,NL-Harman-000040,HARMAN FINOCHEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report. Toxicol Rep. 2023 Jul 17;11:141-144. doi: 10.1016/j.toxrep.2023.07.005",55.0,YR,,F,Y,,,20231211,,MD,NL,,2023,Q4,Adult
233006461,23300646,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Myalgia,,2023,Q4,1,I,,20231211.0,20231215,20231215,EXP,,NVSC2023CA263915,NOVARTIS,,63.0,YR,,M,Y,,,20231215,,CN,CA,CA,2023,Q4,Adult
233006461,23300646,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Headache,,2023,Q4,1,I,,20231211.0,20231215,20231215,EXP,,NVSC2023CA263915,NOVARTIS,,63.0,YR,,M,Y,,,20231215,,CN,CA,CA,2023,Q4,Adult
233006461,23300646,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Decreased appetite,,2023,Q4,1,I,,20231211.0,20231215,20231215,EXP,,NVSC2023CA263915,NOVARTIS,,63.0,YR,,M,Y,,,20231215,,CN,CA,CA,2023,Q4,Adult
233006461,23300646,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231211.0,20231215,20231215,EXP,,NVSC2023CA263915,NOVARTIS,,63.0,YR,,M,Y,,,20231215,,CN,CA,CA,2023,Q4,Adult
233006461,23300646,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, QW",,,U,,,,,1.0,MG,Solution,/WK,2023,Q4,Neoplasm progression,,2023,Q4,1,I,,20231211.0,20231215,20231215,EXP,,NVSC2023CA263915,NOVARTIS,,63.0,YR,,M,Y,,,20231215,,CN,CA,CA,2023,Q4,Adult
233041121,23304112,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,US-AUROBINDO-AUR-APL-2023-078310,AUROBINDO,"Hasan MA, Doroshow J. Acute Interstitial Nephritis- A Complication Of Semaglutide Use.. J-Endocr-Soc 2023;7. 2023;7 (Suppl. 1):A387-A388",75.0,YR,,M,Y,,,20231216,,MD,US,US,2023,Q4,Elderly
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Fluid intake reduced,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Counterfeit product administered,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Plastic surgery,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Muscle atrophy,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Intestinal obstruction,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233056591,23305659,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,209637.0,,,,,2023,Q4,Illness anxiety disorder,,2023,Q4,1,I,20220101.0,20231205.0,20231218,20231218,EXP,,US-NOVOPROD-1150315,NOVO NORDISK,,55.0,YR,,F,Y,,,20231214,,CN,US,US,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Toxicity to various agents,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Lactic acidosis,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Distributive shock,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Overdose,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,D,,Unknown,,,14.0,MG,,,2023,Q4,Suicide attempt,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Toxicity to various agents,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Lactic acidosis,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Distributive shock,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Overdose,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 milligram,,,D,,Unknown,,,420.0,MG,,,2023,Q4,Suicide attempt,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Toxicity to various agents,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Lactic acidosis,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Distributive shock,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Overdose,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3.4 milligram/kilogram,,,D,,Unknown,,,3.4,MG/KG,,,2023,Q4,Suicide attempt,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Toxicity to various agents,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Aspartate aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Lactic acidosis,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Distributive shock,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Overdose,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Alanine aminotransferase increased,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063042,23306304,16,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"30 dosage form, (30 tablets)",,,D,,Unknown,,,,,,,2023,Q4,Suicide attempt,,2023,Q4,2,F,,20231212.0,20231218,20231227,EXP,,NL-ALKEM LABORATORIES LIMITED-NL-ALKEM-2023-15612,ALKEM,"Workum JD, Keyany A, Jaspers TCC. Methylene blue as treatment for vasoplegic shock in severe Metformin overdose: A case report. Toxicology Reports. 2023;11:141-144",55.0,YR,,F,Y,125.0,KG,20231227,,HP,NL,NL,2023,Q4,Adult
233063851,23306385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (3.4 mg/kg),,,D,,,,,420.0,MG,Tablet,,2023,Q4,Overdose,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,NL-AJANTA-2023AJA00269,AJANTA PHARMA,"Workum JD, Keyany A, Jaspers TCC..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report..Toxicology Reports.17-JUL-2023;11:141-144",55.0,YR,A,F,Y,125.0,KG,20231218,,HP,NL,NL,2023,Q4,Adult
233063851,23306385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (3.4 mg/kg),,,D,,,,,420.0,MG,Tablet,,2023,Q4,Distributive shock,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,NL-AJANTA-2023AJA00269,AJANTA PHARMA,"Workum JD, Keyany A, Jaspers TCC..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report..Toxicology Reports.17-JUL-2023;11:141-144",55.0,YR,A,F,Y,125.0,KG,20231218,,HP,NL,NL,2023,Q4,Adult
233063851,23306385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (3.4 mg/kg),,,D,,,,,420.0,MG,Tablet,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,NL-AJANTA-2023AJA00269,AJANTA PHARMA,"Workum JD, Keyany A, Jaspers TCC..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report..Toxicology Reports.17-JUL-2023;11:141-144",55.0,YR,A,F,Y,125.0,KG,20231218,,HP,NL,NL,2023,Q4,Adult
233063851,23306385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (3.4 mg/kg),,,D,,,,,420.0,MG,Tablet,,2023,Q4,Lactic acidosis,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,NL-AJANTA-2023AJA00269,AJANTA PHARMA,"Workum JD, Keyany A, Jaspers TCC..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report..Toxicology Reports.17-JUL-2023;11:141-144",55.0,YR,A,F,Y,125.0,KG,20231218,,HP,NL,NL,2023,Q4,Adult
233063851,23306385,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,30 tablets (3.4 mg/kg),,,D,,,,,420.0,MG,Tablet,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,,20231204.0,20231218,20231218,EXP,,NL-AJANTA-2023AJA00269,AJANTA PHARMA,"Workum JD, Keyany A, Jaspers TCC..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report..Toxicology Reports.17-JUL-2023;11:141-144",55.0,YR,A,F,Y,125.0,KG,20231218,,HP,NL,NL,2023,Q4,Adult
233067441,23306744,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,1,I,20230821.0,20230821.0,20231218,20231218,PER,,US-RECKITT BENCKISER HEALTHCARE INT LIMITED-RB-105198-2023,RECKITT BENCKISER,,29.0,YR,,F,Y,,,20231218,,CN,US,US,2023,Q4,Young Adult
233067441,23306744,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown,,,U,,,,,,,,,2023,Q4,Accidental overdose,,2023,Q4,1,I,20230821.0,20230821.0,20231218,20231218,PER,,US-RECKITT BENCKISER HEALTHCARE INT LIMITED-RB-105198-2023,RECKITT BENCKISER,,29.0,YR,,F,Y,,,20231218,,CN,US,US,2023,Q4,Young Adult
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Decreased appetite,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Hypocalcaemia,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Hypokalaemia,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Vomiting,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Hyponatraemia,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233068721,23306872,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw(0.5 mg 1 bottle subcutaneously per week)",4.278,MG,Y,,,,209637.0,0.5,MG,,/WK,2023,Q4,Hypomagnesaemia,,2023,Q4,1,I,20231101.0,20231207.0,20231218,20231218,EXP,IT-MINISAL02-958928,IT-NOVOPROD-1150904,NOVO NORDISK,,73.0,YR,,F,Y,71.0,KG,20231218,,MD,IT,IT,2023,Q4,Elderly
233087961,23308796,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,20240217.0,,,,,,2023,Q4,Depression,,2023,Q4,1,I,20231211.0,20231217.0,20231217,20231217,DIR,684838,,FDA-CTU,,36.0,YR,,F,N,120.6,KG,20231217,N,CN,US,,2023,Q4,Adult
233087961,23308796,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,20240217.0,,,,,,2023,Q4,Eating disorder,,2023,Q4,1,I,20231211.0,20231217.0,20231217,20231217,DIR,684838,,FDA-CTU,,36.0,YR,,F,N,120.6,KG,20231217,N,CN,US,,2023,Q4,Adult
233087961,23308796,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,20240217.0,,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20231211.0,20231217.0,20231217,20231217,DIR,684838,,FDA-CTU,,36.0,YR,,F,N,120.6,KG,20231217,N,CN,US,,2023,Q4,Adult
233087961,23308796,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,20240217.0,,,,,,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,20231211.0,20231217.0,20231217,20231217,DIR,684838,,FDA-CTU,,36.0,YR,,F,N,120.6,KG,20231217,N,CN,US,,2023,Q4,Adult
233087971,23308797,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Influenza,,2023,Q4,1,I,20231110.0,20231217.0,20231217,20231217,DIR,684824,,FDA-CTU,,47.0,YR,,F,N,78.3,KG,20231217,N,CN,US,,2023,Q4,Adult
233087971,23308797,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Sensitive skin,,2023,Q4,1,I,20231110.0,20231217.0,20231217,20231217,DIR,684824,,FDA-CTU,,47.0,YR,,F,N,78.3,KG,20231217,N,CN,US,,2023,Q4,Adult
233087971,23308797,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Pain of skin,,2023,Q4,1,I,20231110.0,20231217.0,20231217,20231217,DIR,684824,,FDA-CTU,,47.0,YR,,F,N,78.3,KG,20231217,N,CN,US,,2023,Q4,Adult
233090021,23309002,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,,,,,,0.5,MG,Injection,/WK,2023,Q4,Treatment failure,,2023,Q4,1,I,,20231214.0,20231218,20231218,EXP,,CA-MYLANLABS-2023M1134340,MYLAN,lentente de pratique avancee en partenariat avec les pharmaciens: un outil precieeux pour les GMF. Profession Sante. 2023;9:26,72.0,YR,,,Y,,,20231218,,HP,CA,CA,2023,Q4,Elderly
233090021,23309002,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,,,,,,0.5,MG,Injection,/WK,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,1,I,,20231214.0,20231218,20231218,EXP,,CA-MYLANLABS-2023M1134340,MYLAN,lentente de pratique avancee en partenariat avec les pharmaciens: un outil precieeux pour les GMF. Profession Sante. 2023;9:26,72.0,YR,,,Y,,,20231218,,HP,CA,CA,2023,Q4,Elderly
233090021,23309002,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,,,,,,0.5,MG,Injection,/WK,2023,Q4,Dizziness,,2023,Q4,1,I,,20231214.0,20231218,20231218,EXP,,CA-MYLANLABS-2023M1134340,MYLAN,lentente de pratique avancee en partenariat avec les pharmaciens: un outil precieeux pour les GMF. Profession Sante. 2023;9:26,72.0,YR,,,Y,,,20231218,,HP,CA,CA,2023,Q4,Elderly
233100801,23310080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,99.0,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231218.0,20231218,20231218,DIR,684859,,FDA-CTU,,35.0,YR,,F,N,60.75,KG,20231218,N,CN,US,,2023,Q4,Adult
233100801,23310080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,99.0,,,,,2023,Q4,Product communication issue,,2023,Q4,1,I,,20231218.0,20231218,20231218,DIR,684859,,FDA-CTU,,35.0,YR,,F,N,60.75,KG,20231218,N,CN,US,,2023,Q4,Adult
233100801,23310080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,99.0,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231218.0,20231218,20231218,DIR,684859,,FDA-CTU,,35.0,YR,,F,N,60.75,KG,20231218,N,CN,US,,2023,Q4,Adult
233100801,23310080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,99.0,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20231218.0,20231218,20231218,DIR,684859,,FDA-CTU,,35.0,YR,,F,N,60.75,KG,20231218,N,CN,US,,2023,Q4,Adult
233100801,23310080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,Y,,,99.0,,,,,2023,Q4,Flatulence,,2023,Q4,1,I,,20231218.0,20231218,20231218,DIR,684859,,FDA-CTU,,35.0,YR,,F,N,60.75,KG,20231218,N,CN,US,,2023,Q4,Adult
233115621,23311562,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-JNJFOC-20231235704,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,127.0,KG,20231219,,HP,CA,CA,2023,Q4,Elderly
233115621,23311562,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q4,Fatigue,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-JNJFOC-20231235704,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,127.0,KG,20231219,,HP,CA,CA,2023,Q4,Elderly
233115621,23311562,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q4,Streptococcus test positive,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-JNJFOC-20231235704,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,127.0,KG,20231219,,HP,CA,CA,2023,Q4,Elderly
233115621,23311562,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q4,Bradycardia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-JNJFOC-20231235704,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,127.0,KG,20231219,,HP,CA,CA,2023,Q4,Elderly
233115621,23311562,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,Solution,,2023,Q4,Flank pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-JNJFOC-20231235704,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,127.0,KG,20231219,,HP,CA,CA,2023,Q4,Elderly
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,89,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,90,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Injury,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Fall,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Asthma,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Stress,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Rales,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Influenza,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,91,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Rhinorrhoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Chest discomfort,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Prolonged expiration,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Flank pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Productive cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Injury,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Nasal congestion,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Upper respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Fall,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Appetite disorder,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Insomnia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Chest pain,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Angina pectoris,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Wheezing,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Asthma,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Stress,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Sleep disorder due to a general medical condition,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Heart sounds,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Respiration abnormal,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Dyspnoea exertional,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Malaise,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Cough,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Pyrexia,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Rales,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Influenza,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Depressed mood,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233161901,23316190,92,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, QW",,,U,,,,,,,Solution,/WK,2023,Q4,Depressive symptom,,2023,Q4,1,I,,20231211.0,20231219,20231219,EXP,,CA-SANDOZ INC.-NVSC2021CA213425,SANDOZ,,61.0,YR,,F,Y,,,20231219,,HP,CA,CA,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Metabolic acidosis,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Hyperlactacidaemia,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Shock,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Distributive shock,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233194871,23319487,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,420 mg,,,U,,,,,,,,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20231207.0,20231220,20231220,EXP,,NL-SCIEGENP-2023SCLIT00797,SCIEGEN,"Jessica D. Workum, et.al..Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.Toxicology Reports.DEC-2023;11 (1):141-4",55.0,YR,A,F,Y,125.0,KG,20231220,,HP,NL,NL,2023,Q4,Adult
233214741,23321474,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Infected skin ulcer,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,CA-PFIZER INC-202300444326,PFIZER,,64.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
233214741,23321474,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,CA-PFIZER INC-202300444326,PFIZER,,64.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
233214741,23321474,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2023,Q4,Illness,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,CA-PFIZER INC-202300444326,PFIZER,,64.0,YR,,F,Y,,,20231220,,HP,CA,CA,2023,Q4,Adult
233218321,23321832,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5049384,20240331.0,99.0,5.0,IU,,999,2023,Q4,Nausea,,2023,Q4,1,I,20231219.0,20231220.0,20231220,20231220,DIR,685146,,FDA-CTU,,52.0,YR,,M,N,,,20231220,N,HP,US,,2023,Q4,Adult
233218321,23321832,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5049384,20240331.0,99.0,5.0,IU,,999,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231219.0,20231220.0,20231220,20231220,DIR,685146,,FDA-CTU,,52.0,YR,,M,N,,,20231220,N,HP,US,,2023,Q4,Adult
233218321,23321832,1,PS,CYANOCOBALAMIN\SEMAGLUTIDE,CYANOCOBALAMIN\SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,Y,N,LG5049384,20240331.0,99.0,5.0,IU,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20231219.0,20231220.0,20231220,20231220,DIR,685146,,FDA-CTU,,52.0,YR,,M,N,,,20231220,N,HP,US,,2023,Q4,Adult
233305941,23330594,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,/WK,2023,Q4,Joint lock,,2023,Q4,1,I,,20231212.0,20231222,20231222,EXP,GB-MHRA-ADR 28383013,GB-Accord-396736,ACCORD,,59.0,YR,,M,Y,92.0,KG,20231222,,HP,GB,GB,2023,Q4,Adult
233305941,23330594,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,/WK,2023,Q4,Arthralgia,,2023,Q4,1,I,,20231212.0,20231222,20231222,EXP,GB-MHRA-ADR 28383013,GB-Accord-396736,ACCORD,,59.0,YR,,M,Y,92.0,KG,20231222,,HP,GB,GB,2023,Q4,Adult
233313151,23331315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Menstrual clots,,2023,Q4,1,I,20231028.0,20231221.0,20231221,20231221,DIR,685399,,FDA-CTU,,24.0,YR,,F,N,58.5,KG,20231221,Y,CN,US,,2023,Q4,Young Adult
233313151,23331315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Oligomenorrhoea,,2023,Q4,1,I,20231028.0,20231221.0,20231221,20231221,DIR,685399,,FDA-CTU,,24.0,YR,,F,N,58.5,KG,20231221,Y,CN,US,,2023,Q4,Young Adult
233313151,23331315,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,99.0,,,,,2023,Q4,Therapy interrupted,,2023,Q4,1,I,20231028.0,20231221.0,20231221,20231221,DIR,685399,,FDA-CTU,,24.0,YR,,F,N,58.5,KG,20231221,Y,CN,US,,2023,Q4,Young Adult
233316061,23331606,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 milligram, q.wk.",,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Visual impairment,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 milligram, q.wk.",,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 milligram, q.wk.",,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 milligram, q.wk.",,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Myalgia,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 milligram, q.wk.",,,U,,,,,0.75,MG,Solution for injection,/WK,2023,Q4,Heart rate increased,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Myalgia,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233316061,23331606,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Heart rate increased,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018177,APOTEX,,46.0,YR,,F,Y,79.0,KG,20231222,,HP,CA,CA,2023,Q4,Adult
233317351,23331735,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 injection once per week subcutaneous,,,,,11212023CH@1,20240105.0,99.0,,,,999,2023,Q4,Fatigue,,2023,Q4,1,I,20231215.0,20231216.0,20231216,20231216,DIR,684799,,FDA-CTU,,42.0,YR,,F,N,112.5,KG,20231216,N,CN,US,,2023,Q4,Adult
233317351,23331735,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 injection once per week subcutaneous,,,,,11212023CH@1,20240105.0,99.0,,,,999,2023,Q4,Nausea,,2023,Q4,1,I,20231215.0,20231216.0,20231216,20231216,DIR,684799,,FDA-CTU,,42.0,YR,,F,N,112.5,KG,20231216,N,CN,US,,2023,Q4,Adult
233317351,23331735,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 injection once per week subcutaneous,,,,,11212023CH@1,20240105.0,99.0,,,,999,2023,Q4,Vomiting,,2023,Q4,1,I,20231215.0,20231216.0,20231216,20231216,DIR,684799,,FDA-CTU,,42.0,YR,,F,N,112.5,KG,20231216,N,CN,US,,2023,Q4,Adult
233317351,23331735,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 injection once per week subcutaneous,,,,,11212023CH@1,20240105.0,99.0,,,,999,2023,Q4,Headache,,2023,Q4,1,I,20231215.0,20231216.0,20231216,20231216,DIR,684799,,FDA-CTU,,42.0,YR,,F,N,112.5,KG,20231216,N,CN,US,,2023,Q4,Adult
233328901,23332890,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233328901,23332890,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, q.wk.",,,U,,,,,0.5,MG,Solution for injection,/WK,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233328901,23332890,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233328901,23332890,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233366331,23336633,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q4,Aspiration,,2023,Q4,1,I,,20231212.0,20231226,20231226,EXP,CA-HEALTHCANVIG-001066194,CA-NOVOPROD-1152976,NOVO NORDISK,,49.0,YR,,F,Y,172.0,KG,20231226,,MD,CA,CA,2023,Q4,Adult
233382221,23338222,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,99.0,,,,,2023,Q4,Depression,,2023,Q4,1,I,20231217.0,20231223.0,20231223,20231223,DIR,685571,,FDA-CTU,,43.0,YR,,F,N,68.4,KG,20231223,N,CN,US,,2023,Q4,Adult
233382221,23338222,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,99.0,,,,,2023,Q4,Obsessive thoughts,,2023,Q4,1,I,20231217.0,20231223.0,20231223,20231223,DIR,685571,,FDA-CTU,,43.0,YR,,F,N,68.4,KG,20231223,N,CN,US,,2023,Q4,Adult
233382221,23338222,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,99.0,,,,,2023,Q4,Impaired work ability,,2023,Q4,1,I,20231217.0,20231223.0,20231223,20231223,DIR,685571,,FDA-CTU,,43.0,YR,,F,N,68.4,KG,20231223,N,CN,US,,2023,Q4,Adult
233382221,23338222,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,99.0,,,,,2023,Q4,Fear,,2023,Q4,1,I,20231217.0,20231223.0,20231223,20231223,DIR,685571,,FDA-CTU,,43.0,YR,,F,N,68.4,KG,20231223,N,CN,US,,2023,Q4,Adult
233388361,23338836,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q4,Red blood cell count decreased,,2023,Q4,1,I,,20231212.0,20231226,20231226,EXP,CA-HEALTHCANVIG ?E2B_06677148,CA-NOVOPROD-1152771,NOVO NORDISK,,79.0,YR,,M,Y,,,20231226,,HP,CA,CA,2023,Q4,Elderly
233388361,23338836,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q4,Renal impairment,,2023,Q4,1,I,,20231212.0,20231226,20231226,EXP,CA-HEALTHCANVIG ?E2B_06677148,CA-NOVOPROD-1152771,NOVO NORDISK,,79.0,YR,,M,Y,,,20231226,,HP,CA,CA,2023,Q4,Elderly
233388361,23338836,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2023,Q4,Eye inflammation,,2023,Q4,1,I,,20231212.0,20231226,20231226,EXP,CA-HEALTHCANVIG ?E2B_06677148,CA-NOVOPROD-1152771,NOVO NORDISK,,79.0,YR,,M,Y,,,20231226,,HP,CA,CA,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Anxiety,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Feeling abnormal,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Headache,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Malaise,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Executive dysfunction,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233394841,23339484,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,OTHER QUANTITY : 2 bottles;?OTHER FREQUENCY : 1x per week;?,,,Y,D,246221,20240918.0,,,,,999,2023,Q4,Confusional state,,2023,Q4,1,I,20231014.0,20231226.0,20231226,20231226,DIR,685653,,FDA-CTU,,66.0,YR,,F,N,65.25,KG,20231226,N,CN,US,,2023,Q4,Elderly
233436361,23343636,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20231010.0,20231227.0,20231227,20231227,DIR,685773,,FDA-CTU,,71.0,YR,,F,N,121.5,KG,20231227,N,CN,US,,2023,Q4,Elderly
233436361,23343636,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,,,,,,2023,Q4,Depression,,2023,Q4,1,I,20231010.0,20231227.0,20231227,20231227,DIR,685773,,FDA-CTU,,71.0,YR,,F,N,121.5,KG,20231227,N,CN,US,,2023,Q4,Elderly
233436361,23343636,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,D,,,,,,,,2023,Q4,Apathy,,2023,Q4,1,I,20231010.0,20231227.0,20231227,20231227,DIR,685773,,FDA-CTU,,71.0,YR,,F,N,121.5,KG,20231227,N,CN,US,,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Blood loss anaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Intestinal ischaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastric ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Anastomotic ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Melaena,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastrointestinal pain,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Blood loss anaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Intestinal ischaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastric ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Anastomotic ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Melaena,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastrointestinal pain,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Blood loss anaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Intestinal ischaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastric ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Anastomotic ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Melaena,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastrointestinal pain,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Blood loss anaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Intestinal ischaemia,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastric ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Anastomotic ulcer,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Melaena,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233453351,23345335,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,Unknown,,,,,,,2023,Q4,Gastrointestinal pain,,2023,Q4,1,I,20210725.0,20231220.0,20231228,20231228,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-186871,BRISTOL MYERS SQUIBB,,75.0,YR,E,F,Y,78.0,KG,20231228,,HP,IT,IT,2023,Q4,Elderly
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cellulitis,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Right ventricular failure,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Chest pain,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Orthostatic hypotension,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233486621,23348662,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pulmonary arterial hypertension,,2023,Q4,1,I,20230929.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562746,ABBVIE,,59.0,YR,,M,Y,169.0,KG,20231229,,HP,GB,GB,2023,Q4,Adult
233487071,23348707,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypervolaemia,,2023,Q4,1,I,20231205.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562596,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487071,23348707,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lethargy,,2023,Q4,1,I,20231205.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562596,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487071,23348707,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract infection viral,,2023,Q4,1,I,20231205.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562596,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487071,23348707,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20231205.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562596,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487571,23348757,35,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Obesity,,2023,Q4,1,I,20221207.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562687,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487571,23348757,35,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pulmonary congestion,,2023,Q4,1,I,20221207.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562687,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487571,23348757,35,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Chest pain,,2023,Q4,1,I,20221207.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562687,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487571,23348757,35,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypoxia,,2023,Q4,1,I,20221207.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562687,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233487571,23348757,35,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypoventilation,,2023,Q4,1,I,20221207.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562687,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233488551,23348855,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Acute kidney injury,,2023,Q4,1,I,20230609.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562712,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233488551,23348855,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Chronic obstructive pulmonary disease,,2023,Q4,1,I,20230609.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562712,ABBVIE,,59.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233492931,23349293,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Hypervolaemia,,2023,Q4,1,I,20230330.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562656,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233492931,23349293,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,1,I,20230330.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562656,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233492931,23349293,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230330.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562656,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233492931,23349293,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Lower respiratory tract infection,,2023,Q4,1,I,20230330.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562656,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233492931,23349293,34,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,1,I,20230330.0,20231221.0,20231229,20231229,EXP,,GB-ABBVIE-5562656,ABBVIE,,58.0,YR,,M,Y,,,20231229,,HP,GB,GB,2023,Q4,Adult
233497121,23349712,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,,/WK,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233500421,23350042,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Influenza A virus test,,2023,Q4,1,I,,20231219.0,20231229,20231229,EXP,CA-MHPD-E2B_001068328,CA-Accord-397599,ACCORD,,49.0,YR,A,F,Y,98.0,KG,20231229,,HP,CA,CA,2023,Q4,Adult
233500421,23350042,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231219.0,20231229,20231229,EXP,CA-MHPD-E2B_001068328,CA-Accord-397599,ACCORD,,49.0,YR,A,F,Y,98.0,KG,20231229,,HP,CA,CA,2023,Q4,Adult
233514271,23351427,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,Y,,,,209637.0,,,,,2023,Q4,Atrial flutter,,2023,Q4,1,I,20231216.0,20231218.0,20231229,20231229,EXP,GB-MHRA-MED-202312161832129060-JRSHN,GB-NOVOPROD-1153856,NOVO NORDISK,,65.0,YR,,F,Y,114.0,KG,20231229,,MD,GB,GB,2023,Q4,Elderly
233522201,23352220,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Gastrointestinal infection,,2023,Q4,1,I,20231222.0,20231229.0,20231229,20231229,DIR,686048,,FDA-CTU,,77.0,YR,,M,N,146.25,KG,20231229,N,CN,US,,2023,Q4,Elderly
233522201,23352220,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Drug effect less than expected,,2023,Q4,1,I,20231222.0,20231229.0,20231229,20231229,DIR,686048,,FDA-CTU,,77.0,YR,,M,N,146.25,KG,20231229,N,CN,US,,2023,Q4,Elderly
233522201,23352220,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2023,Q4,Ileus paralytic,,2023,Q4,1,I,20231222.0,20231229.0,20231229,20231229,DIR,686048,,FDA-CTU,,77.0,YR,,M,N,146.25,KG,20231229,N,CN,US,,2023,Q4,Elderly
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Depression,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Panic attack,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573071,23357307,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,D,,,99.0,,,,,2023,Q4,Insomnia,,2023,Q4,1,I,20230909.0,20231230.0,20231230,20231230,DIR,686167,,FDA-CTU,,31.0,YR,,F,N,112.5,KG,20231230,Y,CN,US,,2023,Q4,Young Adult
233573081,23357308,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Panic attack,,2023,Q4,1,I,20231030.0,20231230.0,20231230,20231230,DIR,686169,,FDA-CTU,,42.0,YR,,F,N,74.25,KG,20231230,N,CN,US,,2023,Q4,Adult
233573081,23357308,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Suicidal ideation,,2023,Q4,1,I,20231030.0,20231230.0,20231230,20231230,DIR,686169,,FDA-CTU,,42.0,YR,,F,N,74.25,KG,20231230,N,CN,US,,2023,Q4,Adult
233573081,23357308,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,99.0,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,20231030.0,20231230.0,20231230,20231230,DIR,686169,,FDA-CTU,,42.0,YR,,F,N,74.25,KG,20231230,N,CN,US,,2023,Q4,Adult
